0001548123-14-000438.txt : 20141112 0001548123-14-000438.hdr.sgml : 20141111 20141112161522 ACCESSION NUMBER: 0001548123-14-000438 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141112 DATE AS OF CHANGE: 20141112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FLEXPOINT SENSOR SYSTEMS INC CENTRAL INDEX KEY: 0000925660 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 870620425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-24368 FILM NUMBER: 141214183 BUSINESS ADDRESS: STREET 1: 106 W. BUSINESS PARK DRIVE CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 8015685111 MAIL ADDRESS: STREET 1: 106 W. BUSINESS PARK DRIVE CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: MICROPOINT INC DATE OF NAME CHANGE: 19980424 FORMER COMPANY: FORMER CONFORMED NAME: NANOTECH CORP DATE OF NAME CHANGE: 19940620 10-Q 1 flxt10qq314v8.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2014 10QSB 1 flx06q3e



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


[X]

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For quarterly period ended September 30, 2014


[   ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


 For the transition period from _____ to _____


Commission file number: No. 0-24368


FLEXPOINT SENSOR SYSTEMS, INC.

(Exact name of registrant as specified in its charter)


Delaware

87-0620425

 (State of incorporation)

(I.R.S.  Employer Identification No.)

     

106 West Business Park Drive, Draper, Utah  84020

(Address of principal executive offices)


801-568-5111

(Registrant’s telephone number)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [X]   No [  ]


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes [ X ]   No [  ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.:


Large accelerated filer  [   ]  

Accelerated filer                    [   ]

Non-accelerated filer    [   ]

Smaller reporting company  [X]


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.

Yes [   ]     No [X]


The number of shares outstanding of the registrant’s common stock was 53,377,114 as of November 1, 2014.





1





TABLE OF CONTENTS


PART I: FINANCIAL INFORMATION


Item 1.  Financial Statements


              Condensed Consolidated Balance Sheets (Unaudited) at September 30, 2014 and

    December 31, 2013 (Audited)

3


              Condensed Consolidated Statements of Operations (Unaudited) for the Three and Nine    

  Months Ended September 30, 2014 and 2013

4

             

              Condensed Consolidated Statements of Cash Flows (Unaudited) for the

                Nine Months Ended September 30, 2014 and 2013

5


              Notes to Condensed Consolidated Financial Statements (Unaudited)

6


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

12


Item 3. Quantitative and Qualitative Disclosures about Market Risk

18


Item 4. Controls and Procedures  

18



PART II: OTHER INFORMATION


Item 1A.  Risk Factors

18


Item 6.  Exhibits

 21


Signatures

22







PART I - FINANCIAL INFORMATION


ITEM 1.  FINANCIAL STATEMENTS

The financial information set forth below with respect to our condensed consolidated financial position as of September 30, 2014, the condensed consolidated statements of operations for the three and nine months ended September 30, 2014 and 2013, and condensed consolidated statements of cash flows for the nine months ended September 30, 2014 and 2013 are unaudited. The information presented below for the condensed consolidated financial position as of December 31, 2013 was audited and reported as part of our annual filing of our Form 10-K, filed with Securities and Exchange Commission on April 15, 2014. In the opinion of management, the financial statements include all adjustments consisting of normal recurring entries necessary for the fair presentation of such data.  The results of operations for the three and nine months ended September 30, 2014 and 2013, respectively, are not necessarily indicative of results to be expected for any subsequent periods.



2






FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)



 

SEP 30, 2014

(Unaudited)

 

DEC 31, 2013

(Audited)

ASSETS

 

 

 

Current Assets

 

 

 

    Cash and cash equivalents

$         25,766

 

$           35,221

    Accounts receivable

71,989

 

6,425

    Notes Receivable

25,000

 

25,000

    Inventory

7,433

 

6,584

    Deposits and prepaid expenses

11,874

 

11,830

Total Current Assets

142,062

 

85,060

Long-Term Deposits

6,550

 

6,550

Property and Equipment, net of accumulated depreciation

 

 

 

     of $583,636 and $527,106

2,757

 

59,378

Patents and Proprietary Technology, net of accumulated

 

 

 

    amortization of  $665,755 and $587,496

304,459

 

373,489

Goodwill

4,896,917

 

4,896,917

Total Assets

$    5,352,745

 

$      5,421,394

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

Current Liabilities

 

 

 

    Accounts payable

$       218,180

 

$        212,142

    Accounts payable – related party

319

 

6,056

    Accrued liabilities

433,077

 

206,822

    Deferred revenue

-

 

10,000

    Convertible notes payable, net of discount of $58,942 and $4,653

826,058

 

520,347

    Convertible notes payable to related party

40,000

 

40,000

Total Current Liabilities

1,517,634

 

995,367

 

 

 

 

Stockholders' Equity

 

 

 

    Preferred stock – $0.001 par value; 1,000,000 shares authorized;

 

 

 

         no shares issued or outstanding

--

 

--

    Common stock – $0.001 par value; 100,000,000 shares authorized;

 

 

 

         53,377,114 shares and 53,377,114 shares issued and outstanding

53,377

 

53,377

    Additional paid-in capital

24,918,928

 

24,780,929

    Accumulated deficit

(21,137,194)

 

(20,408,279)

Total Stockholders' Equity

3,835,111

 

4,426,027

Total Liabilities and Stockholders' Equity

$     5,352,745

 

$     5,421,394







The accompanying notes are an integral part of these condensed consolidated financial statements



3





FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)




 

For the Three Months Ended September 30,

 

For the Nine Months

Ended September 30,

 

 

2014

 

2013

 

2014

 

2013

 

 

 

 

 

 

 

 

 

 

Engineering, Contract

 and Testing Revenue

$   124,464

$


  33,407

$

 221,117

$


  75,182

 

 

 

 

 

 

 

 

 

 

Operating Costs and Expenses

 

 

 

 

 

 

 

 

    Amortization of patents and

      proprietary technology

25,805

 


26,975

 

78,259

 


80,047

 

    Cost of revenue

4,381

 

6,182

 

7,940

 

14,352

 

    Administrative and marketing expense

165,313

 

167,576

 

515,155

 

511,040

 

    Research and development expense

78,056

 

71,121

 

216,746

 

176,309

 

Total Operating Costs and Expenses

273,555

 

271,854

 

818,100

 

781,748

 

 

 

 

 

 

 

 

 

 

Other Income (Expense)

    Interest expense

 (83,359)

 


(18,232)

 

(131,978)

 


(50,104)

 

    Interest income

16

 

--

 

46

 

37

 

    Gain on stock debt exchange

--

 

68,450

 

--

 

68,450

 

Net Other Expense

(83,343)

 

50,218

 

(131,932)

 

18,383

 

 

 

 

 

 

 

 

 

 

Net Loss

$ (232,434)

$

(188,229)

$

(728,915)

$

(688,183)

 

 

 

 

 

 

 

 

 

 

Basic and Diluted

Loss Per Common Share

$       (0.00)

$


(0.00)

 $

   (0.01)

$


(0.01)

 

 

 

 

 

 

 

 

 

 

Basic and Diluted Weighted-Average

 

 

 

 

 

 

 

 

Common Shares Outstanding

53,377,114

 

49,255,375

 

53,377,114

 

46,955,453

 

 

 

 

 

 

 

 

 

 



















 The accompanying notes are an integral part of these condensed consolidated financial statements




4





FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)




 

 

 

 

 

 

For the Nine Months

Ended September 30,

 

 

 

 

 

 

 

2014

 

2013

 

 

 

 

 

 

 Cash Flows from Operating Activities: 

 

 

 

 

    Net loss

$    (728,915)

 

$   (688,183)

 

    Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

        Depreciation

56,620

 

57,039

 

        Amortization of patents and proprietary technology

78,259

 

80,047

 

        Issuance of common stock and warrants for services

--

 

250,000

 

        Amortization of discount on note payable

83,711

 

10,223

 

        Gain on forgiveness of debt

--

 

(68,450)

 

   Changes in operating assets and liabilities:

 

 

 

 

        Accounts receivable

(65,564)

 

(4,224)

 

        Inventory

(849)

 

273

 

        Notes receivable

--

 

(25,000)

 

        Deposits and prepaid expenses

(43)

 

11,951

 

        Accounts payable

6,037

 

(34,328)

 

        Accounts payable – related parties

(5,737)

 

(5,160)

 

        Accrued liabilities

226,256

 

(14,637)

 

        Deferred revenue

(10,000)

 

10,000

 

 Net Cash Used in Operating Activities 

(360,225)

 

(420,449)

 

 

 

 

 

 

 Cash Flows from Investing Activities:

 

 

 

 

    Payments for patents

(9,230)

 

--

 

 Net Cash Used in Investing Activities 

(9,230)

 

--

 

 

 

 

 

 

 Cash Flows from Financing Activities:

 

 

 

 

    Proceeds from borrowings under convertible note payable

360,000

 

425,000

 

 Net Cash Provided by Financing Activities 

360,000

 

425,000

 

 

 

 

 

 

 Net Change in Cash and Cash Equivalents

(9,455)

 

4,551

 

Cash and Cash Equivalents at Beginning of Period

35,221

 

42,024

 

 Cash and Cash Equivalents at End of Period

25,766

 

46,575

 

 


Supplemental Cash Flow Information:

 

 

 

 

    Cash paid for income taxes

$               -- 

 

$                 -- 

 

    Cash paid for interest

                  -- 

 

                 -- 

 

Supplemental Disclosure on Noncash Investing and Financing Activities

 

 

 

 

    Recognition of discounts on convertible notes payable

(138,000)

 

(20,000)

 
















The accompanying notes are an integral part of these consolidated financial statements



5





FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Condensed Consolidated Interim Financial Statements – The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and  its subsidiaries (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. These statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2013 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on April 15, 2014. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2014.


Nature of Operations – The Company is located near Salt Lake City, in Draper, Utah and is engaged principally in designing, engineering, and manufacturing sensor technology products and equipment using Bend Sensors® flexible potentiometer technology. The Company had a loss of $728,915 and used cash in operating activities of $360,225 during the nine months ended September 30, 2014.  During the nine months ended September 30, 2013 the Company lost $688,183 and used cash in operating activities of $420,449. Through September 30, 2014, the Company had an accumulated deficit of $21,137,194. The Company has not earned any appreciable revenue during the period from February 24, 2004 (date of emergence from bankruptcy) through September 30, 2014. These matters raise doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.


From 2008 through 2012, the Company raised $2,926,391 in additional capital, including accrued interest, through the issuance of long and short-term notes to various entities, including related parties. All of the notes had an annual interest rate of 10% to 12% and were secured by the Company’s business equipment. The notes also had a conversion feature for restricted common shares ranging from $.07 to $.25 per share with maturity dates from March 31, 2008 to December 31, 2013. However, prior to December 31, 2012 all but $327,525 of  the convertible notes were converted to an aggregate of 13,210,663 shares of the Company's restricted common stock at an average share price of about $.17 per share. On December 31, 2013, the Company converted an additional 3,750,000 restricted common shares at $0.08 per share and retired $287,525 in debt plus all accrued interest


During the nine months ended September 30, 2014, the Company has raised an additional $360,000 in operating capital through the issuance of short-term notes to Capital Communication LLC.  The notes are secured by the Company’s business equipment and have a conversion feature for restricted common shares at prices ranging from $0.025 to $0.07 per share, with various maturity dates during the year.


Cash and Cash Equivalents – Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. The cash and equivalents of $25,766 at September 30, 2014 and $35,221 at December 31, 2013 represent cash on deposit in various bank accounts with a financial institution.   


Fair Value of Financial Instruments - The carrying amounts reported in the balance sheets for accounts receivable, accounts payable and accrued liabilities approximate fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates, which approximate current market rates.


Accounts Receivable – Trade accounts receivable are recorded at the time product is shipped or services are provided, including any shipping and handling fees. Due to the limited amount of transactions, collectability of the trade receivables is reasonably assured.  Therefore, the Company has not created an allowance for doubtful accounts. Most contracts associated with design and development engineering require a deposit of up to 50% of the





6





FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)



quoted price of the initial phase of such contracts prior to the commencement of work. As the Company completes each phase or milestone of such contracts, additional funding is normally required from the customer. These deposits are considered deferred income until each phase or milestone is completed and accepted by the customer, at which time the agreed upon price for that particular phase of the contract is billed to the customer and the deposit applied. As the Company’s revenues and customer base increase, an allowance policy will be established.


Inventories – Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method.  Inventories consist of raw materials.


Property and Equipment Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale, or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized.


Valuation of Long-lived Assets – The carrying values of the Company’s long-lived assets are reviewed for impairment quarterly and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. The Company’s analysis did not indicate any impairment of assets as of September 30, 2014.


Intangible Assets – Costs to obtain or develop patents are capitalized and amortized over the estimated life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the rights to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology rights, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The Company’s analysis did not indicate any impairment of intangible assets as of September 30, 2014.


Research and Development – Research and development costs are recognized as an expense during the period incurred until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.


Goodwill – Goodwill represents the excess of the Company’s reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in Accounting Standards Codification (“ACS”) 360, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Company’s targeted market conditions, as well as relevant entity-specific events, such as a change in the market for the Company’s products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 360, management has determined that the value of Company’s assets is not more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods.


Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer.  Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.




7





FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)


Stock-Based Compensation – Under ASC Topic 718, Stock Compensation, the Company is required to recognize the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest.  Prior to 2006, no compensation was

recorded in earnings for the Company’s stock-based options granted under the 2005 Stock Incentive Plan (the “Plan”).  Under ASC 718, all share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period.  On January 1, 2006, the

Company adopted the provisions of ASC 718, for its share-based compensations plans and began recognizing the unvested portion of employee compensation from stock options and awards equal to the unamortized grant-date fair value over the remaining vesting period.  Furthermore, compensation costs will also be recognized for any awards issued, modified, repurchased, or canceled after January 1, 2006.


Basic and Diluted Earnings per Share – Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period.  Diluted earnings per share is computed by dividing net earnings by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At September 30, 2014, there were outstanding options to purchase 2,024,000 shares of common stock and outstanding convertible notes payable with common share equivalents of 18,645,962. These options were not included in the computation of diluted earnings because the related exercise prices were greater than the average market price of the common shares and the common stock equivalents for convertible notes were excluded because their effect would have been anti-dilutive.


NOTE 2 STOCK OPTION PLANS


On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated.  This plan was approved by the stockholders of the Company on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Company’s trading common stock for the thirty-day period immediately preceding the grant date plus a premium of ten percent. The maximum aggregate number of shares that may be awarded under the Plan is 2,500,000 shares.


The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock. Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company’s common stock has limited trading history. The Company uses the simplified method to calculate the expected term. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company’s employee stock options.


During the nine month period ended September 30, 2014 the Company recognized $0.00 of stock-based compensation expense, compared to $0.00 during the same period in 2013. There were 2,024,000 employee stock options outstanding at September 30, 2014. A summary of all employee options outstanding and exercisable under the plan as of September 30, 2014, and changes during the nine months then ended is set forth below:


Options

Shares

Weighted

Average

 Exercise

 Price

Weighted Average Remaining Contractual  Life (Years)

Aggregate Intrinsic Value

 

 

 

 

 

Outstanding at the beginning of period

2,024,000

$           1.10

0.90

$    -

Granted

       -

       -

-

      -

Expired

      -

        -

-

      -

Forfeited

-

     -

-

      -

Outstanding at the end of Period

2,024,000

$           1.10

0.90

$    -

Exercisable at the end of Period

2,024,000

$           1.10

0.90

$    -



8







FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)


Based upon the current options issued as of September 30, 2014, there was no additional unrecognized compensation cost related to employee stock options that will be recognized.  


NOTE 3 INVENTORIES


At September 30, 2014, inventories are comprised entirely of raw materials used for making prototypes and limited production runs.  There was no work in progress or finished goods.


NOTE 4 – ISSUANCE OF STOCK


None during the period presented.


NOTE 5 – RELATED PARTY TRANSACTIONS


The Company has a related party payable to its President, CEO and Director for reimbursement of travel and other related expenses incurred on behalf of the Company. The amount due to the President as of September 30, 2014 and December 31, 2013 is $319 and $2,055, respectively.


NOTE 6 – NOTES PAYABLE


During the nine months ended September 30, 2014, the Company raised $360,000 in capital through the issuance of short-term notes to Capital Communications, Inc.  This is in addition to the $525,000 issued and outstanding as of December 31, 2013.  All of the notes have an annual interest rate of 10%, have various maturity dates during the year, and are secured by the Company’s business equipment.  The notes also have a conversion feature for restricted common shares, ranging from $.025 to $.07 per share.  In addition to two notes for $25,000 each issued in 2013 with discounts, and one of the notes issued on February 25, 2014 for $40,000, these notes have an exercise price which was less than the trading price of the stock on the date of issuance, resulting in a beneficial conversion feature valued at $10,000, resulting in a discount on the value of the note.  On June 20 and June 30, 2014, two notes of $20,000 each were issued with exercise prices less than the trading price of the stock on the date of issuance, resulting in a beneficial conversion feature valued at $4,000 each for a total of $8,000.  On July 23, August 15, September 3 and September 16, 2014, four notes totaling $120,000 were issued with exercise prices less than the trading price of the stock on the date of issuance, resulting in a beneficial conversion feature of $138,000.  The unamortized discount of all notes  as of September 30, 2014 was $58,942, resulting in $58,833 of unamortized discount recorded as part of the $83,711 in amortization of discount on notes payable during the nine month period.  The notes had various maturity dates but, prior to December 31, 2013, all of the outstanding and future convertible notes issued Capital Communications were extended to September 30, 2014 and $80,000 on the notes issued during this three month period have a maturity date of July 15, 2015.  Management anticipates further extending these notes with similar terms as they reach their exiting maturity dates.


On August 8, 2011, the Company issued a promissory note for $40,000 to an existing shareholder. The note has an annual interest rate of 10% and is secured by the Company's equipment. The principle amount of the note, and all

accrued interest is due and payable on or before July 31, 2012 and has a conversion feature for restricted common shares at $0.20 per share. Management anticipates extending this note to December 31, 2014 under similar terms.


NOTE 7 - LITIGATION


R&D Products, LLC - On June 23, 2010, the Company, along with David B. Beck, the Company's Director of Engineering, filed a complaint against R&D Products, LLC, Persimmon Investments, Inc. and Jules A. deGreef, the

managing member of R&D Products, LLC. The complaint alleged that all of the intellectual properties owned by R&D Products and Mr. deGreef, specifically patented applications using Bend Sensor® technology that were filed

jointly by Mr. Beck and Mr. deGreef, and later assigned solely to Mr. deGreef and R&D Products, are the property of the Company. The assignment by Mr. Beck of his rights in the patents and intellectual properties were improperly



9





FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)


given and are the property of the Company. The Company believed that since Mr. Beck was an employee of the Company during the time that he became the primary creative force and inventor of the Bend Sensor® applications for R&D Products and Mr. deGreef, and the inventions and applications were created using Flexpoint resources, the Company claimed that such intellectual properties, patents, etc. filed by deGreef, Persimmon and R&D belong to Flexpoint and therefore is sought financial damages and ownership of all intellectual rights, patents and inventions created by Mr. Beck for deGreef, Persimmon and R&D Products.  


On April 9, 2013, the parties of the above referenced litigation reached a favorable universal settlement agreement that reinforces the Company's rights to the intellectual properties and their related products, including the medical bed. In order to secure the Company had exclusive rights to all patents and intellectual properties associated with this litigation the Company advanced to Mr. deGreef $25,000 to bring current all of the filing and maintenance fees for the patents detailed in the law suit. The advance is secured by a promissory note with an annual interest rate of 10% to be paid no later than December 31, 2015.


NOTE 8 - COMMITMENTS AND CONTINGENCIES


On the same date, as part of the settlement agreement (see Note 7 - Litigation), the Company entered into an exclusive licensing agreement that granted the Company the sole and exclusive rights to all products, devices, and commercial applications of any type or nature that relate to or are derived from the patents and application for patents controlled by Mr. deGreef and his companies. As additional compensation for the settlement, the Company also received a note in the amount of $360,000 from the deGreef companies to be paid with accrued interest no later than April 8, 2015 through future royalties generated from the exclusive rights to technology specifically identified in the settlement and licensing agreements. The note has an annual interest rate of 5% and is secured by the intellectual properties of Mr. deGreef and his companies, including patents issued and those currently under application and any and all devices derived from such.


At the time of this filing the Company does not have orders for products or devices; contracts for, or contracts that are currently being negotiated; or any type of existing or negotiated royalty agreement that uses the patents or technology identified in the settlement and licensing agreement. Also, because the source of repayment of the $360,000 note receivable is from future royalty income from the sales of product, devices or uses of the technology, therefore at this time as stipulated in Accounting Standards Codification ("ACS") 450 the Company is not permitted to recognize a contingent asset.  At such time as royalty income can be reasonably estimated and is "virtually certain", the Company will recognize the note receivable.   


NOTE 9 – NEW ACCOUNTING PRONOUNCEMENTS


In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40) whereby an entity’s management, in connection with preparing financial statements for each annual and interim reporting period, should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date the financial statements are issued. Management’s evaluation is to be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued.  If conditions or events raise substantial doubt about the entity’s ability to continue as a going concern the entity should disclose information that enables users of the financial statements to understand management’s evaluation of the significance of the conditions or events and of management’s plans to mitigate the conditions or events.  


The standard is effective for annual periods ending after December 15, 2016, and interim periods therein. Early adoption of this amendment is allowed.  We are currently evaluating the date at which we will adopt this standard.  


In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-10, which eliminated certain financial reporting requirements of companies previously identified as “Development Stage Entities” (Topic 915).  The amendments in this ASU simplify accounting guidance by



10






FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)


removing all incremental financial reporting requirements for development stage entities.  The amendments also reduce data maintenance and, for those entities subject to audit, audit costs by eliminating the requirement for development stage entities to present inception-to-date information in the statements of income, cash flows, and shareholder equity.  Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued (public business entities) or made available for issuance (other entities).  Upon adoption, entities will no longer present or disclose any information required by Topic 915.  The Company has adopted this standard and will not report inception to date financial information.


In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (ASU 2014-09), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP.  The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services.  ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP.


The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods:  (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures).  We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard in 2017.


NOTE 10 – SUBSEQUENT EVENTS


In October 2014 the Company received an additional $40,000 for which a convertible note has been issued.  The note bears interest at the rate of 10% per annum and has a maturity date of July 15, 2015.










11





 In this quarterly report references to “Flexpoint", "the Company," “we,” “us,” and “our” refer to Flexpoint Sensor Systems, Inc. and its subsidiaries.


FORWARD LOOKING STATEMENTS


The U.S. Securities and Exchange Commission (“SEC”) encourages reporting companies to disclose forward-looking information so that investors can better understand future prospects and make informed investment decisions.  This report contains these types of statements. Words such as “may,” “expect,” “believe,” “anticipate,” “estimate,” “project,” or “continue” or comparable terminology used in connection with any discussion of future operating results or financial performance identify forward-looking statements.  You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report.  All forward-looking statements reflect our present expectation of future events and are subject to a number of important factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.



ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


EXECUTIVE OVERVIEW


Flexpoint Sensor Systems, Inc. is principally engaged in designing, engineering and manufacturing bend sensor technology and devices that use its patented Bend Sensor® technology, (a flexible potentiometer technology). For the past four years, we have been making improvements to our technology and proving the versatility and durability of the Bend Sensor® by manufacturing Bend Sensor® devices and related products and introducing these to a variety of industries. We currently own six patents and through our research and development, efforts are in the process of filing for more that include fully integrated products being sold and supplied to our limited customer base. We have also jointly developing additional commercially viable products, including a universal sensor that will be used in the automotive, medical and industrial industries.

Over the next six to nine months we will concentrate our marketing efforts and limited financial resources on current projects that we believe can be brought to market in the shortest period of time. We anticipate having additional products featuring our patented Bend Sensor® technology on the market over the next 8 to 12 months including products in the medical, sport shoe, residential home care and industrial control industries.

Over the past year we have been enhancing our relationships with various automotive Tier 1 suppliers as they have continued testing and proving our patented horn and seat switch reliability. Previously we announced that our steering wheel horn pad received implementation ready status for a U.S. Fortune 100 automaker that has also identified up to four vehicle platforms being considered for the Company’s longer lasting and more cost effective horn switch.  The horn system has recently successfully completed in-vehicle testing which requires that the system be installed in a vehicle and driven for 150,000 miles without failure.  


We continue to develop new types of products for our Bend Sensor® technologies and continue to receive small repeat production orders from existing customers. We have made improvements on our initial prototype for a Home Monitoring Presence Detection System using our Bend Sensor® technologies and have received development and design orders from various industries.  In addition to the horn switch, we have continued to work with market makers and Tier I automotive suppliers in the U.S and Europe on numerous other applications for our sensors and devises. Based upon our discussions within the automotive industry in the U.S. and Europe our unique sensor systems meet the requirements for manufacturers to have lighter weight, more fuel efficient cars.  Our Bend Sensor® is lighter in weight, has fewer moving parts than conventional sensing devices, is more versatile and, due to its unique design is more cost effective. Product and design changes in the automotive industry are slow, averaging two to three years before actually being incorporated into a commercially viable automotive platform. Because of our recent work with several Tier 1 suppliers, we have shown the Bend Sensor® to be viable as the next generation of sensing devises to the industry. Due to the advanced technology of the Bend Sensor® and its versatility of applications, we anticipate being a part of the changes taking place in the automotive, energy and technological industries.


During the past nine months, we completed the electronics and software that will be used in a running shoe and other sports related products. The completion of these components opens the way for Bend Tech and Flexpoint to aggressively market to major shoe manufactures. It also is a critical piece of the golf training aid that Bend Tech will



12





market. Beyond its sport and recreational value, golf is a major industry that generates jobs, commerce, economic development and tax revenues for communities throughout the country. The total size of the golf economy nationally was estimated at $68.8 billion in 2011, up from $62 billion in 2000 (from http://www.wearegolf.org).  


As part of the golf training project the Company entered into a development agreement with Bend Tech, LLC to manufacture working prototypes of a golf shoe and golf shaft that will utilize a series of Bend Sensors® in a high tech training aid for golf. Flexpoint was paid upon completion of various milestones during the development process.  The agreement provided an added source of income for the Company during the second quarter of the year. In July the Company and Bend Tech announced that all work under the development agreement has been successfully completed and that they were working on finalizing a manufacturing agreement.  


We successfully completed PhaseTwo of the disposable directional colonoscope for Haemoband Surgical, Ltd, a Northern Ireland based company that specializes in unique medical devices. We have made a partial delivery of the products required by  Phase Three and expect to complete the delivery of all products for Phase Three by the end of November.  Under the terms of the agreement we will receive a milestone payment upon completion of delivery for Phase Three.   We will then proceed through Phase Four and Phase Five, the final phases that will bring the project to completion and commercialization.  With the successful completion of Phase Two management believes the Company moves closer to an agreement for a long-term contract with Haemoband.  The estimated volumes quoted for this device are between 500,000 to 1 million sensors annually. The application will use a sensor that is an adaptation of a sensor that we already have commercially available; therefore, the cost associated with the development of this medical application has been marginal. It is estimated that the annual demand for colonoscopy procedures ranges from 2.21 to 7.96 million in the United States and as the overall population continues to age more procedures will be required. One of the difficulties with the procedure is providing an inexpensive means of locating the exact position of the colonoscopes. With the use of our sensor array and monitoring equipment, the initial testing has shown that with the Bend Sensor® technology it is possible to locate the positioning of the colonoscopes. It is anticipated that completion and commercialization of this product will open up significant other markets for additional products that uses similar equipment for other unrelated products in the medical industry.


The Company continues working with HTK Engineering, LLC and Vista Brake who are currently marketing their safety mechanisms specifically designed for garbage trucks and other large commercial and emergency vehicles. Most commercial vehicles have an "air braking system" which can lose pressure and disengage the brakes while the vehicle is still running. Our Bend Sensor® technology is the key component of the HTK and Vista's systems, which provide a backup braking system preventing the vehicle from inadvertently rolling into people, buildings or other vehicles. Part of the marketing effort has been to involve insurance companies who have paid claims related to the initial brake failure. Because our jointly designed systems are easily installed and adaptable to most vehicles insurance companies have indicated they would provide a reduction in premiums should their customers install the one of these systems. There are over 179,000 garbage and recycling trucks in use in the United States. and HTK is also pursuing opportunities for the system throughout Europe and Asia.


We continue to receive development orders from Intertek Industrial Corp. for their ProTek System. The ProTek System is an automotive seat-monitoring device integrated into emergency response vehicles.  This monitoring device places the Company’s Bend Sensors® in each rear passenger seat with a monitor viewable to the vehicle’s driver.  The foolproof system informs the driver if the emergency medical technicians are seated and properly secured prior to departure and while the vehicle is in motion. The system is installed in the seats of the rear compartments of the emergency vehicle and provides the driver with constant feedback as to the “seated and secured” status of passengers and personnel in the rear of the vehicle. The system is currently installed in ambulances and is being tested for use in other types of emergency vehicles. Through its relationship with Intertek the Company has further validated its technology in the automotive and safety industries and is currently working with other companies on similar systems for buses, cabs and heavy equipment operators to ensure the safety of the their passengers and drivers. A national surge in ambulance accidents has called for increased safety standards for emergency vehicles. Due to the rise in injuries and fatalities that result from these accidents, the National Fire Protection Association (NFPA) has taken on the task of rewriting the ambulance standard. As a result there is currently national legislation proposed that could take effect by the end of 2014. The proposed legislation will require a safety system similar to Intertek's ProTek System, which will give Intertek a significant competitive advantage being first to market with an already proven system that will meet the legislative requirements.


Using our Bend Sensor® technology the Company has developed a patented medical bed and with the settlement with R&D Products and Mr. deGreef we are now able to openly market this unique bed. Because of the Bend



13





Sensor’s® predictability the accompanying electronics of the bed are able to determine the position of the person in the bed and how they are moved. The bed has the ability to roll a patient left or right to relieve pressure areas that can cause bed sores or other life threatening complications for patients that are bed ridden as well as facilitate dressing changes. Needed adjustments can be programmed into the bed to relieve pressure areas to meet the required standards for patient care and comfort. We anticipate that progress on this application  will follow completion of the running shoe application.  Our Bend Sensor® technology has many other medical applications that the Company is pursuing.


The Company anticipates marketing a similar bed as part of an in-home specialty mattress. The specialty (non-innerspring) segment of the bedding market has been growing rapidly over the past six to seven years. With the increasing demand of specialty mattresses, almost every commercial mattress company has a specialty bed they promote. The Company has had some discussions with mattress companies who have expressed interest in the concept. Mr. deGreef has been intimately involved with the medical mattress and other products that have been placed on hold during the lawsuit, and has successfully marketed these products in prior years. Mr. deGreef is currently in discussions with additional interested clients.   


Although, so far the volumes for our applications and devises have been relatively small we continue to receive follow up orders for the universal sensor that we jointly developed last year. We expect to receive additional orders from other customers for this sensor as it becomes more recognizable in the market. Currently our customers for this type of sensor include companies in the following industries: automobiles, trucking, emergency vehicles, public transportation, military and other governmental entities. As anticipated, the Company is beginning to see the potential for more significant volumes and revenues from the sale of this sensing devise over the next year and beyond.


Finalizing additional long-term revenue generating production contracts with other customers remains our greatest challenge because our on-going business is dependent on the types of revenues and cash flows generated by such contracts. Cash flow and cash requirement risks are closely tied to, and are dependent upon, our ability to attract significant long-term production contracts.  In the short term, we must continue to obtain funding to operate and expand our operations so that we can deliver our unique Bend Sensor® and Bend Sensor® related technologies and products to the market.  Management believes that even though we have made positive strides forward with our business plan, it is likely that significant progress may not occur for the next three to six months, primarily due to the time it takes for negotiating such contracts.  Accordingly, we cannot guarantee that we will realize significant revenues or that we will become profitable over the next six to nine months.


Management believes with the signing of the development agreement with Bend Tech and receiving the exclusive rights to a group of products that have proven in the past to generate revenue streams, and the recent orders received for its automotive and industrial control devises, the Company is on the threshold of growing its customer base that should help in producing long-term production contracts that will be sustainable in the near future.


On April 9, 2013, we settled all disputes with R&D Products and their related parties. The settlement agreement gives the Company exclusive rights to over four additional patents, patent applications and related products that we anticipate opening or expanding our customer base. With the settlement of the litigation with R&D Products and Mr. deGreef, see below, we have begun marketing efforts on projects that had been on hold since the litigation started. These products had already received market acceptance prior to the litigation and will greatly enhance our product offerings and improve our revenue opportunities.


Our patented technology continues to gain recognition in various markets and industries as evidenced by the recent receipt of an initial production order from CPS Color Equipment S.p.A Italy and orders from a Fortune 100 automotive maker for our horn system.  In October 2013, our horn system was installed in a limited number of vehicles to complete their “in-vehicle-testing” process that is required prior to moving forward with incorporating our system into various platforms of automobiles and trucks.


LIQUIDITY AND CAPITAL RESOURCES


Our revenue is primarily from design, contract, testing and limited production services and is not to a level to support our operations.  Management anticipates that we may not realize significant revenue within the next three to nine months.




14





Over the past nine months, the Company has issued $360,000 in convertible promissory notes with conversion features ranging from $.07 to $.025 with an annual interest rate of 10%. The loans are secured by the Company's business assets, with various maturity dates.  The Company previously negotiated extensions for all of the notes to September 30, 2014.  The proceeds of these notes were used to fund operations, including the various development projects currently underway.  


Management believes that our current cash burn rate is approximately $50,000 per month and the proceeds from the convertible notes and our engineering and design fees will not totally fund our anticipated growth in operations. We will therefore need to raise additional financing. We believe that this additional financing will provide the needed capital to extend operations to the development and production of our growing product offerings and growing manufacturing opportunities. However, we may not be able to obtain financing, or the sources of financing, if any, may not continue to be available, and if available, they may be on terms unfavorable to us.


As we enter into production and development agreements, we must ensure that those agreements provide adequate funding for any pre-production research and manufacturing costs. As we are successful in establishing agreements with adequate initial funding, management believes that our operations for the long term will be funded by revenues, licensing fees and/or  royalties related to these agreements. However, other than the recent development  agreement with Bend Tech that we believe will provide future revenues, we have not formalized any additional agreements during the past year and there can be no assurance that the agreements we currently have will come to fruition in the near future or that a desired technological application can be brought to market on a commercially viable basis.


FINANCIAL OBLIGATIONS AND CONTINGENT LIABILITIES


Our principal commitments at September 30, 2014 consisted of our operating lease of $8,950 per month, and total liabilities of $1,517,634, which includes $826,058 of convertible notes payable, net of discounts. Under the terms of our operating lease, the average monthly payments are $8,950, including common area maintenance through December 31, 2014. The total future minimum payments under this lease as of September 30, 2014 are $26,850.


During 2013 and for the nine months ended September 30, 2014, the Company has issued convertible promissory notes in the aggregate of $826,058, net of discounts, at 10% interest and are secured by the Company’s equipment. With the negotiated extension, notes are due and payable on dates ranging on or before September 30, 2014  through July 15, 2015. (See Note 6 to the financial statements). Management anticipates extending the maturity date of the notes with the same terms.


As of September 30, 2014, we had accounts payable of $218,180 related to normal operating expenses, including health insurance, utilities, production supplies, travel expense, and expenses for professional fees, and $319 related party accounts payable for other operating expenses.


Accrued liabilities at September 30, 2014, were $433,077 and were related to payroll, payroll tax liabilities, accrued professional expenses, accrued insurance expense, accrued interest expense on notes and accrued paid time off.  


In the three months ended September 30, 2014 the Company issued convertible  promissory notes for $120,000.  The notes have an annual interest rate of 10% and are secured by the Company’s equipment.  The principal amount of the notes and all accrued interest is due and payable on maturity dates ranging from September 30, 2014 to July 15, 2015. (See Note 6 to the financial statements).


OFF-BALANCE SHEET ARRANGEMENTS


Other than our current operating lease we have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.


CRITICAL ACCOUNTING ESTIMATES


The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates of particular significance in our financial statements include goodwill and the annual tests for impairment of goodwill and long-lived assets and valuing stock option compensation.  



15






The Company's goodwill represents the excess of its reorganization value over the fair value of the net assets upon emergence from bankruptcy. Goodwill is not amortized, therefore we test our goodwill for impairment annually or when a triggering event occur using a fair value approach. A fair value based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its nets assets. The test requires various judgments and estimates. During 2013 and for the nine months ended September 30, 2014, the Company recorded no impairment charge to reduce the carrying value of the goodwill to its estimated fair value. As part of the impairment testing, the Company considered factors such as the global market volatility, variables in the economy, and the overall uncertainty in the markets that has resulted in a decline in the market price of the Company's stock price and market capitalization for a sustained period, as indicators for potential goodwill impairment. Based upon our analysis for the impairment test for the nine months ended September 30, 2014 compared the carrying value of the Company's net assets to the estimated fair value of the overall Company, and the present values of projected net cash flows of the Company over the next three years, no additional impairment was recognized during the nine months ended September 30, 2014.


We test long-lived assets for impairment quarterly or when a triggering event occurs. Impairment is indicated if undiscounted cash flows are less than the carrying value of the assets. The amount of impairment is measured using a discounted-cash-flows model considering future revenues, operating costs and risk-adjusted discount rate and other factors. The analysis compares the present value of projected net cash flows for the remaining current year and next two years against the carrying value of the long-lived assets. If the carrying values of the long lives assets exceed the present value of the discounted projected revenues an impairment expense would be recognized in the period and the carrying value of the assets would be adjusted accordingly. Under similar analysis no impairment charge was taken during the nine month period ended September 30, 2014. Impairment tests will be conducted on a quarterly basis and, should they indicate a carrying value in excess of fair value, additional charges may be required.


Financial accounting standards require that recognition of the cost of employee services received in exchange for stock options and awards of equity instruments be based on the grant-date fair value of such options and awards and is recognized as an expense in operations over the period they vest. The fair value of the options we have granted  is estimated at the date of grant using the Black-Scholes American option-pricing model. Option pricing models require the input of highly sensitive assumptions, including expected stock volatility. In addition, our stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimate.  Management believes the best input assumptions available were used to value the options and that the resulting option values are reasonable. For the nine month periods ended September 30, 2014 and 2013, we recognized $0.00 and $0.00, respectively, of stock-based compensation expense for our stock options and there is no additional unrecognized compensation cost related to employee stock options at the current time.


RESULTS OF OPERATIONS


The following discussions are based on the consolidated operations of Flexpoint Sensor Systems, Inc. and its subsidiaries and should be read in conjunction with our unaudited financial statements for the three and nine months ended September 30, 2014 and 2013, included in Part I, Item 1, above, and the audited financial statements included in the Company’s annual report on Form 10-K for the years ended December 31, 2013 and 2012.  


 

Three month period ended

September 30,

 

Nine month period ended

September 30,

 

 

2014

 

2013

 

2014

 

2013

 

 

 

 

 

 

 

 

 

 

Engineering, contract and testing revenue

$ 124,464

 

$   33,407

 

$    221,117

 

$       75,182

 

 

 

 

 

 

 

 

 

 

Total operating costs and expenses

   273,555

 

   271,854

 

818,100

 

781,748

 

 

 

 

 

 

 

 

 

 

Net other income (expense)

   (83,343)

        

  50,218

 

(131,932)

 

18,383

 

 

 

 

 

 

 

 

 

 

Net loss

(232,434)

 

      (188,229)

 

(728,915)

 

(688,183)

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss per common share

$     (0.00)

 

$        (0.00)

 

$        (0.01)

 

$      (0.01)

 



16









Revenue for the three and nine months ending September 30, 2014 and 2013 was from design contract, development engineering and limited production. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contract are met and then the sale is recognized as licensing royalty revenue over the remaining term of the contract. Revenue from the sale of a product is recorded at the time of shipment to the customer.  


For the three and nine months ending September 30, 2014 revenue increased by $91,057 and $145,935, respectively, when compared to the same interim periods in 2013. The increase in revenue was primarily due to the Company entering into a development agreement with Bend Tech and the work with Haemoband Surgical, LTC. The Company continues to execute on its business plan by concentrating its marketing resources on a limited number of customers that have the greatest potential to generate the most short-run revenue while still building relationships with our larger customers. Management believes this approach has the highest potential to bring long-term commercially viable products to market during the remainder of 2014 and beyond, and will provide sustainable cash flow to fund the Company's operations in the future. Currently, overall revenues are not sufficient to sustain our operations, but have steadily increased over the past two years and management anticipates that revenues will continue to increase as we continue to execute our long-term business plan and cultivate larger customer base with our existing product offering. However until a long-term production contract is in place there is no guarantee that our current customer base will order in sufficient volumes to sustain our operations. Therefore, management continues to work with larger companies and industries and is hopeful that in the near future we will sign a long-term licensing or manufacturing contract.


Of the $273,555 and $271,854 total operating costs and expense for the three months ending September 30, 2014 and 2013, respectively, $78,056 and $71,121 were for direct research and development cost, respectively. For the three months ended September 30, 2014, total operating expenses increased by $1,701 when compared to the same period in 2013, the majority of the increase related to increased research and development expenses.


Total operating expense increased by $36,352 for the nine months ended September 30, 2014 when compared to the same period in 2013. Of the $818,100 and $781,748 total operating costs and expenses for the nine months ending September 30, 2014 and 2013, respectively, $216,746 and $176,309 were for direct research and development cost, respectively. The increase in operating expense for the 2014 interim periods was primarily due to increases in research and development costs required to move the projects under development agreements toward commercialization.   


The chart below represents a summary of our condensed consolidated balance sheets at September 30, 2014 and December 31, 2013.


 

 

September 30, 2014

 

December 31, 2013

 

 

 

 

 

 

Cash and cash equivalents

 

 

$          25,766

 

$            35,221

Total current assets

 

 

 

142,062

 

85,060

Total assets

 

 

 

       5,352,745

 

       5,421,394

Total liabilities

1,517,634

 

995,367

Deficit accumulated during the development stage

(21,137,194)

 

(20,408,027)

Total stockholders' equity

 

 

$      3,835,111

 

 $      4,426,027



Cash and cash equivalents decreased by $9,455 at September 30, 2014 compared to December 31, 2013. The decrease in cash is due to the timing of payment of expenses and collection of accounts receivable. Our non-current assets decreased at September 30, 2014 due to the depreciation and amortization of long-lived assets. These assets include property and equipment valued at $2,757, net of depreciation; patents and proprietary technology of $304,459, net of amortization; goodwill of $639,950 and long-term deposits of $6,550 associated with the facility operating lease.   


Total liabilities increased by $522,267 at September 30, 2014; the increase was primarily due to the increase in convertible notes payable of $305,711, net of discount.  The Company used the proceeds from the notes to fund



17





operations. Accrued liabilities and accounts payable increased by $232,293 during the period for investor relations and insurance related expenses.



INFLATION


We do not expect the impact of inflation on our operations to be significant for the next twelve months.



ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


Not applicable to smaller reporting companies.



ITEM 4.  CONTROLS AND PROCEDURES


(a)

Disclosure Controls and Procedures


As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer, who also serves as our Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Our Chief Executive Officer evaluated whether information required to be disclosed is recorded, processed, summarized and reported within the specified periods, and is accumulated and communicated to management, including our Chief Executive Officer, to allow for timely decisions regarding required disclosure of material information required to be included in our periodic Securities and Exchange Commission reports. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives and our Chief Executive Officer has concluded that our disclosure controls and procedures are effective at that reasonable assurance level as the end of the period covered by this report based upon our current level of transactions and staff.


However, it should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.  


(b)

Changes in Internal Control over Financial Reporting


Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Management reviewed our internal controls over financial reporting, and there have been no changes in our internal controls over financial reporting for the quarter ended September 30, 2014 that have materially affected, or are likely to affect, our internal controls over financial reporting.



PART II - OTHER INFORMATION


ITEM 1A.  RISK FACTORS


We have a history of losses and may never become profitable.


We are unable to fund our day-to-day operations from revenues and the lack of revenues for continued growth may cause us to delay our business development.  For the nine months ending September 30, 2014, we had negative cash flows from operating activities of $360,225.  We will require additional financing to fund our short-term cash needs and we may be required to rely on debt financing, loans from related parties, and private placements of our common stock for that additional funding. Such funding sources may not be available or the terms of such funding sources may not be acceptable to the company. If the Company is unable to find such funding it could have a material adverse effect on our ability to continue as a going concern.


We may not have adequate resources to successfully manage anticipated growth.




18





We may not be equipped to successfully manage any possible future periods of rapid growth or expansion, which could be expected to place a significant strain on our managerial, operating, financial and other resources.  Our future performance will depend, in part, on our ability to manage growth effectively, which will require us to:


·

improve existing, and implement new, financial controls and systems, management information systems, operating, administrative, financial and accounting systems and controls,

·

maintain close coordination between engineering, programming, accounting, finance, marketing, sales and operations, and

·

attract and retain additional qualified technical and marketing personnel.


There is intense competition for management, technical and marketing personnel in our business.  The loss of the services of any of our key employees or our failure to attract and retain additional key employees could have a material adverse effect on our ability to continue as a going concern.


We may not have adequate manufacturing capacity to meet anticipated manufacturing contracts.


We have completed installation of our first manufacturing line; however, our agreement with a third party manufacturer will allow us to delay installation and approval of a second production line. The second manufacturing line will be needed as a result of anticipated increased manufacturing demand and improved manufacturing efficiencies. We anticipate qualifying our manufacturing facility for ISO/TS-16949 certification as the Company successfully obtains additional manufacturing contracts during the coming year. However, we cannot assure you that we will satisfy ISO/TS-16949 qualification or that the production lines will produce product in the volumes required or that the production lines will satisfy the requirements of our automotive customers.


Our success is dependent on our intellectual property rights, which are difficult to protect.


Our future success depends on our ability to protect our intellectual property. We use a combination of patents and other intellectual property arrangements to protect our intellectual property. There can be no assurance that the protection provided by our patents will be broad enough to prevent competitors from introducing similar products or that our patents, if challenged, will be upheld by courts of any jurisdiction. Patent infringement litigation, to either enforce patents or defend ourselves from infringement suits, will be expensive and could divert our resources from other planned uses. Patent applications filed in foreign countries and patents in these countries are subject to laws and procedures that differ from those in the U.S. and may not be as favorable to us. We also attempt to protect our confidential information through the use of confidentiality agreements and by limiting access to our facilities. There can be no assurance that our program of patents, confidentiality agreements and restricted access to our facilities will be sufficient to protect our confidential information and intellectual properties from our competitors.


Research and development may result in problems which may become insurmountable to full implementation of production.


Customers request that we create prototypes and perform pre-production research and development. As a result, we are exposed to the risk that we may find problems in our designs that are insurmountable to fulfill production.  In that event, we would be unable to recover the costs of the pre-production research and development. However, we are currently unaware of any insurmountable problems with ongoing research and development that may prevent further development of an application.


Economic uncertainties will delay or eliminate new technological investments.


Due to the current downturn in the global economy and financial uncertainties, automakers and other potential customers could delay, significantly curtail or altogether eliminate any further investment in new technology including, the Bend Sensor® technology, until the global financial markets and economies stabilize. Due to our limited cash resources, any delays in bringing our products and technology to market could have a material adverse effect on our ability to continue as a going concern.


Because we are significantly smaller than the majority of our competitors, we may lack the financial resources needed to capture increased market share.


The market for sensor devices is extremely competitive, and we expect that competition will intensify in the future. There can be no assurance that we will be able to compete successfully against current or future competitors or that



19





competitive pressures we face will not materially adversely affect our business, operating results or financial condition. Our primary competitors in the air bag market are International Electronics and Engineering, Siemens, Robert Bosch GmbH, Denso, Inc., Breed Technologies, TRW Automotive, Delphi Corporation, Autoliv Inc., Takata and Temic. We believe that none of our competitors has a product that is superior to our Bend Sensor® technology at this time. However, many of our competitors and potential competitors have substantially greater financial, technical and marketing resources, larger customer bases, longer operating histories, greater name recognition and more established relationships than we do. These competitors may be able to undertake more extensive marketing campaigns, adopt more aggressive pricing policies and devote substantially more resources to developing new products and markets than we can.


Ongoing industry consolidation among worldwide automotive parts suppliers and financial difficulties of U.S. automakers may limit the market potential for our products.


In the automotive parts industry, there is a trend of consolidation through business combinations and acquisitions of complementary technologies among worldwide suppliers as these suppliers seek to build stronger customer relationships with automobile manufacturers. Automobile manufacturers look to Tier 1 suppliers (major suppliers) to provide fully engineered systems and pre-assembled combinations of components rather than individual components. This trend of consolidation of suppliers may result in fewer Tier 1 suppliers and thus limit the marketing opportunities for our Bend Sensor® technology.  In addition, U.S. automakers have closed plants, reduced their work force and some are emerging from bankruptcy. In addition, some Tier 1 suppliers are in bankruptcy or in financial difficulty. These industry trends may limit the market for our products.






20





ITEM 6. EXHIBITS


Part I Exhibits


No.

Description

31.1

Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley



Part II Exhibits


No.

Description

3.1

Certificate of Incorporation of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.1 for Form 10-QSB, filed August 4, 2006)

3.2

Bylaws of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.4 of Form 10-QSB, filed May 3, 2004)

10.1

Lease Agreement between Flexpoint Sensor and F.G.B.P., L.L.C., dated July 12, 2004 (Incorporated by reference to exhibit 10.2 of Form 10-QSB, filed November 15, 2004, as amended)

10.2

Addendum to Lease Agreement between Flexpoint Sensor and American Covers, Inc., dated March 29, 2012  (Incorporated by reference to exhibit 10.2 of Form 10-QSB, filed May 15, 2012)

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Label Linkbase Document

101.PRE

XBRL Taxonomy Presentation Linkbase Document      





21





SIGNATURES


In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, who are duly authorized.


FLEXPOINT SENSOR SYSTEMS, INC.


Date: November 12, 2014


/s/ Clark M. Mower

Clark M. Mower

President

Chief Executive Officer

Principal Financial Officer


Date: November 8, 2006



22


EX-31 2 ex311.htm 302 CERTIFICATION OF CLARK M. MOWER, CEO Exhibit 31

Exhibit 31.1


CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


     I, Clark M. Mower certify that:


     1.   I have reviewed this quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc.;


     2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a      material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


     3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


    4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:  


a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;  


b)

designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles;


c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


     5.   The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);


a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.




Dated: November 12, 2014

/s/ Clark M. Mower

Clark M. Mower

Chief Executive Officer






EX-31 3 ex312.htm 302 CERTIFICATION OF CLARK M. MOWER, CFO Converted by EDGARwiz

Exhibit 31.2


CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


     I, Clark M. Mower, certify that:


    1.   I have reviewed this quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc.;


     2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


     3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


    4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:  


a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;  


b)

designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles;


c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and  


d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


     5.   The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);


a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.




Dated:  November 12, 2014

 

/s/ Clark M. Mower

Clark M. Mower

Principal Financial Officer






EX-32 4 ex32.htm SECTION 1350 CERTIFICATION Converted by EDGARwiz

    Exhibit 32



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc. (the “Company”) for the period ending September 30, 2014 as filed with the Securities and Exchange Commission (the “Report”), I, Clark M. Mower, Chief Executive Officer and Principal Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


     (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


     (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.




Dated:  November 12, 2014

/s/ Clark M. Mower

Clark M. Mower

Chief Executive Officer

Principal Financial Officer




EX-101.PRE 5 flxt-20140930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.INS 6 flxt-20140930.xml XBRL INSTANCE DOCUMENT 0000925660 2014-09-30 0000925660 2013-12-31 0000925660 us-gaap:MinimumMember 2014-01-01 2014-09-30 0000925660 us-gaap:MaximumMember 2014-01-01 2014-09-30 0000925660 2014-01-01 2014-09-30 0000925660 2013-01-01 2013-09-30 0000925660 us-gaap:NotesPayableOtherPayablesMember 2008-01-01 2012-12-31 0000925660 us-gaap:NotesPayableOtherPayablesMember 2012-12-31 0000925660 us-gaap:NotesPayableOtherPayablesMember 2012-12-01 2012-12-31 0000925660 us-gaap:NotesPayableOtherPayablesMember 2013-12-01 2013-12-31 0000925660 2014-07-01 2014-09-30 0000925660 2013-07-01 2013-09-30 0000925660 us-gaap:NotesPayableOtherPayablesMember us-gaap:MinimumMember 2013-12-31 0000925660 us-gaap:NotesPayableOtherPayablesMember us-gaap:MaximumMember 2013-12-31 0000925660 2005-08-25 0000925660 2012-12-31 0000925660 2013-09-30 0000925660 us-gaap:PresidentMember 2014-09-30 0000925660 us-gaap:PresidentMember 2013-12-31 0000925660 2013-01-01 2013-12-31 0000925660 flxt:ConvertibleNotesPayableTwo2013Member flxt:CapitalCommunicationsIncMember 2013-12-31 0000925660 flxt:ConvertibleNotesPayableOne2013Member flxt:CapitalCommunicationsIncMember 2013-12-31 0000925660 flxt:ConvertibleNotesPayableFebruary2014Member flxt:CapitalCommunicationsIncMember 2014-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:CapitalCommunicationsIncMember us-gaap:MinimumMember 2014-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:CapitalCommunicationsIncMember us-gaap:MaximumMember 2014-09-30 0000925660 flxt:ConvertibleNotesPayableFebruary2014Member flxt:CapitalCommunicationsIncMember 2014-01-01 2014-09-30 0000925660 flxt:ConvertibleNotesPayableJuneThirtieth2014Member flxt:CapitalCommunicationsIncMember 2014-01-01 2014-09-30 0000925660 flxt:ConvertibleNotesPayableJuneThirtieth2014Member flxt:CapitalCommunicationsIncMember 2014-09-30 0000925660 flxt:ConvertibleNotesPayableJuneTwentieth2014Member flxt:CapitalCommunicationsIncMember 2014-09-30 0000925660 flxt:ConvertibleNotesPayableJuneTwentieth2014Member flxt:CapitalCommunicationsIncMember 2014-01-01 2014-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:CapitalCommunicationsIncMember 2014-01-01 2014-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:CapitalCommunicationsIncMember 2014-09-30 0000925660 us-gaap:NotesPayableOtherPayablesMember us-gaap:InvestorMember 2014-09-30 0000925660 us-gaap:NotesPayableOtherPayablesMember us-gaap:InvestorMember 2014-01-01 2014-09-30 0000925660 us-gaap:SettledLitigationMember flxt:ResearchAndDevelopmentProductsLLCMember flxt:NotesReceivableTwoMember 2013-04-09 0000925660 us-gaap:SettledLitigationMember flxt:ResearchAndDevelopmentProductsLLCMember flxt:NotesReceivableOneMember 2013-04-09 0000925660 us-gaap:SettledLitigationMember flxt:ResearchAndDevelopmentProductsLLCMember flxt:NotesReceivableTwoMember 2013-04-08 2013-04-09 0000925660 us-gaap:SettledLitigationMember flxt:ResearchAndDevelopmentProductsLLCMember flxt:NotesReceivableOneMember 2013-04-08 2013-04-09 0000925660 2014-11-01 0000925660 flxt:FourNotesMember flxt:CapitalCommunicationsIncMember 2014-09-30 0000925660 flxt:FourNotesMember flxt:CapitalCommunicationsIncMember 2014-01-01 2014-09-30 0000925660 us-gaap:SubsequentEventMember us-gaap:ConvertibleNotesPayableMember 2014-09-30 0000925660 us-gaap:SubsequentEventMember us-gaap:ConvertibleNotesPayableMember 2014-01-01 2014-09-30 0000925660 us-gaap:NotesPayableOtherPayablesMember flxt:CapitalCommunicationsIncMember us-gaap:MaximumMember 2014-09-30 0000925660 us-gaap:NotesPayableOtherPayablesMember flxt:CapitalCommunicationsIncMember us-gaap:MinimumMember 2014-09-30 0000925660 us-gaap:NotesPayableOtherPayablesMember flxt:CapitalCommunicationsIncMember 2014-01-01 2014-09-30 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure 25766 35221 71989 6425 25000 25000 7433 6584 11874 11830 142062 85060 6550 6550 583636 527106 2757 59378 665755 587496 304459 373489 4896917 4896917 5352745 5421394 218180 212142 319 6056 433077 206822 10000 58942 4653 826058 520347 40000 40000 1517634 995367 0.001 1000000 0.001 100000000 53377114 53377114 53377 53377 24918928 24780929 -21137194 -20408279 3835111 4426027 5352745 5421394 -68450 -9230 9230 -728915 -688183 56620 57039 78259 80047 250000 83711 10223 65564 4224 849 -273 25000 43 -11951 6037 -34328 -5737 -5160 226256 -14637 -10000 10000 -360225 -420449 360000 425000 360000 425000 -9455 4551 42024 46575 -138000 -20000 2926391 0.10 0.12 327525 13210663 3750000 0.08 287525 2024000 1.10 2024000 1.10 2024000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Condensed Consolidated Interim Financial Statements &#150; </strong></font><font style=" color: black;"><font style=" font-size: 10pt;">The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and &#160;its subsidiaries (the &#147;Company&#148;). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. These statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2013 included in the Company's Form 10-K filed with the Securities and Exchange Commission on April 15, 2014. In particular, the Company's significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report.&#160;In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2014.</font></font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Nature of Operations &#150; </strong></font><font style=" color: black;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">The Company is located near Salt Lake City, in Draper, Utah and is engaged principally in designing, engineering, and manufacturing sensor technology products and equipment using Bend Sensors</font></font><sup><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">&#174;</font></font></sup><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> flexible potentiometer technology.</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> The Company had a loss</font></font><font style=" font-family : Times New Roman; font-size: 10pt;"> of $<font>728,915</font> and used cash in operating activities of $<font>360,225</font> during the nine months ended September 30, 2014. During the nine months ended September 30, 2013 the Company lost $<font>688,183</font> and used cash in operating activities of $<font>420,449</font>. Through September 30, 2014, the Company had an accumulated deficit of $<font>21,137,194</font>.</font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> </font></font><font style=" color: black;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">The Company has not earned any appreciable revenue during the period from February 24, 2004 (date of emergence from bankruptcy) through September 30, 2014. These matters raise doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.<br style=" color: black; font-size: 10pt;"/> <br style=" color: black; font-size: 10pt;"/> </font></font></font><font style=" font-family : Times New Roman; font-size: 10pt;">From 2008 through 2012, the Company raised $<font>2,926,391</font> in additional capital, including accrued interest, through the issuance of long and short-term notes to various entities, including related parties. All of the notes had an annual interest rate of <font>10</font>% to <font>12</font>% and were secured by the Company's business equipment. The notes also had a conversion feature for restricted common shares ranging from $.<font>07</font> to $.<font>25</font> per share with maturity dates from March 31, 2008 to December 31, 2013. However, prior to December 31, 2012 all but $<font>327,525</font> of&#160; the convertible notes were converted to an aggregate of <font>13,210,663</font> shares of the Company's restricted common stock at an average share price of about $.<font>17</font> per share. On December 31, 2013, the Company converted an additional <font>3,750,000</font> restricted common shares at $<font>0.08</font> per share and retired $<font>287,525</font> in debt plus all accrued interest<br/> <br/> During the nine months ended September 30, 2014, the Company has raised an additional $<font>360,000</font> in operating capital through the issuance of short-term notes to Capital Communication LLC.&#160; The notes are secured by the Company's business equipment and have a conversion feature for restricted common shares ranging from $<font>0.0025</font> to $<font>0.07</font> per share, with various maturity dates during the year.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> 1.10 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>NOTE 4 &#150; ISSUANCE OF STOCK</strong></font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">None during the period presented.</font></p> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Cash and Cash Equivalents &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of <font>three</font> months or less. The cash and equivalents of $<font>25,766</font> at September 30, 2014 and $<font>35,221</font> at December 31, 2013 represent cash on deposit in various bank accounts with a financial institution.&#160;&#160;</font></p> <p style=" line-height: 10.65pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Fair Value of Financial Instruments</strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"> - The carrying amounts reported in the balance sheets for accounts receivable, accounts payable and accrued liabilities approximate fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates which approximate current market rates.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Accounts Receivable &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">Trade accounts receivable are recorded at the time product is shipped or services are provided, including any shipping and handling fees. Due to the limited amount of transactions, collectability of the trade receivables is reasonably assured.&#160; Therefore, the Company has not created an allowance for doubtful accounts. Most contracts associated with design and development engineering require a deposit of up to <font>50</font>% of the quoted price of the initial phase of such contracts prior to the commencement of work. As the Company completes each phase or milestone of such contracts, additional funding is normally required from the customer. These deposits are considered deferred income until each phase or milestone is completed and accepted by the customer, at which time the agreed upon price for that particular phase of the contract is billed to the customer and the deposit applied. As the Company's revenues and customer base increase, an allowance policy will be established.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Inventories &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method.&#160; Inventories consist of raw materials.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Property and Equipment</strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"><strong> </strong></font><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>&#150;</strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"> Property and equipment are stated at cost. &#160;Additions and major improvements are capitalized while maintenance and repairs are charged to operations. &#160;Upon trade-in, sale, or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> 6182 7940 14352 165313 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Valuation of Long-lived Assets &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">The carrying values of the Company's long-lived assets are reviewed for impairment quarterly and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. The Company's analysis did not indicate any impairment of assets as of September 30, 2014.</font></p> <p style=" line-height: 12pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Intangible Assets</strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"> &#150; Costs to obtain or develop patents are capitalized and amortized over the estimated &#160;life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the rights to several patents and proprietary technology. &#160;Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology rights, over their estimated useful lives, which range from <font>5</font> to <font>15</font> years. &#160;An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The Company's analysis did not indicate any impairment of intangible assets as of September 30, 2014.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Research and Development &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">Research and development costs are recognized as an expense during the period incurred until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.</font></p> <p style=" line-height: 12pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><em><strong>Goodwill </strong></em>&#150; </font><font style=" color: black;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Goodwill represents the excess of the Company's reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in Accounting Standards Codification (&#147;ACS&#148;) 360, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Company's targeted market conditions, as well as relevant entity-specific events, such as a change in the market for the Company's products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 360, management has determined that the value of Company's assets is not more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods.</font></font></font></p> <p style=" line-height: 10.65pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> 167576 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Revenue Recognition &#150; </strong></font><font style=" color: black;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. &#160;Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. &#160;Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.</font></font></font></p> <p style=" line-height: 10.65pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Stock-Based Compensation</strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"> </font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">&#150; Under ASC Topic 718, Stock Compensation, </font></font><font style=" color: black;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">the Company is required to recognize the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. &#160;Prior to 2006, no compensation was recorded in earnings for the Company's stock-based options granted under the 2005 Stock Incentive Plan (the &#147;Plan&#148;). &#160;Under ASC 718, all share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. &#160;On January 1, 2006, the Company adopted the provisions of ASC 718, for its share-based compensations plans and began recognizing the unvested portion of employee compensation from stock options and awards equal to the unamortized grant-date fair value over the remaining vesting period. &#160;Furthermore, compensation costs will also be recognized for any awards issued, modified, repurchased, or canceled after January 1, 2006.</font></font></font></p> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p> </div> 0.25 2013-12-31 2008-03-31 515155 511040 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Basic and Diluted Earnings Per Share &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. &#160;Diluted earnings per share is computed by dividing net earnings by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At September 30, 2014, there were outstanding options to purchase <font>2,024,000</font> shares of common stock <font style=" font-size: 10.0pt; color: black;">and outstanding convertible notes payable with common share equivalents of <font>18,645,962</font>. These options were not included in the computation of diluted earnings because the related exercise prices were greater than the average market price of the common shares and the common stock equivalents for convertible notes were excluded because their effect would have been anti-dilutive.</font></font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 10.5pt 0pt 2.25pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>NOTE 1</strong></font><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>&#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></font></p> <p style=" line-height: 12pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Condensed Consolidated Interim Financial Statements &#150; </strong></font><font style=" color: black;"><font style=" font-size: 10pt;">The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and &#160;its subsidiaries (the &#147;Company&#148;). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. These statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2013 included in the Company's Form 10-K filed with the Securities and Exchange Commission on April 15, 2014. In particular, the Company's significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report.&#160;In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2014.</font></font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Nature of Operations &#150; </strong></font><font style=" color: black;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">The Company is located near Salt Lake City, in Draper, Utah and is engaged principally in designing, engineering, and manufacturing sensor technology products and equipment using Bend Sensors</font></font><sup><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">&#174;</font></font></sup><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> flexible potentiometer technology.</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> The Company had a loss</font></font><font style=" font-family : Times New Roman; font-size: 10pt;"> of $<font>728,915</font> and used cash in operating activities of $<font>360,225</font> during the nine months ended September 30, 2014. During the nine months ended September 30, 2013 the Company lost $<font>688,183</font> and used cash in operating activities of $<font>420,449</font>. Through September 30, 2014, the Company had an accumulated deficit of $<font>21,137,194</font>.</font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> </font></font><font style=" color: black;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">The Company has not earned any appreciable revenue during the period from February 24, 2004 (date of emergence from bankruptcy) through September 30, 2014. These matters raise doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.<br style=" color: black; font-size: 10pt;"/> <br style=" color: black; font-size: 10pt;"/> </font></font></font><font style=" font-family : Times New Roman; font-size: 10pt;">From 2008 through 2012, the Company raised $<font>2,926,391</font> in additional capital, including accrued interest, through the issuance of long and short-term notes to various entities, including related parties. All of the notes had an annual interest rate of <font>10</font>% to <font>12</font>% and were secured by the Company's business equipment. The notes also had a conversion feature for restricted common shares ranging from $.<font>07</font> to $.<font>25</font> per share with maturity dates from March 31, 2008 to December 31, 2013. However, prior to December 31, 2012 all but $<font>327,525</font> of&#160; the convertible notes were converted to an aggregate of <font>13,210,663</font> shares of the Company's restricted common stock at an average share price of about $.<font>17</font> per share. On December 31, 2013, the Company converted an additional <font>3,750,000</font> restricted common shares at $<font>0.08</font> per share and retired $<font>287,525</font> in debt plus all accrued interest<br/> <br/> During the nine months ended September 30, 2014, the Company has raised an additional $<font>360,000</font> in operating capital through the issuance of short-term notes to Capital Communication LLC.&#160; The notes are secured by the Company's business equipment and have a conversion feature for restricted common shares ranging from $<font>0.0025</font> to $<font>0.07</font> per share, with various maturity dates during the year.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Cash and Cash Equivalents &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of <font>three</font> months or less. The cash and equivalents of $<font>25,766</font> at September 30, 2014 and $<font>35,221</font> at December 31, 2013 represent cash on deposit in various bank accounts with a financial institution.&#160;&#160;</font></p> <p style=" line-height: 10.65pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Fair Value of Financial Instruments</strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"> - The carrying amounts reported in the balance sheets for accounts receivable, accounts payable and accrued liabilities approximate fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates which approximate current market rates.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Accounts Receivable &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">Trade accounts receivable are recorded at the time product is shipped or services are provided, including any shipping and handling fees. Due to the limited amount of transactions, collectability of the trade receivables is reasonably assured.&#160; Therefore, the Company has not created an allowance for doubtful accounts. Most contracts associated with design and development engineering require a deposit of up to <font>50</font>% of the quoted price of the initial phase of such contracts prior to the commencement of work. As the Company completes each phase or milestone of such contracts, additional funding is normally required from the customer. These deposits are considered deferred income until each phase or milestone is completed and accepted by the customer, at which time the agreed upon price for that particular phase of the contract is billed to the customer and the deposit applied. As the Company's revenues and customer base increase, an allowance policy will be established.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Inventories &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method.&#160; Inventories consist of raw materials.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Property and Equipment</strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"><strong> </strong></font><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>&#150;</strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"> Property and equipment are stated at cost. &#160;Additions and major improvements are capitalized while maintenance and repairs are charged to operations. &#160;Upon trade-in, sale, or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Valuation of Long-lived Assets &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">The carrying values of the Company's long-lived assets are reviewed for impairment quarterly and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. The Company's analysis did not indicate any impairment of assets as of September 30, 2014.</font></p> <p style=" line-height: 12pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Intangible Assets</strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"> &#150; Costs to obtain or develop patents are capitalized and amortized over the estimated &#160;life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the rights to several patents and proprietary technology. &#160;Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology rights, over their estimated useful lives, which range from <font>5</font> to <font>15</font> years. &#160;An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The Company's analysis did not indicate any impairment of intangible assets as of September 30, 2014.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Research and Development &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">Research and development costs are recognized as an expense during the period incurred until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.</font></p> <p style=" line-height: 12pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><em><strong>Goodwill </strong></em>&#150; </font><font style=" color: black;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Goodwill represents the excess of the Company's reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in Accounting Standards Codification (&#147;ACS&#148;) 360, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Company's targeted market conditions, as well as relevant entity-specific events, such as a change in the market for the Company's products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 360, management has determined that the value of Company's assets is not more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods.</font></font></font></p> <p style=" line-height: 10.65pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Revenue Recognition &#150; </strong></font><font style=" color: black;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. &#160;Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. &#160;Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.</font></font></font></p> <p style=" line-height: 10.65pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Stock-Based Compensation</strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"> </font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">&#150; Under ASC Topic 718, Stock Compensation, </font></font><font style=" color: black;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">the Company is required to recognize the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. &#160;Prior to 2006, no compensation was recorded in earnings for the Company's stock-based options granted under the 2005 Stock Incentive Plan (the &#147;Plan&#148;). &#160;Under ASC 718, all share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. &#160;On January 1, 2006, the Company adopted the provisions of ASC 718, for its share-based compensations plans and began recognizing the unvested portion of employee compensation from stock options and awards equal to the unamortized grant-date fair value over the remaining vesting period. &#160;Furthermore, compensation costs will also be recognized for any awards issued, modified, repurchased, or canceled after January 1, 2006.</font></font></font></p> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p> </div> </div> <div> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>Basic and Diluted Earnings Per Share &#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;">Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. &#160;Diluted earnings per share is computed by dividing net earnings by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At September 30, 2014, there were outstanding options to purchase <font>2,024,000</font> shares of common stock <font style=" font-size: 10.0pt; color: black;">and outstanding convertible notes payable with common share equivalents of <font>18,645,962</font>. These options were not included in the computation of diluted earnings because the related exercise prices were greater than the average market price of the common shares and the common stock equivalents for convertible notes were excluded because their effect would have been anti-dilutive.</font></font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> </div> </div> 0.17 0.07 P5Y P15Y <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 10.5pt 0pt 2.25pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>NOTE 3 </strong></font><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>&#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>INVENTORIES</strong></font></p> <p style=" margin: 10.5pt 0pt 2.25pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">At September 30, 2014, inventories are comprised entirely of raw materials used for making prototypes and limited production runs.&#160; There was no work in progress or finished goods.</font></p> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 10.5pt 0pt 2.25pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>NOTE 2 </strong></font><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;"><strong>&#150; </strong></font><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>STOCK OPTION PLANS</strong></font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for <font>ten</font> years, unless terminated. &#160;This plan was approved by the stockholders of the Company on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Company's trading common stock for the <font>thirty</font>-day period immediately preceding the grant date plus a premium of <font>ten</font> percent. &#160;The maximum aggregate number of shares that may be awarded under the Plan is <font>2,500,000</font> shares.</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <p><font style=" font-family : Times New Roman; font-size: 10pt;">The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock. Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. The Company uses the simplified method to calculate the expected term. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options.<br/> <br/> During the nine month period ended September 30, 2014 the Company recognized $</font><font style=" font-family : Times New Roman; font-size: 10pt;"><font>0.00</font></font><font style=" font-family : Times New Roman; font-size: 10pt;"> of stock-based compensation expense,</font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> compared to </font></font><font style=" font-family : Times New Roman; font-size: 10pt;">$</font><font style=" font-family : Times New Roman; font-size: 10pt;"><font>0.00</font></font><font style=" font-family : Times New Roman; font-size: 10pt;"> during the same period in 2013. There were <font>2,024,000</font> &#160;employee stock options outstanding at September 30, 2014. </font><font style=" font-family : Times New Roman; font-size: 10pt;">A summary of all employee options outstanding and exercisable under the plan as of September 30, 2014, and changes during the nine months then ended is set forth below:</font></p> <div> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <div> <div class="CursorPointer"> <table cellspacing="0" cellpadding="0" width="100%" style=" border-collapse: collapse;"> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; border-bottom: #000000 1pt solid;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>Options</strong></font><br/> &#160;</p> </td> <td align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 1pt solid;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; border-bottom: #000000 1pt solid;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>Shares</strong></font></p> </td> <td align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 1pt solid;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; border-bottom: #000000 1pt solid;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>Weighted&#160;</strong></font><br/> <font style=" font-family : Times New Roman; font-size: 10pt;"><strong>Average</strong></font><br/> <font style=" font-family : Times New Roman; font-size: 10pt;"><strong> Exercise</strong></font><br/> <font style=" font-family : Times New Roman; font-size: 10pt;"><strong> Price</strong></font></p> </td> <td align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 1pt solid;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; border-bottom: #000000 1pt solid;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 9pt;"><strong>Weighted Average Remaining Contractual&#160;Life (Years)</strong></font></p> </td> <td align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 1pt solid;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; border-bottom: #000000 1pt solid;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>Aggregate Intrinsic&#160;Value</strong></font></p> </td> </tr> <tr> <td style=" vertical-align: top; font-family : Times New Roman; border-top: #000000 1pt solid; border-left: none; border-right: none; border-bottom: none; border-color: #000000; padding: 0px; text-align: left;">&#160;</td> <td align="center" style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: top; font-family : Times New Roman; border-top: #000000 1pt solid; border-left: none; border-right: none; border-bottom: none; border-color: #000000; padding: 0px;">&#160;</td> <td align="center" style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: top; font-family : Times New Roman; border-top: #000000 1pt solid; border-left: none; border-right: none; border-bottom: none; border-color: #000000; padding: 0px;">&#160;</td> <td align="center" style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: top; font-family : Times New Roman; border-top: #000000 1pt solid; border-left: none; border-right: none; border-bottom: none; border-color: #000000; padding: 0px;">&#160;</td> <td align="center" style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: top; font-family : Times New Roman; border-top: #000000 1pt solid; border-left: none; border-right: none; border-bottom: none; border-color: #000000; padding: 0px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Outstanding at the beginning of period</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>2,024,000</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>1.10</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>0.09</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; text-align: left;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Granted</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; text-align: left;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Expired</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><strong><font>-</font></strong></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td style=" vertical-align: bottom; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;">&#160;</td> <td style=" vertical-align: bottom; text-align: right; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td style=" vertical-align: bottom; text-align: center; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; text-align: center; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Forfeited</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; text-align: left;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Outstanding at the end of Period</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>2,024,000</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>1.10</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>0.09</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; text-align: left;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Exercisable at the end of Period</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>2,024,000</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>1.10</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>0.09</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> </table> </div> </div> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Based upon the current options issued as of September 30, 2014, there was no additional unrecognized compensation cost related to employee stock options that will be recognized.&#160;</font></p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><font style=" font-family : Times New Roman; font-size: 10pt;">A summary of all employee options outstanding and exercisable under the plan as of September 30, 2014, and changes during the nine months then ended is set forth below:</font> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <div> <div class="CursorPointer"> <table cellspacing="0" cellpadding="0" width="100%" style=" border-collapse: collapse;"> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; border-bottom: #000000 1pt solid;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>Options</strong></font><br/> &#160;</p> </td> <td align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 1pt solid;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; border-bottom: #000000 1pt solid;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>Shares</strong></font></p> </td> <td align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 1pt solid;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; border-bottom: #000000 1pt solid;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>Weighted&#160;</strong></font><br/> <font style=" font-family : Times New Roman; font-size: 10pt;"><strong>Average</strong></font><br/> <font style=" font-family : Times New Roman; font-size: 10pt;"><strong> Exercise</strong></font><br/> <font style=" font-family : Times New Roman; font-size: 10pt;"><strong> Price</strong></font></p> </td> <td align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 1pt solid;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; border-bottom: #000000 1pt solid;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 9pt;"><strong>Weighted Average Remaining Contractual&#160;Life (Years)</strong></font></p> </td> <td align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 1pt solid;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; border-bottom: #000000 1pt solid;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>Aggregate Intrinsic&#160;Value</strong></font></p> </td> </tr> <tr> <td style=" vertical-align: top; font-family : Times New Roman; border-top: #000000 1pt solid; border-left: none; border-right: none; border-bottom: none; border-color: #000000; padding: 0px; text-align: left;">&#160;</td> <td align="center" style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: top; font-family : Times New Roman; border-top: #000000 1pt solid; border-left: none; border-right: none; border-bottom: none; border-color: #000000; padding: 0px;">&#160;</td> <td align="center" style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: top; font-family : Times New Roman; border-top: #000000 1pt solid; border-left: none; border-right: none; border-bottom: none; border-color: #000000; padding: 0px;">&#160;</td> <td align="center" style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: top; font-family : Times New Roman; border-top: #000000 1pt solid; border-left: none; border-right: none; border-bottom: none; border-color: #000000; padding: 0px;">&#160;</td> <td align="center" style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td colspan="3" align="center" style=" vertical-align: top; font-family : Times New Roman; border-top: #000000 1pt solid; border-left: none; border-right: none; border-bottom: none; border-color: #000000; padding: 0px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Outstanding at the beginning of period</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>2,024,000</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>1.10</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>0.09</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; text-align: left;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Granted</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; text-align: left;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Expired</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><strong><font>-</font></strong></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td style=" vertical-align: bottom; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;">&#160;</td> <td style=" vertical-align: bottom; text-align: right; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td style=" vertical-align: bottom; text-align: center; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; text-align: center; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Forfeited</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; text-align: left;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Outstanding at the end of Period</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>2,024,000</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>1.10</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>0.09</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td style=" vertical-align: top; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; text-align: left;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: top; text-align: left; font-family : Times New Roman; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap;">&#160;</td> <td align="left" style=" font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> <tr> <td width="100%" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Exercisable at the end of Period</font></p> </td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>2,024,000</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" colspan="2" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>1.10</font></td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap;"><font>0.09</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> <td style=" vertical-align: bottom; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: center; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">$</td> <td align="right" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>-</font></td> <td align="left" style=" border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;">&#160;</td> </tr> </table> </div> </div> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> </div> 78056 71121 216746 176309 273555 2500000 2024000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>NOTE 7 - LITIGATION</strong></font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt; font-style: italic;">R&amp;D Products, LLC -</font><font style=" font-family : Times New Roman; font-size: 10pt;"> On June 23, 2010, the Company, along with David B. Beck, the Company's Director of Engineering, filed a complaint against R&amp;D Products, LLC, Persimmon Investments, Inc. and Jules A. deGreef, the managing member of R&amp;D Products, LLC. The complaint alleged that all of the intellectual properties owned by R&amp;D Products and Mr. deGreef, specifically patented applications using Bend Sensor</font><font style=" font-family : Times New Roman; font-size: 7pt; vertical-align: super;">&#174;</font><font style=" font-family : Times New Roman; font-size: 10pt;"> technology that were filed jointly by Mr. Beck and Mr. deGreef, and later assigned solely to Mr. deGreef and R&amp;D Products, are the property of the Company. The assignment by Mr. Beck of his rights in the patents and intellectual properties were improperly given and are the property of the Company. The Company believed that since Mr. Beck was an employee of the Company during the time that he became the primary creative force and inventor of the Bend Sensor</font><font style=" font-family : Times New Roman; font-size: 7pt; vertical-align: super;">&#174;</font><font style=" font-family : Times New Roman; font-size: 10pt;"> applications for R&amp;D Products and Mr. deGreef, and the inventions and applications were created using Flexpoint resources, the Company claimed that such intellectual properties, patents, etc. filed by deGreef, Persimmon and R&amp;D belong to Flexpoint and therefore is sought financial damages and ownership of all intellectual rights, patents and inventions created by Mr. Beck for deGreef, Persimmon and R&amp;D Products.&#160;</font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">On April 9, 2013, the parties of the above referenced litigation reached a favorable universal settlement agreement that reinforces the Company's rights to the intellectual properties and their related products, including the medical bed. In order to secure the Company had exclusive rights to all patents and intellectual properties associated with this litigation the Company advanced to Mr. deGreef $<font>25,000</font> to bring current all of the filing and maintenance fees for the patents detailed in the law suit. The advance is secured by a promissory note with an annual interest rate of <font>10</font>% to be paid no later than December 31, 2015.</font></p> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>NOTE 8 - COMMITMENTS AND CONTINGENCIES</strong></font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">On the same date as part of the settlement agreement (see Note 7- Litigation), the Company entered into an exclusive licensing agreement that granted the Company the sole and exclusive rights to all products, devices, and commercial applications of any type or nature that relate to or are derived from the patents and application for patents controlled by Mr. deGreef and his companies. As additional compensation for the settlement the Company also received a note in the amount of $<font>360,000</font> from the deGreef companies to be paid with accrued interest no later than April 8, 2015 through future royalties generated from the exclusive rights to technology specifically identified in the settlement and licensing agreements. The note has an annual interest rate of <font>5</font>% and is secured by the intellectual properties of Mr. deGreef and his companies, including patents issued and those currently under application and any and all devices derived from such.</font></p> <p style=" line-height: 10.65pt; margin: 0pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">At the time of this filing the Company does not have orders for products or devices; contracts for, or contracts that are currently being negotiated; or any type of existing or negotiated royalty agreement that uses the patents or technology identified in the settlement and licensing agreement. And because the source of repayment of the $<font>360,000</font> note receivable is from future royalty income from the sales of product, devices or uses of the technology, therefore at this time as stipulated in Accounting Standards Codification ("ACS") 450 the Company is not permit to recognize a contingent asset.&#160; At such time as royalty income can be reasonably estimated and is "virtually certain", the Company will recognize the note receivable.&#160;&#160;</font></p> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>NOTE 9 &#150; NEW ACCOUNTING PRONOUNCEMENTS</strong></font></p> <p style=" margin: 0pt 0pt 0pt 54pt; text-indent: -54pt; font-family : Times New Roman;"><font style=" font-size: 10pt;">&#160;</font></p> <p class="MsoNormal" style=" text-align: justify;"><font style=" font-size: 10pt;">In August 2014, the FASB issued Accounting Standards Update No. 2014-15, </font><em><font style=" font-size: 10pt;">Presentation of Financial Statements &#150; Going Concern (Subtopic 205-40) </font></em><font style=" font-size: 10pt;">whereby an entity's management, in connection with preparing financial statements for each annual and interim reporting period, should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date the financial statements are issued.&#160; Management's evaluation is to be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued.&#160; If conditions or events raise substantial doubt about the entity's ability to continue as a going concern the entity should disclose information that enables users of the financial statements to understand management's evaluation of the significance of the conditions or events and of management's plans to mitigate the conditions or events.&#160;<br/> <br/> The standard is effective for annual periods ending after December 15, 2016, and interim periods therein.&#160; Early adoption of this amendment is allowed.&#160; We are currently evaluating the date at which we will adopt this standard.&#160;<br/> <br/> In June 2014, the Financial Accounting Standards Board (&#147;FASB&#148;) issued Accounting Standards Update (&#147;ASU&#148;) No. 2014-10, which eliminated certain financial reporting requirements of companies previously identified as &#147;Development Stage Entities&#148; (Topic 915).&#160; The amendments in this ASU simplify accounting guidance by removing all incremental financial reporting requirements for development stage entities.&#160; The amendments also reduce data maintenance and, for those entities subject to audit, audit costs by eliminating the requirement for development stage entities to present inception-to-date information in the statements of income, cash flows, and shareholder equity.&#160; Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued (public business entities) or made available for issuance (other entities).&#160; Upon adoption, entities will no longer present or disclose any information required by Topic 915.&#160; The Company has adopted this standard and will not report inception to date financial information.<br/> <br/> In May 2014, the FASB issued Accounting Standards Update No. 2014-09, </font><em><font style=" font-size: 10pt;">Revenue from Contracts with Customers</font></em><font style=" font-size: 10pt;"> (ASU 2014-09), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP.&#160; The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services.&#160; ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP.<br/> <br/> The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods:&#160; (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures).&#160; We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard in 2017.</font></p> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>NOTE 10 - SUBSEQUENT EVENTS<br/> <br/> </strong></font><font style=" font-size: 10pt;">In October 2014 the Company received an additional $<font>40,000</font> for which a convertible note has been issued.&#160; The note bears interest at the rate of <font>10</font>% per annum and has a maturity date of July 15, 2015.</font></p> </div> </div> 124464 33407 221117 75182 25805 26975 4381 271854 818100 781748 83359 18232 131978 50104 16 46 37 -83343 50218 -131932 18383 -232434 -188229 0.00 0.00 -0.01 -0.01 53377114 49255375 53377114 46955453 68450 68450 360000 0.05 2015-04-08 25000 0.10 2015-12-31 0.00 0.00 P1M2D P1M2D 319 2055 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>NOTE 5 &#150; RELATED PARTY TRANSACTIONS</strong></font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">The Company has a related party payable to its President, CEO and Director for reimbursement of travel and other related expenses incurred on behalf of the Company. The amount due to the President as of September 30, 2014 and December 31, 2013 is $<font>319</font> and $<font>2,055</font>, respectively.</font></p> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p><strong><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">NOTE 6 &#150; NOTES PAYABLE</font></font></strong></p> <p><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">During the nine months ended September 30, 2014, the Company raised $<font>360,000</font> in capital through the issuance of&#160; short-term notes to Capital Communications, Inc.&#160; This is in addition to the $<font>525,000</font> issued and outstanding as of December 31, 2013.&#160; All of the notes have an annual interest rate of <font>10</font>%, have various maturity dates during the year, and are secured by the Company's business equipment.&#160; The notes also have a conversion feature for restricted common shares, ranging from $<font>.025</font> to $<font>.07</font> per share.&#160; In addition to two notes for $<font>25,000</font> each issued in <font>2013</font> with discounts, and one of the notes issued on February 25, 2014 for $<font>40,000</font>, these notes have an exercise price which was less than the trading price of the stock on the date of issuance, resulting in a beneficial conversion feature valued at $<font>10,000</font>, resulting in a discount on the value of the note.&#160; On June 20 and June 30, 2014, two notes of $<font>20,000</font> each were issued with exercise prices less than the trading price of the stock on the date of issuance, resulting in a beneficial conversion feature valued at $<font>4,000</font> each for a total of $<font>8,000</font>.&#160; On July 23, August 15, September 3 and September 16, 2014, four notes totaling $<font>120,000</font> were issued with exercise prices less than the trading price of the stock on the date of issuance, resulting in a beneficial conversion feature of $<font>138,000</font>.&#160; The unamortized discount of all notes&#160; as of September 30, 2014 was $<font>58,942</font>, resulting in $<font>58,833</font> of unamortized discount recorded as part of the $<font>83,711</font> in amortization of discount on notes payable during the nine month period.&#160; The notes had various maturity dates but, prior to December 31, 2013, all of the outstanding and future convertible notes issued Capital Communications were extended to September 30, 2014 and $<font>80,000</font> on the notes issued during this three month period have a maturity date of July 15, 2015.&#160; Management anticipates further extending these notes with similar terms as they reach their exiting maturity dates.<br style=" font-size: 10pt;"/> <br style=" font-size: 10pt;"/> On August 8, 2011, the Company issued a promissory note for $<font>40,000</font> to an existing shareholder. The note has an annual interest rate of <font>10</font>% and is secured by the Company's equipment. The principle amount of the note, and all accrued interest is due and payable on or before July 31, 2012 and has a conversion feature for restricted common shares at $<font>0.20</font> per share. Management anticipates extending this note to December 31, 2014 under similar terms.</font></font></p> </div> </div> 525000 0.10 40000 10000 0.0025 20000 2014-06-30 2014-06-20 0.025 0.07 25000 20000 4000 4000 8000 53377114 25000 120000 138000 58833 2014-02-25 40000 2011-08-08 0.10 0.20 40000 0.10 2015-07-15 0.001 1000000 0 0 0 0 0.001 100000000 53377114 53377114 0.07 2012-07-31 360000 FLEXPOINT SENSOR SYSTEMS INC 0000925660 10-Q 2014-09-30 false --12-31 Smaller Reporting Company 2014 Q3 EX-101.SCH 7 flxt-20140930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 102 - Disclosure - STOCK OPTION PLANS link:presentationLink link:calculationLink link:definitionLink 103 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 104 - Disclosure - ISSUANCE OF STOCK link:presentationLink link:calculationLink link:definitionLink 105 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 106 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 107 - Disclosure - LITIGATION link:presentationLink link:calculationLink link:definitionLink 108 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 109 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 110 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 303 - Disclosure - STOCK OPTION PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Debt Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - STOCK OPTION PLANS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - ISSUANCE OF STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - LITIGATION (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 flxt-20140930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 flxt-20140930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 flxt-20140930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Amendment Flag Current Fiscal Year End Date Document Period End Date Entity Filer Category Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] Accounts receivable Accounts Receivable, Net, Current Accounts payable - related party Accounts Payable, Related Parties, Current Related party payable Accounts payable Accounts Payable, Current Accrued liabilities Accrued Liabilities, Current Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property and Equipment, accumulated depreciation Additional Paid in Capital Additional paid-in capital Amortization Amortization of patents and proprietary technology Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Amortization of Debt Discount (Premium) Amortization of discount on note payable Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Shares not included in computation of diluted loss per share as their effect would have been anti-dilutive Assets Total Assets Assets, Current [Abstract] Current Assets ASSETS Assets [Abstract] Assets, Current Total Current Assets Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents, Period Increase (Decrease) Net Change in Cash and Cash Equivalents Cash and cash equivalents Cash and Cash Equivalents at Beginning of Period Cash and Cash Equivalents at End of Period Cash and Cash Equivalents, at Carrying Value Chief Financial Officer [Member] COMMITMENTS AND CONTINGENCIES [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Common Stock, Par or Stated Value Per Share Common stock, par value per share Common stock - $0.001 par value; 100,000,000 shares authorized; 53,377,114 shares and 53,377,114 shares issued and outstanding Common Stock, Value, Issued Common stock, shares issued Common Stock, Shares, Issued Common Stock, Shares Authorized Common stock, shares authorized Common stock, shares outstanding Common Stock, Shares, Outstanding Condensed Consolidated Interim Financial Statements Consolidation, Policy [Policy Text Block] Convertible Notes Payable, Current Convertible notes payable, net of discount of $58,942 and $4,653 Cost of Revenue Cost of revenue Debt Instrument [Line Items] Schedule of Long-term Debt Instruments [Table] Debt Conversion, Original Debt, Amount Outstanding notes payable converted to stock Debt instrument, maturity date range start Debt Instrument, Maturity Date Range, Start Debt Conversion, Converted Instrument, Shares Issued Restricted shares of common stock issued Shares issued from conversion of convertible debt Debt Instrument, Face Amount Debt instrument, face amount Debt Instrument, Convertible, Beneficial Conversion Feature Discount for beneficial conversion feature NOTES PAYABLE [Abstract] Debt forgiveness Debt Instrument, Decrease, Forgiveness Debt Conversion [Line Items] Conversion of convertible notes, amount Debt Conversion, Converted Instrument, Amount Stock issued for debt Debt Disclosure [Text Block] NOTES PAYABLE Debt instrument, conversion price Debt Instrument, Convertible, Conversion Price Debt instrument, maturity date range end Debt Instrument, Maturity Date Range, End Debt instrument, interest rate Debt Instrument, Interest Rate, Stated Percentage Convertible notes payable, discount Debt Instrument, Unamortized Discount (Premium), Net Debt Instrument, Maturity Date Debt instrument, maturity date Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum Debt instrument, maximum interest rate Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum Debt instrument, minimum interest rate Deferred Revenue Deferred revenue Deposits Assets, Noncurrent Long-Term Deposits Depreciation Depreciation Description of New Accounting Pronouncements Not yet Adopted [Text Block] NEW ACCOUNTING PRONOUNCEMENTS Disclosure of Compensation Related Costs, Share-based Payments [Text Block] STOCK OPTION PLANS Basic and Diluted Loss Per Common Share Earnings Per Share, Basic and Diluted Basic and Diluted Earnings Per Share Earnings Per Share, Policy [Policy Text Block] STOCK OPTION PLANS [Abstract] Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Unrecognized compensation cost related to employee stock options that will be recognized Equity Issuance, Per Share Amount Issuance of stock, price per share Price per share Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Finite-Lived Intangible Asset, Useful Life Intangible assets, useful lives Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Accumulated Amortization Patents and Proprietary Technology, accumulated amortization Finite-Lived Intangible Assets, Net Patents and Proprietary Technology, net of accumulated amortization of $665,755 and $587,496 Gain (Loss) on Disposition of Assets Loss on asset disposal Gain (Loss) on Sale of Property Plant Equipment Loss on sales of equipment Gains (Losses) on Extinguishment of Debt Loss on extinguishment of debt Goodwill impairment charge Goodwill, Impairment Loss Goodwill Goodwill Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Intangible Assets Accumulated goodwill impairment Goodwill, Impaired, Accumulated Impairment Loss Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Valuation of Long-lived Assets Impairment of long-lived assets Impairment of long-lived assets Impairment of Long-Lived Assets Held-for-use CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] Cash paid for income taxes Income Taxes Paid Accounts receivable Increase (Decrease) in Accounts Receivable Accounts payable Increase (Decrease) in Accounts Payable Accrued liabilities Increase (Decrease) in Accrued Liabilities Accounts payable - related parties Increase (Decrease) in Accounts Payable, Related Parties Deferred revenue Increase (Decrease) in Deferred Revenue Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Increase (Decrease) in Notes Receivable, Current Notes receivable Increase (Decrease) in Inventories Inventory Deposits and prepaid expenses Increase (Decrease) in Prepaid Expense and Other Assets Interest Expense Interest expense Cash paid for interest Interest Paid Inventory Inventory, Net Inventories Inventory, Policy [Policy Text Block] Finished goods inventory Inventory, Finished Goods, Net of Reserves INVENTORIES Inventory Disclosure [Text Block] Inventory Disclosure [Abstract] Inventory, Work in Process, Net of Reserves Work in progress inventory Interest income Investment Income, Interest Issuance of common stock and warrants for services Issuance of Stock and Warrants for Services or Claims Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Legal Matters and Contingencies [Text Block] LITIGATION Liabilities and Equity Total Liabilities and Stockholders' Equity Current Liabilities Liabilities, Current [Abstract] Liabilities Total Current Liabilities Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liquidity Disclosure [Policy Text Block] Nature of Operations Litigation Case [Domain] Litigation Case [Axis] Maximum [Member] Minimum [Member] Net Income (Loss) Attributable to Parent Net loss Net Loss Cash Flows from Financing Activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Cash Flows from Investing Activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Net Cash Provided by (Used in) Investing Activities Net Cash Used in Investing Activities Cash Flows from Operating Activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net Cash Provided by (Used in) Financing Activities Net Cash Provided by Financing Activities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Used in Operating Activities NEW ACCOUNTING PRONOUNCEMENTS [Abstract] Noncash Investing and Financing Items [Abstract] Supplemental Disclosure on Noncash Investing and Financing Activities Net Other Expense Nonoperating Income (Expense) Nonoperating Income (Expense) [Abstract] Other Income (Expense) Notes Payable to Various Entities, Including Related Parties [Member] Promissory Note [Member] Convertible notes payable to related party Notes Payable, Related Parties, Current Notes receivable Notes, Loans and Financing Receivable, Net, Current Notes Receivable Notes Receivable, Related Parties Notes Payable, Current Total current notes payable outstanding Operating Costs and Expenses Operating Expenses [Abstract] Operating Expenses Total Operating Costs and Expenses Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Other income Other Nonoperating Income Payment for acquisition of equipment and proprietary technology from Flexpoint Holdings, LLC Payments to Acquire Productive Assets Payments for the purchase of equipment Payments to Acquire Property, Plant, and Equipment Payments for patents Payments to Acquire Intangible Assets Preferred Stock, Par or Stated Value Per Share Preferred stock, par value per share Preferred stock - $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding Preferred Stock, Value, Issued Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Deposits and prepaid expenses Prepaid Expense and Other Assets, Current President [Member] Proceeds from borrowings under convertible note payable Proceeds from Convertible Debt Net proceeds from issuance of common stock, warrants and options Proceeds from Issuance or Sale of Equity Proceeds from notes payable - related parties Proceeds from Related Party Debt Proceeds from Issuance of Common Stock Proceeds from subscriptions receivable Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment, net of accumulated depreciation of $583,636 and $527,106 Property, Plant and Equipment, Net Bad debt expense Provision for Doubtful Accounts Range [Axis] Range [Domain] RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Related Party Transaction [Line Items] Amount of transaction Related Party Transaction, Amounts of Transaction Related Party Transactions, by Related Party [Axis] Related Party [Domain] RELATED PARTY TRANSACTIONS [Abstract] Rental Income, Nonoperating Sublease rent income Payments on convertible notes payable Repayments of Convertible Debt Principal payments on notes payable - related parties Repayments of Related Party Debt Research and Development Expense Research and development expense Research and Development Research and Development Expense, Policy [Policy Text Block] Accumulated deficit Retained Earnings (Accumulated Deficit) Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Engineering, Contract and Testing Revenue Revenues Exercisable at the end of the Period, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Expected term Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Exercisable at the end of Period, weighted average remaining contractual life Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Outstanding, weighted average remaining contractual life Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Stock Option Activity Schedule of Finite-Lived Intangible Assets [Table] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Short-term Debt [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Administrative and marketing expense Selling, General and Administrative Expense Exercise price of stock options granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Forfeited, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-based Compensation Stock based compensation expense Stock-based compensation expense for employees Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Market value of options at time of issuance Share Price Expired, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Granted, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Exercisable at the end of Period, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expired, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Forfeited, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Exercisable at the end of the Period, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Shares authorized Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Granted, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Outstanding at the beginning of period, weighted average exercise price Outstanding at the end of Period, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock-Based Compensation Outstanding at the beginning of period, shares Outstanding at the end of Period, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding at the beginning of period, aggregate intrinsic value Outstanding at the end of Period, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Short-term Debt Short-term debt Short-term Debt [Line Items] Short-term Debt, Type [Domain] Short-term Debt, Type [Axis] CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract] Stock Issued Stock issued for debt Stock Issued During Period, Shares, Share-based Compensation, Gross Stock-based compensation - stock options granted, shares Stockholders' Equity Stockholders' Equity Attributable to Parent [Abstract] Stockholders' Equity Attributable to Parent Total Stockholders' Equity ISSUANCE OF STOCK [Abstract] ISSUANCE OF STOCK Stockholders' Equity Note Disclosure [Text Block] SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS [Abstract] Subsequent Event [Table] Subsequent Event [Line Items] Subsequent Event [Member] Subsequent Event Type [Domain] Subsequent Event Type [Axis] Supplemental Cash Flow Information [Abstract] Supplemental Cash Flow Information: Title of Individual [Axis] Title of Individual with Relationship to Entity [Domain] Accounts Receivable Trade and Other Accounts Receivable, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Basic and Diluted Weighted-Average Common Shares Outstanding Weighted Average Number of Shares Outstanding, Basic and Diluted Additional capital raised through issuance of long and short-term notes to related parties. Additional capital raised through issuance of long and short-term notes to related parties Additional Capital Raised Including Accrued Interest Through Issuance Of Long And Short Term Notes To Related Parties Common Stock Share Subscribed But Unissued Subscriptions Receivable During Period Dollar amount of subscriptions to be received during the period from investors who have been allocated common stock. Subscription receivable Conversion price of shares of restricted stock used as collateral on line of credit. Conversion price of shares of restricted stock used as collateral on line of credit Conversion Price Of Shares Of Restricted Stock Used As Collateral On Line Of Credit The average conversion price for converted debt instruments. Average conversion price for converted debt instruments Debt Conversion Converted Instrument Average Conversion Price Per Share Document and Entity Information [Abstract] Document And Entity Information [Abstract]. Employee [Member] Employee [Member] Expenses paid by increase in convertible note payable Expenses paid by increase in convertible note payable. Expiration of warrants outstanding The value of warrants that expired during the reporting period, as calculated by applying the disclosed pricing methodology. Extinguishment of unamortized discounts on modified convertible notes payable Extinguishment Of Unamortized Discounts On Modified Convertible Notes Payable Extinguishment of unamortized discount on modified convertible notes payable. Gain on forgiveness of debt The (gain) loss on forgiveness of debt. Gain Loss Debt Forgiveness Gain Loss On Conversion Of Notes Payable To Common Stock Loss (Gain) on conversion of notes payable to common stock Loss on conversion of notes payable to common stock. Gain (loss) on stock debt exchange Gain (loss) on stock debt exchange. Gain on stock debt exchange Legal Settlement [Line Items] Legal Settlement [Member] Legal Settlement [Member] Legal Settlement [Table] Line Of Credit Two [Member] Line Of Credit Two [Member] Capital Communications, Inc. [Member] LITIGATION [Abstract] Litigation [Abstract]. Notes Receivable [Axis] Information by note receivable, an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s). Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. Notes Receivable Interest Rate The annual interest rate for notes receivable. Interest rate Notes Receivable Maturity Date The maturity date for notes receivable. Maturity date Notes Receivable Name [Domain] The name for the particular note receivable, an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s). Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. Notes Receivable One [Member] Note Receivable One [Member] Information on the note receivable, an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s). Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. Notes Receivable Two [Member] Note Receivable Two [Member] Information on the note receivable, an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s). Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. Number Of Shares Of Restricted Stock Used As Collateral On Line Of Credit Number of restricted common stock used as collateral on line of credit. Number of restricted common stock used as collateral on line of credit Price Per Share Fair Market Value Fair market value of common stock measured on a per share basis. Fair market value of shares, per share Promissory Note Eighteen [Member] Promissory Note Eighteen [Member] Promissory Note Fifteen [Member] Promissory Note Fifteen [Member] Promissory Note One [Member] Promissory Note One [Member] Promissory Note Seventeen [Member] Promissory Note Seventeen [Member] Promissory Note Sixteen [Member] Promissory Note Sixteen [Member] Recognition of discounts on convertible notes payable Recognition of discounts on convertible notes payable. Restricted Stock Issuance One [Member] Restricted Stock Issuance One [Member] Restricted Stock Issuance Two [Member] Restricted Stock Issuance Two [Member] Share Based Compensation Arrangement By Share Based Payment Award Options Expired Intrinsic Value Aggregate intrinsic value of options that expired during the period. Expired, aggregate intrinsic value Sharebased Compensation Arrangement By Sharebased Payment Award Options Expired Weighted Average Remaining Contractual Term 1 Weighted average remaining contractual life of options that expired during the period. Expired, weighted average remaining contractual life Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Intrinsic Value Aggregate intrinsic value of options forfeited during the period. Forfeited, aggregate intrinsic value Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term 1 Weighted average remaining contractual life of options forfeited during the period. Forfeited, weighted average remaining contractual life Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value Aggregate intrinsic value of options granted during the period. Granted, aggregate intrinsic value Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term 1 Weighted average remaining contractual life of options granted during the period. Granted, weighted average remaining contractual life Stock Incentive Plan Premium Percentage Purchase premium, percentage Purchase premium stated as a percent of the market price per share applied to the awards for a required period as part of the stock incentive plan. Stock Incentive Plan Premium Period Purchase premium, period preceeding grant date Period preceeding the grant date of stock options issued under the incentive plan that include a purchase premium. Stock Incentive Plan Term The term of the stock incentive plan unless otherwise terminated. Effective term Stock Issuance [Axis] Stock Issuance [Axis] Stock Issuance [Domain] Stock Issuance [Domain] Stock Issuance For Retirement Of Line Of Credit [Member] Stock Issuance For Retirement Of Line Of Credit [Member] Stock Issuance Investor Relations Services Transaction One [Member] Stock Issuance Investor Relations Services Transaction One [Member] Stock Issuance Investor Relations Services Transaction Two [Member] Stock Issuance Investor Relations Services Transaction Two [Member] Stock Issuance [Table] Stock Issuance [Table] Stock Issuance To Consultant Transaction One [Member] Stock Issuance To Consultant Transaction One [Member] Stock Issuance To Consultant Transaction Three [Member] Stock Issuance To Consultant Transaction Three [Member] Stock Issuance To Consultant Transaction Two [Member] Stock Issuance To Consultant Transaction Two [Member] Stock Issued For Accrued Liabilities Stock issued for accrued liabilities Represents the amount of stock issued for accrued liabilities. Debt Instrument Number Number of notes issued Represents the number of debt instrument issued during the period. Entity Current Reporting Status Employee stock options outstanding Counterparty Name [Axis] Counterparty Name [Domain] Convertible Notes Payable [Member] Capital Communications Inc. [Member] Capital Communications Inc. [Member] Convertible Notes Payable One 2013 [Member] Convertible Notes Payable One 2013 [Member] Convertible Notes Payable Two 2013 [Member] Note Two 2013 [Member] Convertible Notes Payable Two 2013 [Member] Note One 2013 [Member] Convertible Notes Payable February 2014 [Member] Note February 2014 [Member] Convertible Notes Payable February 2014 [Member] Convertible Notes Payable June 2014 One [Member] Note June 2014 One [Member] Convertible Notes Payable June 2014 One [Member] Notes Payable June 2014 Two [Member] Convertible Notes Payable June 2014 Two [Member] Convertible Notes Payable June 2014 Two [Member] Convertible Notes Payable June 20, 2014 [Member] Note June 20, 2014 [Member] Convertible Notes Payable June 20, 2014 [Member] Convertible Notes Payable June 30, 2014 [Member] Note June 30, 2014 [Member] Convertible Notes Payable June 30, 2014 [Member] Convertible Notes Payable June Thirtieth, 2014 [Member] Note June 30, 2014 [Member] Convertible Notes Payable June 30, 2014 [Member] Convertible Notes Payable June Twentieth, 2014 [Member] Note June 20, 2014 [Member] Convertible Notes Payable June 20, 2014 [Member] Capital raised through issuance of long and short-term notes Debt Instrument, Issuance Date Debt Instrument Convertible Beneficial Conversion Feature June 2014 Total Discount for beneficial conversion feature, June 2014 notes, total Total amount of a favorable spread to a debt holder between the amount of debts being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date. Investor [Member] A Shareholder [Member] Debt instrument, issuance date Litigation Settlement [Abstract] Litigation Status [Axis] Litigation Status [Domain] Settled Litigation [Member] R&D Products, LLC [Member] R&D Products, LLC [Member] Receivable Type [Axis] Receivable [Domain] Notes Receivable [Member] Outstanding at the end of period, weighted average remaining contractual life Outstanding at the beginning of period, weighted average remaining contractual life Debt Instrument, Convertible, Number of Equity Instruments Stock options outstanding Outstanding convertible notes payable, common share equivalents Four Notes [Member] Four Notes 2014 [Member] Four Notes [Member] Class of Stock [Axis] Preferred Class B [Member] Redeemable Preferred Stock [Member] Series F Preferred Stock [Member] Prepaid Pension Costs Common Class A [Member] Land Preferred Class A [Member] Common Class B [Member] Eighty Thousand Dollar Note [Member] $8,000 Note [Member] Eighty Thousand Dollar Note [Member] Four Notes 2014 [Member] EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0"7#_[BQ`$``'(2```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%U/PC`4AN]-_`]+;\W6 MM2JB87#AQZ62B#^@K@>VL+5-6Q#^O=WXB"$((9)X;EA@[7D?FO"$O;W!HJZB M.5A7:I41EJ0D`I5K6:I)1CY&+W&71,X+)46E%61D"8X,^I<7O='2@(O";N4R M4GAO'BAU>0&U<(DVH,*=L;:U\.&MG5`C\JF8`.5IVJ&Y5AZ4CWTS@_1[3S`6 ML\I'SXOP\8K$0N5(]+A:V&1E1!A3E;GP@93.E=Q)B=<)2=C9KG%%:=Q5P"!T M;T)SY_>`];ZW<#2VE!`-A?6OH@X8=%'1+VVGGUI/D\-#]E#J\;C,0>I\5H<3 M2)RQ(*0K`'Q=)>TUJ46I-MP'\MO%CK87=F:0YONU@T_DX$@XKI%PW"#AN$7" MT4'"<8>$HXN$XQX)!TNQ@&`Q*L.B5(;%J0R+5!D6JS(L6F58O,JPB)5A,2O' M8E:.Q:PQNZC[,#_)Q]B",T`T.KC0L=B8733V%3@C2[8Q,&@?4E;&N0 M?77"-C'T*Z<'[O09T#0X$N2>;-HV1OUO````__\#`%!+`P04``8`"````"$` MM54P(_4```!,`@``"P`(`E]R96QS+RYR96QS(*($`BB@``(````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````(R2ST[#,`S&[TB\0^3[ZFY("*&ENTQ(NR%4'L`D[A^UC:,D0/?V MA`."2F/;T?;GSS];WN[F:50?'&(O3L.Z*$&Q,V)[UVIXK9]6#Z!B(F=I%,<: MCAQA5]W>;%]XI)2;8M?[J+*+BQJZE/PC8C0=3Q0+\>QRI9$P4P>J/OH\^;*W-$UO>"_F?6*73HQ`GA,[RW;E0V8+ MJ<_;J)I"RTF#%?.&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;',@H@0!**`` M`0`````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````"\6,MJPS`0O!?Z#T;W M1M[-HTF)DTLIY-JF'R!LQ3:Q)2.IC_Q]19HZ"83MQ>S%(`FOAMG=V;&7Z^^V M23ZU\[4UF8!1*A)M[%>W=\M7W6C0GS) M5W7GDQC%^$Q4(71/4OJ\TJWR(]MI$T]VUK4JQ*4K9:?RO2JUQ#2=27<90ZRN M8B:;(A-N4\3[MX'X<&CB\.\' MY^^:NI];\DC%XZX4LE"`G1J2&YP,62B]HSK72K]U,EDXH>J&6_!(O0-N-$#" M06Y7@[2M&=2!AOC9H,]5-`F]Y5RNG@++O[GN/0TE]M_326O M?G6L?@```/__`P!02P,$%``&``@````A`#-8E2X9`P``Y`@```\```!X;"]W M;W)K8F]O:RYX;6R45EUSHD`0?+^J^P\4[Q>^3"Y)15.()$>=+IZL2>5IB\`: MMX)@P1J3?W^S&,DH7LX\P8+3V]/3S7IU_;K(M!=>5J+(N[IU8NH:SY,B%?E3 M5Y_2FQ_GNE;).$_CK,AY5W_CE7[=^_[M:EV4SX]%\:P!0%YU];F4RTO#J)(Y M7\352;'D.;R9%>4BEK`LGXQJ6?(XK>:L;A,OR&(QB-A,) M'Q3):L%SN0$I>19+H%_-Q;+2>U`&\7S-=R^)*^JF0/.WJ MI[`LUGSG0;E:]E[T7>5JLU4]!VK=FY0"!=?WJ7J1R#N]-TVR>_>+B:2ZW#P'>0/BU M@K!/?=7RNKVM(@PFQ?Q<"OG&@GRCOBA@A$KU`#JS=*V\%'!3!JFEB&,4+R0# MGT3^@,%=%`Z#@4MAT7>'+O%\A&(C%/MK*$"@(>,@F%KO(\A$%#B-,)D.0ND< M2>8=!9,!\1ME3O=AHNEHY$X>6'C#HN"6!#>!YQ+*7,\+IX2BEFS(2P-3.P/W M%-'0^\W",0U"PL:@:H1++U#ISWT&`;GS"0TG@8]K'#!5L]UYJR:*IFIR-6VU M-=K-P4ZXV*^<^,-Z]&-W0A\8G0!3UU.L=S;'-K#,?0P24C]B8_?![0_QO!P\ M=JMEPF%`@UM7[879XB%;!RPW&@5T!`)%S"6U?6E`;GWB[YSS\/LFQQ;.UQ:-OP<"-S0`'6PG:V6*U$&V(#+6&2X M'?6!;;(`B[V/6SM[C,1E"4?'"V<#1,+&R8#%_W&B9,[35<99,<,X.!YVR[/_ MCICJ#>.`0A]]M4V+8W9(%AP=NV76C[@=JL5YL5MN]<)/8L=P"S@PFP.SGOG[ MZ=4*S"$J.#AV;5:CQH"3,(FS!(YH=5%G7#UZ8_L'I?<7``#__P,`4$L#!!0` M!@`(````(0!E_\J`*@4``#T3```8````>&PO=V]R:W-H965T&ULE)C;CJ,X$(;O5]IW0-QWP("!1$E&S:%W1YJ55JL]7-/$25`'B(`^S-MO M&1-P57H2YF:F@S__^'>5[<+K+Q_ER7@335O4U<9D"]LT1)77NZ(Z;,Q__GYZ M"$VC[;)JEYWJ2FS,[Z(UOVQ__67]7C[XM<)'7^6HJJ M4R*-.&4=C+\]%N?VHE;F<^3*K'EY/3_D=7D&B>?B5'3?>U'3*//5UT-5-]GS M"7Q_,"_++]K]CROYLLB;NJWWW0+D+#70:\]+:VF!TG:]*\"!G':C$?N-^ZS??VN*W;>B$C#;$"<9@>>Z?I'HUYU\!)VMJ]Y/ M?03^;(R=V&>OI^ZO^OUW41R.'82;@R-I;+7[GH@VAQD%F87#I5)>GV``\*]1 M%C(U8$:RC_[_]V+7'3>FZR]X8+L,<.-9M-U3(25-(W]MN[K\3T%LD%(BSB`" M/081YBRQU(AZ@TG69=MU4[\;D#7PSO:CI[L MM#%A+L=@!21+(H6$?6(RQ_-\C[C4`=?U;)*\B=[N.(PQ`J0Z$'`63J%&!B%F MNL';QB1,XC?)]@LD4@B\?/1.XW>72.X2Z2T"V?.QO7GQDYU(_%P'MNU-T47V8'^;'ST)$ULDZR*%*%N>&Y*L MC?5F7T\IM3GJS<'2(TL[U9N9Y_(I=9`G6:)H^__MC)0P\42F.E*(\L1\[C(2 MRQ@#`0]\'.Q$!^!P8YR\(L4`LS7KR-KR9ZQ)F%@C`XL4HJP%D(2D/4;MC#DD MGHG>[C`_\(A`J@,L\%U[RE-DC,&>.#]H/4VL30FN]I&!&598X'(ZZ3$A6,A) M-B>("%G(;)J2B`A"%GA3!8`-RF-]=E8R503`*3/N@L$D/!A4S*V=?#/=ZC*!-UA2#(H8I=20I:8C*R?>&R=$L$CVT\R,E+A:@6B M5G=:)=B6/.SGVY(T7GYTIX^88O34HP./!T8%UP\]3N8FF2&2WA#!%N61/]^B M*A!0Y$A>1?)S":9ARLUK@SK!;8>1-9Q@"0:I2;,W10@+W7`*/_8G3_SY_E1] M@/Q-PL/:4XRJ,1]@77GNM"IZ)&8(86'H.&0%)Q@)G'#)Z.F'$3^$G78:"S8I M2P#-Y+QRC*G"`9DE3J*!469)'L:W&I.A<=F7<@_VPB:'9'H#P.9D%?#SYE3M M@,R1"8[@(F'*5.ZZ0<`8F8`8,=[2X=R]*CH1\[F.O+28WN7Y2\X]3J.I;B74 M1WLIFH.(Q>G4&GG]*F\<7)C)\>EX&_+HR(]9\CQB*_C$OGZ>R-L3^=P:.\#E MQ3D[B#^RYE!4K7$2>WB5O0A@B3;J^D/]Z.IS?X7P7'=P;='_>81K*@$?[_8" MX'U==Y&ULG)K;;J-($(;O5]IW0-R/ M;0ZV<11G--`[NR/M2JO5'JZ)C6,TMK&`3&;>?JNI-J8*IAHF%TEL/JKK[Z[N MOXW[\?W7\\GYDI557ERVKC=;N$YVV17[_/*R=?_Y^^.[R'6J.KWLTU-QR;;N MMZQRWS_]_-/C6U%^KHY95CL0X5)MW6-=7Q_F\VIWS,YI-2NNV06N'(KRG-;P MLGR95]?3W%\L5O-SFE]^'.^*XNJ.-0S"#?'1/N:-_/-'"(]/>YS4*"[W2FSP];]X#VH<./. MGQZ;#OHWS]ZJSO].=2S>?BWS_>_Y)8/>AG'2(_!<%)\U^FFOWX*;Y[V[/S8C M\&?I[+-#^GJJ_RK>?LOREV,-P[T$15K8P_Z;RJH=]"B$F?E+'6E7G"`!^.V< MX\9U7],='QOZ6I8IWMK*,8W2$,LMSZQ MVE!$]1%_V2(D62B$\9N M5X*/JQI]$\U_P_*+$<'\HV#M\:[O M7O<6OG]/#]<8O#ZLCPC06P*V4MK+7M]$!?@15X#,<`8X>:V$D@BB8D-5R)6O M8=O2@XR4O950$D&R]V"=F3X(S5U\%%@=Q`8RA=1;6A)S71"J1(3JT,[6*29Y M&#STP>[BV9O&AKG-XRA@^A(#B/EC.\,(S5][72=_/9M#6,(L.M`ANSK\*&R7 M"UR//(2&D\#I8$>4B%`IVOPAM,&]W$Q;;>?'^^4=6\02Z*&TO)A9 MQ7KS#^J%/!,[HD2$2M'NV)%B*2_T4DMY62TY\:R($A$J05OD>`EHJ&04^N6% M$);7>M8I+?WO>J"\))MNII3R)(0*TF[9$31N+^*AQQ)AT8JO7I(1FZEO191I M:KA(J11MG1TIEO)"H[64E^3&1H(549Z$$`D^\W190D.SU2M:LU$PT'#_H00[ MH@R"EBI\F/"9F8\KI^8N+H1OS@TD"I%,&V>&&(6.A3;?T>7D:]JV/S20*`'C M"(@2HU`)VEG'2T`?II.Z5TX("?DEOA51!K&7$[33%3"RG/1=O)SX8P(?(5&( M%5%B%#H6S,^BP\(>V83!P@)>29V1(D(E3+)KX,Q M?FT@48+5TI48A4J8Y-?!@%_WYS5"PKQ&0-"H3$/#"!7`_-JR,`WY-)NV<8!0 M.Z]]!B0&&,[.S(?1/ATPGQZWX6CNXO.A-Z_1C[\_K^U^;=H9EDH'XH?\.ACR M:_Z,TT##21BSL_NU&(5("2?Y=4/;_-I`D@0[HD2$2ICDU^$8OS805I,'!S-Z M^U=#""*5B%`%VADG^UV(?BK[G8&,DB`:4()A1"420I7\D'.'0\[-/OK$!A+R M3.R($A$J!5KJ#HJ\VH::MLX,A$0)5D29IH:C4`F33%M_2\/W'3W',Q!^$S_T MPZYR5+UF2G4Z5 MLRM>]9$T'QX0M>^VQ^4^^/K8$GL_]A[@]!2\/V\OP"FV:_J2_9&6+_FE@\,7=7%M3H$]%S6<7VO^/<)YQ0S.7RUF`!^*HKZ]T`VT)R"? M_@<``/__`P!02P,$%``&``@````A`,,(>(-Y`@``RP8``!D```!X;"]W;W)K M&ULE)5=;]HP%(;O)^T_6+YOG(0F4$2H6A!;I56: MIGU<&\`TSA=*26ACJ%3&-YC1O%\F*Q&&8$DE%C;W"6%^CH8I",#Y7;"UY M;;V(YA6UX-^4HC%O:I)=(R>I?EDW-TS)!B26HA+VM17%2++QTZI6FBXKR+V+ M;BE[TVX'[^2E8%H95=@`Y(@W^C[S';DCH#2=Y`(2N+(CS8L,/T3C68K)=-+6 MY[?@6].Y1J94VR]:Y-]$S:'8T";7@*52+PY]RMTM6$S>K5ZT#?BN4)5&2?JQ"O*,V MX)Q:.IUHM46P:>"9IJ%N"T9C4';)!E"?\\D@DEOSX!:U2X$VT(W--![>3L@& M2LCVS.,9ID_,SA#)`2'@[V`2HG=-7C;G8`B!4,GMOGAFU91U$=_W967?FAKV'_OH MF4L%NT3TO,&.O]Z;@S]JIF;M$]+RE_^/-P:=U._;#-],S_VIF=S8.D^,> M]*;\>>1?UX:N^#/5*U$;5/$"]D\8#"&7]J>1'UC5M*_E4EDX1=K+$CX:'-[9 M,`"X4,J^#=QY=_@,3?\"``#__P,`4$L#!!0`!@`(````(0`QF69`L@0``$,5 M```9````>&PO=V]R:W-H965TS>Y.]R6:S'\^(K9(!VM#,.//O]S2GQ?X`1'U0T>JBNL[I+M*+ M[Y]YYGS0DJ>L6+IDY+L.+1*V2XO#TOWG[]=O3Z[#J[C8Q1DKZ-+]HMS]OOKU ME\69E6_\2&GE`$/!E^ZQJDYSS^/)D>8Q'[$3+>"?/2OSN(++\N#Q4TGC73TH MS[S`]R,OC]/"189Y.82#[?=I0E]8\I[3HD*2DF9Q!?KY,3WQ"UN>#*'+X_+M M_?0M8?D)*+9IEE9?-:GKY,G\QZ%@9;S-8-Z?)(R3"W=]8='G:5(RSO;5".@\ M%&K/>>;-/&!:+78IS$#8[I1TOW2?R7P33%UOM:@-^C>E9ZY\=_B1G7\KT]T? M:4'!;:B3J,"6L3F.H]%DZH\)P)TM MY=5K*BA=)WGG%=4V MO<15O%J4[.Q`[X%R?HI%)Y,Y,%_\P=DTCG49!DX)DF?!LG2GK@-><*CRQRH( MIPOO`RJ32,P:,?#>8(B.V-B(('QJ,!XH;F2#E:KL]G)>U`FP4"?**^2N\0=5 M2M#_[.F*#"'AO6*ZST#3",E(U]FL38$/; MQ+CS&C'JG4/#XHT-Z1`7W2-.@$UQ1HNO$=,KSH9TB(/E-MPY`3;%&4V_1DRO M.!O2(4X$J+&OW&X],<@4:=1NC9B^UNM#:*TW>T2C&&1J#/7F7R.F3R,B5*L[ M?"2P7DTC0^C?_G52CS)57N^`&XT$S>I53$8$%K'R,CIW(]%#)(M]_.[:$]S] MM7UG$AG&2I`JPEK<+9CKS+7Z$['+WR\4LT$7:H4=@OJ%VI@NH6+'OU\HYH0N M])JGL@GL,+$=M3%=0F'"#P@5H\QN-2.'(&AHMPY$Z_T@QHA+<$5F9D@0:I4104^-+5@NIKXH>PB+>$5F<$@0?U"D4C%=`E]*,!(2X)% MUSO(;<$.*-M1&W.ET4H?/!1B]2AC6XC,1)`@U2V[2UM`RFQTJ2WA=7M!!2WA M%9F9($$WI"*3"NHR5<3'W;M5@*&C[U9F*$B0*D+Q"]=3"Z9+J)%>_8\N04MJ M16882%"_P,&I%0"/ZN0-@0)MM.74W.]K2GWSM!U$(G4270X:P71#8$L@39>$A34[+`]W0+.-.PM[%.16!I_7FU^8,[3FH3\&:/^`( MZQ0?Z,^X/*0%=S*ZAZ'^:`H%+?$0#"\J=JJ/@+:L@L.K^NL1#BLI')+X(P#O M&:LN%^*8K3G^7/T/``#__P,`4$L#!!0`!@`(````(0`$W??U^P(``-0(```9 M````>&PO=V]R:W-H965TB9 M"LEX'6/7=;^]8&IL4\8^!`QXX$ MS6-\[T;K$-N+>9O/'T;W\N@=R8+OOPB6?6,UA;"A3+H`&\Z?-/0QTUTPV3Z; M_=`6X(=`&4E"(!_5#&] M,R`0\M(^]RQ318PGH15,G8D+<+2A4CTP38E1NI.*5W\-R#U0&1+O0.*#^L.X M9WFSP`W"#[#`>JT4>+ZQ^%XPG5VAQ3:^VI@2HLAB+O@>P=8#Y;(A>B.[$3!W M^1@W?6+_"PR2TB3WFB7&4XP@"PE%?EYXOCNWGZ$RZ0&S/,><(%8=0I=!TR:F MPX2I.]9''388Z%U`PL#N$).<0+QA" MUN]`?*_'#`Q-AH9T67PHS[@Q/0DVZ+$/?]+SMY$N#09V8N_U1.7J(B*YB%B/ M(08^0F!HW^]CH$_J-GU_C3X MU-])=98&,VM7?ENSK>UJ9"PQ8R.YK,<0`T_A1SQI\*FGL,_*[$F#.:3I>/YQ MFL:908RH3RYRP"VCE;S/8?R96\0&ULC)3+CILP%(;W ME?H.EO>#@824H)#11%':D5II5/6R=HP!*]A&MG.9M^\Q3E"F&;79`(;?WW]N M>/%XDATZ<&.%5B5.HA@CKIBNA&I*_//'YB''R#JJ*MIIQ4O\RBU^7'[\L#AJ ML[,MYPX!0=D2M\[U!2&6M5Q2&^F>*_A2:R.I@Z5IB.T-I]6P278DC>,9D50H M'`B%N8>AZUHPOM9L+[ER`6)X1QW$;UO1VPM-LGMPDIK=OG]@6O:`V(I.N-TBP)$0Z&W.91GV726?P+,EENW$9Z)$=M;I^7OH$K.K$!)SQ2XGRE) M&J5YEF0S3W4X)@,;O<[>W&))QB-SI#VR!VB6P7-]$J3C8HW MSH"YW]F+H6%7U'0R'[G!.6BNG:>34?+&&C3W6WOQ7];3>.0&ZZ#YIW68Z]#U MGC;\&S6-4!9UO!YFUL^@"5,=1W[A=#]T>:L=#./PV,+APV$$X@B^UUJ[R\+_ M-^-QMOP#``#__P,`4$L#!!0`!@`(````(0`J"`4*HP(``,,&```9````>&PO M=V]R:W-H965T>>>^W+ZO9%UNB9:R-4D^$H M"#'B#5.Y:,H,__SQ<#/'R%C:Y+16#<_P*S?X=OWQP^J@],Y4G%L$#(W)<&5M MNR3$L(I+:@+5\@:^%$I+:F&I2V):S6G>!IWNW;&Z9D"Q1;40O[VI%B)-GRL6R4IML: M?+]$$\I.W-WBBEX*II51A0V`COA$KSTOR((`TWJ5"W#@RHXT+S*\B99W,TS6 MJZX^OP0_F+-G9"IU^*Q%_E4T'(H-;7(-V"JU<]#'W+V"8'(5_=`UX)M&.2_H MOK;?U>$+%V5EH=LI&'*^EOGK/3<,"@HT09PZ)J9J2`"N2`JW,Z`@]*6['T1N MJPPGTR"=A4D$<+3EQCX(1XD1VQNKY&\/BHY4GB0^DL#]2!*EP21.9_,1+,1G MU!F\IY:N5UH=$&P:T#0M=5LP6@*SO=>_606/CF3C6#(\PPC"#;3G M>1TO9BOR##5E1\R=Q\#U##/O,03RZ9."1,Z3>K_,)VT'=MJN["Z9._]B*+1X M7R@9"IW<_UO0!6485'HC21CV_#X'CYF<8=(>,;`*D/%6'1CVSAEK$D8]KU?V MF!'*T.7QR@X\]+QX,^2%/63NNY^&9R49&)[^CZP##V63,+XP[#&3:2<I2-`;5O(#0,)A!J;6?0GYA5=N=Y*VR,#VZQPI^%AQ. M0Q@`N%#*GA9NSO6_G_4?````__\#`%!+`P04``8`"````"$`/6"@J*4"``#% M!@``&0```'AL+W=ON39"M3F.@A`CWC)5B+;*\<\?]U<+C(RE;4$;U?(1O:M&9(YMD4^@DU4^[[HHIV0'%5C3"OO:D M&$FV>JA:I>FV`=\O44K9D;M?7-!+P;0RJK0!T!&?Z*7G)5D28-JL"P$.7-F1 MYF6.;Z+5[1R3S;JOSR_!]^;D'IE:[3]K47P5+8=B0YM<`[9*/3GH0^$>03"Y MB+[O&_!-HX*7=-?8[VK_A8NJMM#M#`PY7ZOB]8X;!@4%FB#.'!-3#20`9R2% MVQE0$/K27_>BL'6.DUF0S<,D`CC:B") MLB"-L_EB`@OQ&?4&[ZBEF[56>P2;!C1-1]T6C%;`[)RED)//8_#Z-ZO@T9'< M.)8=XD8;HFSU!3=L#<>@RB"<@PJ@Y$DS`9^GX/'I">8-\3(*D"F6W5@ MV#LGK$D8G2E[S`1EZ/)T90<>>UZ^&?*6/63ANS\+X1@R&SF>_8^N`X]UDS`> M>+VPQZ2S7CD,3GHQTH7=.=VO`Y_K)F>Z'I/ULFD3E=?TX\5^;Y+KBGWC3 M&,34SHV*".*&I\,4NXG[032\@"G2T8H_4EV)UJ"&EQ`:!G,HMO9SR"^LZOIO M>:LLS(_^MH;?!8?O(0P`7"IECPLWZ88?T.8/````__\#`%!+`P04``8`"``` M`"$`@Z08PL`"``"8!P``&0```'AL+W=O`_OZ_/EA@92[N2MJKC M!7[@!I]O/W_:')2^-0WG%@%#9PK<6-NO"3&LX9*:2/6\@YU*:4DM+'5-3*\Y M+8=#LB5I',^)I*+#GF&MIW"HJA*,7RFVE[RSGD3SEEJ(WS2B-X]LDDVADU3? M[OLSIF0/%#O1"OLPD&(DV?JF[I2FNQ9\WRBF85D95-@(ZX@-] MZ7E%5@28MIM2@`.7=J1Y5>"+9'VYPF2[&?+S5_"#.;E'IE&'KUJ4WT7'(=E0 M)E>`G5*W#GI3ND=PF+PX?3T4X*=&):_HOK6_U.$;%W5CH=HY&'*^UN7#%3<, M$@HT49H[)J9:"`"N2`K7&9`0>C_\'T1IFP)G\RA?Q%D"<+3CQEX+1XD1VQNK MY#\/2HY4GB0]DL#_D23)HUF:+Y836(B/:#!X12W=;K0Z(&@:T#0]=2V8K('Y M=4=@Q6$O'+C`"XP@6`-5N-MF\7Q#[B!U[(BY]!BX!DP2$`1$@S*H35=V8*?L MK^PQLQ-,'A`C@P"9;M"!"PRN0MK2 MY5/BO++'S.9#YN/H:7LD"QUU*NMZ-8..?[NR[M!8/HN7P9:7]Y@)QN?C"-Y6 M=N#W4NXQ$Y2A-4^]OZWLP&//Z?)YL3UF.61\%L,OY&24\UZI5Q^1=>"Q;!:O@ATOZS&YMYO"1R;L>[M^0OH!(KFN^1?>M@8QM7?3 M+X%SX6D8S!?I,%O#!@S&GM;\!]6UZ`QJ>05'XV@![:7]:/4+J_IA/.V4A9$X MW#;P!>3P]L<1@"NE[./"#>_P3=W^!P``__\#`%!+`P04``8`"````"$`N.7+ M)QP%``!T%```&````'AL+W=O M_SPSGB%>?7LOCM9;5C=Y5:YMLG!M*RO3:IN7^[7]S]]/#X%M-6U2;I-C569K M^R-K[&^;7W]9G:OZI3ED66N!A;)9VX>V/2T=ITD/69$TB^J4E3"RJ^HB:>&Q MWCO-JI.#K4=3VG2/+21@O+>HJ-:K?+T^RQ2E^+K&S12)T=DQ;XFT-^ M:CZM%>D4'M*J.(&)Y_R8MQ^=4=LJTN6/?5G5R?,1]OU.>))^VNX> M1N:+/*VKIMJU"S#G(.AXSZ$3.F!IL]KFL`/I=JO.=FO[.UG&-+"=S:IST+]Y M=FX&WZWF4)U_J_/M'WF9@;,R:%#P*9A942$MI=00`^+2*7*8&>"1Y[_Z> M\VU[6-O,6PC?903DUG/6M$^Y-&E;Z6O35L5_*"+*%!JAR@@#>C5.%S001'A? M6W&0J-O@8](FFU5=G2W(&EBS.24R!\D2+,N=,?#/]9W!EN2<[W)2-Q74#83C M;4/YRGD##Z9*$EV1Z(KXBD)<)`[@71AAYT/&^VQ2#'NPK9[-NYCM\".4\(&D M7[A3Q/<4&AJL,QU-BM@1X/QYF@E%SF:UBPM^E84FQ@ M!1>SZ#&4>!V63\(@U,?CX;C':>].C0IR?3J5%!M4QJH12I"*"M=U#:K;XQJ6 M-P=+BG4L9BP;H40YBS-F4`V'/1'T!T>#\N=`2;$!U2<&1A`E"$5(X/?+8L8; MXX--:5BRHPW*Q?VC*,4&%M6=$:%$87'J>H8@'@H"X7J]LS6N<`Z7%!M<1I`B ME""7)T2_*GKKYK`&1:"0#KTEBRN'I+SOM6Z6@6=$*U(:Y*.^,,I(K(V+D/G] M@=8)KY3_"818NH>%C/5''O.-H`8)F4U7ARTA&LW1J< M444CI4$X6-<+R;U0/(N`DP8^U(:7!M`67>YX9[8UW"*6%AGR,Z MWJQ>0+"2`^2E1[$^=U1H40.?%\T([YY$QY-%>GIPL:1KP37R*I(O9G"\T7N4 M!"0P3Z^AH(3W54>'F]4:R+@W<&/I2&EXUTD9,=AC-8SLGBOZQ-6Y9G4',FX/ MW&P/2J/2G3'7-Y(RUA10J`-ZRVFS>@09-XE!-%3"H6:8<-PHV+&R@QL@\"[0 M>UYWG=$I)K[PCEL&[\^;HAPVA8!"](R#$Y.A0E"7\=[)&B2]TCB^?BOO9NF- MPZP;D=*H.&MNZG81WQ'HB$;GN-_3Z+AC\#ZWT7]*HR(HB.\QP\6Q)@E#P;Q; M#I35>W)5H5CKAT5O$!E%AYIA#II%3YFY+M&=9[2,:2\&=-PZN)%BD=(,&49' MY;Y&!P5#0S]*4._+GX=4SC(2T:ATD=)@M`5CHWIS1Z`CSFH@\I>R@6:^W$5* M@VB4AR0(J>'GV-#X@1O2?HLZX*PF0L=-1)C%6FD0\($2PN`WV>BLH*%/DJXH`979P$3A!B[B)49E'`.!9/>.LU&1YE6L^%":!1J MHVM$2H._MZ^_:>F2JV]:>&^$URJG9)_]3.I]7C;6,=O!>7$7/B1=C;=&^-!6 MI^[ZY+EJX;:G^WJ`V[T,[E;9_````__\#`%!+`P04 M``8`"````"$`;/P+>D`#```4"P``&````'AL+W=O=L1G*M)=>4/@B#V:TP;5SM,NFL\6%'0C#RR;%V31FB3CE18`#\O M:Y>QN@6+):VH>%>FKE-GD^=5PSJ\K"#N-S3$V%\,#.UZ"G,8_]L0].\VE.(0*9=JY'2YUS^!)/]D]E/:@=^=DY."KRNQ"^V^4;H MJA2PW1%$)`.;Y.^/A&>04;#Q!I%TRE@%`/#NU%26!F0$OZG/#Y"0U%=02@:E(SRBBO<0'O#TC1'X[HYP$L;C.@?%@K\)8:,GP6+('4(JT3V$@PCJW M(\I),Q?6."#&)L!"2T8ZQZ,P#BU!:@@&"0H.`@,0HKP=4$ZR`!,+4$MB!1C' M41)924Z/!=$H&8XO`,(?X1BPOP"EV`(;66!:LLO<>&B7W_'X,(["_70C;?$M M5%)L48WWMKKDM&2LTH6^W!U6U?5V<=B`2FZ!DF(3*@XL*"W1>X@"]3(5:9_" M0),GWE$[Z=]%*;;0D+GP0DN&*E\6=GI^S,`9WX(CQ1:.530++3F/=P$LXZ!_GU#NG4?-Z[XI/]KC5%4@;V#6Z-+(A-1 M]N*K2POISFT@6IUIL=7HU:,P3!*$K##2?HT):)T!'^3PM/G'A\ZHFP5<:61% M]@/V:C2@OM?H8[_%*_(#=RO:<*Q] M-```;*P``!0```!X;"]S:&%R9613=')I;F=S+GAM;.R=VW(;U]7G[Z=JWJ%+ MI8RD*I#F0=0AL?D5S(/#+Q+)$%0\KM1WT02:)&P`C70#DIB:B[S#W,Y4^0GF M(?PH>9+Y_=?>N\\@(_>7__9Q.HG>)UD^3F=? M/=K>W'H4);-A.AK/;KYZ].[R>./5HRA?Q+-1/$EGR5>/[I+\T;_M_^?_]&6> M+R*>G>5?/;I=+.:__^*+?'B;3.-\,YTG,ZYO=_<>19.-4K!M%A_&B=9]G MZ45R,]8$8/1I/&W=]>3XS=%_/3\[.;V,!D>G@[.+:/#=X/+H[2`Z.3UH$N2' M/LGC":HV2C]&?DKOF?4^V^,_KG;T7+[::EPZ66<;CT?$X'S+$=TFWF&`4'JH,<(TYY\\XG7>+0?-SSL7N`/^\VQ_1,.!Y/DBPZ@/$W M:=;FP&`:3W3#13)/LP5Z%QVDTWD\:]T9>)I.I^DL&BS2X0^]:'`;9TD>G2T7 MIJ4\WJ3BX.STD/4Z.HSXT^#LS9XL6AP]B/-;T]BA_I#\;3E^'T]8T-:-_:%9@3S* MDF'"35>3ENR=I@LF>;'R^LGL/2-WU%LV01I==1/,28+2=( MPR@:)9`T',<+K)BN/=Y[M=M[L?O"'GV\M_.RM[WUHC4^C\)%NT?ORL;)(L[N MHLMD>#M+)^G-7>>[XJFDZ^_ENUZ\V.N]W-OS[WKULO?\=>M=WZ3IZ,-X,FG2 MX#BU8MV]WKX9QU?CR7@Q;C.Z6/%Y?->UW,WKT0:RX5@VCV%MDQSNSY;P<[+Z ME8?)=8(]&3$0HK)L2=B3GW[\ZN] M?K[C&/J\]V*OK3"KQHL6Z?TSK(OF/:PULW";3D:X]"?1$>+79M=Y%IB1RXC` MW<=;FUM;VQ',C5#29?*':+N'8=8_4>XL3+Q7BM5*O]JR=&%^^AIC\:(93I#%67-=@8 MSZ)A/!^C^LWE1ZPJJGH]'HX7S5O5,3M9Y8*NAS"KK%M=X-2_,6I-AYVM8K^I85;/5'.L>]0QZV7RD(?J]4N0C MC+83KP>?:6G$ND\X`5WW[GMD&(0@#&`:M=8L.791RF>0&Y2ZZOU]^M`*5]!N.>U[1H'G%_R\*_]\4L(.4 M6`UXL<+U]4?3\Q4G/(BR0'CP\=P!LQR4EJ,&?5 M_<[Z?72=I=.H7,[^$-$QJ/?[YCS$EDD'6_JC[Y?Y0M`X=^AGF,Z&1$J&D_6`?A5F MMO!AF<,WK56A.&C:JE>"S%?ZGQ,`2SP;)M('1*NPHK9`'^),X2_3`]#D2?9^ M/.P`KPU]#*Y&6/"%F49G16< MV^:WX53FOR*4`M0(L.:!S`:V[D#K6D%;^G=^$;K6O34%!7T565&$YDSB/;)R M'M\Y@1#_O9UK#MRBIFODYD--R3T>SQ`"V;?[J,G289*,O+!?I5F6?N"1G$05 MZ!KIJ0<'@:'-=Q<$`YW>C\E(15=W)#7:!'0^:)(@0;`I"-K:'P3L5X33*V^, MXD7T-3F>V4P31_0P0:2%FJ^]]WFED%8^.5C.YY-$*Z@P.@A`-577DE:[RX)R M+;DSTM$B_MA6N^:=SNXWB:^1<$APAB599FC[+#K%OHBF4E[$S746XB(9IC;TY/CDH$\JK7]PGIV>13Y%!D_Z'_G_-_5%_M?CODG_[MB/W+` M6X_XVY!,0A;A@Z(_<$G,A^JBH0R?UXQ"Q#? M2(DD=#*=Y>ED/`*:C1`P9',\#:*%+@P67'"6K7/F7;/.;JZ^>G1\K/SHEJW( MS^/__N4MD`Z;;RE%*?YR%B^)@"$4V?7T\Z>2_FMGFZ";E&*@&]6<+$>)),*& M,Q>")3B>@!#3,9(Q@!6(S.`NYYF\!QM('4K%?OI1";A\>96/1^.8=%4>/=4P M__S'_P``S1)UOAU\5*&607LBA#1&FB6]:`102!>R'D8B MZ=1(3MFI?LXU"A$3A#-3$E(Y(`RP6,(W>"6R5=S+]>3N9B$ MZ16Q[]!__F8K:7Z;A'Q&I!W(KK`JOTV7$UZ2\,+8!H"]WR]G`!8,QH?QXM9& MG`J5RT_#NW@V6\+OAY=A/8[7>"W#JAG<*8%.$8%9D-5-IE?XL)#9#;PKINL7 MYDD>'<.]B(K$GUB9"<\6]`^2X3(SS&>K?.1QLZ%20D5+:D!"P+OR,6:6/(M*$-T+](%%9\$0%)1L%,58(4&N;8%% M3?*@*LC>MM<5T-833T@NF(3HYD\_0I&>3.<$0:P/',:D`:^EK[U(PA17H.H, MUN6Y\JWB:QQ=QV.@BB/(Y59O8X*HJR29M9A:4T/6>FWEDQ9)-@C21%\Z0T"= M5$N`R+=*C"M4FE!R*5].T#P]X6`S0P1:89Z7[)]/%4LAO0LLD?T?ST8LG\61 MO%9\#50L;F'Z-+Z37BBH'&K]@FQ>+V%S$%!-IBFASS<+=[&&83Z-%^;TKT.( MHHG_)I;7RW8TS@F"8`QSGDD/!_&$:#'^`8DE0=O36AQF,:O4B]XM8A=6\TPR MNT$21\%$F67BUE%BFJ*L`W>4*0C)"<*[O"8X0C?A(WHBHUSF!A@J'2V'B(5N MED%TGZ"BSLOG2\C-A]EXOI"__S5]V$__JUA] MT2/4\BN^3F7M-F2)KO%T5@F88W'P'.0E\/,5UI8B>A^1Z,2O`JGD/H,IC6[Q M.[&%W=+^QR]W7O5>;[M2SU)XQ8`P@M053ML3NR^V>CL[>]'(B9$4F:@AB8B7 M55EW;H12.J[>_(BOIV]&AY_TP*XWVN8`1.\B>OSBU:O>]JM=D\_UB'V^L]5[ M_ORUK%Z6+F]ND>`F835/X]@SDXMIYO=M\CO;O>U=Z@VOGV^V4>JO*'B&U8+% MN,6WR;IB+6:L&`XRBN:F=Y_*\6\^C MIP*GFA[BEX%S2('8G5?Q[(=L.5\,[YZQ&*OX%V`.'1T(/:7:>`Q6&Z5+,F;Q M%>G>ZD+BR5WI[TYN&<<%S%H"&_DYN@$KWNBW89+-G)_J1'Q-3*?I5]RPE0,U MDO?[\"555LPJCMPJASF)02%"$Z&\RM\MGY1E=WJ4TL)2B1"/C]Q?5SQ:R;@P M4WDRY>*\[_AO5P8!QT`ME=8C)1=R6LICU;X,2=1[DVT MQ*3>$B)O2(=ATNO$@0-!#S$!$"^O//2Y0%?L)`N(6[UQ&O)X<^NE:'J\B4%$ MR5R5R`%A]`[%?VN4S16\M,>Z@M98P;:&9W_"Q!+!]$X5D M>'>%:CW>I1-@CY>GUS_]:"QP\ZD6IHU1_F>FPW@Q3+ZYR9*;P-G=WL[V5N_% MBUTW`0.&=7YV\,,*Q,B[1I."D7:VZI'H=EE4I_Z/-[=?ELS9C,X`-,THHR[` M);$:NQ3<7;H27.6Y@QQ?BX8G5*Q?E2\T8@>N4"TK M,Z5=SINV-V\.B&,,`'C)!YE_@M(8\RQLB669/T-3U$8`WZ4L_+$B$#VG+L%T M--2F@C(4!'@@%98%-+4J`:-\GLR4)0;AY'Y,@4^NZ4F-"[R2.,9J?_%4GX800U]-JQKX?.TQOO' MBJ7_HOX3S;2,WD]X/%M:_LPIK/#U/7'`YZ_IBA!@PW1L2)6H!B!<*H$%AB,R M"%?QQ!RI];NZ8I+/9E1[W,@M-$LQD@I^;/8R&?!+/XZ1!$";F(2`P:2K9!B# MD(-_'4^G"0DV^5'YJ-)Q%]$PQ'%[?5T\8X,,K9J:W*4S+KZ\]1!18L22%$X%ZP<&7^"* M7&?AO]0R7&;QJ)(N!:0&*F09A%FS$6(#+\2M!5EUW*J%YTH8Y+?C^9S+6DU? MBS36<8O5D:JX2^&!W6\X3\8%69H8A$D$PPX1%ZRR7C,93RV5Z?&N;`IP)U<] ME31)#P]`.^IP$:"TV1P>MJF4,Z`X*6&.*"'%)O-U2%GF>JEV2I\U&NCR(V;!: M#T*9$X%$R_D2>02SQ826W)>#6TBP.TXANTH&+,?9W#N&F8_D2 M^2R)*8";;A9\5$PE(Z5!/Z39#X!?\'*%`]Q$EEDX,8D9R@^<$4M@Q1>TU^O) M^ELP$B4RND:?M*1POIW3MF#.2%DR%C&>:324^WD#@)`YR`_>:!2:``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`2P(PQS$AB`(! MV)RBD38B!K_EU3($P&7MGZF,1AQ6CD<<)N@JA:BO&GC#HAA$7PA8;_.C8MMR M:8$PIGN_O5ZV*^SI*4F1[3NOW%5>:5!7X$#+]^MU7GRP7`:%D0?,,Y.BVW'$ M=,KYZT)E7$MNL?1L64);=`QL8J`.VV!>UR:>TPO4/!FJ# MBU0K,`,6YB31C$>IQ=H2V<4'_,8BF5-*=9LSJX:U``B&EESI#Q`%_%*QSC7F MJ#LD!6&@E_DP.WFTN.W'4P8P(\; M"NYZ1[DN+@E7L,0+^C6,1R0+P7:O+YZR4J9/9>5%UOW[Y>A&Z%I&%,#IH28QT_)#".?Q-4)>_5M@X1.H*7EF"^^0OA1#;_+# M2@[J+\9LEWU*(?_)LEX31H@*2V-IBGH,^6:G<4.\):X?K#!?Q!`Q+`[:[;MT M*Z@$8U+HE`%($DJ6O-8K"I$+_J2NXX,#I[EE[Z#!O2#;DKZ@/L62EUSVULQ; MI4[M*U5*U+3EI\*]ZOI[&^']HDA@\VYESAZ)B2WR@!90N>BUZHY+#7=-)JL2 M.-TN\$+VD03TA8N,)73KQ[._E$,*1,#C,D)WMIPYT?J0:_,;X2M=F2X)C-FS M_4"N%1240OLERA5DD?4-C9Z(A-O9@11+@N0`%`F`7)PM=TE/#*Y6Z6IY)T.+ M\1M_1"XJ%M#Z121YC1R\T=Q*M<-/Q]<"\BL;(M!3Z(Z?;*O*P#VJ%EAH[JD* M:5$16.#0J*Y+8#CC+OI<%S=2FCJQQ4A)'$-$O),+.J ME#`)]T+9FRR]HWE3W>2.^P5((55$=&HF2?TR'IH4;UB!&O<':K'88+L?LB"+ MP+P,`_WV^B/J;MDN[H8?1R^Q4'CEA'2)70WGK0]I=29(F3MYPN@+2H M%ONJ(Q1\9.'7UF6>$ZHNZ5U2$4+NHQ`'OW%"`%*WQTHNB!(&YR&`M2Q]9.*I M*-E2*$HCLNS50J:#%4I(0M,-X>]BPYQ^'1J8ZVN/60;6:F-1YQZC$&+@QRW8 M#WU!.BV)\R;42%<*1_3!G*XO(&H:M`DB>@Y155B$"[=)>0@4R#!B88!5:(U\ M7K/G%_<$`X@;Q[J=4\@N-FOH+VZG!FG80C1,**1?N7IS_&MJI**.4THL*@\& MR&6OMYXI@+=)OF=BG7.:AZ4IG/MJ61:(4RNY#`$L*!/%1YCF\-D5 MG5BE50G(96G[(N&,06BX@-DH!+;&1K/R*P64>1(1>UM.YV&1K5HAECZG`X." MT0K[,YTPBD''RPQ^9((C*@M7I,\%\U8=,VA:!P[BBO6K.MUQYP;TZ!U6R".7 M")Q8LGE<"V\1%1L^A@!(Q,/076-5.@SG8E]M)-W_=7;SX>8A+&YC7_91T*%S MS-Y`2[H^3(%1GUFTZ\9.CLI"NUDX5(%?Z5`A`WLGTA.=DB MWW:/E'\2U?VNMB=3=);7NB:KTP[V$44*(AKM]+;HHE;_GIDXLP"!!/,7:WGJ M7\K]B2=5BL$7Z'*U%30TZ%B+1"#4I%G&D.C#0D96'W?^XOE>[_6+G=`K$*9O M?%&"Q&<0S%/*-C(<(N=R-(Q@BX/>EBOL6Y)T;RBT)1^5/\-&&PI6S`CGZ0A0 M,1B#BU'4W4$X?4#H$#.O\&^MB*DX4/W5UJ`Z-=F?-EOLM7A[[1&D7E,2JKSV M]34U(Q\MEKA>29.-(("=9FAP>7;P)XXKT5DET3DGJK5W[[;NN'>7;K<5.-76 MW9TVSOIUR]#=M'2F$G^]BOS^*A97VP<7^SCS_O*&+$9$NZ-ZY_E_"YX-<51-M#R`BP2&W:]7!)$D41M>)D@R6)2.% M#FQ0!;W>_CF:]#KSH(H0;(.$8)P31$DP%2E7/NF!TEST;TT9J`T]+C_]>'F+ M"Q"\,"QH?7.:A7^'`05_#E@(1<*,H82#+MW.G1VV%6BBF^QP%=H7SS0SQ[VZ MZEJV3E`OF`GGV=TL9"V``?4T15!JWU^E+;D"/ETZ[HE3RHE6,]V%K2F/YS". M0-OB=DQ='YA]%U!ST?9(KG(N9&\/:QXERH1/2R4=N3X=+UULIEHQA@ECZ+BI M7!0]EEPMV^9+3^E-OR5Q_"[&4$`K,;08)\>\T]NK'9[F34?`)(O:1I^P_$P\ MC7!U$XJ,3G0G,8'A8,@JRCE;4+(ANV@L3$DQV()PVI069(-\^X,E;LK(R(KTB+MXLA MCQQ2AGAK9D\$H-LM"29)*\7$)`%!^<&BBR($/O!)3$+IGWY\H_Z0I]\!;?/6L6/]8F,5[3*4`(DD?_KQ+VK* M;[[MK!)3L:;2(1(!Y1D\3F*:3SUN_K#1_.$;99O:IUL??9QK"U3S[N,TNT[4 M]=V\T$$>:RJQ.+><5/-^SVF7J';3N?=^PE?TQ2RKINY[89H`8K4@\I`4B!M( M@%5:H9>SB@IC=HNL*:@!#%CQ#(6"U&P*"\%JA/;>?QC_(@^&I%NF"\]>%@'1VL-L6P<^J.PJN9\M97FQH"$*H MSGX9>.XCAE6'7Z8=-=8;[HH_+7]U,AB\L[.V=?:3PL&6B#5O6"E$_A2GYY:8 M>G!YJKHR'JT*+TX>F.'@Y_W+RZ_BRXOB&?[!W8.9Y/D MU7<^1/N>T;[Z^>:;+B'<0P0KJ9:XCZH\:#&D.\!*"K;.F9QJ>`M.Y#PZLZ4- MH9_!Y2P93Z_HT[#69`,E&5%*%>T%X^']OM"5[T)2")?1L^MU^;5?9X;VU1S3+O'1J"I'EY*ZU<$H0 M#*+S_G?]K]\<-3E8N_C0\KRPY:D]TARO$W]I/W@W\JJA9'=R`'MT*WMB']@) MR];6ZFZVL`V]%H)(*K4A&XN51/-4LZ["6; M]@D;>+V14DN3K)G;]Z[HRZ?!UM[XCI0U=K[[W;RUS;QZW4F#K30EN;>#`FW+ MJ?*EMLW))PD\)L;G`A)#LS/+9$BN, MP8SP6KV!78Q6B"3I8K,Z^^[A1^OYP`8=)*C)VQ-5^1*GSRA3+6'0SI;QROX< MOE\"`PK&0^AC#D(I^&[YSB)#`]/K?/DMV>&RZ28=$A=ZZ>S+"YK!*TV@F#9^ M?&>W%S)[.D6L$JT8.\J_;U.^DX"P.2E=ALVJ-K#6Z_&VY\W_:6S1I+=WBVG+ MVU7+=Z6(T,N*\3%11RI6.A0).M^1T)<(&O*F7U_M[DJ^.M\@%.PZ172(96:I M'$GE8SY*\7+;G2_BRHHN/\0X)77N[%L]:(??5LU:&35Z`%(W5SH09(5MY/"+ M>P[(0#`L&>G,<3/N#1W;K?*(5XEN]^&*$\E'DJ]R9F"*4L""TIGV+%)`7[YDQ9J?D"+\N]+Q-V?E+GU6G]0+LHE$LD`A[SO+0FZRE_X0LL)J%5(RTFDGXJ,D>62769 M:8>;Q#N'[.YUH\9V2S6`QE@;G^CVI)`W5@G(6IK]ET6? MR'S:=GMZ\HDT"1UY@Q"6NL,AVY^X%KRXTY!F_8&H3H#SWB=K:XK>0XIN3RY-O M[&S]+QO?S2JO/(017T8;47EW?1SBM\7^Q7^)I_,_'"IA:TVY#P\?6.I(O&(61%-H+*U#P"X M\S&%N4CCT@FVH)#`OY"I3G;TE&)AK2032B3XP]`K!Z=B$(!S_4V2^-]@1:X= M)=9A:JKK@@;(Z!S?:4&%[VY9*93XJAE.2;SO^U4!"5(L\ZE2G*/W@]_\V M1S>A?\O^\H*LT.W+J(K',$N2=VNS=D?4<&9V\WQ!)S4565`5^^'C!5\^8N+/CY;^HNI=;:%RTAI6R7DZ/O=:@N[,3,B=>2Q#;C97XF M\!L,Q5EG-UHPSO&UKOW4'O-+9$\VUQ&1YVT2;K_J1>7%VU0G06YD:Q6MTH+8 MJ0[D][(!AVT@6WN74%DE5PZ`:7LPDL8$[3!\(W`M<-8GA( M/@6'4CDT\_\+]:/]NM[+!S8%S[A8,R!BJ[CN6&MM=OJI9D%,;L+A(SSJEEKG0'(^@89T1:$%5()S'2BRXFJB^&FUT'DO;!QI;$696%*2*&\ M!MZXI,5/QI7-A"<@38<%EN?NC.(IP,ZIB1/V-2 M8$=5,<7Q!Z@.;AF064AL<9R.ZZ4`/4VBU^8H<9=.M[U?<+K$L6]H!9/$9*%[ M2J`NQIPU9XE3`4U^TO'([U/;G0TV08LR.M15*UJXSP2X@T%<%[K,'[DY55I9 MQJJZXG.]E8'-3DJZ/99G/.@VI/`P,AY_8!_\*8@:00W`H MVI`K<%E]._!.)62>M@T")25:J_JRK*"J<6@-'0PJ#!?,$CW!,,4C-M&(F9!2 M49`BH<+/5Y;-#864BA_';0@5B`G5DQ6N.?_'X+A;0_EF=06PD5H-E]YN3SB< M(Z>]V5M\1X6);GGT8AOD&U;"S-Z3^])$KG`P^NPB%1SGJS"W[=,!]UI(]>#L M[=N32_=-J/[I8<2GR_2=A*/3KH\DW'OS0WCV%7CVW@&0E\+@3@6=UD"3LIO,$,^+@IB%ZY!<'.TRG5QOI<)#05 M23+R@`(F#RO%MU`/MG7H6SD-I,W9)6HGBV(_ MR[.1="'LG"C$O;(,5=[XW71^#P![PK0F7A-\$I^I%AGJ8@H!3!5$5*7;*4,S MFJS+O#L,WT72>W#%G;;K,Q5N7XF0M]NT)PA=O+IK!2M;]6L`W*H?KHW$3ZK" M!S&R0Y!RI_G&"8MG5VOUWN],IN372N,@]M84%DA>'%)9@89F\^9AG,W)E((IOT;J^R%N2Z#VH71,C&4%T6Y@4## MB,S*V]&JP(Q25@7>N$2^.0MG4X-_D=3[M_Y!F0"_%0I?YOK;BU],6:0?Y7RN M<'HW[$N\23ENC$7_@ZE0H6=L!_A(3Y+ND"8P8UA#FP)L=#*[S[:%-!PH38F2YGMM+%V`;%6QJ`F[MI/@SH! MKX.=`"$P`4;VO-7.?K--FKY-SA8*.HIC.LR`>K@%BC`':TN*589SIT??1M7/#EVV]^R*^^=K7$ M]=^GY%%WJ'Q2)")=CE^3/>X/OH915L/K7-EW#(&@RD-4?WFT8Y^R$&]R#)EG*\><7Q:FNG'>S^$=$[@@M@4"?7CXLQ4 MC@H(W]Y1Q_4W=FXZ#4J(`ENR!AR\;GOR=K;V-IYO/6M/ZQ-.E_BY4]IGMWZ6 M$'L@RTR"FB90O=P`+;LN8\@N?HL*S$/.93`,PI;AD)U.)SCCC*IEJ3VF-%40 M(N)[2LU-R&S%=>>NL_-'$QOL&,CF6??%A,-!F=@$QL4.*'L,-J$91$:;WVS)-'M> MIHX,U7G]5B>)L#\&Q;6R\@N(S.W(AP"_ MT=\,B^.!FZ7&_F%&!&I7*K9(/U9[O#R)9ES7HO-$>XN*]Q:L_Q7X*L:YM0CB MH*(4C>8")#A@"AQBD*TJA\UQKI62D42BP6%U"H68.M>])RH_ M6T2&R/_6.7N-Q?7:<.K$M,7#KRA^=@ZVZ_$5T?HE##`RM=$!.2@W(#![%M:^ M+(7?8H>I]6A(*-T^NZ*`X(M.%%"K^A:>@<,*S"5^1[$=X:;32,14FRNOI/5U M-K)X1'_1H:[$U=S^K5?"X@2L(+&0H'4SL4*H?(D>!=9YF[9=@NN,%>953+WT M8C@$7Q97R5>CE;:STQFX71^E'J!TXFDE"8N@- M7G@?7='BTF#Y/GEGX^!:&4%@#]_K:PHX^0HTPWY`YR&Z&LYP&BQT]/Z1K"R8 M&G*BIVY3-M]U>29>2PR*=;"V%^-@?_".SVI97SEVNOSHV0UGCBO5H/PRFR+8 MD"^QL/0322412GJD5(T54Y&$`<\**EDOJ#1U5(S6)LN'7B1E;/7C6JH"X5/Q M7IE]J6\8)C2UR\+9I^L04SYHH;-(=*04$PBKH#E($BKLMO%6DZ@Q60+Y8"%1 MNL:1ZXU%ZO9Q5PV(=Q3,,+AEUM&!.1Q*<2Z84Z%*C=/*DHL[\<)K3R5R80CS M=J9(]?4CH6!8T\)`4V3Y65/F/)TO.?1V6/G,AA>_9WKCU,ZV?D\>R3R%WJCG3*B>NGT3 M805-0-_IY,ZP%4H?KG*B['1><3*)5`*[L!H,5QAR.]RP8LS]^EJ6H-""(&T! ML5L8*TL%]*\9$S-R9FDT:"P-7A-/A``\?09E'*\RBRS*\VQQP:%B_?QZ$BPX9EWTP4@ZP M\F*/PLJ(S+]!9]MKMQDAKO4HNR-B$'!@B`MM!<3(&;E-9,*TURJ%V@JT\40 M^2IXL.\#%OKM0;.SZ>ZXE>IJ%30HH2P>%@^ZY2N6NES'0J,J]8Y+N(@]G(W6 M05#E[HV?`Z+8RVF%<#9C@*H"6+PFYVG?EG9"@(O'5+HM8/GO68NGXV?BO3Z2 MR#G'61H:@94%RU(U]7B)"`ZPFAWSOJ6<(,&:'D&*$<&6+S$5%\,]QD,4B22& M>%N7@^`Y?2I`U1,)UFB,0!%2,=33L9&Y@L)B7/_--0F2W^T*A?ZP?5"0\Q`X M\JH`%BI%3`XE.BITWDT4QN\D=4R-WR=I@M,/0\5NS1R8TZ"N>`7$-)%?A;)5*`F-NDC\6W@$LG4G&X`MDUIUL[)#HS^_8N!(=:?M*>UMZ\X:'.J^>RR["K%^O>==?BBW(+,N;\ISQOAV% MWKP;[H5C?;MON`#>%^>756*JYD`!\S"S\+GWYBT#VR/J-K5)K$/%J7D?=SQX MMDSSF?8Y!X1XEJ]HR1%[PCEVW.$/(XGOW)K/Z&.9WY.':X[]?^NVT4_1ND.K M:>?/HJ?O!H?1XQ;3R'9LA@]>[S09A.JQ/7+CC=4L6Q(5_?6-/GYZ0N27_T?S MT5.B)HO_R"I9D<&?0Z5XVBT'IJ#YD-OX:C4E[['L4>4%.HY7L4\+R(A97.G[ M>=<\MJ3U9HEPL0&STC7=O/$M+-%I"']]:WV&K7E7N&1%#T``'"@.06\.]\0? M!M[\_:T_=&'5:YZ$4\2;#WZ:;/`5P)/R$U0(22DNIT`#]HWYQG7PSE_\!RZ/ M?(AJ+9F^>^3"GSEP3H,\ZUIPA^\V=TK==O26Z(E/YAZIH;PYAQ=;]UY>T:-^ MP@ZGXL7-(0^3VE3O%=U^Z87#'BS_6=%0FRXB>BRQ=3K)K73MQBHZ;AQ?.JDJ MC\XC"O#2-0YN6_[ZX:>\L'S:4R`RM1X)5`-ZVSO"C64UXJI;M&Q+E$&N;+$& M@97-7?Y)8&/SN4O;[Q*:>&8F@$6W>;D3K?F8MQH^/6,ET\K<6"+W-X>;1@A" M2519G-Q\[%M;)1O7DY;*2OT&)\-DCG2<(TBB!@6O$=N.8P ME:W`5?7LUJMOF]MP0U=FR_?)M.?J1G-A[LK[NOSOJ0Z`U9;+FL'HIHA]$I09 M;9?:UEYS;K9R_G")*G"(^KR`O)C+ZK#=0/(Q!JK'`772I_+TB M/F#F??%B>(HVF/+TBN9"GN.MK!Z\$N>?5D]\>)C60?D]8(.[]U$8PHZ?$PLT M)]+"UO="=X=/'7X]K85E(3R,_AM9K3G?>K#O=90?0<\)[^Z+BLC\IDN*O-7:$4M&?*T'-J12AL:K%3>DX7%O>FD\: MY;ZSQ1UH\+F4ER,6.]@_DQ?'JG-H6(ZZ_`582U8X;!XW6BO4]5U$Y+:+%XSX MLM&DVC(RM>1^\^YRYW+5;`YL5]*HLC&C>%VOV.X%I97]S('.GN=%F1(W!2HO M=P>,]^=^V"NP&:D'0.K0G,(]Q**I87-:-[7<("Y7,_@UL.Y]1..02@V M;=WG.D[N2^>\K:95FJ^Y=__-K[=0,C@/+=0OS>WJ.YML:%78JE/OEB-Z@7/. M/J#F$AVI\G(O^FC?[-.[LO"5LS*6QE7$G>3:[H?^\,J9=AK!Q97/FF6>&0W)(Z?*[Y\#7 MOKAQXD7A0A^]'^J:&SK1V@L?%OI?[ZRSF:XEJ1VN;3\*W87^XB;Z=U>__M5E MDK[X[N='UTTU$!$F"_TQ3;<7@T'B/+J!G;R/MFX(WVRB.+!3^!@_#))M[-KK M!!L%_L`8#L\'@>V%.I=P$3@R0@([?MIMSYPHV-JI=^_Y7OK"9.E:X%Q\?`BC MV+[W`>KSR+2=7#;[L"<^\)PX2J)-^A[$#:+-QG/Z45S2^#XR:MH#2!^]^]=E'[[&_[GW1_>O1O^ZYMO__&# MN_[GC[_?_^[';_1!KH;(!!\TRWP_;!0+7W/)@\R"J\M-%):&C,'KC*"+IS#Z M&EKX'00#F(<_N[I,?M:^V#Y<&2$\)_*C6$O!RV`?NQ+:@XB7;K?M5^B`([1&+IH,8Z M:O68S``+XPG[<9EV.XL68KI_\4)D]2\>T1]91=$O"/IBW-OOB)T=`//^](/O M/81\EI;LMK`0<&)OFV)<'%M[E?SJH.UG5CE'HXX6P/U+E_/.M'>KN@7U6WW# MDDP"V@2A-\OYJG^D MJSD+\4&/YAL6O'I&^F&"KYZ%6O#?JC=.LR1G]@6RD*>E'M8EAN^G\_E\-CJ? MS69S@I4"17W58)`D5<) M`D5>97.G'KTZ5>Y5@D"15PD"15YE!=T>O0K5=\5]E2!0Y%6"0)%7>YM\9AEX MKMRK!($BKQ($!WN5K:Y@/7V"?>L*W97^`QJ1VW;#"8=AH21;^985 MV`%Z(7.?9`OF:N9IR080$WE(2+;HP\9R-T+61M)"SD;20-)&TD+61N@Z59TK M9W(=[6!G_+6#+6LV'/+"KZR>9H$$>$7$5(,@;?;Y;&U2P6AKFZZV0G[9ZQM+ M`U]L'5]A:4N+?3M;&E18V=)"UD8Q;G+O"L*+)3ZFYPHDK_@6?OXV&*"(-\SQ MO$J"67[".CC?DI).=]7FMHHG5H.$JN$J&[=@&'1$V%9$'9YQ#9Y1)D@&SR'ZS1K] MP),T'X?HAT)%I1.!%Z7Z(;BD]?<9#W@8*@MJ<`$-ZB8\?2*`Y6B.`)R@`@$> MWLHX@/!4@0"F^3D""-`2`1;"/229OC0`.`@E74I5E6*(6Z'GE92`!\:*+!@U.UGR!O5 MY7QEA)"D"QA*1B`--#'27U22G`LZ2P#-C"Q[G(>0H,!4I!H"P%$"@3@"ZC#J M,2@:@6DT*!J"*01A##YAGZ#1((R0BC``'B6]HIPGC(01XX0T$`BJ,B2)!D-5 MBJ085.7(TA6&JA1)(*C*D-03JE(DQ:`J1Q)7J$J1!`(PHB1#4D^H2I$4@ZH< M6;H"[Y!2X@H"056&))X8'SE%#FC9E!=1:?UT^J;ZJ?:\:2VDCNH63>#WO#E? M/?&5(_B"K:7(4AIOE[/Q,#763K7'*/9^AD4FWC;GP`4WUO$VR]1SZ)6OL;V] M0)+7-UX'HXBP%E.I'RK9NM9%>>_\'(#E<"):+6>+^M;" M_*O($(O;K1'2"@*+.ZHQ(-<9AMY#H*JR2!C+#R)%0/\V)DU88Y]=4O@)IL9EI)#DWI?><62L,O`4-]B)R*!;E@ MZ'ULI8[X/\ALK8%ZS-PJYR*#+)`Z?!%`7R4$X:I1(=M?>IZ"4AGQ!W65: M6@L(-PB;QMTWS1+>@A!33790I#EPI$8723_5*=UGY1`>VOKM43O-6WQ1"VB? M%W'D/X2E;A69NE1WE%EOSN$!91OY&9;(J%2TRR7&NF"'ZV(&J-792\;94R=I M#2\V/S0\*$Z M\'S!X6^U,^V#@\FW*&6,(,+N=YX/MR3BK@9N3#G`?A0L^<5L*Z%)%M3(N,<- MW&XFLF#GMZLLD)#)@GDOE07#4U=9H)[+&H.U1!:('*@G#K*JOPHPF.([(FDMR?5_I1C%7<(97!1665?A1C M=2P9JU16Z4YU(*'XU%=DU)=I?V.L^Z8L#@RDP&!CR7RMGY\(3@")\OS$X`X,J(&(1[ M15*2'EWG25O!#5V%(+$_X#`J(^CF>>O;H9U&\8N&N_Z%.-'I$TEQ?XRB@B-1 M`BZU9`#]"9[&#`]ZUH`7SI`8P[CCVT5,T1=$>D:2'LO10&N.1HP_7-%T00.M MN1@QJ>+\24;,QW"[*SPDYE(6`?Z774IHQ%9$"*[4 M9(3<>2G-O=AQB;Q&Z[JL8K;&H/-<$L__U M>5LYM%B_4`$+5V-_;.3^^*+Q=Z^?[/['D`$$S9K[[WOD0I$['0 MR_>?\$$+T(NA_`;IYE,"-^_#7VT7>PO]/S?+Z?SZQC+.9L/E[,P8>332/S(O'A$>MQ9FP&_G-Y M;:&3#QP^VSP$V+"+F1LQ2(J'SU_]#P``__\#`%!+`P04``8`"````"$`^V*E M;90&``"G&P``$P```'AL+W1H96UE+W1H96UE,2YX;6SL64]OVS84OP_8=R!T M;VTGMAL'=8K8L9NM31O$;H<>:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L*]`" MNW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5QVZM= MKGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CM MA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@>WLR MH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4 MAQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E; MG4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P]?O/R M\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B M6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`-> MG]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/' MM;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>11U, M2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L> MFT1.[P:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[^`'' M*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684 MZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A5^7R MQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[*GC8; M^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O- MB&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.% MBW21#/&8I#[2>B_[J&:+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P M'ZE0$+(/994FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE: M!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IV MO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E M<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*D MK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3 M*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:P,``+L+```8````>&PO=V]R:W-H M965T&ULE);;CILP$(;O*_4=D.\;,#EMHI!JPVK;2JU4]7CM M@)-8"YC:SF;W[3N#"0&S6;$W"8??_WP>>\RL/C[EF??(E1:RB`@=!<3C12)3 M4>PC\OO7_8<;XFG#BI1ELN`1>>::?%R_?[72]W5R MX#G3(UGR`M[LI,J9@5NU]W6I.$NK07GFAT$P\W,F"F(=EFJ(A]SM1,+O9'+, M>6&LB>(9,\"O#Z+49[<\&6*7,_5P+#\D,B_!8BLR89XK4^+ER?++OI"*;3.8 M]Q.=L.3L7=WT['.1**GESHS`SK>@_3DO_(4/3NM5*F`&F'9/\5U$;NDRIF/B MKU=5@OX(?M*M:T\?Y.F3$NE747#(-JR38=N?/..)X2FL'/%P1;92/N#0+_`H M@""Z$F`0_>\QF/MQE7+O`?^U"PZ$HOIU6E;$[ M9MAZI>3)@_T*X+IDN/OI$HQ?3@OD`[6W*([('!8N(AK6YG$=K/Q'R'Y2*S96 M`;^-@G85\5F!"P@,#0CD9C@(BA$$UPO)-O9!.V[HQ.TKQHVB`P)9:(/@AAG# M7GT],S@(=*UY3QIW2V@5DY9BVE7$KRDZA)GR=#,41@=DW*S+KQMU819ML MWE7$?<6%O4,&FWDX&8J[9#?=N!NK:),MNHJXK[A"-GL+&8J[9-3=Z%8RK8I@ M0A?4W6[V?1O]"AA4T_"4H=@!<^IK8R7MP#VVON0*&WXY!Q\.*';8+A5F:\!* M.FQ.F<1]R16VQ5O84.RP76PMFY5TV)Q"B?N2BTFG#"B<%\,35ZD=.J<"-[6F M@^=42_R"YAH?'L*#%Y;:([M]A%"G#C>UILT7.B43OZ"YQH>']7`^>[2W^4*W M*JC5=/C9]A)YQ%:'PM#F:=.[U4U5\P*ZH)+M^3>F]J+0 M7L9W,#088<.B;!]E;XPLJS9B*PWT/]7E`9ID#I_E8`3BG93F?(,?_:;M7O\' M``#__P,`4$L#!!0`!@`(````(0#D)]A^@P4``#D;```9````>&PO=V]R:W-H M965T:=T#<%VL@BY*TBAUI1AJ-9KFF MB).@"A`!5:E^^SG&D,9.VB>97&0Y^?QC_\<+-NMO7^5)^21-6]351C4U0U5( ME=>[HCILU+__BEX6JM)V6;7+3G5%-NIWTJK?MK_^LK[4S7M[)*130*%J-^JQ MZ\XK76_S(RFS5JO/I()_]G539AW\;`YZ>VY(MNL+E2?=,@Q7+[.B4IG"JGE$ MH][OBYP$=?Y1DJIC(@TY91W4OST6YW94*_-'Y,JL>?\XO^1U>0:)M^)4=-][ M454I\U5ZJ.HF>SM!N[_,69:/VOV/&_FRR)NZK?>=!G(ZJ^AMFY?Z4@>E[7I7 M0`NH[4I#]AOUU5REIJOJVW5OT#\%N;23[TI[K"]Q4^Q^*RH";D.>:`;>ZOJ= MHNF.AJ"P?E,ZZC/P1Z/LR#[[.'5_UI>$%(=C!^EVH$6T8:O=]X"T.3@*,IKE M4*6\/D$%X%TI"]HUP)'LJ_^\%+ONN%%M5W/FAFT"KKR1MHL**JDJ^4?;U>6_ M##('*29B#2(VU'[XW]*LA6,Z[A,JLT$%/D<55YM9SGSQ3%V@UGV#X'-463[= M('<0@<\?(@O'F;F+^>.VS`>5Y54%O'VT03I+5)_W(.NR[;JI+PH,)DA%>\[H MT#17H$P3;D.W8>FY=H&?]0!(/15YI2H;%6H(Q5OHMI];R[+6^B=TM7Q@O'N, MS3/^R-">184#%H#WB?",+Q2*A2(Q$-^JF+Q&(A9))P$=K+KZ!9USZM?]@3': M0F%JR]@<;PQ,FN/P-?'O(*9@9?``$S(&FO'#.>%2$8[$=Q"^O@E*I#*"\Q8& M_./>4ICS5@SX8B`0`R$+UQKRC, M>24&?#$0B(&0!=A,38=F)`9B,9",@4D7%.U-[S`3>[DFPU3Y>),I#%/9M/M; M+I\VCS%0@^L0$9+FHT2`$B%*1"@1HT2"$JF,X'R&96KJ,UT29E!8/M710AL5 MAOK52\L2AI+'&)G?*!$P8L'6F*7EVDMA*@]1C0@EXNE5;->`%]]U$E0BE1&< MW;!JBG;3%5AN-RTDVKW@Z^@Q1F8W2@0#X?9^&YKH-2H0H42,$@E*I#*",YMN M5.[<[LC-IH5$LY>"V8R1F8T2P4!E+R4F1I@(O`&2909'@@%Q>N?M MI6,+4UJ(:T0X$N-(@B.I%.%]IYN)IV<=DVU!N"75%KJ>-T!2WYF.!`D&%>;[ MS(1%E>_"(7Z9"$=B'$EP))4BO.]TY_&\[VR_POLNC$#/9)#$5']`V&QN6W-' MG!@"E`CQRT0X$N-(@B.I%.%]I_N8YWUGNQ_>=V&O[YD,&DR=]U,EWU=]#C%M MRS1<5TA?,#"2](4X$N%(C",)CJ12A+<>FO0_K*>EQ"E>6,8\DT'#K3><7(G] MV1\(B:L!CH0X$N%(C",)CJ12A#>>;J\F?1Y94]EFC._KXO:4'KQ"5MA]B*$9 MPF+H#_]+[682$B3$52(8F8[>V+`3HY+TAR(3TZG5LGK#_HT M8`XW;-?H]4G%ZXP>?`IQSUS!*>]M/#17<&Y[&T_H$X\[<<]:>??T?6L%AUFW M.H&U@C,MB.O7"L&#BW-V(+]GS:&H6N5$]M`40Z-'\@U[],%^=/6Y/R=_JSMX M9-%_/<(C*@*'8(8&\+ZNN_$'O<#UH=?V/P```/__`P!02P,$%``&``@````A M`"96'SM,"@``;2\``!D```!X;"]W;W)K&ULK)K; M'EH?O?_[A_ MW78[I_/Z\+3>E8?BH?NK.'7_?OSWO^[?R^.WTVM1G#O@<#@]=%_/Y[=IOW_: MO!;[]:E7OA4'./)<'O?K,_SS^-(_O1V+]5/5:+_KVX/!37^_WAZZM;[OCB<:Y-CL5N?H?^GU^W;"=WVF\_8[=?';]_?_MJ4^S>P^+K= M;<^_*M-N9[^9!B^'\KC^NH-Q_[1&ZPUZ5_]@]OOMYEB>RN=S#^SZ=4?YF._Z M=WUP>KQ_VL((Q+1WCL7S0_>+-%]-T/^VQ?M)^=TYO9;OWG'[%&\/ M!/)K04G^ZP+**LNP%_I,NG=CL>C MF]O)YTT@GRL3^"M-K.M-+!R0^($VDYY].[;&-V)$%^;"&N),P@_9]O:334?8 M%'Y<>]H;;`L_9-MASQH-?MO?"3:$'[*AW9M8@[NAF/9+(\6YMI3)'BNSS=OV MZZRKDGBQ/J\?[X_E>P>N#)!?I[>UN,Y84V&'Z5M;-`G]43Y#(@N7+\+FH0L# M@90]01'^>+0'M_?]'U`X&ZF9<8VE*^:H$%4B;!BEHC::+&B,.(RXC'B,](P$C(2,1( MS$C"2,I(QLB2D14CN4JTJ,$\:U%K7U;A;4BHJ^#@I,YJ,H)+*X7+&NCAFCBF)-H\CXW:\:D1HG:M$BRO<'ZZ( MJU#K<:T)Q!5/-9=$"2+3.(RXC'C,QV\TZK0:"_B@$6&'0D8B9AU+,FJ&D3"2 M,I(QGZ4D-!TK1G*5:+&XNRH60JW'HB9J+"118L$T#B,N(Q[S\1N-&@M;3_&@ M$36Q8"1BUK$D2BP821G)F,]2$B46C.0JT6)A085IA5'O2GMB7WQ^W6Z^S4JH M;;BGMZP&AK#[E'M2X:('J3*NGK#@I,P158^(Y*ZS;@C/85#EH(J0RY&'B+Q\ M1.H"Q!H9J_R`5'C&D*,($=G'B.HG2V+/G'"42ZY:<91K2(^%V+I>$8MZIPN[&LR_F7@")\*CWT=O](O,'%6W3<,% MHKL&.1+9`_EDR!X-!L;-WN7-/$1D[B."2X=R=Y_HO0JD:CBISF?U+#B=\I]Q MUPI)CJ./)+*I%F(Z-:H21+?5>08]-!K5"E!\18 MQ>6HJNI:3PFQ,[XB)>J-M)82-8(:QAF8BX>N(DO4\I0JM3PE(I4K&]JD\KB7 MSU4!(O(*$9%7Q+UBKDH0D5>*B+PR[K7DJA4B\LH155YZ+,1^]XI8"+EQJ91( MSP9C<3X7U2L:4@4M$%%*.HA@;:3DGY%9+JJHH8>(['U$I`HD@FJ\8!^2"I,K MDD@K0CD@LD_PC!=[GZ**&F9HKU9B;5^_+ZH6`RM4Z1-M3$Z.JI:R$]OI*T)= M[[ZULJN15G921>6(6LI.[+"OB$6](0<_3,F9)9&6#6/C7C9'%=7%`A'E MGX/H8N*ZJ**&'B*R]Q&1*I#H=V57#PA4.,9(-M3*3@Z;[!-47>Q]RON584.U M[&I[K>PDTB9ZQ,I.;:A?8<6F^XI0UWMT+=02T1)@#C52U1A-U@(1):Z#B%0N M(E)Y$BF79A\1S7(@D1*>D*-((IL:QHCHC`DBZE>*B%09(O):(B+5"A%YY8@J ME1X+R)%K8B'DQMU.(BT;QL8Z;B[>7YIW.XEH-`ZI+MR.7%110P^16G;,/I"J MWY5=W5"):R0;:F7'[!/JQ(7>IZBBWF=HKY9=;:^5G43:1/.R4QOJH19[^BO* MKGX$H)5=C;2[G511LBTLJ:*4=!"1RD5$*D\B2%:\WOE<%2`B58B(O"+N%7-5 M@HB\4D3DE7&O)5>M$)%7CJCRTF(!VZUK8E')];)#I&7#V'C0-$<5U<4"$>6? M(Q'\J;\.:-L#\F8>(C+W$4$**,M5RVY:H6(O')$ ME9=>GM<]HK'Y(QI$6C:,C6>+ MM=>GR[.18^%%V&-:G\5T:E0EB#XN3S:H#)W5\JQ5<*N\6)Y2I06$EV?C!;W4 M4T(\)_G\W5/TQE@H2:2^8^5HP9'#DQF"J^?6_0VG+GU#/"0=2J>G/(V\,`'CK2='?:D<*3M/+#1@2/5 M==/H&2RHX4AU?3&/V`.8]NH-DW$DFDS%RQ+>M7@R%2]#^(%L,A6O1/B!Y00B MU78`7D-,Q4L&W@1>*D"/VX[`*P(X?]L1>.`/YVD[,IM,9ZT=F$^FXN45/_]B M`AUK.^!-IN(5%6_AP^2WS;T/4]\V\_[=-*QN`L:\P]LN&'EUAGYS"#YV?EN_ M%,GZ^+(]G#J[XAG*:%"]RSO6GTO7_SB7;[#ZA(^6RS-\[ES]?(7/V@MXIS7H MP<.MY[(\XS]@"/WF0_G'?P```/__`P!02P,$%``&``@````A`*;ZS%Q_`@`` M?08``!@```!X;"]W;W)K.$)$VET1>##Y^_[US-XN9% M->09C)6ZS6D2Q91`*W0AVRJGOW_=7UQ18AUO"][H%G+Z"I;>+#]_6FRU>;(U M@"/(T-J-$?4@U+XWC&%)XH!^;BRXO4.K,"$(DV43CV3T`TZ@"M1TG<& M)H2_],^M+%R=T_0JFL[CRP3A9`W6W4M/28G86*?5WP!*=E2!)-V1X/-`DDSB MV?\Y6/"G#^^..[Y<&+TEV#*H:#ON&S#)D/?]>#`0CUUY<$[GE*"K%FOPO$RF MUPOVC(D3.\QMP.!ZP`P(AJ*#,JJ-5_9@K^PSZUVY#89CF?1]F]'.?N(E`>?2NTL?:.?9`^[;'P('GS*N[,;6 MA/LC;)SNT'.\`[3#N>]?:[SF`9L\CA!<:NWV&Q1FPX]C^0\``/__`P!02P,$ M%``&``@````A`(N9#4R"`@``,08``!@```!X;"]W;W)KOL%9-TXK':*AKROO'RY M!2LPH4@3):EG$KK%`/!)E/2=@0GAS\-[*TO7%#291_,TG6;S&=*LP;H[Z3DI M$1OKM/H=4/&.*[`D.Q9\[U@NLRB=32YC%/T'"0L1#09ON>/+A=%;@DV#DK;G MO@7C'(G?=X16/';EP06=48*Q6JS"TS).TP5[PM2)'>8F8/!YP(P(AJ*C,JJ= MK^S!7MGGUH=R$S:.99+W92[_1\:#"XK/0_!I-O(&Y8"9'F$.*3@QB)#S#7HP MU@`+>21](`[2`72&--*<+^W!@_28W-T.SLE1,+,Q#R2 M/W8JNMLY=A>G\U>B841#!RLP-7R"MK5$Z(T?OP1[\3,?]!H7M;NQ>% M[8Z2N.]DS')6R;*M*,MR2*JN[G\_"1*I)/!4*FNBZU"V/SX\@D@D2`#D_>]_ M;MXZ?ZQV^_7V_:$[N.IW.ZOWY?9I_?[RT/WWO[S?;KN=_6'Q_K1XV[ZO'KI_ MK?;=WQ__^8_[']O=M_WK:G7HD,/[_J'[>CA\3'N]_?)UM5GLK[8?JWO>YO%^KW;.$QWG_'8/C^OERMGN_R^6;T? M&I/=ZFUQH/KO7]W;;+#]CMUGLOGW_^&VYW7R0Q=?UV_KP5VW:[6R6T_#E M?;M;?'VCZ_YS,%XLV;O^`^PWZ^5NN]\^'Z[(KM=4%*_YKG?7(Z?'^ZOW%;4VQ4E%X.MV M^TU)PR>%J'`/2GMU!(I=YVGUO/C^=JBV/X+5^N7U0.&>T!6I"YL^_>6L]DMJ M4;*Y&DZ4TW+[1A6@_SN;M>H:U"*+/^N?/]9/A]>'[JA_-1CWKTG=^;K:'[RU MF/!LKD3,&1+C@^%AS>7MU.)N/K MVYOS)>EH76WZJ4\Y'%_=#/IWHU\4O-8%;Z3@)T])&5.?DG[J4TX^5]<[77`@ M[?/9RQQP"ZE?]%D'H\^==D"MVH2VU4B?O-8!-Y/ZY;*K'5#+-J>5)AY_LL;< MQ`-IXU^T5*_ISG5V.(O#XO%^M_W1H2&'>NS^8Z$&L,%4V7%>-+WQF"D_2Q3* M$.7R1=D\=.E**`GVE-U_/`Y&P_O>'Y212ZV9G="8BCDK5/HI6\<&K@T\&_@V M"&P0VB"R06R#Q`:I#3(;Y#8H;%#:H&J!'H7G&"/*A[\C1LI&Q8A;=\9`@F:% M;,X*+N+8P+6!9P/?!H$-0AM$-HAMD-@@M4%F@]P&A0U*&U0M8`2$!IF_(R#* MANXC1M*,S)28:0UEYC&S)J9D?I0(!\8$$0$(@$9`82`(D!9(!R8$4 M0$H@59L80:-A_N\(FK*AP9+N%<>`X%#7B$;GHG:4'*,&Q`7B`?&!!$!"(!&0 M&$@")`62`(!\0'$@`)@41`8B`)D!1(!B0'4@`I@51M8L2"GG$NB(52F[%HR+A^ M4*_O[W,@#A`7B`?$!Q(`"8%$0&(@"9`42`8D!U(`*8%4;6(T/#U7&0VO'M*& MDRL*U(6/:$!](`"0$$@&)@21`4B`9 MD!Q(`:0$4K6)T?`TNE_0\$IM-GQ#Z';-_7L.Q`'B`O&`^$`"("&0"$@,)`&2 M`LF`Y$`*("60JDV,AA_0.HS1\O_WR%0[F5'1R!J;KJU[MZ@X>`XB%Y&'R$<4 M(`H118AB1`FB%%&&*$=4("H1508R(ZFQEUMYIE$[:Q`Y MB%Q$'B(?48`H1!0ABA$EB%)$&:(<48&H1%09R(R%FF=>$(MF6FK$HD%6JMS8 MJ7)4<1`=M=9&@R$59.0B\A#YB`)$(:((48PH090BRA#EB`I$):+*0&9XU)3R M@O`T,U`C/.U):?/DJQ8JJ>%;V>,@$(MF7FG$0D\UZ2FB-?NXM88(LH0Y8S$JV`DEUTBJ@QDAD=- M22\(3S.#-<+3(",\&DD]';5G90;11>0A\AF)5\#(#(^U`1&*BF,1(8H9B7W" MJ!T>77M!&:IR1N)5,&J'!UJB,E1F>-3$M1V>9I/M2FW!'E[7RV^S+8T#](1] MXAE\1)MI]9CW1>W.4>,;46O02)[>YEHU&AV[I<-(5"XB#Y'/2+P"1L9ZT=C: MM`A%)5&#JL:L$ON$D0P<*:(,4(A^]`E2%B")$,7HEJ$H198AR]"I052*J M#&3$8DBCQ`6QJ.5FJC`R[[GV8@*K9"7(871W#**K$?U0&]W#_G#<[UL/!QX6 M\QF)><"(>D7K2<":MX5:-;II-M:O!G2ZUC_KEA:)G+,OUF@HN9#(J5F5,KJM MS]._ZEL/5!D+I"UR=FX-EXQHAO/SBRI990;$>O:K6%7GM=DE+EO`H$NW1T^- M*(>Y!>:L:J4GJUKIR4A4'B-1^>@5H"ID)%X1(_&*T2M!58/6_.:LD@QQ&TB5=1G3':?4_JV=Y MK)*"/B.Q#QB)*M2(LO&,?20J[ERQ1M2,C!*T3QF=K7W&*JE7SO;M3&P:>BAW MQ9)59D-;C5.QZD3:J76+"T+=+',8H6Z0D79:)9W-H3JK?!U*QW49B.7H5:"J9"1>%:/:RTP["N(EL5!R MZZZHD=$;)M:];#[4*LD+AY'T/Y?1V8[KL4H*^HS$/F`DJE"C7Z5=4U52@SIQ2LAQFJ\Y8"2M'&K4"D^$*-9H*`43 M1G+&E)'4*V,DJIR1>!6,1%4R$J^*4:TRT^ZRQ1`:PB#M-#)ZP\1ZCIMS06E2 MAY%R/M-#(:>@QWNW9!,]1JFG]!VC6K`D;:-8AZ$^?%?*A5TEB.1G11 MK'(9BUEQH+Z MR"6Q4'+K;J>1T1LFUI+3?*A5DA<.(^E_KD8T/SDS!]1.4LQG)S$/&/UB#MAX M41[6+U?_<@YXE'.'BKG&<@-(Y-2L2AG]?`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`0``__\#`%!+`P04``8`"````"$`ZF/4M;<$``#X M$P``&````'AL+W=O5CXLWW MSRSU/G@A$Y%O?3()?8_GL=@G^7'K__/WZ[>E[\DRRO=1*G*^];^X]+_O?OYI M'UA74QQH8X')*8OXCXDO&\U$8*GD8EQ"]/R5G6UK)XC+DL*MXO MYV^QR,Y@XBU)D_)+&?6]+%[_..:BB-Y2P/U)IE%17`XZ)Q^517XL_#V_!!=TO(O6>`2($ MMMY_O7`90T;!S(3.T%(L4@@`/KTLP=:`C$2?6Y^"XV1?GK8^FT]FBY`14/?> MN"Q?$S3I>_%%EB+[3RL1%92VI4)[B(G$%-[[O#0Z#7!D%8`T-'H'6F+9U9HV%$ M`"KC@:(R%`DJ?`IE.\^>#RD0FB274D@;:V@IFZT<]/E M?5>H;+JJ)+J;V^T"8=M0V&HQ@=#NN\!SIHM*`AW40M-3.R3EUMS<=X7*IJM* MTD6S>L0N*IMVM62J1KZ=)`(E:L>KNGVZG"P&TZ1.FDYJD9FHN;OL!.=^=*:4 MMN5-$X<#$XYZR[)JXOERN/*DX@A-LHHU:I$YV8L>2#CA+;ETID8EKV8,)1'H\)M:TR:9$#TT.#3[J37XNZ MPT(E?]63KH?$GW?FO10Y,%@/H%@#A0)=UN8!4(@,1 M#=V(J$40][TI;;/^M:B+B%H,H+@G','0ZJ#E19.!625*>C!9!#&`JY"=+#:H M12:HVZ9D[$'T(890VE97]"X'N-2T:4V!FB_&@.I2A#(&GDU0/>L.?8@BE+8% MJG='H`Z*H%,VXF6N3EING"S1L_7@@MQ.Y_WV4]JFMUK4;3_F8(E5.`*3.FAY M<;)$SX+"<,A'O_F4MN4-#8#(@18(]Q!)*VP)5L034Z_:GA?6\Y)F+.&9PB3#8CQ5)M'989Q'"M M\L",*6T39BUJ]:.^9]&7&1DOCOP7GJ;2B\4%[U`HW$(TTN9^YXGB$F[+I^LG M?>\3-+_`O@N;/;_0\``/__`P!02P,$%``&``@````A`**EE77B!0`` MH!@``!@```!X;"]W;W)KW6ROA5-6];GK2W6KFT5Y[S>E>?#UO[[K\^KR+;:+COOLE-]+K;V MCZ*U/SS]_-/C:]U\;8]%T5D0X=QN[6/771X;8SPT"R)4>_W95Y\JO.7JCAW&*0I3ED'_.VQ MO+37:%6^)%R5-5]?+JN\KBX0XKD\E=V//JAM5?G#E\.Y;K+G$\S[N_"S_!J[ M_S`)7Y5Y4[?UOEM#.`=!IW..G=B!2$^/NQ)FH-)N-<5^:W\4#ZGGV\[38Y^@ M?\KBM35^M]IC_?I+4^Y^*\\%9!OJI"KP7-=?E?3+3GT%%SN3JS_W%?BCL7;% M/GLY=7_6K[\6Y>'80;D#F)&:V,/NQZ>BS2&C$&8M`Q4IKT\``#^MJE1+`S*2 M?>__?RUWW7%K>^$ZV+B>`+GU7+3=YU*%M*W\I>WJZE\4"1T*@T@=Q`-Z/2[7 M,@I$$-Z.XB!1/\%/69<]/3;UJP6K!N[97C*U!L4#1+[.##F&N;XW59BC"O)1 M1=G:&]N"6;10GV]/4?CH?(.4YEJ23"6"*M*K0E4"Z`9$F+B)^';2KR1*K$A4 M$11:@E]`[`%-LOM.%6$\2`@))&@YB1)#H8T;1YLA++*AQ#?1E)AF+W:'F2,:2L(^>T$82C:>DG'H`^/4 M"!9LJ/LSIRZB>)NQ,(B'$L3;1#(8;]^/I^9XY+K^N&X)GK(WUCMN%U9=1/%B MU@@2E)B%]=D,4I3@#&3@PK^A`@0Q_C^(ZB*&R'I&@A*\?^1M!)M":HX+5\J1 MG^`)V`=F"N<77J]F8&-@+*W6S"9/:Y!^%49^\$[VA&K)=U>XOXKNW=@?RJ,Q ML=F;F'SSZC!O2V@650H&QV%?E\\PIS7!I[GW)!7N_@4FJV\EB]$H$:LUZ3;:LU M.J_]QAT6!L5CIG&CI-CH2=K8CDS4\QI,P4='FY+A,)()$0?C]13L+JL04Z\P M>KVNIVD&H>N-S;8?3W4,G3//]XS52M&87=S(V=0GXLDSFVD$JV`S9:,"$8Z+ ME:(QJ[B!-O4(?RR'SAIQ``F/P`P^%:9B)?S0H*=PS"1NP$W=P>?N(,SVOQ+$ MGG113045$#9YET'T:K9-V7)*M.:ZG$(P)[:34RKQI>L;38;B,8.83YW$I@_] M:7ABBWGGU1JSBTSPYKR#XJDVOKCY2FSZ9A>)67--M$9G+Y:\.Z=:8/(;O8;2 MJ4:]G`[;NDD'ZV;HGK@K)(IF\%"P"`]$=^`I-35]X?)-*U%DWGU2W#D)31^S MB&7O%>I5F3D9/)_Q-)IFX(5O[%\=!A/MSQB99'ZQD'+J&\+ECWI]Z*V-#&]3 MFM8R2\FL8R'EU$*$.SX'Z25)+"+V@TG%30$,CXN&EIM9R$+$J94(EQ$DTG0* M+Y!R1,!N3030#]][V)/,218R3AU%N,S-DC[TM=@RV(1,D!*!'P:;<98DC^H- M;?FV[M5\6W-+T:*Y;3TKH7QW68J'7D"[(O<4+3+YC)Z,)9[74$+E$XO[MJ?4 MU).%RVU%B^8),=`[&DK(G&79.O30&^#G8,]"<(?1(I-B7&@ZE5./&264$\*8 MF5S(J:YB&>4OX`DOZC#7@FO$L.WPT'T1ZG.'MGW"1Q0]Z>YSC``Y\.7[%#\GC6'\MQ:IV(/ M(=WU!JRGP1-F_-#5E_Z4]KGNX&2X__4(?PDHX&S378-X7]?=]8,Z.1W^MO#T M'P```/__`P!02P,$%``&``@````A`#J7VD_M!```'A8``!D```!X;"]W;W)K M&ULE)AOCZHX%,;?;[+?@?!^A!9%-.K-R+^]R=UD ML]F[^QJQ*AF@!IAQYMOO*46DQ=OJFV$HOS[T/#TMQZZ^?1:Y\4&J.J/EVD03 MVS1(F=)]5A[7YL]_HA?/-.HF*?=)3DNR-K](;7[;_/[;ZD*KM_I$2&.`0EFO MS5/3G)>65:T'*AHM4)$\:&']]RL[U5:U('Y$KDNKM_?R2TN(,$KLLSYJO M5M0TBG3Y_5C2*MGE$/H=M3/P5V7LR2%YSYN_Z>4/DAU/#4SW#")B@2WW7P&I4W`49":X M'49*59^.!R%M3X'H3>7HH M;J<"UYO*LT.9=R)PO8D\.A2+3W:;.T'2))M512\&+$B8SOJ(I6#& MA+L0D6",8)$(QX0L$HT1/!-5XCL(NKU)<`76W-`5E@\.;$5J=U@GX(9F($<< MPY8SL!A[PZ11^EHBT!*AEHBT1*PB!*\@F*%7:H\8O#9A)OKX\5RRB",>7S^S MN>N*S_WA\ZD[FTL&!L/G>-P_'#Z_TS\:/G=F&$MK+1X^GV(;3_OQ";;`7OFX M+0P6;?&D76'+$;>UY04[>.K<7MQN$[Y`(,_#6%YI`C''W@))YH4"X7H>\J0, MCC@!)O0S*&G$*D*P"#X$CUO$8-$BC"0'MIQ1C,W7$@$G.I\=U\;R/A(*!&3` M="KY'&G?$JL(P2/XFCSN$8-%CV92]FXYPE?7"WR>G#E:2#;ZG%'8&#R@$FI5 M(E'%GMH>GDM6QBH5P2A6P$N?\"EDHGH[8IU$P["\)+:<4;CA:XF`$SRIV)9A MVW:_:[2+-]1J1%HB5A&"5PO1*[5'#)8]DO;D+6<4\?F<4+@8:#5"K4:DU8A5 M&H)'"+[WPX12F]32LDOREZV#%";X>B30(Z$>B?1(K$1$KUAU*2T^?;V$>$T* MA4;_*<&C@JF#E)YQ'042Z%5"/1+ID5B)B)ZQ/$J%$Y(+A$0AQ1& M^'HDN(-@)&W+X1U(*@,B/1(K$=$M5HX^[A8O7@6WL+3C;I&JPN45E1X)]$BH M1R(]$BL1T2M(@*%7C_UZ0:R7[N=+!RDSC.LHD$"O$NJ12(_$2D3TC!6MC^<7 M+W&%_!JO1E4=W.67%@G8V15,R]#.T4^2\`XT6HUC'0EAQW+RJVX(=XL?N_&C MDX)41^*3/*^-E+ZS(S4'?ISTK?UQWRMFYP52^Q8MX9QCW!Z@)1QF0+O5=X#3 MN7-R)'\FU3$K:R,G!WB5/9G#:"M^OL=O&GIN#W)VM(%SN?;?$YS#$CC]L"<` M'RAMKC?L!?W)[N9_````__\#`%!+`P04``8`"````"$`T_+@V88"``!4!@`` M&0```'AL+W=OKCQ^6.VWN;0W@ M"#*T-J>UX-!6SG0%>](=4PY+))&6*RY8&ALR< MPZ'+4@JXT6*KH'6!Q$##'=9O:]G9`YL2Y]`I;NZWW870JD.*C6RD>^I)*5$B MNZM:;?BF0=^/\8R+`W>_.*%74AAM=>DBI&.AT%//E^R2(=-J64ATX&,G!LJ< MKN/L>D'9:MGG\T?"SHZ>B:WU[HN1Q3?9`H:-;?(-V&A][Z%WA=_"P^SD]&W? M@!^&%%#R;>-^ZMU7D%7ML-MS-.1]9<73#5B!@2)-E,P]D]`-%H"_1$D_&1@( M?\QI@L*R<'5.IVDT7TRF,<+)!JR[E9Z2$K&U3JN_`13W106NOK0;[OAJ:?2. M8+L1;3ONAR?.D/CU6K`(CUU[<$X7E*",Q?P>5G$Z7;('-"WVF.N`P=]GS(!@ M*#HHH]KYRA[LE7TJOI3KL#&625Z7F1[+^-"GV+JWC?I#B!N;2&<#?Z@@8&8C MS'Q`'!E%R/E&/1A[@0U]SN\DXP`Z0QIIQM+>?)+ZZ7K'OS_75S'DO=_!Y$9U M_<=P>JSZ=M0>?"RUWPES.YX8'+R7;B[?;:4_=,R_WQG'%Z?IB]Z%6QRNB@)3 MP6=H&DN$WOH;FN#P#[O#QV.=^/E\N3_+UOW&PO=V]R:W-H965T98E>N+:"%4E.)P$&/&*J514>8)__[J_ MNL;(6%JEM%053_`+-_AF\_G3^JCTWA2<6P0,E4EP86T=$V)8P24U$U7S"KYD M2DMJ8:MS8FK-:=HA+-2VK!?U.( MVIS8)!M#)ZG>'^HKIF0-%#M1"OO2D&(D6?R05TK370EQ/X:"7@JF ME5&9G0`=\8Y>QKPB*P),FW4J(`*7=J1YEN!M&-^N,-FLF_S\$?QH>N_(%.KX M58OTNZ@X)!O*Y`JP4VKOH`^I,\%A<0 MD(LK3E_NN&&04*"91'/'Q%0)#L"*I'"=`0FAS\WS*%);)#@*)O-E,`T!CG;< MV'OA*#%B!V.5_.M!84OE2:*6!)XMR70QEH1XAYKX[JBEF[561P0]`Y*FIJX# MPQB(WPX((G'8K0,G>(D1^&J@"$^;-$(::,9+.W`CW26WM<`UZ3DS>SO*Q4>D''@HU5J:3A]D#[JL M'X*[<;/@>K($W]YO4G=PJ.$M,VB97CC_*9H;V*/O@P,/I5K+93BK(6\S0%;@ MT?NQN%-#@=;2[X%PN7A5&C_'_#V77.?\"R]+@Y@ZN!D5P`Y##=E8:`UKP7\OSA< M7AA]&&5*V=,&A$GW1]S\`P``__\#`%!+`P04``8`"````"$`S+^TIOP%``#= M&@``&0```'AL+W=O+J"ZJ)N06UJV/#7(X5"5^(N5;C9N>&VGQN>@A_NY47;K!6EWZF*N+ M]O7M\JTD]05,O%3GJO]B1L.@+M<_C@UIBY1)&NPT#Z-\*?W3:_T%W(A^_ MMM7^]ZK!@#;4B5;@A9!7JOIC3T6P.1KM?F85^+,-]OA0O)W[O\C';[@ZGGHH M]QPRHHFM]U]/N"L!43`S0W-JJ21G"`#^!G5%6P,0*3ZW(0+'U;X_;<-T,9LO MXS0!]>`%=_US14V&0?G6]:3^CRNQC")NBX7V5/3%;M.2CP#J#=K=I:#=DZS! M\!`3MR"CO!8D1$>-/%`KVW`9!N"_`V3?=TF>;:)W0*,4.H]KL&,[IHEGR]G5[MQ@)ON8U%(O(4$ M8%=Q)2HN(^&%Z?4VU%39="4DO*'UCH'&T[.Y;9V:*ILI<4G&>$//*#?-LOIDJ]ERLD!TH^E"2,P"J7R-`B4P`/[I,&W3F1"- M$TKH^&M`T8S08C7=<6RCY410B3F&2UE",R5*")KCVQ5*!'UP_F6$(D2.E.B@ M:Y9I2@E:4?*>8)&$4P0,LQRC063FM+J2$YUSS?-$3IP5#&]AY"-![2Y*[I9]JL[!JOY*K&?$R%EL><)A9'L&+%J4?_2;Y0M1(BB%DM,M(&D!AU1U6$"4:[E@2BRN(*W/VR_'0;;9L[S(#+P1+$; M3V01R80W015:AS(#$,`83W0753#M48>J+N!X"BT?/!UTDL8>SV0T9I-!9"*: M7$&4DH'WS".J;=5/B!R(WD4GE#CM1S.\H\BH!:)3SPD MR4>RZ"`R(56':>,I3D_F_CW*M,T>'43C'DWO(A2F;4T]BE4C<$B%E@>DJ<4Y M#-+%T@-2MM-*DAH#D0FI>A$S(;7XYG:7IF.2&40.2"DA>#-*2K5'D*I&$)!R M+1](+=*AD*(L]3@\IY*`9)<.(A/2*^\WJ44X$Y".:889`"@B899@!)Z+9793"M*TF M3570'%"AY`%H9I$.!32+\QFTQ.T4V486AP1T$)F`JJ.R,?49:/F/)M.VO%$# M;D#O(I1,$HK>HFJP!*)?]AG=:.4H1":BZJAL(FK1S43] MQA23"=%XZ+.[^(1ILT1T1$<]REG'!U&+I9)JDZ2IK>[.":3'*.CK*9-]"W7TOVKUC:\SRT:8GT[AXO= M*29@&\V^'40&R*DZ[YF.+0JZ#3)&&XC=1HK%I7N6KA]@`J!11BL+6%DY5_+U`[^IM_>@^?H!3L\.:VBU?H!# MH&,E36`E=:YDL+)PKBQA)7>M9#%$C5PKX,8I!R=.'^""W]G8228`#-P*.%)) M`!AXOW6L(`0K_+Y'FH./"Y?BB/\HVF/5=,$9'Z!(_*G>\L\3_$=/+E`\^,1` M>OBLP/X]P6W3`R']\`-<1_+#U.Y_````__\#`%!+`P04``8`"``` M`"$`T;;A[(T"``"(!@``&0```'AL+W=OBR>$+&TG M+P9?CL^YJUF?W^N&W$GKE&ESFD0Q);(5IE!ME=.?/Z[.EI0XS]N"-Z:5.7V0 MCIYO/GY8'XR]=;64G@!#ZW):>]]EC#E12\U=9#K9PI?26,T];&W%7&5.'KG*:K:#F;3>?+!=#LI/-7"CDI$7OGC?X= M4,F1*["D1Q9X'EDF\VBVB"<)B/Z'A`6/^@`ON>>;M34'`DT#DJ[CV())!L1O M1P2A(':+X)PN*`%?'53A;I.LXC6[@]2)(^8B8&!]P@P(!J*#,JB=KHQ@5,;< MHBL7P3"62=^6F;Q'!L$YA?7)^54R\`;E@)F.,+,!\2Q`@)P>((*A!E#(D?3+ MW`;0"=)`<[HT@GOI(;E'"\S)R)F_Y'?^'BD$/Y<*EFD_?N/N@"8;1X`3-Y]& MX-B_.Q2//1-.!YS#(QL,-T+_6<.-+ MZ/88`R^-\8\;$&;#/V3S!P``__\#`%!+`P04``8`"````"$`MP6K'\T"```) M"```&0```'AL+W=OS&06X-"JG2K[E;:E5:KO3P[QH!5C)'M-.W?[Q@G%)*HI2]XA=N\,WZ\Z?57NE' M4W)N$3#4)L6EM4U"B&$EE]0$JN$U?,F5EM3"JRZ(:32G6;M(5B0.PSF15-38 M,R1Z#(?*<\'XG6([R6OK232OJ(7\32D:6 M%"/)DH>B5IIN*_#]'$TI.W*W+V?T4C"MC,IM`'3$)WKN>4F6!)C6JTR``U=V MI'F>XDV4W$81)NM56Z"_@N]-[QF94NV_:I%]%S6':D.?7`>V2CTZZ$/F0K"8 MG*V^;SOP4Z.,YW17V5]J_XV+HK30[ADX($1 MY&J@"T_K:+Y8D2>H'#M@;CT&KJ^8#D%`M%,&M?'*#NR476E=*K<^T)>)+\M, M/B+CP"F&ZVOR\^N.URM[S+2'F76(@4&`C#?HP-`#:&1/^K2V'C1"&FC&2SMP M*]T5UT>F[9'HMVS^$5H''M(>(G#Z>AZ7EXL'FVR\`P<>2OG(N0,WD'O;W9WC M:;@,(+.W=[Y;-U0X1/K-B!;A93/+H>K;4@X\E/*1O'TR2ZX)_X55E$%,[-U1C=M!OX MF]CMS]/X--GX'P'IOL`@;FC!?U!=B-J@BN?`&09N\FH_ROV+50WD"9-461C! M[6,)OUP.XR8,`)PK98\OH$RZG_CZ/P```/__`P!02P,$%``&``@````A`/*\ MG29"`P``60H``!D```!X;"]W;W)K&ULE%;;;J,P M$'U?:?\!^;TA3DA(HI`JW:J[E;;2:K679P=,L`H8V4[3_OW.V)0"N>X+@N'X MS)P9S]C+V]KSI^5>JF>=<6X\8"AU1#)CJH7OZSCC!=,#6?$2_J12%== M=1/+H@**C;.DQ"OBQ>.VE(IMM]X]G M:2.+OPY$;5".RX9VSPQ;+97<>U!O0.N*X>ZA"R`^'@L$@=@U@B,2$@_<:$C@ MRXK.1DO_!43'->;.8>#Y@6D0/CAM/(.WZSTC&#UC5C"4.V=HN_D(I.-FW'6# M21]#Z@*UT#3 M=HWB1U/<71?TXSH;19/OV@*9:\45'!<\[7H]GVH$=UTY2S"V^[:]8V#CM=6< MYT5PE]=9@@-:G*^M%K`[A,X'%Y.$Z[H>G"5H%X;.3NR*>=?K>3$([KIREL#. MBKSK%SF_E\;PBB^YYK+`EFH2# M\&*-:#TGW#RUDZ,V]42%)T3UQL<%46XF0/[!8NXN% MW_R!@[UB6_[$U%:4VLMY"IQ#6WSEK@;NP\@*N@2.=VG@2+>O&5SA.)R!0\QJ M*J5Y_P#/?G,I7/T#``#__P,`4$L#!!0`!@`(````(0`"!4DHJ@(``"<'```9 M````>&PO=V]R:W-H965TTT[=_O#$XH-%'+"\+#\3ES9NQA??.L*O(D MC)6Z3FD43"@1-=>9K(N4_OE]?[6DQ#I69ZS2M4CIB[#T9O/YT_J@S:,MA7`$ M&&J;TM*Y)@E#RTNAF`UT(VKXDFNCF(.E*4+;&,&R=I.JPG@RF8>*R9IZAL2, MX=!Y+KFXTWRO1.T\B1$526ZTU;D+@"[TB9Y[7H6K$)@VZTR"`RP[,2)/ MZ39*;E(1/7%20`3Z(DG@PH M"'M.:0S",G-E2J?S8+:83".`DYVP[EXB)25\;YU6_SPH:I/R7&UJ=\RQS=KH M`X%V`]HV#`]/E`#QY5P@"<1N$9S2!24@8Z%^3YMHL5B'3V":'S&W'@//5TR' M"$&T4P:U\-XJ;`-F9ME-,(.;AQJ'"/]$D;+R64[.'Y'7Q$$ M#Z6.D7,[JR%OVYQI>_<_Z`YN'&H<(T,[T1L[?C#YVZ^$*<074566<+W'H1/# M?>ZBW3S<73C>0 M.4PK[6!"M:\E_)`$7.E)`.!<:W=:@'#8_>(V_P$``/__`P!02P,$%``&``@` M```A`!+>Y0&Q`@``O0<``!``"`%D;V-0&UL(*($`2B@``$` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````G%5;3]LP%'Z?M/]0Y1U2 M"AH32H-"&B!:ZV2U"^+),HE++=(XLDU5]NMWTJPT79U*\&:?RW>^<_&Q=[U> M%KT55UK(C,R.W)3Z>G#2MS5LB2#YUWKIUK__LW+U6R MXLH(KGL`4>JALS"FNG)=G2WXDNE34)>@F4NU9`:NZL65\[G(^$AF;TM>&G?0 M[_]P^=KP,N?Y2?4!Z#2(5ROS5=!<9C4__4#>*R#L>T%5%2)C!K+T)R)34LNY MZ47KC!>>VU9ZP`[S[$T)\^[W/;=]]7#&"AX"L#]GA>:>NQ-X]YS514N94-KW M5N9JQ3,C54^+/U"V@=-[9IK7=(;.BBG!2@.T:K/FLCD7E3;*?Y3J52\X-]IS MP:`1;HYMV_997/B#RXT%G/8M:X2&"2CV.1)A"JZ3>L&@8-X2V M7:0P&S0J#=2+QF73;2';S#]R"!,TBA".1A1..!G'HX#`Y288!RB,ON!R]AD? M3"#:Y%-A_KG8P^#99!),GVAR2W%\A^+;.`P0H4$8)C-$K,PP2<)?-$E)G"": M0M;8:A:CAPB19!I''7J,9W7%-J%K2"O*-!IORIL&4_)$R12B!6$=V0Z*$A)A MF@9/PM,1SX;WT<'C6(3!%WS.K3ZM M2:`C;I@H.O@`Y+<:O?";Q[ MV/JJJ$'"!2M?>+ZU.534']5#\QO[9Q>G_?,^_$$MF>?N_EW_+P```/__`P!0 M2P,$%``&``@````A`,6/JI0Q`0``0`(``!$`"`%D;V-03>INF*C-!FH+*3`\&)LEM,OFW!)@U)M.N_-^NZ.M&3Q_"^>?)\ M7ZK%03?))SBO6E,CDN4H`2-:J"ENC?0B68NS%'C3W66R8&&Y;IWF(1[?#EHMWO@-/_\<_8%``#__P,`4$L!`BT`%``&``@````A M`)ZT!```S$0`` M&@`````````````````C!P``>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0 M2P$"+0`4``8`"````"$`,UB5+AD#``#D"```#P`````````````````0"@`` M>&PO=V]R:V)O;VLN>&UL4$L!`BT`%``&``@````A`&7_RH`J!0``/1,``!@` M````````````````5@T``'AL+W=O0<``$8I```9`````````````````+82``!X;"]W M;W)K&UL4$L!`BT`%``&``@````A`,,(>(-Y`@`` MRP8``!D`````````````````9AH``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$N-81PQ`@``$P4``!D````````` M````````,24``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`(.D&,+``@``F`<``!D`````````````````3RT``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&S\"WI``P``%`L``!@````````````````` MF#4``'AL+W=O&UL4$L!`BT`%``&``@````A`/MBI6V4!@``IQL` M`!,`````````````````#'D``'AL+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4 M``8`"````"$`47$#0WL#``"["P``&`````````````````#1?P``>&PO=V]R M:W-H965T&UL4$L!`BT`%``&``@````A`.0GV'Z#!0``.1L` M`!D`````````````````@H,``'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`*[J9-EW#```)C\``!@`````````````````+)D``'AL+W=O(%``"@&```&`````````````````#&J@``>&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`#J7VD_M!```'A8``!D` M````````````````WK```'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,R_M*;\!0``W1H``!D````````````````` MI;L``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`/*\G29"`P``60H``!D`````````````````H,<``'AL+W=O&UL4$L!`BT`%``&``@````A`,6/JI0Q`0``0`(``!$` M````````````````X=$``&1O8U!R;W!S+V-O&UL4$L%!@`````D`"0` *K@D``$G4```````` ` end XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
LITIGATION (Details) (Settled Litigation [Member], R&D Products, LLC [Member], Notes Receivable One [Member], USD $)
0 Months Ended
Apr. 09, 2013
Settled Litigation [Member] | R&D Products, LLC [Member] | Notes Receivable One [Member]
 
Legal Settlement [Line Items]  
Notes receivable $ 25,000
Interest rate 10.00%
Maturity date Dec. 31, 2015
XML 14 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
ISSUANCE OF STOCK
9 Months Ended
Sep. 30, 2014
ISSUANCE OF STOCK [Abstract]  
ISSUANCE OF STOCK

NOTE 4 – ISSUANCE OF STOCK

 

None during the period presented.

EXCEL 15 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W-U]B-C@P M-#`V9C'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E M;%=O#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-534U!4EE?3T9?4TE'3DE&24-!3E1?04-#3U5.5#$\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-534U!4EE?3T9?4TE'3DE&24-! M3E1?04-#3U5.5#,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E;%=O#I% M>&-E;%=O#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O6QE#I!8W1I M=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0 M&UL/CPA M6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G M92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7V8V839A,3(S7SAE8S!?-#4T8U\X83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!296=I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)U$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO3QS<&%N/CPO2!#;VUM;VX@4W1O8VLL(%-H87)E'0^)SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'!E;G-E2!496-H M;F]L;V=Y+"!N970@;V8@86-C=6UU;&%T960@86UOF%T:6]N(&]F("0V M-C4L-S4U(&%N9"`D-3@W+#0Y-CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M6%B;&4@+2!R96QA=&5D('!A6%B;&4L(&YE="!O9B!D:7-C;W5N="!O9B`D M-3@L.30R(&%N9"`D-"PV-3,\+W1D/@T*("`@("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO2!496-H;F]L;V=Y+"!A8V-U;75L871E9"!A M;6]R=&EZ871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQAF5D/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`P,"PP,#`\3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W-U]B-C@P-#`V M9C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(&]F('!A=&5N=',@86YD('!R;W!R M:65T87)Y('1E8VAN;VQO9WD\+W1D/@T*("`@("`@("`\=&0@8VQA'!E;G-E'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO6%B;&4\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO6UE;G1S(&9O'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO2!&:6YA;F-I;F<@06-T:79I=&EE'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N M/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W-U]B-C@P-#`V9C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)R!M87)G:6XZ(#$P M+C5P="`P<'0@,BXR-7!T.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^/'-TF4Z(#$P<'0[(&9O;G0M6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4 M:6UE7-T96US+"!);F,N(&%N9"`F(S$V,#MI=',@28C,30X.RDN(%1H97-E(&9I;F%N8VEA;"!S=&%T M96UE;G1S(&%R92!C;VYD96YS960@86YD+"!T:&5R969O2!R97%U:7)E9"!B>2!A M8V-O=6YT:6YG('!R:6YC:7!L97,@9V5N97)A;&QY(&%C8V5P=&5D(&EN('1H M92!5;FET960@4W1A=&5S(&]F($%M97)I8V$N(%1H97-E('-T871E;65N=',@ M6EN9R!C;VYD96YS960@8V]N2!B92!E>'!E M8W1E9"!F;W(@=&AE(&9U;&P@>65A6QE/3-$)R!M87)G:6XZ M(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$ M)R!C;VQO6QE/3-$)R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,36QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/B!F;&5X:6)L92!P;W1E;G1I;VUE=&5R('1E8VAN;VQO9WDN/"]F;VYT M/CPO9F]N=#X\+V9O;G0^/&9O;G0@6QE/3-$)R!F;VYT+69A;6EL>2`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`Z(%1I;65S($YE M=R!2;VUA;CLG/B8C,38P.SPO<#X-"@T*/"]D:78^#0H-"CQD:78^#0H-"CQP M('-T>6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UEF4Z(#$P<'0[)SY#87-H(&%N M9"!C87-H(&5Q=6EV86QE;G1S(&%R92!C;VYS:61E2!L:7%U:60@6QE/3-$)R!L:6YE+6AE:6=H=#H@,3`N-C5P=#L@;6%R9VEN.B`P M<'0[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R<^)B,Q-C`[/"]P M/@T*#0H\+V1I=CX-"@T*/&1I=CX-"@T*/'`@2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T M>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!F;VYT+7-T>6QE.B!I=&%L:6,[)SX\6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R<^("T@5&AE(&-A&EM871E(&9A:7(@=F%L=64@8F5C875S92!O9B!T:&4@ M:6UM961I871E(&]R('-H;W)T+71E6%B;&4@87!P2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE M/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R!F;VYT+7-T>6QE.B!I=&%L:6,[)SX\2!A2!C;VUP;&5T97,@96%C:"!P:&%S92!O6QE M/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UEF4Z(#$P<'0[(&9O;G0M6QE/3-$)R!M87)G:6XZ(#!P=#L@ M9F]N="UF86UI;'D@.B!4:6UEF4Z M(#$P<'0[(&9O;G0MF4Z(#$P<'0[)SX@4')O<&5R='D@86YD(&5Q M=6EP;65N="!AF5D+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)R!M87)G:6XZ(#!P=#L@ M9F]N="UF86UI;'D@.B!4:6UEF4Z M(#$P<'0[(&9O;G0M2!A;F0@=VAE;F5V97(@979E;G1S(&]R M(&-H86YG97,@:6X@8VER8W5M2=S(&%N86QY2`Z(%1I;65S M($YE=R!2;VUA;CLG/B8C,38P.SPO<#X-"@T*/"]D:78^#0H-"CQD:78^#0H- M"CQP('-T>6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE M2!C=7)R96YT;'D@:&%S('1H92!R:6=H=',@=&\@2!T96-H;F]L;V=Y+B`F(S$V,#M0871E;G1S(&%N M9"!T96-H;F]L;V=Y(&%R92!A;6]R=&EZ960@9G)O;2!T:&4@9&%T92!T:&4@ M0V]M<&%N>2!A8W%U:7)E2!R:6=H=',L(&]V97(@=&AE:7(@97-T:6UA=&5D('5S969U M;"!L:79E65A6EN9R!A;6]U;G0@97AC965D M2!P2`Z(%1I;65S($YE=R!2 M;VUA;CLG/B8C,38P.SPO<#X-"@T*/"]D:78^#0H-"CQD:78^#0H-"CQP('-T M>6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE'!E M;G-E(&1U2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,38P M.SPO<#X-"@T*/"]D:78^#0H-"CQD:78^#0H-"CQP('-T>6QE/3-$)R!M87)G M:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/D=O M;V1W:6QL(')E<')E2=S M(')E;W)G86YI>F%T:6]N('9A;'5E(&]V97(@=&AE(&9A:7(@=F%L=64@;V8@ M;F5T(&%S2!U<&]N(&5M97)G96YC92!F6EN M9R!V86QU92!O9B!I=',@;F5T(&%S2=S('!R;V1U8W1S(&%N9"!S97)V:6-E6QE/3-$)R!L:6YE+6AE:6=H=#H@,3`N-C5P=#L@;6%R M9VEN.B`P<'0[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R<^)B,Q M-C`[/"]P/@T*#0H\+V1I=CX-"@T*/&1I=CX-"@T*/'`@2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF M;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R!F;VYT+7-T>6QE.B!I=&%L:6,[)SX\6QE/3-$)R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CLG/E)E=F5N=64@:7,@65R(&ES(&9I>&5D(&]R(&1E M=&5R;6EN86)L92!A;F0@8V]L;&5C=&%B:6QI='D@:7,@2!A M2!T:&4@ M8W5S=&]M97(N("8C,38P.U)E=F5N=64@9G)O;2!C;VYT2!R979E;G5E M(&]V97(@=&AE(')E;6%I;FEN9R!T97)M(&]F('1H92!C;VYT2`Z(%1I M;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X-"@T*/"]D:78^#0H-"@T*#0H\ M9&EV/@T*#0H\<"!S='EL93TS1"<@;6%R9VEN.B`P<'0[(&9O;G0M9F%M:6QY M(#H@5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@F4Z(#$P<'0[(&9O;G0M M6QE/3-$)R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^(#PO9F]N M=#X\9F]N="!S='EL93TS1"<@9F]N="US:7IE.B`Q,'!T.R<^/&9O;G0@6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/G1H92!#;VUP86YY M(&ES(')E<75I&-H86YG92!F;W(@2!I;G-T2!V97-T+B`F(S$V,#M0 M2=S('-T;V-K+6)AF5D(&%S(&%N(&5X<&5N65E(&-O;7!E;G-A=&EO M;B!F2`Q+"`R,#`V+CPO9F]N=#X\+V9O;G0^ M/"]F;VYT/CPO<#X-"@T*/'`@2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T M.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO M<#X-"@T*/"]D:78^#0H\+V1I=CX-"@T*/&1I=CX-"@T*/&1I=CX-"CQP('-T M>6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE2!D:79I M9&EN9R!N970@:6YC;VUE(&)Y('1H92!W96EG:'1E9"UA=F5R86=E(&YU;6)E M2!D:79I9&EN9R!N970@96%R;FEN9W,@8GD@=&AE('=E:6=H=&5D M+6%V97)A9V4@;G5M8F5R(&]F(&-O;6UO;B!S:&%R97,@86YD(&1I;'5T:79E M('!O=&5N=&EA;"!C;VUM;VX@6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE M'1087)T M7V8V839A,3(S7SAE8S!?-#4T8U\X83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@ M:60],T1%9&=A2`Z("=4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R<^/'-TF4Z(#$P<'0[)SY/;B!!=6=U2!T:&4@0F]A2!T M:&4@2=S('1R861I;F<@8V]M;6]N('-T;V-K(&9O2`Z M(%1I;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X@/'`^/&9O;G0@F4Z M(#$P<'0[)SY4:&4@0V]M<&%N>2!C;VYT:6YU97,@=&\@=71I;&EZ92!T:&4@ M0FQA8VLM4V-H;VQE2!!4T,@5&]P:6,@ M-S$X+"!W:&EC:"!I2!U2!A9F9E8W0@=&AE(&9A:7(@=F%L=64@;V8@=&AE M(&5S=&EM871E+"!A;F0@=&AE2=S(&5M<&QO>65E('-T M;V-K(&]P=&EO;G,N/&)R+SX-"CQB2!R96-O9VYI>F5D("0\+V9O;G0^/&9O;G0@F4Z(#$P<'0[)SX\9F]N M=#XP+C`P/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL93TS1"<@9F]N="UF86UI M;'D@.B!4:6UE6QE/3-$)R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B!C;VUP87)E9"!T;R`\ M+V9O;G0^/"]F;VYT/CQF;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^)#PO9F]N=#X\9F]N M="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R<^(&1U65E('-T;V-K(&]P=&EO;G,@;W5TF4Z(#$P<'0[)SY!('-U;6UA M65E(&]P=&EO;G,@;W5T2`Z(%1I;65S M($YE=R!2;VUA;CLG/B8C,38P.SPO<#X@/&1I=CX-"CQD:78@8VQA6QE/3-$)R!B;W)D97(M8V]L;&%P M6QE M/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N M93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D M97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@8F]R9&5R+6)O='1O M;3H@(S`P,#`P,"`Q<'0@6QE/3-$)R!M87)G:6XZ M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^/'-T6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE M.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M M#L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`Q<'0@6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@ M;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B M;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@8F]R9&5R+6)O M='1O;3H@(S`P,#`P,"`Q<'0@6QE/3-$)R!M87)G M:6XZ(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z M(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^/'-T#L@<&%D9&EN9RUL969T.B`U<'@[(&)O M'0M86QI9VXZ(&-E;G1E6QE/3-$)R!F;VYT M+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^ M/'-TF4Z(#EP=#LG/CQS=')O;F<^5V5I9VAT960@079E#L@<&%D9&EN9RUL969T.B`U<'@[(&)O'0M86QI9VXZ(&-E;G1E M'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T* M/'1D(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@ M=&]P.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE M9G0Z(&YO;F4[(&)O'0M86QI9VXZ(&QE9G0[('=H:71E M+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@<&%D9&EN9RUL M969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&-O;'-P86X],T0S(&%L:6=N M/3-$8V5N=&5R('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!F;VYT M+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+71O<#H@(S`P,#`P M,"`Q<'0@#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1C96YT97(@'0M86QI9VXZ(&QE9G0[ M(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D97(M;&5F=#H@ M;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P M,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C,38P.SPO=&0^ M#0H\=&0@8V]L6QE/3-$)R!V97)T M:6-A;"UA;&EG;CH@=&]P.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O'0M86QI9VXZ M(&QE9G0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&-O;'-P M86X],T0S(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG M;CH@=&]P.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R M+71O<#H@(S`P,#`P,"`Q<'0@F4Z(#$P<'0[)SY/=71S=&%N9&EN M9R!A="!T:&4@8F5G:6YN:6YG(&]F('!E6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@F4Z(#EP M=#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L M969T('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT M.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE M.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF M86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E2`Z M(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\=&0@2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Y<'0[('9E#LG/B0\+W1D/@T* M/'1D(&%L:6=N/3-$2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Y<'0[('9EF4Z(#EP M=#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L M969T('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT M.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE M.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF M86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E6QE/3-$ M)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D M97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE M6QE/3-$)R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N M;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X M="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US M<&%C93H@;F]W6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@ M8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!F;VYT+69A;6EL>2`Z M(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)R!V M97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A M;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O M#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L M:6=N/3-$;&5F="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R M9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C M,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O M;6%N.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z M(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^ M#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4 M:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R M9&5R+6QE9G0Z(&YO;F4[(&)O6QE/3-$)R!V97)T:6-A;"UA;&EG M;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#L@<&%D9&EN M9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S M='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO M;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\ M+W1R/B`\='(^#0H\=&0@=VED=&@],T0Q,#`E('-T>6QE/3-$)R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I M9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N M;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#LG/@T* M/'`@2`Z(%1I;65S M($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^1W)A;G1E9#PO9F]N M=#X\+W`^#0H\+W1D/@T*/'1D('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE M.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA M;&EG;CH@F4Z(#EP=#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\ M=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@ M8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Y<'0[('9E6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N M;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B M;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI M;'D@.B!4:6UE6QE/3-$)R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@F4Z(#EP=#L@=VAI=&4M#LG/B8C M,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!B;W)D97(M M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N M;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P M,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9EF4Z(#EP=#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI M9VX],T1L969T('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@ M9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[ M('9E6QE M/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4 M:6UE6QE/3-$)R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET M92US<&%C93H@;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET M92US<&%C93H@;F]WF4Z(#$P M<'0[('9E#LG/B8C,38P.SPO=&0^#0H\+W1R/B`\ M='(^#0H\=&0@#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[ M(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D97(M;&5F=#H@ M;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P M,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C,38P.SPO=&0^ M#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H M="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=VAI=&4M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=VAI=&4M6QE/3-$)R!F;VYT+69A M;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O M6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N M.B!L969T.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R M+6QE9G0Z(&YO;F4[(&)O#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V M,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"<@9F]N="UF86UI M;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY M(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX] M,T1L969T('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI M=&4MF4Z(#$P<'0[)SY%>'!I M2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO M=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@8F]R9&5R+6QE9G0Z M(&YO;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M M2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[ M('9E#LG/B8C,38P.SPO=&0^#0H\=&0@2`Z(%1I;65S M($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$ M,B!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#EP=#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M'0M M86QI9VXZ(&-E;G1E2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\ M=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[ M(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4MF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M'0M86QI9VXZ(&-E;G1E#L@9F]N="UF M86UI;'D@.B!4:6UE6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT M.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE M.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF M86UI;'D@.B!4:6UE2`Z(%1I;65S M($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE M=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT M+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O6QE/3-$ M)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@ M8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A M9&1I;F#L@=&5X="UA;&EG;CH@F4Z(#EP=#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!B M;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z M(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T M97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O M;6%N.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z M(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^ M#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4 M:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE M9G0Z(&YO;F4[(&)O#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\ M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"<@9F]N="UF86UI;'D@ M.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE M=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\+W1R/B`\='(^#0H\=&0@=VED=&@] M,T0Q,#`E('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P M.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P M,#`P,#`[('!A9&1I;F#LG/@T*/'`@2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T M>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R<^1F]R9F5I=&5D/"]F;VYT/CPO<#X-"CPO=&0^#0H\=&0@ M2`Z M(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL M93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=VAI=&4M2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C,38P M.SPO=&0^#0H\=&0@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[ M('9E#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!C;VQS<&%N/3-$,B!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO M;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M'0M86QI9VXZ(&-E;G1E2`Z(%1I;65S M($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@ M8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=VAI=&4M2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^ M#0H\=&0@F4Z(#$P M<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@ M<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$ M;&5F="!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#$P<'0[('9E M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R M:6=H="!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#$P<'0[('9E M6QE/3-$ M)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D M97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=VAI=&4M6QE/3-$)R!F;VYT+69A M;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O M6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N M.B!L969T.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R M+6QE9G0Z(&YO;F4[(&)O#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V M,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"<@9F]N="UF86UI M;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY M(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX] M,T1L969T('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI M=&4M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O6QE/3-$ M)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C M,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@8F]R9&5R M+6QE9G0Z(&YO;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=VAI=&4MF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M M'0M86QI9VXZ(')I9VAT M.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y M<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@ M<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$ M;&5F="!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#EP=#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4MF4Z(#EP M=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M'0M86QI9VXZ(&-E;G1E2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C M,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@8F]R9&5R M+6QE9G0Z(&YO;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=VAI=&4M2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\ M=&0@F4Z(#$P<'0[ M('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@<&%D M9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F M="!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#$P<'0[('9E#LG/B0\+W1D/@T*/'1D(&%L:6=N/3-$2`Z M(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]WF4Z(#$P<'0[('9E#LG/B8C M,38P.SPO=&0^#0H\+W1R/B`\='(^#0H\=&0@#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C M,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O M;6%N.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z M(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^ M#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4 M:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R M9&5R+6QE9G0Z(&YO;F4[(&)O6QE/3-$)R!V97)T:6-A;"UA;&EG M;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#L@<&%D9&EN M9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S M='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO M;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\ M=&0@'0M86QI9VXZ M(&QE9G0[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D97(M M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z M(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C,38P M.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=VAI=&4MF4Z(#$P<'0[)SY%>&5R8VES86)L92!A="!T:&4@96YD(&]F(%!E6QE/3-$)R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@ M=&5X="UA;&EG;CH@F4Z(#EP=#L@=VAI=&4M#LG/B8C,38P.SPO M=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@ M;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B M;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A M9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Y<'0[('9E2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\=&0@ M2`Z M(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B0\+W1D/@T*/'1D(&%L:6=N/3-$2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9EF4Z(#EP=#L@=VAI=&4M#LG/B8C,38P.SPO M=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@ M;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B M;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A M9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Y<'0[('9E6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@ M9F]N="UF86UI;'D@.B!4:6UE6QE M/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N M93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[ M('!A9&1I;F#L@=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US M<&%C93H@;F]W2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!B M;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z M(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US M<&%C93H@;F]W6QE/3-$)R!M87)G:6XZ(#!P M=#L@9F]N="UF86UI;'D@.B!4:6UEF5D+B8C,38P.SPO9F]N=#X\+W`^#0H\+V1I=CX\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQD:78@:60],T1%9&=A2`Z("=4:6UEF4Z(#$P M<'0[)SX\F4Z(#$P<'0[(&9O;G0M2!O9B!R87<@;6%T97)I86QS('5S960@9F]R(&UA:VEN9R!P3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W-U]B M-C@P-#`V9C'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4 M:6UE6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI M;'D@.B!4:6UE6QE M/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE M/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE=R!2;VUA;B<[)SX-"CQD:78^ M#0H\<"!S='EL93TS1"<@;6%R9VEN.B`P<'0[(&9O;G0M9F%M:6QY(#H@5&EM M97,@3F5W(%)O;6%N.R<^/&9O;G0@F4Z(#$P<'0[)SX\F4Z(#$P<'0[)SY4:&4@0V]M<&%N>2!H M87,@82!R96QA=&5D('!A6%B;&4@=&\@:71S(%!R97-I9&5N="P@ M0T5/(&%N9"!$:7)E8W1O2X\+V9O;G0^/"]P/@T*/"]D:78^#0H\+V1I M=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQD:78@:60],T1%9&=A6QE M/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF M86UI;'D@.B!4:6UE2!D M871E2!T:&4@ M0V]M<&%N>2=S(&)U&5R8VES92!P2`R,RP@075G M=7-T(#$U+"!397!T96UB97(@,R!A;F0@4V5P=&5M8F5R(#$V+"`R,#$T+"!F M;W5R(&YO=&5S('1O=&%L:6YG("0\9F]N=#XQ,C`L,#`P/"]F;VYT/B!W97)E M(&ESF5D M(&1I2!D871E'1E;F1E9"!T;R!397!T96UB97(@ M,S`L(#(P,30@86YD("0\9F]N=#XX,"PP,#`\+V9O;G0^(&]N('1H92!N;W1E M2!D871E(&]F($IU;'D@,34L(#(P,34N)B,Q-C`[($UA;F%G M96UE;G0@86YT:6-I<&%T97,@9G5R=&AE'1E;F1I;F<@=&AE2!D871E2`S,2P@,C`Q,B!A M;F0@:&%S(&$@8V]N=F5R'1E;F1I;F<@=&AI7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA6QE/3-$)V9O;G0M9F%M:6QY M(#H@)U1I;65S($YE=R!2;VUA;B<[)SX@/&1I=CX@/'`@2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF M;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R<^/'-T2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X@ M/'`@2`Z(%1I;65S M($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7-T>6QE.B!I M=&%L:6,[)SY2)F%M<#M$(%!R;V1U8W1S+"!,3$,@+3PO9F]N=#X\9F]N="!S M='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE2P@ M86QO;F<@=VET:"!$879I9"!"+B!"96-K+"!T:&4@0V]M<&%N>2=S($1I2!2)F%M<#M$(%!R;V1U8W1S(&%N9"!-F4Z(#$P<'0[)SX@ M=&5C:&YO;&]G>2!T:&%T('=E2!B>2!-2!G:79E;B!A;F0@ M87)E('1H92!P2!O9B!T:&4@0V]M<&%N>2X@5&AE($-O;7!A;GD@ M8F5L:65V960@=&AA="!S:6YC92!-F4Z(#=P=#L@=F5R=&EC M86PM86QI9VXZ('-U<&5R.R<^)B,Q-S0[/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R<^(&%P<&QI8V%T:6]N2!C;&%I;65D('1H870@2!D94=R965F+"!097)S M:6UM;VX@86YD(%(F86UP.T0@8F5L;VYG('1O($9L97AP;VEN="!A;F0@=&AE MF4Z(#$P<'0[)SY/;B!!<')I;"`Y+"`R,#$S+"!T:&4@<&%R=&EE2=S(')I9VAT2!H860@97AC;'5S:79E(')I9VAT2!A9'9A;F-E9"!T;R!- M3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W-U]B-C@P M-#`V9C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS<&%N/CPOF4Z(#$P<'0[)SX\2`Z(%1I;65S M($YE=R!2;VUA;CLG/B8C,38P.SPO<#X@/'`@2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T M>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R<^3VX@=&AE('-A;64@9&%T92!A2!A;'-O(')E8V5I=F5D(&$@;F]T92!I;B!T:&4@86UO=6YT(&]F M("0\9F]N=#XS-C`L,#`P/"]F;VYT/B!F&-L=7-I=F4@2!A;F0@86QL(&1E=FEC97,@9&5R:79E9"!F6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF M86UI;'D@.B!4:6UE6UE;G0@;V8@=&AE("0\9F]N=#XS-C`L,#`P/"]F;VYT M/B!N;W1E(')E8V5I=F%B;&4@:7,@9G)O;2!F=71U2!I;F-O M;64@9G)O;2!T:&4@6%L='D@:6YC;VUE(&-A;B!B92!R96%S;VYA8FQY(&5S=&EM M871E9"!A;F0@:7,@(G9I2!C97)T86EN(BP@=&AE($-O;7!A;GD@ M=VEL;"!R96-O9VYI>F4@=&AE(&YO=&4@3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W M-U]B-C@P-#`V9C'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!M87)G:6XZ(#!P="`P<'0@ M,'!T(#4T<'0[('1E>'0M:6YD96YT.B`M-31P=#L@9F]N="UF86UI;'D@.B!4 M:6UE'0M86QI9VXZ(&IU2!T;R!C;VYT M:6YU92!A2=S(&%B:6QI='D@=&\@8V]N=&EN=64@87,@ M82!G;VEN9R!C;VYC97)N('1H92!E;G1I='D@2!A9&]P=&EO;B!O9B!T:&ES M(&%M96YD;65N="!I2`R,#$T+"!T:&4@1D%30B!I6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SY2979E;G5E M(&9R;VT@0V]N=')A8W1S('=I=&@@0W5S=&]M97)S/"]F;VYT/CPO96T^/&9O M;G0@2!A;&P@97AIF4@2!E>'!E8W1S('1O(&)E(&5N=&ET;&5D(&9O'!E9&EE;G1S+"!O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@:60],T1%9&=A M2`Z("=4:6UE M2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T M>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R<^/'-T2!D871E(&]F($IU;'D@,34L(#(P,34N/"]F;VYT/CPO<#X-"CPO9&EV M/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W-U]B-C@P-#`V9C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO6QE/3-$)V9O M;G0M9F%M:6QY(#H@)U1I;65S($YE=R!2;VUA;B<[)SX-"CQP('-T>6QE/3-$ M)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE7-T96US+"!);F,N M(&%N9"`F(S$V,#MI=',@28C,30X.RDN(%1H97-E(&9I;F%N8VEA;"!S=&%T96UE;G1S(&%R92!C;VYD M96YS960@86YD+"!T:&5R969O2!R97%U:7)E9"!B>2!A8V-O=6YT:6YG('!R:6YC M:7!L97,@9V5N97)A;&QY(&%C8V5P=&5D(&EN('1H92!5;FET960@4W1A=&5S M(&]F($%M97)I8V$N(%1H97-E('-T871E;65N=',@6EN9R!C M;VYD96YS960@8V]N2!B92!E>'!E8W1E9"!F;W(@=&AE(&9U M;&P@>65A6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI M;'D@.B!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE=R!2;VUA;B<[)SX-"CQP/CQF;VYT M('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!F;VYT+7-T>6QE.B!I=&%L:6,[)SX\6QE/3-$)R!F M;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@ M.B!4:6UE2!I2!I;B!D97-I9VYI;F2!P2X\+V9O;G0^/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL93TS1"<@9F]N M="US:7IE.B`Q,'!T.R<^/&9O;G0@6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^(&]F("0\9F]N=#XW,C@L M.3$U/"]F;VYT/B!A;F0@=7-E9"!C87-H(&EN(&]P97)A=&EN9R!A8W1I=FET M:65S(&]F("0\9F]N=#XS-C`L,C(U/"]F;VYT/B!D=7)I;F<@=&AE(&YI;F4@ M;6]N=&AS(&5N9&5D(%-E<'1E;6)E2!H M860@86X@86-C=6UU;&%T960@9&5F:6-I="!O9B`D/&9O;G0^,C$L,3,W+#$Y M-#PO9F]N=#XN/"]F;VYT/CQF;VYT('-T>6QE/3-$)R!F;VYT+7-I>F4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG M/E1H92!#;VUP86YY(&AA2!A<'!R96-I86)L92!R M979E;G5E(&1U2D@=&AR;W5G M:"!397!T96UB97(@,S`L(#(P,30N(%1H97-E(&UA='1E6QE/3-$)R!C;VQOF4Z(#$P<'0[)R\^#0H\+V9O;G0^/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL M93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE M/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE=R!2;VUA;B<[)SX-"CQP('-T M>6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UEF4Z(#$P<'0[)SY#87-H(&%N9"!C M87-H(&5Q=6EV86QE;G1S(&%R92!C;VYS:61E2!L:7%U:60@6QE/3-$)R!L:6YE+6AE:6=H=#H@,3`N-C5P=#L@;6%R9VEN.B`P<'0[ M(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R<^)B,Q-C`[/"]P/@T* M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^)SQD:78@:60],T1%9&=A M2`Z("=4:6UE MF4Z(#$P M<'0[(&9O;G0M6%B;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,@ M87!P&EM871E(&-U6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF M86UI;'D@.B!4:6UE6QE.B!I=&%L:6,[ M)SX\2!A6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI M;'D@.B!4:6UE6QE/3-$)V9O;G0M9F%M M:6QY(#H@)U1I;65S($YE=R!2;VUA;B<[)SX-"CQP('-T>6QE/3-$)R!M87)G M:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE6QE M/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R<^26YV96YT;W)I97,@87)E('-T871E9"!A="!T:&4@;&]W97(@ M;V8@8V]S="!O2!U2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X-"CPO9&EV/CQS<&%N M/CPO'0^)SQD:78@:60],T1%9&=A2`Z("=4:6UEF4Z(#$P<'0[(&9O;G0MF4Z(#$P<'0[ M)SX@4')O<&5R='D@86YD(&5Q=6EP;65N="!AF5D+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE M/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE'0^)SQD M:78@:60],T1%9&=A2`Z("=4:6UEF4Z(#$P<'0[(&9O;G0M2!A;F0@=VAE;F5V97(@ M979E;G1S(&]R(&-H86YG97,@:6X@8VER8W5M2=S(&%N86QY2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X-"CPO9&EV/CQS<&%N M/CPO2`Z(%1I;65S($YE=R!2;VUA;CLG M/CQF;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7-T>6QE.B!I=&%L:6,[)SX\6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R<^("8C,34P.R!#;W-TF5D(&]V97(@ M=&AE(&5S=&EM871E9"`F(S$V,#ML:69E(&]F('1H92!P871E;G1S+"!A;F0@ M=&5C:&YO;&]G>2!R:6=H=',@87)E(&%M;W)T:7IE9"!O=F5R('1H96ER(&5S M=&EM871E9"!U2!H M87,@=&AE(')I9VAT&-E961S('1H92!F86ER('9A M;'5E(&]F('1H92!I;G1A;F=I8FQE(&%S7-I2!I M;7!A:7)M96YT(&]F(&EN=&%N9VEB;&4@87-S971S(&%S(&]F(%-E<'1E;6)E M6QE.B!I=&%L:6,[)SX\6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R<^4F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&-OF5D(&%S(&%N(&5X<&5N6QE/3-$)R!L:6YE+6AE M:6=H=#H@,3)P=#L@;6%R9VEN.B`P<'0[(&9O;G0M9F%M:6QY(#H@5&EM97,@ M3F5W(%)O;6%N.R<^)B,Q-C`[/"]P/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQD:78@:60],T1%9&=AF4Z(#$P<'0[ M)SX\96T^/'-T6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N M="UF86UI;'D@.B!4:6UE&-EF5D+"!B=70@:7,@=&5S=&5D(&9O2!L979E;"X@5&AE('1E7-I2=S('1A2US<&5C:69I8R!E=F5N=',L('-U8V@@ M87,@82!C:&%N9V4@:6X@=&AE(&UAF5D(&1U2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X-"CPO9&EV M/CQS<&%N/CPO'0^)SQD:78@:60],T1%9&=A2`Z("=4:6UEF4Z(#$P<'0[(&9O;G0M6QE/3-$)R!C;VQO&ES=',L('-E2!IF5D(&%S('1H92!S97)V:6-E6QE M/3-$)R!L:6YE+6AE:6=H=#H@,3`N-C5P=#L@;6%R9VEN.B`P<'0[(&9O;G0M M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R<^)B,Q-C`[/"]P/@T*/"]D:78^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6QE.B!I M=&%L:6,[)SX\6QE/3-$)R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,34P.R!5;F1E6QE M/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF M86UI;'D@.B!4:6UE2!IF4@=&AE(&-O'!E;G-E(&EN(&]P97)A=&EO M;G,@;W9EFEN9R!T:&4@=6YV M97-T960@<&]R=&EO;B!O9B!E;7!L;WEE92!C;VUP96YS871I;VX@9G)O;2!S M=&]C:R!O<'1I;VYS(&%N9"!A=V%R9',@97%U86P@=&\@=&AE('5N86UOF5D(&=R86YT+61A=&4@9F%I2!A=V%R M9',@:7-S=65D+"!M;V1I9FEE9"P@6QE/3-$)R!M87)G:6XZ(#!P=#L@9F]N="UF86UI;'D@ M.B!4:6UE'0^)SQD:78@:60],T1%9&=A2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE M/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R!F;VYT+7-T>6QE.B!I=&%L:6,[)SX\6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE M=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^0F%S:6,@96%R;FEN9W,@<&5R M('-H87)E(&ES(&-O;7!U=&5D(&)Y(&1I=FED:6YG(&YE="!I;F-O;64@8GD@ M=&AE('=E:6=H=&5D+6%V97)A9V4@;G5M8F5R(&]F(&-O;6UO;B!S:&%R97,@ M;W5T&-L=61E9"!B M96-A=7-E('1H96ER(&5F9F5C="!W;W5L9"!H879E(&)E96X@86YT:2UD:6QU M=&EV92X\+V9O;G0^/"]F;VYT/CPO<#X-"@T*/'`@2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,38P M.SPO<#X-"CPO9&EV/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W-U]B-C@P M-#`V9C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R6QE/3-$)R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^02!S=6UM M87)Y(&]F(&%L;"!E;7!L;WEE92!O<'1I;VYS(&]U='-T86YD:6YG(&%N9"!E M>&5R8VES86)L92!U;F1E2`Z(%1I;65S($YE=R!2;VUA M;CLG/B8C,38P.SPO<#X@/&1I=CX-"CQD:78@8VQA6QE/3-$)R!B;W)D97(M8V]L;&%P6QE/3-$)R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8V]L;W(Z M(",P,#`P,#`[('!A9&1I;F#L@8F]R9&5R+6)O='1O;3H@(S`P,#`P M,"`Q<'0@6QE/3-$)R!M87)G:6XZ(#!P=#L@=&5X M="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^/'-T6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B M;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#L@ M8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`Q<'0@6QE/3-$)R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R M9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@8F]R9&5R+6)O='1O;3H@(S`P M,#`P,"`Q<'0@6QE/3-$)R!M87)G:6XZ(#!P=#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE M=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^/'-T#L@<&%D9&EN9RUL969T.B`U<'@[(&)O'0M86QI9VXZ M(&-E;G1E6QE/3-$)R!F;VYT+69A;6EL>2`Z M(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^/'-TF4Z M(#EP=#LG/CQS=')O;F<^5V5I9VAT960@079E#L@ M<&%D9&EN9RUL969T.B`U<'@[(&)O'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N M/3-$8V5N=&5R('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!F;VYT M+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[ M(&)O'0M86QI9VXZ(&QE9G0[('=H:71E+7-P86-E.B!N M;W=R87`[('!A9&1I;F#L@<&%D9&EN9RUL969T.B`U<'@[ M)SXF(S$V,#L\+W1D/@T*/'1D(&-O;'-P86X],T0S(&%L:6=N/3-$8V5N=&5R M('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!F;VYT+69A;6EL>2`Z M(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+71O<#H@(S`P,#`P,"`Q<'0@#LG M/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1C96YT97(@'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R M9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I M;F#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@8V]L M6QE/3-$)R!V97)T:6-A;"UA;&EG M;CH@=&]P.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R M+6QE9G0Z(&YO;F4[(&)O'0M86QI9VXZ(&QE9G0[('=H M:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@<&%D9&EN M9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&-O;'-P86X],T0S(&%L M:6=N/3-$8V5N=&5R('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+71O<#H@(S`P M,#`P,"`Q<'0@F4Z(#$P<'0[)SY/=71S=&%N9&EN9R!A="!T:&4@ M8F5G:6YN:6YG(&]F('!E6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@ M;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P M,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@F4Z(#EP=#L@=VAI=&4M M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE M/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4 M:6UE2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E2`Z(%1I;65S($YE M=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG M/B8C,38P.SPO=&0^#0H\=&0@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Y<'0[('9E#LG/B0\+W1D/@T*/'1D(&%L:6=N M/3-$2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Y<'0[('9EF4Z(#EP=#L@=VAI=&4M M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE M/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4 M:6UE2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E6QE/3-$)R!B;W)D97(M M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N M;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P M,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D M97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W M6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I M9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N M;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N M="UF86UI;'D@.B!4:6UE2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W6QE/3-$ M)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE M=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)R!V97)T:6-A;"UA M;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#L@<&%D M9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F M="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z M(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^ M#0H\=&0@'0M86QI M9VXZ(&QE9G0[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C M,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!F;VYT+69A M;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI M9VX],T1R:6=H="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=VAI=&4M6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z M(&YO;F4[(&)O6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!T M97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#L@<&%D9&EN9RUL969T.B`U M<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\+W1R/B`\='(^ M#0H\=&0@=VED=&@],T0Q,#`E('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE M.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D M97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#LG/@T*/'`@2`Z(%1I;65S($YE=R!2;VUA M;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^1W)A;G1E9#PO9F]N=#X\+W`^#0H\ M+W1D/@T*/'1D('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B M;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@F4Z M(#EP=#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX] M,T1L969T('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I M9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N M;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N M="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E M6QE/3-$ M)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D M97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE M6QE/3-$)R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N M;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X M="UA;&EG;CH@F4Z(#EP=#L@=VAI=&4M#LG/B8C,38P.SPO=&0^ M#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N M93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D M97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I M;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Y<'0[('9EF4Z(#EP=#L@ M=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T M('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N M;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B M;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI M;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E6QE/3-$)R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P M.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P M,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG M;CH@8V5N=&5R.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@ M;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@ M;F]WF4Z(#$P<'0[('9E#LG/B8C,38P.SPO=&0^#0H\+W1R/B`\='(^#0H\=&0@ M#L@=&5X M="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R M9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I M;F#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI M9VX],T1L969T('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS M1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=VAI=&4M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O6QE M/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO M;F4[(&)O#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T* M/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY(#H@5&EM97,@ M3F5W(%)O;6%N.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N M;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI M=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T M>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R M+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P M.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@9F]N="UF86UI M;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4MF4Z(#$P<'0[)SY%>'!I2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\=&0@ M86QI9VX],T1R:6=H="!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O MF4Z M(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\=&0@2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C,38P M.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!S='EL93TS M1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=VAI=&4M'0M86QI9VXZ(&-E M;G1E2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[ M('9E#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#EP=#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4MF4Z(#EP M=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M'0M86QI9VXZ(&-E;G1E#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE M/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4 M:6UE6QE M/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4 M:6UE2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W M:&ET92US<&%C93H@;F]W6QE/3-$)R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@ M8F]R9&5R+6QE9G0Z(&YO;F4[(&)O6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R M:6=H=#L@9F]N="UF86UI;'D@.B!4:6UE#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O6QE/3-$)R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I M9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@F4Z(#EP=#L@=VAI=&4M#LG/B8C,38P M.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!B;W)D97(M;&5F M=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE M.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[ M('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S M($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N M.B!C96YT97([(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C M,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!F;VYT+69A M;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI M9VX],T1R:6=H="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[ M(&)O#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D M(&%L:6=N/3-$;&5F="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI M=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@ M8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG M/B8C,38P.SPO=&0^#0H\+W1R/B`\='(^#0H\=&0@=VED=&@],T0Q,#`E('-T M>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@ M;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B M;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A M9&1I;F#LG/@T*/'`@2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T M.R<^1F]R9F5I=&5D/"]F;VYT/CPO<#X-"CPO=&0^#0H\=&0@2`Z(%1I;65S($YE M=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG M/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@8F]R M9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=VAI=&4M2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\ M=&0@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!C M;VQS<&%N/3-$,B!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#EP M=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M'0M86QI9VXZ(&-E;G1E2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Y<'0[('9E#LG/B8C,38P M.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@8F]R9&5R+6QE M9G0Z(&YO;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI M=&4M2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y M<'0[('9E#LG/B8C,38P.SPO=&0^#0H\=&0@F4Z(#$P<'0[('=H:71E M+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@<&%D9&EN9RUL M969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL M93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#$P<'0[('9E#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL M93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#$P<'0[('9E6QE/3-$)R!B;W)D97(M M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N M;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P M,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O6QE M/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO M;F4[(&)O#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T* M/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY(#H@5&EM97,@ M3F5W(%)O;6%N.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N M;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI M=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T M>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R M+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P M.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@9F]N="UF86UI M;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O6QE/3-$)R!M87)G:6XZ M(#!P=#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^ M#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO M;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4MF4Z M(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M'0M86QI9VXZ(')I9VAT.R!F;VYT+69A M;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('=H:71E M+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@<&%D9&EN9RUL M969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL M93TS1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=VAI=&4MF4Z(#EP=#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M'0M86QI9VXZ(&-E;G1E2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Y<'0[('9E#LG/B8C,38P.SPO=&0^ M#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"<@8F]R9&5R+6QE9G0Z(&YO M;F4[(&)OF4Z(#EP=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[ M('9E#LG/B8C,38P.SPO=&0^#0H\=&0@F4Z(#$P<'0[('=H:71E+7-P M86-E.B!N;W=R87`[('!A9&1I;F#L@<&%D9&EN9RUL969T M.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS M1"<@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#$P<'0[('9E#LG/B0\+W1D/@T*/'1D(&%L:6=N/3-$2`Z(%1I;65S($YE M=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!W:&ET92US<&%C93H@;F]WF4Z(#$P<'0[('9E#LG/B8C,38P.SPO=&0^ M#0H\+W1R/B`\='(^#0H\=&0@#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^ M#0H\=&0@'0M86QI M9VXZ(&QE9G0[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#LG/B8C M,38P.SPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!F;VYT+69A M;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O M#LG/B8C,38P.SPO=&0^#0H\=&0@86QI M9VX],T1R:6=H="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=VAI=&4M6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z M(&YO;F4[(&)O6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@=&]P.R!T M97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#L@<&%D9&EN9RUL969T.B`U M<'@[)SXF(S$V,#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M6QE/3-$)R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[(&9O M;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!B;W)D97(M;&5F=#H@;F]N M93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[ M('!A9&1I;F#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\ M=&0@86QI9VX],T1L969T('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CL@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O#LG/B8C,38P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S M='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=VAI=&4MF4Z(#$P M<'0[)SY%>&5R8VES86)L92!A="!T:&4@96YD(&]F(%!E6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG M;CH@F4Z(#EP=#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@ M86QI9VX],T1L969T('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R M9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T M=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y M<'0[('9E2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E M#LG/B8C,38P.SPO=&0^#0H\=&0@2`Z(%1I;65S($YE M=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9E#LG M/B0\+W1D/@T*/'1D(&%L:6=N/3-$2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y<'0[('9EF4Z(#EP=#L@=VAI=&4M#LG/B8C,38P.SPO=&0^#0H\=&0@ M86QI9VX],T1L969T('-T>6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R M9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T M=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Y M<'0[('9E6QE/3-$)R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N M;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B M;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI M;'D@.B!4:6UE6QE/3-$)R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W M2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!B;W)D97(M;&5F M=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE M.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[ M('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W-U]B-C@P-#`V9C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA&EM=6T@6TUE;6)E M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^36%R(#,Q+`T*"0DR,#`X/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^1&5C(#,Q+`T*"0DR,#$S/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W-U]B-C@P-#`V9C'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'!I'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'!I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7,\'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7,\&5R8VES86)L92!A="!T:&4@96YD M(&]F(%!E'0^)S$@ M;6]N=&@@,B!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M2!P87EA8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XD(#,Q.3QS<&%N/CPO'1087)T7V8V839A,3(S7SAE8S!?-#4T8U\X83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO6%B;&4L(&1I6%B;&4@6TUE;6)E'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4@ M6TUE;6)E'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^2G5N(#,P+`T*"0DR M,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^075G(#@L#0H)"3(P,3$\'0^)SQS<&%N/CPO M2!D871E/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#Y*=6P@,S$L#0H)"3(P,3(\'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^1&5C(#,Q M+`T*"0DR,#$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]F-F$V83$R,U\X96,P7S0U-&-?.&$W-U]B-C@P-#`V9C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^07!R(#@L M#0H)"3(P,34\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%B;&4@ M6TUE;6)E2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#Y*=6P@,34L#0H)"3(P,34\ XML 16 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVENTORIES
9 Months Ended
Sep. 30, 2014
Inventory Disclosure [Abstract]  
INVENTORIES

NOTE 3 INVENTORIES

At September 30, 2014, inventories are comprised entirely of raw materials used for making prototypes and limited production runs.  There was no work in progress or finished goods.

ZIP 17 0001548123-14-000438-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001548123-14-000438-xbrl.zip M4$L#!!0````(`.Z!;$6MH?1-SD\``&+*`P`1`!P`9FQX="TR,#$T,#DS,"YX M;6Q55`D``_#-8U3PS6-4=7@+``$$)0X```0Y`0``[%UK<]LXEOT^5?,?N-[9 M[IDJV>9#I"2GDRG'3GJ]D\2>V-G9;RF(A"1,*%)#D+8UOW[O!5\@18H4+?D5 M=75U6R*(>W!Q<>X#(/7;7^_GKG)+`\Y\[^V!=J0>*-2S?8=YT[<'$3\DW&;L M0.$A\1SB^AY]>["D_."O[_[XA]_^X_#P+*`DI(XR7BJ_^Y.)7* MOZ-!?.'BZ\6U\='N)]]^/`92?X7P6D>_R$<;^O:X.W![,P7)P<']_= MW1WAY2,_F![KJFH<)RT.DAM' M90$.+0'GU#Z:^K?'<`'NU?J'JG9H:)E.^.&4D$5VRX3PL1"37*BX9>+>AP5@ M$Y?>+WSFA4>V/Q*&.%)N%R`!7$V7[@(7'PW M"^CD[0%V?IAV<73/G0/E..XH-A?;]T)Z'RK,>7MP4125M:%>R,)E\EWV+7/P M^PFC@2+@T,(84BV=7?SMX)T*_XQTT[+4WX[+-Z>BCBMD)9(6-&"^LR)?3%3X M+E;HZ-#(.T^N%'N6>DF_2@:_5A]_-UZ:-HQ#30?SVK8VSE$;WT>?OW]F'IM' M\\]T/J;!$R@GZY;3Z9QF(\LN.`#C?N$RFX4Q1L5AT"ZFXF09GGPEWI2>WC-^ M\"[]JC"NWXXKN\HA'%=AV'S>8&Z"\!S(_EU*#&HV<_FUTDW45S[R1:3_2*([AGKT'B1.C0VUZ&Q.QWJWRWU\_V-XPF-0PHS]=V%F?IW;<\!SX4#XHE^%AP0.]F];3P?VS`VMPUC=[;1_VZ\ MP``,(M+!3Z4,U#R%AUW&["C-$V0T$O<*S)V MN%>$^OA^%5`N(+]LVOU*7=R"OH)`:GD3$(\3.X0&_/U2OE*DP]+0GX`0=[L3 MN)_;IYS;'>YK&M\U_65F/9N7[G=6G8UCTC/?NZ5!R"`&DV.SFSL?FR2!Z1E9 ML)"X9_Y\'GG,)L+Z+CS[92^KZYD?A#P3AIHY9M!JMG?@2S$RQP(7\A M\P*4M0^5UOP2>=_5W1TL@._NY#U'V M(3A\U^MV;Z=Y,7VJLT&3;/Z,IOYYJQBLWWBU5YK2]_;YR^WW, M6+;I!.X%3`H/_>!54^,K^]-[>]N3UC]VRHP(K?KVD8 MNM3YQ$(V%2X@,LO4`]7@>]$=L@_?3I+VHGY_4IMRFZ3 M(U(OVYQS15R')(QXT8AJM+5-*\[[/B-<]M!^$? MF4<\FWG3?-;Q*&IF`<6\L\X^GN24D(K+:2XH5\L!*BB8GMMN*!LXT_:5RQ;JMN(]^%`C;WY=[=U!^.].>XJGOO='\ M?$6T,^TI7KFP'4N+QIS^*X+;/]S"?U;+MJ4&VS>Z76Z0O22RLO8F])I-Z-E2 MU^BEVMVS>7K,WV4.*9_G)K7:_>9%^AAP,S5- MD!I[OXI6)J78]P+^;-=SMOH(QZ(R_N_#OR)V2UQ8&/PT/"-!L&3>]'^)&U$A M_(9,M0,E,;$Y6\/P*/KYL"R?CO>2.`#,.H5 M&/]NK$5HF+JN/0AA6BO/:]U?:'@6!0'J\9HSS%8W8S+W"8.:2U@CI@LC;747=$>(+-`P):@AI3`(-. M9M,WC!R!W&VSP&$'JS"'_3;BK@*Z(,SY<+^`((#"&A.AQ2GG-.0EVQQU&;:F M#0<2D!;B.N/3U,W5!/`,]0'PJH%T(F6MKZN6+JWD3:5VH-FAJ5IJ*Y'G=.%S M!IPKFGSQ/;LDO1.76J8IB:^3L2&2+AS:`0'7.W@8$_S?R'H4]))!Z)U&ND2:LW[;9!6`=/U%)4 M/-Q,4#?7`4G6H&^6W?]:05UXNZ]KQJC?("9)6Y*:5BFTT;L1KC;4ANIJ:E24 ML1&.#C2K:SI$=@]"4;U MD%27>BZ+'8<7'@^#"$.*;QZ)_1N$;HR+R87,:\ZBN>0JC"KV;!$/C^35MH'< MAP.N8N$FNK=,8PMH:[;=RV96Q=Z-&AWJL!JE0'&]K$ZXJNB],1M0C?Z@&RJY M08E,7,(Y[NLX98A5S-_,%^IJV:F=W(<#KG(+3<:X);@2!V5US2HGT%P2,;6! M94BA@]1SL\@JBF_0P&AD&M:@A3Q8B#';78>^_0/466.F,_Q='\;/;8)J-OJL87<6J"U&FQT`>LU*.MPC;@&7!><1Q*FQIB] M!I-I&(.!IO770(HE-<"YC$+8-\TP-3)^=TR2N%I@A>VI?B=N%T@J851M ME]6)[L#2&PD^=1R&-03B7A$&Z7*R?9]M[W2B9;T_TH8C78H):L1LAJ4#7^O] MP5`=Z:,-D7RE(6$>=3Z0P`,SX852X@3/+62@JIB[44&'NJ89`TU.>IM%=H;8 M(70_U-6^.M0'H^X`A<7-?->A`<=:8;C,`'4*W(VA86J:Q,^K`EH#Z!*(]R', MU0?MQ4NAP:GGK`'3*>A>JL(KDOD7:[G;`:M)@$UVY+P/6%V@4^!:LVVAI+,$JUVE8WW_Z%*)9]/+B1``&OT'"0+BA?RC'US3X);9 MX.,"",'9/-\2+W%G^CJ<=J+%P:[?8?5_\CG''!0D31E,#^6Y!'WG$HQ5"4:% MA"*16<,^;MVM$U#>7[?].;TA]YC;L"Q*LOKMI#=,'AZ;HSPL]&P^1'--L*WM M=%X!>[`=A=@!)9R>T_C_%U[I[$4I;;6&VQ@/'GDA?'85^'A,S'F__,9QKR!^ M&Q$XMU,[9+>%9-$:M9-;-+Z1+A\>:"_UH6@'ZC;F!E)[+#/Q&__4!J(.:'DW M)1-7P2Z[%->2:HJ9>V$J&F6MS$"\OI`],A@5?-1L$@-].-+,@E'D7;>1VI*' MRBPXU(9&*ZGR7GDFM"5%%>,`R]*+AR:R?EM(K."MQF&:`]48M9%XZOPSXB%: M`+B!JHW<006Y-0YX,-3-0J91(V13+!64UZB*H:K*U<^66#K%%H,*:FS$)P[< M2=:QD>22`J7A7$[0MY>JX=DIN0I6;)S4(>1I4M+1**PKMI846MI@T76C,[95 MU[MZ-C2#UX5R+=.T"F<,F^4]`&&7Z+"OZUL&F!ZDE)SQL(*QF\VN/UH'3!+3 M!5$%G3?[$'U@;`G2^A!OV(7Z2P=XV\IL0IJ<]TQSTLISGQGN+CZCOU:G;<1O M=0A=7,VAIHU,;=?#*.WQ9XB[Q.66:@S:+/M$5D=HHY9!>%&91M^0"Z?;!E=] M8G[4LCQ0A&H.-E+C^E/TW7!7N*5F%9N:M98J'HJ[=,PB`]LE7]!U2Y>/NK01 M^`"(G9(+K6\U&L*&$&N*@*,N>21^KK:EP.HKGCA!IM2AW\,_+ET@`1#ZPQ@%P<$ M^BQMA]?*V1@06%2G2-CLAJA&M=E+YU:G5%.[>)NRRMK+?3C>+EZFK-"N>*N? M;+P2CQZ7V2)'W*DT->K+I^@W$;P-R%U<#P!N?`BT.^*Z)VK5BNU#7=,-[;O1 ML(>HJW*^N>O':C6U8FO1:#Z4AH]3=$*9O/;2]J<>2XH020&"7WHU!_!RL)T\ MDV8,Q3+K(GH;H#NY)UW=!N;\)$-RAN$K88)3;#=R!*.(J"O=N[F9!7XTG>6% M-GR;!.['IB]L$F)N_.I(6U,K_)S^W5(;?U%C?7@[TBUCI"6Z>)01K3O&F_;\ M%=K'Q[V`/6RX0*84OQ-O24G>BY(_S%GA;S?5C'A+@*0:'4^C:87J>5><#Q]O M_.JB?+P5[GL[XZT]E[T)SOJ3L2M/X5:@#LQ`K-YTVQJ'&JQU? MLI*L>[3R=/3R43HM1U_AXW5\1W1[\'5G#0T=7(=5.G?>'N)VAE<9#VQC>,;` M+#^8T'UT\0F6E(+2.9&[Q=,:RNP2L?:\,)["&$=O)5Z7-Q[BIME4XKZ>;_,FR3[W*=W M)'`N%^)=3-+QUW]0-IWAPZ2@8F#2#_=`JN!PKP)FYR%.JT>'JVP3.%TK^+!' M0KXS=7V)Q/NP,L6T."]60T$K=K)UE$]K,Y7/0:\F'J_7:I*NQ>MUBE;3YL'K MQ[*:%90K#V=QWV5._'H$^,M>W@#L]ZYO_\C'4[L'9TJ" MZ]-3B*[ZYF`X0@?\J\+#I4O?'DS@]L,)F3-WJ9PHO]ZP.>0=7^B=\M6?$^_7 M-P>_3,,W?_P#]K=([U'F))@R[T11%^$;I=A#J8/X?KP;FV4=K+\GOLS9O^F) MHN4RQ,TG"N8FS,X[!M<$J0=^`ITYN+GE*+GVX(,(8-E<2*T,_BV#'^2P>8Y;";2,JJ$27>8MRK^1/GHTON%SP#%-73E!\KU MDL,]O`=:L(\46(KIB"WU#8-[>#3FX"6)V*+^,W:77.\/WIS%*-,OAF_^&S0/D80%0/X05TX@>TISB^XOEA!IRXKN)`QNWZ^-(U#M<"6&U@#@$5 M9\(<9;Q,1X9J6@1P)UM`6*-,J0<4@FWA.EV@CI@G-/'-$XH4TRO4<3J'F;=) M"EL"RV=^Y((0"@*)Z`"@_S/R;''ZYXZ%,]'CW..<@Y2!7L96D_!8"_573;<9'Y^Y'?`)`+#3+\ M>=PC9$+P,T-^PEOGC&.0I\"_IZ!=5]%,(:=_!!@5?+TDLR.7!+V2+,ZF'IN` M5E$EE1-T!Y,.GT'C'NJ(P-J&&%71E-!/^I(T6+DJQ0`):G[A!^%1;K(7\37B'T"7.21F'![PJA(=MH*C`I4R#D)ED*_1)D0%J3`XF->,W)+P0BHMZ+< MPB+=9&FBGK$5`\L!?+X'AAI;-QH2)*'8H812&"="AH5X3-U0^D1_0`B:V MAZOI/"`POI[R+20SL6;A'NI-@4N#'VZA*[BGYP2C6GVJJV(8_/WL(`2!\'7+QD>K;&!;6@O MF>%!OV*Y%C[L'(DR`=^)I7=E`5X#G(L_IQ#`24IMHI=:<]P>1MG89A`_$+`W MWC"'#UF\L518E']*>\(O!OJP-]+,@B1A:)%P"H3/T'S]=*<=O$>VOUKNRK#4 MGJZ7NG)BJT;2!_/':,@+9SR)3ZXQ](II7TT#A_.-;C#DR`(5&!8Q6<-A3QL: MVQA>7U=[_?ZHT!4Z7K&)43&40M`3S["'SC=]ZA(X(7[.LRQ(UWJ:,>AIHWY1 MUF,9Y@8F^%3D/"-_@5ZJ9OI-#>8DQ!8ABL! M;GM!MA*-(;P=^U%8"G_C8U1+C&4Q`&`(%09$E*F?Q&0V#;PXJ*N,Q,J)$`Y? MBED#W#`3`_>3D,SVL622B!719?*&C_@%[SAR@L3%`2`@Y*\Y4@PK03L9!M;FM6M9Q'NYTNJFS/]B0 MA+%NC'8WS&P*]WZ*?"%LR"D10V^D6SUCI!7I#`B,9#NO,(-BZ[676$=,:F+? M%;Z)M^%ZF5R4R)*M!C&3/C;'S!+W8`_QQPK0TG!>?>460GX_0BH.Q5S+(H)X MCS;.^2@D)*<0X"<90=Q!2H!Q!IQ"@7'&"T\>IZ86!OA?*+QP72]=1\0B8^28 M'<6)?W')C3%:PH=1L_@I7EXQ-N)R/_'!=K9UH4QH',=BTH)8`V;'-19\(8,2 MOU->P5H=*D#0Q9^.9)CJH#A/,(IB@[*O7.!O58CWH8CD>X[B<<$ZHA8A)'S& M7R1-DB2T'W\UQS]2_MN_`P*$P!2"4%R_JXUTD>>.HY*W-/1!SRRC\B=YDB2T M:N='&Q+]"=W;Z58/"L29GDX#.JV:7J.G:VK/LDIN.=%H8C7YW%7H'I\Q4D@H MQ,3%X$1Q"U''1CH3O%O4MS:HT?>1=P#J30!L/:"CJ6D56&%9,FD@YP/TLW(C'-8T2!\0D66#,Y,-F`=A* MF,-3ZBJJ:2527-%2(0Y+6*R6J*KX*7W?2.&W2Y1/G\ZDXH^\Z#?C"S$!HM;S M4)(HS;A:GCODB5*;.L/MQ4R1,G.),:3P!VLM%3G/$U11UM5&=K:)TV[7J]U[ M31YEUZLE]J8WIF#1=&T-JNY`_DYJ4(DM//564%7%ZO+F@]*7:U07U]??3K^< M?5`N/RK7-Y=G?VLJ6NUV+3T+G7WQO:J<*JLPUQ.,3`5UQ-#:>EN=5J[;[JQ[ MG\9/NMV)!1!T;.(/27^=R[5=["I#(>HQ5$*1[`=R!D81!Y:0.MII\QD0(XAQ MA4>)?7F\N0ON/TX2,H$RM)6J MC=D;6%:IT!16!$RBIV(X9/9T75NY=77W+J#)6HLA^1CDB9^RP.`I#0*P9I%O MZ`I5$*F,@+_#Q\((O8P4%Y58IPVQN1`@'JEM]83 M%H@3[I>3;)

* MMW7S7+Y%$`7(UIZ-]#?`<) MK-CTO16*&%.;1#S;[63S.7682'*#0E*2;8&%I=,.+%?>4933K>$JK@#:O3(B)E]&G':)'PI;>]1C>J2.E&(>-[MS)!/Z,8JG:SUC2 M020+^'+^47\J?^\J[^<=_)='!W:!OLR31&A7NN>.*3](^<-1ON%(%]F4\Q,U MT-GLB4&L7>T*)6*:2C:#""G$.K8`O>!3]+VC&Z+@I]!I3T7_"KK^L0I.^Z(\ M+W@@[$.\H*C#,/'2A=NSOF)4#!D[M"F*'$4!=E72.3XR-$WS=L2]\`+I[C#" MU#JA"NP(;6_`Q)))T2_;*_IMU?3_DP2Q#(D/,N#$FBF`P\F=+=$T2@"),BI3 MUZ7T.`+,P@R),/CM0Q#^M6?UHX*#;HPW0\'B"AM>I5X<6L!T`'AX=)D9I6%Z MJ(:):F%\M3''R*BF#,37YCM9( M,BU->:;TL`WD=XG:Q/$4FQF!%>O`?H`]*-=8IMG`+[,4K&RAE0N75@`'!E;U MI&UM#D14X!=ZQT%)>"[P:&'9R3]+T3:5MJ2?OZ7J4%6VV<@SZD0"+]VE@^E! M$0B,YX+JGG.$E/]Y.G532W=47.U8>?JL*C9_FQK&;&WTE)K%')>\P+'$4JE) M@$F!?4%0!HB;**9D"NT!QT%X%V+6]+;&[JKBZYBUV5;)0O#;HCGP`1[ACM M2C.)7<:BZ.X(4-<>)H?@V1,XT*A?WP%32AV<9>Z:8WY'W4Y6Y"[B M2V3C498B3A@0U&;1I'0Z#94#(@/T!&K*PC`RD8P.GM*Z'L-T#+,G-'&M,5?IV'APU&T^9LQ5>C"VNIU>O8E>"P\/59]E[05>W^J`%@7%%U(" MN6HKEU%3VG=QP:JW]GN=EE'Y7&_,@ADW1LE$7KD,3]P(S%_;D\T)Z$Y*V>\N M;6I0[#PL^:M2ZSUIP&WKM1[Z<](T,ESA70^7V%)M#9_4W6"ZXLBM5I**XF4D MVI)$B9;WKGA0#CLWY1XX]\+Q"YUQ,D'I#ICP'DQ+E`V962"&@,=8 MZ3B@+ZBL0LA3'-`PI5(*//G?&OE\GMBS?H/7(O+_*:0/8O;9PK3TK(ISD0?? MV'Q[H^QQ`GLG&62'4VQC/B9%(GY@:4AZRBR,BY.GN*&D%A6/:IBBVLB1V7FI]DL>F+ M)C,AS(0VXU//':;PH%XG2U2,:I0014+%$V;>ZH;&>Y-(H",2(28OTSK(X$E_ M)IFG\JTPL0@Q$AV#>CJ^0X8MG)1CS-DV:C@,RJ^,7QO$YJE,K5E'PF-&D"UO M$2!0!J"Q,1-'.,8Z6/F2'$EN8_&\&\I91WD_DH"" MOF_"GSQ%Y(UQRRU`L7) M6+PG-3=S1)AQEP$AO`YQ*2G&T@B?RFCQA#2;@N7Z!*F."C,H%S^&$##9'LQ2 M.NF#>=A0X1X-ZW0!#1E.**9DO,W$(I3)1G]$O*9:9T/$558.QFA"#,K"*MQ3 M'<[66ELUA*>V]:3_5)2Y-Q),3E\BQK.2IM>F5)S4`P69JQ2RIRPU2^E.$ZZD M^LL?;\P(6!".;%]?_%(X[N25)BH^I:#R[Y$!O,H"M#TKI4HI[]2P:5`E!WR+ M\CQ[#)4E-]Z4/(9X"@5AC\&"&B\7$&J53,\E6 MRI_.L:K6+<)#-=8?R9X#6#8=A&0WIH"$4\28G>72FL`B8=C^+^'A8150%)RJ8I\'M,`Y8,8Y2T:1U2S=FLCF11]5T3@+_)D9'TD@%9`;<1D MO0:[E6N`&PI[0F3N$IF[&%>5R$V6JHS*ZM@5&7.>EQ7$(KI)JXJ>H,X/H8@* M)X!9LRXUC./,8%9_RO8EJ/`NN-0W0[.Y'#Y]BFJM5%P]2I,6_TR<4=;[0E.6 M*S%3/5N4UWT0!J`>_6#L#JB)A:L2,,!"3`!HIJGFRJ0T1O,8IZMRF\S';"QB MPC(9JIX4]S9E0`"?37>CB1@@MRN_34/F$-#&JTXH*@5-O5;WN,@&SA7PZVP4 MV-8AUJ3KG`&MT8&_O1GV1G9]H#+*S`*&)=:RKKH3Y0WBE)_H``A\,M5#I"RG MM7I>XJ^/I>1F;5%(<$V-K\4GW7+#9EP_ MS@>O`@A&=^4JCWJ7X\CYPXV,Z1@K]R):KZ2QJ)SW@JP5D-,H`14+@"@P=T^5 M`&)&459/!;898&& M[@_YC$:^U$U2R/(K3^:S])12MQ.&;56<5NH#-=F9/$8J<%3!Z$)>5L[_DQLA MK#I1FIE\68)=?J&5&ZXT57)N0EHE.=E(,`-@5L(5PX6&/DRTCR*94J.RY>3Y M%4V83#O+E.9;]PF3D@)2[&$QM+YZF/2%2LSP4&)(GM8`9VX7, MN!>J%A;B9IT22UF#2)H%N]:!I&`4O1@7Z%9=`_(V@9?*UW9I+2US,9\@/+#X ME6ML[X1:Y#L))!J*-\$$+..#UF'#H@7(3;VQK:UD<@9FE&7YQD$&(PH-9%J> M&$^\8"H,@)3)W-)B%KHE(AKCLC=!,,E2A"B:0*=]066-N;H,>9P+I"D\PAM3 M=YU"=8=.6YY]9\.(J4I'((6*[T4^8^E*YU*WF\W]!EK-`V.7K`?;4$,X'=7% MNN0D0Y-31U!-#A%-T*U1&H;I*79($<1"""EV!\7O]2EI6SH_FV53M>L/0%.VM`BL*>1&Z>L MH7;"G,NE;_W3]JGCD&S"0B1!-L[@5 M(SO3A_K;3J#%W9G':K_>?RP9?6<3_NOJO4I-U=6L#_FW8=B7+J374%` MC1*R2Q"Z);>&=.K<&O*'NJ"D[MT.="=*\6:$6K3.F^)7U>+C1%^;[?3JJ*X=.BE:+V.[="XCZ);DN%7F]KFX6ZSLPRUDKXC-0\2 M`(=@4E-L&F\>`26E5]6"9;5H79\T5"T)2JW"K"65BA0GRBT`R^R2IQ9]_ZKL M37D+'E0/FUW=KFR7)2G^^+&'D5%$WP>BN MLM3)?0GJ^V7M(%2'>]E#S7R!MKTP7J2,EUQV4+O1;'=GVVAE7=1RS=+F'Z;V MB#]GCV`X:Y.FV=9ONC*=2DG-U2@VR\@E-ATV]KN]QM%^OI&?KJG4,Z%SX(U3=).OO4RT=41AMFP0C-!BJ6DRM9G64(\UM: M97/.:)16M,H3Z@(ADU!,(1L.Q4`'>C+W)<8[=S7O;4U?]"J3;H$*R.N+2R-L MGFNO#NKFRFBR;Y3\9RW^L]9`>&E@=J5`%K*FL5T1E2B@)TW/6*"`0/YZDQCW MQFJ#Q?C,;;!:FU0H2Q>!;5Z]%=QXW[]^[7_[G=I^G7^^.#\[/^Y?W%C]X^/+ M[Q?K:O++^?'YZ?7BPA[\ERG`J^]$'.';]SA&W?XQAV^<8=OW'G+-^X4 M;4LOL.&[[#A.VSX M#AN^PX;OL.$[;)[]#IMZ?HFM]['S-0]\S<,67O/P.J2+KTG@:Q*>XYJ$UR$] M?,T`7S/`UPSP-0.O_IJ!UP'7W+-_NWKVOPZNXN[WW/V>N]^_7?GG/N#>NMQ3EWOJ8J^ MQBF%6V%R*TQNAKWN\9875&>`Q-[2J: M4SN&>9O(TVQVV5])&G[O#7F!WV,YV94D_=7O8\XM_GU[<7'Y[ M1/_7+=C7"NO++=18H&T14A\$-/%"C"`5RQUD#ZHA55S\)3M*!G$03R?*+-"% M;,JQC59*F/C13`D:.4S\@$JNT+2!WX-!$E$*VA!O';C#TW!0'BQ:HCOU//&O M`(K?@*1S`%T*U%V(^'*(>3?A/:;G:KSHSJJ+;O.HTRQ>N/`CJ1ECOD'5D+VU#)DMP^70=#-^DZ8B)5AFE[2`KB-;I`0Q2VZ<>,K+ MX+8+)-MO&R2O;RZ/_\>ZO+HYO[RPKK[T+VIBI;5^0_VQKUS'XESZ5C\9)1&P M)C7K;?:DJ_)38(<.(NH)8*M,,RCF?DRHL$;%V0R/Y@)O,/Y+MGV67^+9:BS4 MH0I_2HE.5$[JR!.F=@)(FJA,P96A-MG7#%W8\DB&6&\>8.'XGS]U4UYN`U!( M)AG(^&@LE<)]]-I*B+H`'D7>(Z871(@]0)KC5!SM=MR.?=4\$1/ MO:%2QWSSRW;G1O&T]S*[3KV-$W&U`T3/,P8%@/A:`]*YH57C9'P[V,W&<]T/2EN M#+QZ0$W#S'W`\ST9V$:OJ\SQHP[X9F=AG0V>Y)8``>C]XGX;1?YA=@G<(0G'2*V-TAT MD\-\%(5R?88Z8[P0$Y0I]&ZD6G&"'4=>I_NTA(K$"2O`$S/>@W!`R7@X?IK] M)9/6)TDL(V*W?RJ`P%2%\23-Z-(90%*N5&MI*0+W`<[!;$-@M-8@_M_#2D.= M\V['=NJ'4@&/](7&JR@'37^O"S'R\1-7!_H(S&!N:+D.5'I:(!/_?$SR4W%3 M_!H$'3,QBMW1<])Z1TD"TFS5XBS?/LW7;8#IJW(CW/'$HZB(*AJFEI!J>T5^ MCHB'>]9Q5O`5RR;WI4N/,974UL8$$@G!Y3$WG;*GL[-RC1TH!T:G>$DV(4Y( M^W"JE`X))P2;*ORG7U^9H0CKEX5RS1U2G2]K]V?3V%?5I2VG!XQ(U=\W8\_H M%V)[LR5B[BNE&VCF+HO$JF!IXXE2$G2&JJ/K;S8X[U>P(S!7$RN`WLI):Z4+#^-,)!B MR@P%,OBJZI`D;.E*V(J6VY3/)?$!F^_(7%]`CEOA!0_OYYD5ZPI\5MD8N??C M>9=:#'_8.4["*`BO`LH0-HZP4FD/A.=%$QLM`[R#D3Y/L%F,^OS@.O'=AYU6 ML_G?.RG-MYA5$NYBJJ$]B6"G]+_,(W(<&O]VRE]$KF704[MPA!S!(MP&<1R, M_Z$'\,0P?@_*P1?I5Z%,6,M]%P>3PC/;_FO1_8'C*&>$J_TA_)`=+?V6U MX.A.$9'Y!WW:*'0S:*+1I!7A,RU8'4R*G=R.T?0^[,CIK7O/ MYN\06)BQV$6^%/C<0VA/TI_HU_7PA_H[.6JO_NX6EJ$P=:`.!H?)=W8VNPQO MFG7)K;>0E0@*0#-P,'`\ M.W`J#82M6+00N5V;7?LE]UYOXA+;;^X=CE*' MEVOR[Q+37XN(STSE,4*_&9%^`1S!^\_[O\;]G]V4)^0(WO]GWW^6_U>V_W/L MH"=UHJ\XL^>N[)(93_DH%?5.$$"&KQJ%R2#94D>KISQ+F8)&3R_DZ<*1=,." MJ801GYF)"CTAORV[*%5;5W>QZJ\,/?1:EV8FS%T>2V;&689Q&%Z82[*,E+FH MDII%[=>Z.C,(T]IK+0:7YQ*A>AXYEJ$M0=HWJ:*;>\TCULXO3CLO#RVR0(>Q MI6Q5GDI!O](EF0&5W5>(*&ODE-5\/$_G[%O+RJX2WGJK_NQ2:=B^+7TV&^QE M+P4SP!H,*H:`M\(!#`&O9=8,`0P!#`$,`0P!#`$,`0P!:W&#<*I+S527S[)3 M.^>RO!EG-@?*-A@H>XT^[=<>)6-8>4E<\N:3619#S,L)-[,D;8TDOSL"2Q@EZ[ M].1;9,^1I4(O;>:F+=?>G.SRDC(77B;L<+++RTIVT21LG4ML#3BZ_,F%'=LO MS*_)CFUF`':&O&3-R,Z031[GUJ8_:YX=6(&^//QD!?I:9KTA!)T/D+`B'PN6>)WQ^85\PYXB\T2@3P\I+XI*WZ1;A'!&6)%;0K*#? MI(+F-)"7%--_FYZP(_MU^#'9D"US)HA@"&` M(8`A@"&`(8`A@"&`,UJ>,J/E,HFCV/:1-,N.K?A.6,)WK&!H78G0#3C1Y>VX MNSF.ML$X6KO1;'<;0,0K='J_]G@:P\MV<ZW%X/)R0M(L0ZRB MGU:`FGO-(];.+TX[<[;+UJ4NU%#0KW1).,F%DUPXR85]V^S;9M\VA[<8`A@" M&`(8`A@"&`(8`A@"&`(8`A@".,GEZ2_V$>'`C>Q;3W"2R]OVE?BA&`0C'X9SP'X>3X0? MV?@W^!#%5B@\.X:_Q($EQA,OF`H!TP@&?Z4CQW=V;#VXGF?="BM[UUYA62N= M26J-?_TEB79'MCUY?^)&`R^(DE!<#H\-@KY)4HZ!K.CZS@X%+4#8Q[_]EV7]JE]V/;@33N+!J[)'S)=>XUPNY53Z@]B]=^/I#3)=^C[+ M=3[LW-BC5N\`#Q@^*J%O8OAAYP07]H^CKSL?<1XP#?SE3Z?.R`ZO^_U6N]/M M'1P>H&<)=L#$ M\/`X.8!9?=AI[M!GA6CTN=3;G(&N9T\BV!/]+]/[^YQNZ_GJH*!(U*^LU@38 M,?!WDK;7ULCR_)[NA47TUKUG&PLR MUMS=^29NZF/I[&QV&=XTZY*V6LBYS*+,HL_&HK\)7!'A%/:B%M"NGYH^[*@] M$L])@J6BJL]+Q%7H#A92P,#!P+%QX#B:CQN6$EGKFQC;KH]GAV-X.+0'<6)[ MV49]<8?">O>[L,/H9^9KYNMGY^M*%30:A6)DQ\(Z!S9V_<@=9-OR;]M+5H?E MS99^T:[-KOV2>_]$=6`U^7?]E6]+3F7#D8851/H%<`3O/^__&O?_%6>#\_ZS M_+^]_>?<[XTT.+P50`:=P(*A->$,\+>5`L+I99P!OM6,P_#"7(*+P!G@G`'. M,L0JFC/`MXEG7@ZT<`8X9X!S!OA6<,IJ/AYN<_AJ_=G"VS9@A@"&`(8`A8GQN$4UUJIKI\#FT?*Y0XE^6M.+,Y4+;! M0-EK]&F_]B@9P\I+XI(WG\RR&&)>3KB9)6EK).EU+@TKZ%>@H#F-Y24E)[Q, M9.%\%LYGX7P6=F.S&YO=V!S)8@A@"&`(8`A@"&`(8`A@"&`(8`A@".!\ENW/ M9SG],7%#SF=Y0UYM#I=QN&PK&89AA;F$\UDXGX4EB17TVJ4GWR)[CBP5>FDS M-VVY]N9DEY>4N?`R88>375Y6LHLF8>M<8FO`T>5/+NS8?F%^379L,P.P,^0E M:T9VAFSR.+(L"2Q@F8%_285-*>!O*28_LM$ M%DX#>5EI(-SSA!W9K\./R8YL9@"&@+?.`0P!KV76#`$,`0P!#`$,`0P!#`$, M`9S1\I09+9=)',6VCZ19=FS%=\(2OF,%0^M*A&[`B2YOQ]W-<;0-QM':C6:[ MVP`B7J'3^[7'TQA>MHM+_LYY+B4(T]IK+0:7EQ.29AEB%?VT`M3<:QZQ=GYQ MVIFS7;8N=:&&@GZE2\))+ISDPDDN[-MFWS;[MCF\Q1#`$,`0P!#`$,`0P!#` M$,`0P!#`$,!)+D]_L8\(!VYDWWJ"DUS>MI>;(VB#K1PD@LGN7"2RU9PRF+OCOZ`'@KCL^/>SWZR'NE0R1,SF1W@ MUU^2:'=DVY/WUX,[X22>N!Q>W]FA^&1'PCD.QA/A1W;L!OYU'`S^NIS@/Z/^ M(';OW7AZ@W.X`>CZY,$?/_[MORSK5_V^;R(2=CBXZ_O.B;@77C`9`ZZ=_L`7 M"LMU/NSLQ'?E5]^O3W8L1PSU% M'W::.Q\/#IN]_8SRN2.M1-31+%&=A42U6NW6!HG:;Y:MU-%\HMJM_8/N)I=J MOU6V5`NH:AWL=YI'*U%U.1$AL*,_4G^-,DK:*W!2^Z#3Z_4R2F9>GQ^]7#+Z M86C[(X$T?YIF/[FRI_A5_\$.'24WG^&'<73N2T]D1GIGX=;2:Z,=ZT?DOO== M[\-.'"9BQ_IEO?31I>CT3`F1W2TA4O7E3F"H62)[6T)D?J=_$Z@EA-,'%6./ M!/WQQ([%F>V&_[:]Q)"G_3I2#F^ET1\]BVAYABC,1;G;Q57H#HQI'&S5-$I8 MIMXT2K73QJ:Q8!9&^>ZY'X>N'[F#`O<4%-C_B]?"]<"KH M.ZBIPS9(('%T-8$EZNR)"4RO':@BL53/U27QZ7CQH%/"B\VC3G,%0F\7$WI; MN=]I.#!/:"NCM+L^2E=9THMD?"M"97='_22^"T(XEF1:[:`W0V"SUSQL]TK4 M6F;>G%^<@8'3HZ.18>:OF\J-\94<,%N$_4785K4$S79W/4M016-^";Z(D>U] MM>-8A!%8M,=`,_Q2^`-71.E9*9M6E:;\B,-WOM]J=;N_@ M\`CW]"=]+,P?!'\JG`1_DD=!2[UN':?*=83I\279E>,7ES>GUH&U:WTYOSG_ MW+\YO[R@4VKA4O+9L/T&#LC/O#KJ"WSXO>7&MN<.Y(N_$;'X_R?651@XR2". M&M:7+\?6K$OFT=MC7?K6/Q-?6.U.PP*6;#8HDP(%QO:G#^LT[L M>]>Q/NU9G\3@K]S/?HJL$U"V@S@(,?_BU(>%%&!]^:.&-70]0#@;>'\\\6P7 MR+5'\#]1;%7.LX$9')$['@>^=>[?BR@FVZ\!'P9[%@@D4.S!W/I[``&?0R&& MDAJ8I3W"GB=C08@"I%2.L6?=P!,&49XG1D!H?&?3!WP8WPE_$_"G09S8GC4) M@PGZCF#LX,&'7]].2T<@&K^&!GG1!+!JB$XGV)L)G`C0>++LR01V79K=5A(A MZ9\PA^4:L"H(U[79!V4^KRB!F>1DXZ`[*WN/9Z]8#.[\P`M&4[FT#R(4BB?^ M#&!QX5VPB+A6R%6S"X=?>+!>H65'$5`.ST6!)^"Q.#!_23\LWVU`>-I*M7M3 MO;6*>24GR+N9&,HT?`#/)%M']REZOX@^;ICN4W0.W(O1<^/5&+ M'/7!NA6>*^XU7P*'P*$E)>[!1AHL`3P<3(4HO,AR$I1`^BJ&S9*O@`^W8F"/ M-0V@0,.I-0@%<.$][$P0P@AR8D"P$FC\Z6MCS)SLP;1K"C)^(7$!EX<>IDTU MWT9[3TL*&R?%^LP3/R;([Q98+D$"BQSE$-0:``R-TWU.!G=5G-70[->P1`QP M*&4)>#8E,0//HDP`-R&:@^1D]*@)A0+6`*85@7@EP.SP7M\&4P;&=NPQ')SE M/!'VPNC.G2!;($SFJ)1BTB@(2+I0>DE,`<.5KT&YWI"]@B)_"X:";.GE6WV0 M5L\Z(C7=:2@D4MI(RJA]&X`,PU;"=@)2`'*ZL3LBKH1O;73\@R8>VO=!2&F3 M8%&#^$6P.(V"8A5^K'LQ\`(=Q8*2Y)'DDN+13)EXVS M';LP34!W/XB%G*>-DN7C8N"8`$6POS`*4I5+R,G/Y+]I*D@0V']^H/0Q<(=O MG8B!M+4Z+>++WMX\L$$$*U)R&*OR M][V]P]@A',:.+[]^/;_Y>GIQA MP>2@I(#)A:"KY;@4-]]%8(Q=H-`=P$$W196?\QJ?DC](JA&X?`//P)(`.XOP M(8_%(^ETS;V&J`@\:;158F**N8ZX=\GXP)_#\6>,7C/`@YP!@[H=7SV=`#2$ MEF_'$H!)':#TXWOA#VC*`DB[:*`.`6]FK&/CK01K^F\H>V'@>9DQ8)KQ",8# MFAZ(\9[5AW"EU^*'$2O@J1&/+&B:TP&$PM3W2 M3P!A&)\TE[5L:XW#5>Z`Z3IH<@W=3&>8?(HGJED.BZ0ZH26ZDP>+.JJB5]`4 MI'5SJFCN*7HX?_--&T'S#B@U7&!I6`21T.H5YIWX:#*83$=,B)R`_PN"H-@_ MS[5H;L_56QD(@=86NW="YH*TFGO[/42CUX)V_3@[+1+`P5XH2R5WL`S@7<`H MP"?W0MIITFK1,&.144\K_0\IZS9^"S]IX)^R;Z2W)33W\%;@<+X8!3$9:/\@ MH$G1:`B"X$:HY0F9TI\IX9D6(3.)E.&JV0<1(Q.;520%$`G^@*=H>+G"7SS1 M(7&AF$@_LE80B\&%)$Z"%!GEN.;(E3E0F*(@!+`M*1Z`U2X%2"UZ"NTX0YJU MHB";;<,XZ%'%%`Q%>PWB#DLZ2:2!#@O1'PP0'7':U^@!MT,G@NUW"&%(L-[M M](^O=WZVNKUFCC=5WLG&MJV^7%_#O MXU,R?^L9NW_[KSDS3?^_UYW$*N'7]1%GWEN[\KN5EV)FKHN8-*-TX('(?=CY M&@4703BVO2QCTTQ)_C,!J1I.EZ$!CNK]9`3/H4W3E1)WUK_^I!5U*99\GY`U M?1'LT5.[K5[#FIF"&->GX@HL%%AB"4Z`?&>I^PH&C:6DF%SP.4""0"(!*@#- MKI/;.)BX`Z"FM]MM_CQ+S"_+4/.`.(O'@!Z%?XK]4N($O36K2%^)>>A3AVPA48IBI0WL$:@_.+Z*A['_;!:47);<8 M&8W)/1C`VJ'K*=%%N&K"]BV8#C$YZB7P)P3LMC6BM1^HM_-"N/%:GJTQ+TG@]+MV(#ZYP]H]G#D2H(S?,A8H)R M?<$D!,Y28$P*3;O49U4R*QB4K&X*E!L\GE]]?5H&C"$3PA^DT8K2V=NRD#OW MNHEG^S3>6)ZH1>7C!2?Q;?A+IIS2#WC8B10>(7>(X1#%4<9`M)1)>8JPL)Q, M0&+-U.>%H`7HM=_(2:-^AF3-]66672\=$C/GK`!`/0AHZ-(P<0,^SUL*G?WX!^(_OK3X3]^KJ,(C*?[U]_-AS,5T6RH&0K/'0-):.XH0\_@S0P,0_&? MQ`T5GP;FH1VP]MX-DBA_5+93!0%4&/G)2.U(6*0IYPD<(8@3K)S#FG8IH;RLB!0Z-@TJC M_X$UCN"5,!&]1YI'#5H7D(KOG$AMCBL@2%9VXV"7&,6$*GUBR]`(=EF>%T"5 MV=&=-0194KZN"#-][@(//01(2SPMD4S#DCC?DGU&G4P48 M156,H)0'!GI"\G$.Q4O1E0[8>)Z:BAB4E_"U++V;)+=`JG6+X4411>GJ_8PC MCFT'*+ZW78]T%(Z(S]&.O@O($DA_;Z["]PFZ3!0\-;(=(3Q!1Q:8Q2),=P>W M4:L0.OL9>Z/VFSQ`J904N3`+YT1R6/)M&H!%.Z=&C]7B9DR!G$),D:V=0<+> M7(C[:D\?8Z\VCQYIKWY#596H\_QQZA`A4_`8C&G@X3!ZG!%JO4/$4>3^K,&3 MXNM@`J$+1TBNA^5-G2JAHDL=DVF94X"2_K7O>]=[UN=^_ZJXG0-T+$S`AAVX M$X\4O$&`LL"RX[<:*4+CU%?A*EC^48#*$U@+3`_ISZ"$B1"4_U"$H8S##?0* M(0:@IU(ZHB>QDB;!V30VII?Y"*D=CE,?")_3,8A?>DIL9:0-T-/SFEA MS,\10Q1%#+"B%1'%8H*S&J!T(DP.[C"30_)W8:4(96$F#AEL4="PQOB#/Q-G ME#JBM+L##Q)3Z0I1$J8,:(FRL[N7TH#^9US+]$&YG>G6&_NZ'JOI5L"9V%_5 M<&JHU`GA$F!I(S1`^XBT"K*$G.(83C?PY'MC9]ZY/^-.).3Q@?,\^L>)3L#X M,$!@5WRB%50!^^/<1'VI"V#'@G`6XU4(&3@^A26!KTZMDPD*-P6WD=T<5QZV MX%7O7"*S@L+TO8-DC+XY_*-<<*GH7#P7I`8ET&.R8RIH3NZ,@J$=;7^^D\(@ M7>PB%V49!D%,OC$G=5/E5<4BFQ3L'%O2&22@,;0!;9B^)K'X34*.X2CP7$=& M/DH/41@A,)6B(V+4Q;Z*BDE.0*53;@SG-Q6&/ZAR_,^KULPHB^OU;1VK>OOGZY/__7]].+&.OVW]MN5(]8BCUXM M!]?E(`X0N'#A4*UDCHF02#U6TH0J:XPA7M2'&B3^F<`V*9RN3.JH)R.5#%ZL0U7V M0,KVI34Z"PH]6^UN=[]KEIS*MRX:JZ389F$E<*?3;1XL/]3B(M"2^M5VJ]5: M8:R26LZ%5;L'/5B.14/U'705([:=!6%_C`KQ?]6I3(]=6J*YJ$ZW=]@TRG0K M1UF:F))RRX7[V]X_.EB>F&,X`E\.M7V?$E!:_K&`@&[GL&4&DXP7UZV6/BS) M=%H\\0/8O6[M:NDYHU=%H>:-?@B2;Y;QK#SZ48G>7,S]AZV#[F'MT<\5`A?K MY8]6`:_#3J=GE,L7WEUSX%60#`2^TW[LP*O@6JO3.CHX?.S(JZ!'+1UB6CIHP-[_`F6@ML".CH' MR])Q`9:\1@'YNQD.+,6Y!?N_"^+>[63$5`ZS)#7M9BGN+:"FUVRW#C=!3,U* MZ_S2("Z8B+0^NQT#KG+OKC5L M*48N&A;,AW;[J-:PIW:(KIY(-TGX9$?N`!N]N%YB)*:TF[6@,FNUD!'4WOG8 MW#,-@P5#KDA?+0A]1OJ6[+B1HV\7"&QMFL!:H+P!`@N=/G)U[$8I=R7=BS%\ MMO`<@;/3.3AHM0SA7(V0M4ZFM5@%E$ZF>]3N]3KFJ6<;)K-8A;R@G5FL@,IW M9O^HU^OV.NN9#'4P^6R[/@+YI>SY=B)NP?P=W&%WA(S66"(+#7CS%R)!::??@EL/_J6YKJ"+C]6A6DI M307=@JTW.LUN\^B/:\J*=K)BEJ\4R?FCO*.;KM;\\N58_8YHR,:^>0CD'^9; MZOOYEB8+)V)L06%`;=A_HQP"/=W#9YSN55)F/?34YLXAOWJ27Y43]R0WR=(> MAZVO&YOC'RULQ=+J[3:[N\W#\OF8E*[*K.WF$^W>I2]J,"LUX-D#>^Y)ML>W$E.W44C9A.B5JGEH1_ M8$$+)2?7,91;AH^NSOB/H;A=0O&_.DO1VVZ:O9B7)]CXR?0&T\!L*J29U_*A MW:G2QF\QB:9GED)]._W2OSD]L:[ZWVY^MVZ^]2^N^\?8F6\=U7"/:%^_%8LW MDZ:<];%![H/_)J;%G#\WCJQ4"AK6\>DE)=BDG?&&E#OHCF^3,!)IC7!H@]TJ M"UXHSU&_7J31;)^2[*AFZ5;9WYLN56_G89>BS?_J8!$IW[30,;7:F,1F_ZN`2B)<2]6$)[ M&\_%A*I6YT^`";.26;/D=\N3>5T#DU*O"Q&M.>8`O.M",'I;#JDHE@ M:&3@17=!&.]BTBDEXE%N][%Z&LN]0>VI-BJR7V4N><^EZA$WRQ74LIHCLE?6 M3Q%DAIP2[1D9SB6I9VVG),640+MB*ZB&?/K>#K&`*I\W&)DM![&6LY$V M/"ST`\FZB&4%+/])7#J]EZ4[JBHE2;A*F(RH`8R0O6DDM@*GN@,J"PNHBQS5 M_,`^H.U'E;58;)%;ZKUF.X];N"&%7QSD?X#ID_3B7!EG84L?`D4W$K:P4Q@E MEZL-!N;(_1PV,_]CR@K'M&PRFN028_%L;HO5RX":,W$;)MCCL=U3H#]#4DF" M*DE25&08H9KG8R+\0.@4:V!!+RTPH(X3H2T[MM"OTF1Z1%[56TUGF6H1(VV1 M>)0]CM(!BLX70Y>ROTMV&U/-95[[W_.\6C*/PHOUPFE*Z%7FVIF[FO;&;:JN ML_!O`VO232XV$6J7@`SML>P**O>&]C&_HMNRD+/7O4KRJ<8#^!NQKCCGPYEG M9E82];+FW;:6+R]7J MS%\P1+[$MV66J7`,OI5]-VE!C-]7FG@HGGGM=`@3!2*6T M8T8F#4"L,\OVHE M/*XX,S=FNCA8;G<7BOSR:`VZ*-V_K)^"A7T(!NZ$EFV8A+*,E*:AMB/5%R1P MD0N6G8W=EL(Q=MS$7TQE&U+5$53\<(GE\ENBJL^JC45*8MK?3+-)( MFZ#-]*AS(SHWXM^UD*$0AH!IU"R*N$.)1-NH&EG2$)O1,\V]=F%!,^.JBO-, MCI/-ID29Y'95=6.."TN.H:L7?I4>+?/GSRLLO11.=`:\=9RA!#Z;G4&K@Q?S MLC4+X<8Y(\T>B<]]V)]$9KUFL3KJD^-<@9;$C@-&ID*G[$*.PK4IE1'"Y<>= M1Z\QM4^INCU.N?!,,6%*>47TX@_C/13M4ZY';2OCSU2`4&%X'L+A7%?#R]G- M9R^L,I-Y:_$]T\`G2E=>A6+L)N,+8;!728Z#=#`_R1JTYJW!W!G49(-LR>A& M+R-@4`BK'+>;BS,0Z1X9#'ZV>S4VKCCV/)+/[('H2TS6%'9+$ACF;@V>/V[N M7/2+QW?KV9_VO/W):)Z+(./KZ[OCI-Q&>?-D[>UBUNM):BZ M#NR12V#_6&4)#IX`<&:O%VMU6NU.JVK"-P\!_F0-,--[-,R4S:?*,%FS;&X8 M0)M!V3.K/(YSPJGDQ'2P:8ZQMJ!11<'9G4" M]49;$J9Z9:F;\V#WDE9A:V&WURZN<7M!2X8GQ\A>ITCBS-VXA3+DPRTXJ_4V M8Y"TYGL2#@\[G;6?T,IMZ5Y%:<7ZSJ+*C&[O5EN4M_]A#5QT/5*_2B;'RLC^]PZKR M'-(KN\S[T4PUYZQ1?<1=!12[O*L9M&U5NIU5?Y9+'HY_V?U2'E&^4@'JN;S#KR["[-AIN9*JIMI0O MAU\"^(WO7&."*=:5$.$W0;X>(IMO0=,?\W0Q]=.16G3@?!,C-\*NO?$% M7J>83J2J'N[CV9?3_W]U>7YQ8UV?7EQ??K.N?[^^.?UZ;9U?')N^FOR+9_Q& M`JMUO'/?$3_^1TRS<:M*VS[B0AW!66^_F?,(Y=^3#7,2#(@M;O""LO3ME3>, MMIJ[_Y+O-1^R<^DZ>S2NKQ>3)]X@B897OR8;IZX;V9YZ=`5)UJ]DA M,)*0;\X]FKU1E>JT?[/*HS%W.??2V4W)B#J#;S)IK&SJ2=N2WY#".ZH& MD?M6&*:R8.%?G;)!C'?`,+_^\N,V]-SW^-_P\?\`4$L#!!0````(`.Z!;$6_ M1?@K3@P```&H```5`!P`9FQX="TR,#$T,#DS,%]C86PN>&UL550)``/PS6-4 M\,UC5'5X"P`!!"4.```$.0$``.U=2W/CN!&^IRK_0=%>(\L>[R.>&F=+:X\G MKG+&+GLWV=L61$(RLA2A$)1MY=<'H$B;Q+-!4B;LY#(/L;O1W?C0:#1`\-./ M3ZMD](`S1FAZ.CXZ.!R//CX\'3/$L.:+:&.O%WT]W#.BFQB":I,"YZ$9U8B'^]XHJ\4,I*/QX7I$M+IR9&10OQO4I%- MQ$^3HP^3XZ,#;L28]]]HM.O!C";X%B]&XN]?;B\;;2X2_+2F),T/(KJ:"HKI M(GG*)]&<'7&%"_Y\N^9H8F2U3G#UVWV&%Z?C@O3#X=&WAR?'AZ+9;VK,TZXJ M,$K;JU`P]Z!"M.BB@^"N*Q&A)-HD1=<+@#8DXZ<GR6-4U#651) MY/]4NKLYV$N**=NL5H6T"Z&R\+<\;NQ M:DL<+)22@5K*X0$.BWAN,_4@M\&.:5!-!(Z*+"+*Z$PH$)!AF4=X6.UY_K!(1J`F+>29#IGSNZYIJZ)L,:-Q3!IZ5E"@8U*=>)%#N]"A,3_?`8<2(\*ASAM8D M1XDI`;13R^F?B7KX_H?-_C!SVR0!1LEAH>,+I?$C24QPD!]+_?_R>/@.-\_D M!B.@<_8+>]EUWX71=3<97G-H?7Y:XY3A61I?Y_0(WOPLMHKF7!)#@LR M=16E#9L$,486!,=V_+20H-O@ADH('EGM_>$%,Z]F2LQ]K\'R1@,\SB_3+D^^(HRXT$-'8V,VR;-@'N8Q;+%9(K\6-F/K!X//[3T7J=. M6_0CIR&MN:-820GK<-E7FHI=+&Y'NMQI7F8?QM#KH%<"K9%^P`I5CC/,+4PS0M@X/^9=C?OB"2"C6N=SMLYWC.`U-TC]*E'/ZAY*7I M;O(`^AFWDFDU?/7D`T/#+JD%V=TJO M32V$!9@[G'"9RR\XY18ELS2>Q2N2$I8+^QX-6OF@1 MJ*'MA`6S6SX04+(;"O7Q8ZQ/VI6)?'CP>,4EH-T=XI*YA;"VL&\QP]S- MXB*(!3I6GN'Q`PH^/I:WB#D.\6$AI]B35<>"J7QDIY:+ M2";JX7'B%6=@5G<(,\8&PMKJO%RM$.9&&\0Z/*E#T:>.)%E$(V$Q8"*O54U""KQ>-EY*>WT@R'=3R8I:/<0&9 MAP>95^AJY9,.D0S:GF4_?9!SP'.^\.2+@HW0[AQ'&48,\R&RY(,FQ<8];C"? M;#>X M^0M0C\F`!0P?-UHA@_;@+GU,\5&G4<3V4".P0S!ZS7BI_(-C\J>\SN':_::UJEM M]W8BLZ_]VG6ILYC-GE]W$Z4MXVZMDT/9J[5P!`LW8%("=T>?Z8BUU=F(:2ZP[X*:;`(<:0<'@[H(_.P-Q?HP=`])2#NM>2K)"!:-<(ZX*4K1,0; MH:YG`F+B`U2:)+[A4=E_@.Y@T[4/+KKS"!&4/%HO0H-C.4;W&0[`* M@6&TGGD`8R&$Q9)`OK]8Z.&0?26-QE@8R.'@PC3QR7:>'IS3S3Q?;)+J(GHS MS)PL*LPL+,'"#!CF/!S29VBS-QLM_H!*M18O$O84R\Z@I;_9`5N)!B9G46 M472L;Q6>'1RTW^*)KOD2CB>!S,VJTM774LSGN$$\3@0V>-X?],PNV2_F&NU6 MIT\/@T5;>4-_]?46[4W]8!CZ"'/B$R;L_0&WA1/WBVB80A740WE;QCP;E&F* M]RPO\8&G^&>^]X=5NVM>9W)_;KM"8"`GS)T:-[\XT!:.>BF^X)2EO'NH6MWV MJL"5-:E@',@I!ZW^TL==?;!K8(4`5F%]ERBU.VCOT%2:K_`8R&UEJM*P3SB" M^9Q(#/`SCWW#L,UW(?O"H.E#DD>!;`Z>XW6&(X+JE^LKEP*I),K]/W62MXX@ MB\%]@J79C.:*GV&_,/H__(V*;O#I]O&*=E@"?-7BAS"`]?\[%_<[^_5V&6/+ M&=#KEL:CSOLHABV]Z@))\9W>G[;5M'R92I]BU!=/.DBH;^CY2GBKT.ONKMZV M\WRUJ&!X$D9LK`?NW>;W.6'%\OHFPRNR69DF7RB?/`F[^=XJ*-NZIM=)V=UV M]3[MH0:`QHL'0M,C`Q-#`Y,S!?9&5F+GAM;%54"0`#\,UC5/#-8U1U>`L``00E M#@``!#D!``#M75ESVS@2?M^J_0]:[^O:CNV9R20UV2W'L:>\9<_HX-W>!,4^#L)X]FDO3_>]U`_#O4F:>7'@13A&G_9>4;KWC[__^4^__&5_ M_RQ!7H:"R>/KY%<\G4[NYRB*T.O?)K?X&26K/US>7=Y/SKSD$E? M@^RM09GXQ\/5'\ND(<`ZC*ER_I9U!!#_YXH(LJ6L"_U\4I`>??CPX;#XZQMI M&K`("<^CP_]<7]W[<[3PML2AF'B_)'<:?DR+'Z^P[V7%2`HM.>%2T/_;WY#M MTY_VCX[W3XX.B!)[9/PFD]4(>HF?X`C=H>ED_<_?[BZ;0Q+&V6$0+@[7-(=> M%!&1"P[9ZY+@*0T7RPAM?ILG:,H5?S.V5*H?J3Q_+;@=MI>*_!O%U`GV`S3U M\B@S*".#MPF)\<(+X_T%6CRBQ*2T5;X&))T3H1(_?T3[;Y8P*"^3NUE$%!;I M!A!KUF5Y-\+6):5\IQ%Z66(BZH&/%X>%G-/H)=M/<>HM`[&(!?'QNZ,?WGTX M>5?(4FG>7HQEW$:*HG5;(4*%;9UR]"`*'&+X!#7(P/YBH5Q2/,,F@U5V**7#,7!UO!4 M`I4`5O2RZ2?"?H5Y1+,;G#"#;A%PIU[Z6$1=DKC./&]Y2)4Y1%&6;GXIU-M_ M=[1.9_ZZ_OGW"ZH0N@J?4'`9D[1J%CY&Z#1-4982'=%EAA;IIM_(>T11D1PK M-\W"C-I#K>EA7T:AB6:01^AF"@CZX#UN<50SC3J#FH%4&%3-M,7H:;(QV/K+ MKI2B3A.\T!QK;,`07][4F'R\%M(@Y]B8X"5!"9H;D3T46\]&/ M,(F.G_:R)$?;'W&<$=\_CQ#);,B\+$4S^H\>P7M'M$.G+R'/;1M_KT&O]/=^ M=;BN)/@L+:H4+#VN*\F\$1_A3IBJ'M,T,Y:1GHG[-UYE<+-X2*!WZD5I(VA8 M'-IKHMXB7X"#RZ2I#6^-QN0`L^:7C,&MB8?EY.>PGZ[!%3G.'%DGPXO!74 M$NKP=/+T^75+UUATE+*NG''C@7LNPXO4V ME$4N4]\TR+O5U\-:2@7ZO;VE,_:V[._W&?:_7<8^$9E,R6XC+R8@6H3YXA8E M(0YJ[JO29&U&'R+R_*:8U/OEBYV?G+$OG$L>A\Z`C"9*<=LC#>48<[XS,V!L26 M#W:K2\.GW[OITSHV95GA+DR_720(7<89(BEU=N=EVFFCJ7Y-S0/E^]T91[5_WZ&T^PKSOZ+ MLCODXUE,=S@+ZZVW.SA^9;7OFA-:ZGL7/+:/8;+@WG;5:L:"`6[T"W8U;_*L MN'F7A,I5W8/I>9JH'U.S,GX_N^#/79O?Y1F74(6MG^8I^1@TUZVR\@*I9T%RE MLG%.7614+*L%TT=V5S9L+1YD%DJT&#B42DQE!=G#^3SE'H^U>HF!FKCM1CPPY.0 M@9VD1CA6[."EIKX`-[72>;V>W#SE+(K03.N*#BESF+(-Z,@98YU0VCCG93N8 M,BZ8T(^E\*DUD]'4VGFTM3P7.+E#69@46Q4:Y:AQ8V+ M.45N+L.OC6%:(%&OVT[/"'%`69PPN45)L=Y*"UJNO>0;RHJR%A;L9.C+P(+I M[:['RRZ_*>BHM1`GQ;_3PSZF(I1\@J7%K56$&DCJU<8P'4S.`FI/N6279:\F2C5A3?TA`LEG];0%A,P=N0.8(F7Y^K?Q%ZK9C#5[< MFXV5>-G8'9(&`?..8GW3L%\"$`C#OFU81XCAWRPLIS7T/)0R`[E`P&3@A)G` MF\_XA(#:_=U>IC%Z6$%9%?=D]%EYJH7?UWAEL-5W6_@#T>Y6X";C7;KX5^?S MPG$UI3`KN/E702R>-TJ*,P`O;1'E^6]H68OST%-:AL.\Y)-;G0=Z]XK:.3J? M+G`>9^G-M/2;6D(%<9#+J-@<^OMXR,X3]`W2>G:@T_4`0'HV#Q%]`]&+_="+ M;J;3T$<)F)E(M*B!$&SA8L8BKZ)&]B+#?`#`.?7]`OFWWBO-"$HZAR@]RY.D MF,PR$:32M`8EN:;N!S(-$[2.8$I]#N$M.M_S=99(.;L&5VCF1?M#VY=.40'R&QA]5#.K%A>C^:F`H_[V\X"R'7XZWM7Q!JS M8I?D/O.R/`56\B#26D1FDSJC)#AW@XD%BO8V@P,'!RMJQ_RJL'HH?TD$G`

XML 19 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Condensed Consolidated Interim Financial Statements – The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and  its subsidiaries (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. These statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2013 included in the Company's Form 10-K filed with the Securities and Exchange Commission on April 15, 2014. In particular, the Company's significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2014.

 

Nature of Operations – The Company is located near Salt Lake City, in Draper, Utah and is engaged principally in designing, engineering, and manufacturing sensor technology products and equipment using Bend Sensors® flexible potentiometer technology. The Company had a loss of $728,915 and used cash in operating activities of $360,225 during the nine months ended September 30, 2014. During the nine months ended September 30, 2013 the Company lost $688,183 and used cash in operating activities of $420,449. Through September 30, 2014, the Company had an accumulated deficit of $21,137,194. The Company has not earned any appreciable revenue during the period from February 24, 2004 (date of emergence from bankruptcy) through September 30, 2014. These matters raise doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

From 2008 through 2012, the Company raised $2,926,391 in additional capital, including accrued interest, through the issuance of long and short-term notes to various entities, including related parties. All of the notes had an annual interest rate of 10% to 12% and were secured by the Company's business equipment. The notes also had a conversion feature for restricted common shares ranging from $.07 to $.25 per share with maturity dates from March 31, 2008 to December 31, 2013. However, prior to December 31, 2012 all but $327,525 of  the convertible notes were converted to an aggregate of 13,210,663 shares of the Company's restricted common stock at an average share price of about $.17 per share. On December 31, 2013, the Company converted an additional 3,750,000 restricted common shares at $0.08 per share and retired $287,525 in debt plus all accrued interest

During the nine months ended September 30, 2014, the Company has raised an additional $360,000 in operating capital through the issuance of short-term notes to Capital Communication LLC.  The notes are secured by the Company's business equipment and have a conversion feature for restricted common shares ranging from $0.0025 to $0.07 per share, with various maturity dates during the year.

 

Cash and Cash Equivalents – Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. The cash and equivalents of $25,766 at September 30, 2014 and $35,221 at December 31, 2013 represent cash on deposit in various bank accounts with a financial institution.  

 

Fair Value of Financial Instruments - The carrying amounts reported in the balance sheets for accounts receivable, accounts payable and accrued liabilities approximate fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates which approximate current market rates.

 

Accounts Receivable – Trade accounts receivable are recorded at the time product is shipped or services are provided, including any shipping and handling fees. Due to the limited amount of transactions, collectability of the trade receivables is reasonably assured.  Therefore, the Company has not created an allowance for doubtful accounts. Most contracts associated with design and development engineering require a deposit of up to 50% of the quoted price of the initial phase of such contracts prior to the commencement of work. As the Company completes each phase or milestone of such contracts, additional funding is normally required from the customer. These deposits are considered deferred income until each phase or milestone is completed and accepted by the customer, at which time the agreed upon price for that particular phase of the contract is billed to the customer and the deposit applied. As the Company's revenues and customer base increase, an allowance policy will be established.

 

Inventories – Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method.  Inventories consist of raw materials.

 

Property and Equipment Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale, or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized.

 

Valuation of Long-lived Assets – The carrying values of the Company's long-lived assets are reviewed for impairment quarterly and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. The Company's analysis did not indicate any impairment of assets as of September 30, 2014.

 

Intangible Assets – Costs to obtain or develop patents are capitalized and amortized over the estimated  life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the rights to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology rights, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The Company's analysis did not indicate any impairment of intangible assets as of September 30, 2014.

 

Research and Development – Research and development costs are recognized as an expense during the period incurred until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.

 

Goodwill Goodwill represents the excess of the Company's reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in Accounting Standards Codification (“ACS”) 360, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Company's targeted market conditions, as well as relevant entity-specific events, such as a change in the market for the Company's products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 360, management has determined that the value of Company's assets is not more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods.

 

Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer.  Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.

 

Stock-Based Compensation – Under ASC Topic 718, Stock Compensation, the Company is required to recognize the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest.  Prior to 2006, no compensation was recorded in earnings for the Company's stock-based options granted under the 2005 Stock Incentive Plan (the “Plan”).  Under ASC 718, all share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period.  On January 1, 2006, the Company adopted the provisions of ASC 718, for its share-based compensations plans and began recognizing the unvested portion of employee compensation from stock options and awards equal to the unamortized grant-date fair value over the remaining vesting period.  Furthermore, compensation costs will also be recognized for any awards issued, modified, repurchased, or canceled after January 1, 2006.

             

Basic and Diluted Earnings Per Share – Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period.  Diluted earnings per share is computed by dividing net earnings by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At September 30, 2014, there were outstanding options to purchase 2,024,000 shares of common stock and outstanding convertible notes payable with common share equivalents of 18,645,962. These options were not included in the computation of diluted earnings because the related exercise prices were greater than the average market price of the common shares and the common stock equivalents for convertible notes were excluded because their effect would have been anti-dilutive.

 

XML 20 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) (USD $)
9 Months Ended 12 Months Ended
Sep. 30, 2014
Dec. 31, 2013
STOCK OPTION PLANS [Abstract]    
Outstanding at the beginning of period, shares 2,024,000  
Granted, shares     
Expired, shares     
Forfeited, shares     
Outstanding at the end of Period, shares 2,024,000 2,024,000
Exercisable at the end of the Period, shares 2,024,000  
Outstanding at the beginning of period, weighted average exercise price $ 1.10  
Granted, weighted average exercise price     
Expired, weighted average exercise price     
Forfeited, weighted average exercise price     
Outstanding at the end of Period, weighted average exercise price $ 1.10 $ 1.10
Exercisable at the end of Period, weighted average exercise price $ 1.10  
Outstanding at the beginning of period, weighted average remaining contractual life 1 month 2 days   
Granted, weighted average remaining contractual life     
Expired, weighted average remaining contractual life     
Forfeited, weighted average remaining contractual life     
Outstanding at the end of period, weighted average remaining contractual life 1 month 2 days   
Exercisable at the end of Period, weighted average remaining contractual life 1 month 2 days  
Outstanding at the beginning of period, aggregate intrinsic value     
Granted, aggregate intrinsic value     
Expired, aggregate intrinsic value     
Forfeited, aggregate intrinsic value     
Outstanding at the end of Period, aggregate intrinsic value      
Exercisable at the end of the Period, aggregate intrinsic value     
XML 21 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE (Details) (USD $)
9 Months Ended 12 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Short-term Debt [Line Items]      
Capital raised through issuance of long and short-term notes $ 360,000 $ 425,000 $ 525,000
Debt instrument, interest rate 10.00%    
Convertible notes payable, discount 58,942   4,653
Amortization of discount on note payable 83,711 10,223  
Convertible Notes Payable [Member] | Capital Communications Inc. [Member]
     
Short-term Debt [Line Items]      
Discount for beneficial conversion feature, June 2014 notes, total 8,000    
Convertible notes payable, discount 58,833    
Convertible Notes Payable [Member] | Capital Communications Inc. [Member] | Minimum [Member]
     
Short-term Debt [Line Items]      
Debt instrument, conversion price $ 0.025    
Convertible Notes Payable [Member] | Capital Communications Inc. [Member] | Maximum [Member]
     
Short-term Debt [Line Items]      
Debt instrument, conversion price $ 0.07    
Note One 2013 [Member] | Capital Communications Inc. [Member]
     
Short-term Debt [Line Items]      
Debt instrument, face amount     25,000
Note Two 2013 [Member] | Capital Communications Inc. [Member]
     
Short-term Debt [Line Items]      
Debt instrument, face amount     25,000
Note February 2014 [Member] | Capital Communications Inc. [Member]
     
Short-term Debt [Line Items]      
Debt instrument, issuance date Feb. 25, 2014    
Discount for beneficial conversion feature 40,000    
Convertible notes payable, discount 10,000    
Note June 20, 2014 [Member] | Capital Communications Inc. [Member]
     
Short-term Debt [Line Items]      
Debt instrument, face amount 20,000    
Debt instrument, issuance date Jun. 20, 2014    
Discount for beneficial conversion feature 4,000    
Note June 30, 2014 [Member] | Capital Communications Inc. [Member]
     
Short-term Debt [Line Items]      
Debt instrument, face amount 20,000    
Debt instrument, issuance date Jun. 30, 2014    
Discount for beneficial conversion feature 4,000    
Four Notes 2014 [Member] | Capital Communications Inc. [Member]
     
Short-term Debt [Line Items]      
Debt instrument, face amount 120,000    
Discount for beneficial conversion feature 138,000    
Promissory Note [Member] | A Shareholder [Member]
     
Short-term Debt [Line Items]      
Debt instrument, face amount $ 40,000    
Debt instrument, interest rate 10.00%    
Debt instrument, conversion price $ 0.20    
Debt instrument, issuance date Aug. 08, 2011    
Debt instrument, maturity date Jul. 31, 2012    
XML 22 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 23 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTION PLANS
9 Months Ended
Sep. 30, 2014
STOCK OPTION PLANS [Abstract]  
STOCK OPTION PLANS

NOTE 2 STOCK OPTION PLANS

 

On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated.  This plan was approved by the stockholders of the Company on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Company's trading common stock for the thirty-day period immediately preceding the grant date plus a premium of ten percent.  The maximum aggregate number of shares that may be awarded under the Plan is 2,500,000 shares.

 

The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock. Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. The Company uses the simplified method to calculate the expected term. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options.

During the nine month period ended September 30, 2014 the Company recognized $
0.00 of stock-based compensation expense, compared to $0.00 during the same period in 2013. There were 2,024,000  employee stock options outstanding at September 30, 2014. A summary of all employee options outstanding and exercisable under the plan as of September 30, 2014, and changes during the nine months then ended is set forth below:

 

Options
 

 

Shares

 

Weighted 
Average
Exercise
Price

 

Weighted Average Remaining Contractual Life (Years)

 

Aggregate Intrinsic Value

                 

Outstanding at the beginning of period

    2,024,000     $ 1.10     0.09     $ -  
                                 

Granted

    -       -     -       -  
                                 

Expired

    -       -     -       -  
                               

Forfeited

    -       -     -       -  
                                 

Outstanding at the end of Period

    2,024,000     $ 1.10     0.09     $ -  
                                 

Exercisable at the end of Period

    2,024,000     $ 1.10     0.09     $ -  

 

Based upon the current options issued as of September 30, 2014, there was no additional unrecognized compensation cost related to employee stock options that will be recognized. 

XML 24 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Sep. 30, 2014
Dec. 31, 2013
CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]    
Property and Equipment, accumulated depreciation $ 583,636 $ 527,106
Patents and Proprietary Technology, accumulated amortization 665,755 587,496
Convertible notes payable, discount $ 58,942 $ 4,653
Preferred stock, par value per share $ 0.001 $ 0.001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value per share $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 53,377,114 53,377,114
Common stock, shares outstanding 53,377,114 53,377,114
XML 25 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTION PLANS (Tables)
9 Months Ended
Sep. 30, 2014
STOCK OPTION PLANS [Abstract]  
Schedule of Stock Option Activity
A summary of all employee options outstanding and exercisable under the plan as of September 30, 2014, and changes during the nine months then ended is set forth below:

 

Options
 

 

Shares

 

Weighted 
Average
Exercise
Price

 

Weighted Average Remaining Contractual Life (Years)

 

Aggregate Intrinsic Value

                 

Outstanding at the beginning of period

    2,024,000     $ 1.10     0.09     $ -  
                                 

Granted

    -       -     -       -  
                                 

Expired

    -       -     -       -  
                               

Forfeited

    -       -     -       -  
                                 

Outstanding at the end of Period

    2,024,000     $ 1.10     0.09     $ -  
                                 

Exercisable at the end of Period

    2,024,000     $ 1.10     0.09     $ -  

 

XML 26 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
9 Months Ended
Sep. 30, 2014
Nov. 01, 2014
Document and Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2014  
Entity Registrant Name FLEXPOINT SENSOR SYSTEMS INC  
Entity Central Index Key 0000925660  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2014  
Document Fiscal Period Focus Q3  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   53,377,114
XML 27 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]            
Cash and cash equivalents $ 25,766 $ 46,575 $ 25,766 $ 46,575 $ 35,221 $ 42,024
Net loss (232,434) (188,229) (728,915) (688,183)    
Net cash used in operating activities     (360,225) (420,449)    
Accumulated deficit $ (21,137,194)   $ (21,137,194)   $ (20,408,279)  
Shares not included in computation of diluted loss per share as their effect would have been anti-dilutive     2,024,000      
Stock options outstanding 2,024,000   2,024,000   2,024,000  
Minimum [Member]
           
Finite-Lived Intangible Assets [Line Items]            
Intangible assets, useful lives     5 years      
Maximum [Member]
           
Finite-Lived Intangible Assets [Line Items]            
Intangible assets, useful lives     15 years      
XML 28 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]        
Engineering, Contract and Testing Revenue $ 124,464 $ 33,407 $ 221,117 $ 75,182
Operating Costs and Expenses        
Amortization of patents and proprietary technology 25,805 26,975 78,259 80,047
Cost of revenue 4,381 6,182 7,940 14,352
Administrative and marketing expense 165,313 167,576 515,155 511,040
Research and development expense 78,056 71,121 216,746 176,309
Total Operating Costs and Expenses 273,555 271,854 818,100 781,748
Other Income (Expense)        
Interest expense (83,359) (18,232) (131,978) (50,104)
Interest income 16    46 37
Gain on stock debt exchange    68,450    68,450
Net Other Expense (83,343) 50,218 (131,932) 18,383
Net Loss $ (232,434) $ (188,229) $ (728,915) $ (688,183)
Basic and Diluted Loss Per Common Share $ 0.00 $ 0.00 $ (0.01) $ (0.01)
Basic and Diluted Weighted-Average Common Shares Outstanding 53,377,114 49,255,375 53,377,114 46,955,453
XML 29 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
LITIGATION
9 Months Ended
Sep. 30, 2014
LITIGATION [Abstract]  
LITIGATION

NOTE 7 - LITIGATION

 

R&D Products, LLC - On June 23, 2010, the Company, along with David B. Beck, the Company's Director of Engineering, filed a complaint against R&D Products, LLC, Persimmon Investments, Inc. and Jules A. deGreef, the managing member of R&D Products, LLC. The complaint alleged that all of the intellectual properties owned by R&D Products and Mr. deGreef, specifically patented applications using Bend Sensor® technology that were filed jointly by Mr. Beck and Mr. deGreef, and later assigned solely to Mr. deGreef and R&D Products, are the property of the Company. The assignment by Mr. Beck of his rights in the patents and intellectual properties were improperly given and are the property of the Company. The Company believed that since Mr. Beck was an employee of the Company during the time that he became the primary creative force and inventor of the Bend Sensor® applications for R&D Products and Mr. deGreef, and the inventions and applications were created using Flexpoint resources, the Company claimed that such intellectual properties, patents, etc. filed by deGreef, Persimmon and R&D belong to Flexpoint and therefore is sought financial damages and ownership of all intellectual rights, patents and inventions created by Mr. Beck for deGreef, Persimmon and R&D Products. 

 

On April 9, 2013, the parties of the above referenced litigation reached a favorable universal settlement agreement that reinforces the Company's rights to the intellectual properties and their related products, including the medical bed. In order to secure the Company had exclusive rights to all patents and intellectual properties associated with this litigation the Company advanced to Mr. deGreef $25,000 to bring current all of the filing and maintenance fees for the patents detailed in the law suit. The advance is secured by a promissory note with an annual interest rate of 10% to be paid no later than December 31, 2015.

XML 30 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE
9 Months Ended
Sep. 30, 2014
NOTES PAYABLE [Abstract]  
NOTES PAYABLE

NOTE 6 – NOTES PAYABLE

During the nine months ended September 30, 2014, the Company raised $360,000 in capital through the issuance of  short-term notes to Capital Communications, Inc.  This is in addition to the $525,000 issued and outstanding as of December 31, 2013.  All of the notes have an annual interest rate of 10%, have various maturity dates during the year, and are secured by the Company's business equipment.  The notes also have a conversion feature for restricted common shares, ranging from $.025 to $.07 per share.  In addition to two notes for $25,000 each issued in 2013 with discounts, and one of the notes issued on February 25, 2014 for $40,000, these notes have an exercise price which was less than the trading price of the stock on the date of issuance, resulting in a beneficial conversion feature valued at $10,000, resulting in a discount on the value of the note.  On June 20 and June 30, 2014, two notes of $20,000 each were issued with exercise prices less than the trading price of the stock on the date of issuance, resulting in a beneficial conversion feature valued at $4,000 each for a total of $8,000.  On July 23, August 15, September 3 and September 16, 2014, four notes totaling $120,000 were issued with exercise prices less than the trading price of the stock on the date of issuance, resulting in a beneficial conversion feature of $138,000.  The unamortized discount of all notes  as of September 30, 2014 was $58,942, resulting in $58,833 of unamortized discount recorded as part of the $83,711 in amortization of discount on notes payable during the nine month period.  The notes had various maturity dates but, prior to December 31, 2013, all of the outstanding and future convertible notes issued Capital Communications were extended to September 30, 2014 and $80,000 on the notes issued during this three month period have a maturity date of July 15, 2015.  Management anticipates further extending these notes with similar terms as they reach their exiting maturity dates.

On August 8, 2011, the Company issued a promissory note for $40,000 to an existing shareholder. The note has an annual interest rate of 10% and is secured by the Company's equipment. The principle amount of the note, and all accrued interest is due and payable on or before July 31, 2012 and has a conversion feature for restricted common shares at $0.20 per share. Management anticipates extending this note to December 31, 2014 under similar terms.

XML 31 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS (Details) (USD $)
Sep. 30, 2014
Dec. 31, 2013
Related Party Transaction [Line Items]    
Related party payable $ 319 $ 6,056
President [Member]
   
Related Party Transaction [Line Items]    
Related party payable $ 319 $ 2,055
XML 32 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Debt Instruments) (Details) (Notes Payable to Various Entities, Including Related Parties [Member], USD $)
1 Months Ended 60 Months Ended 9 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2012
Dec. 31, 2013
Minimum [Member]
Dec. 31, 2013
Maximum [Member]
Sep. 30, 2014
Capital Communications Inc. [Member]
Sep. 30, 2014
Capital Communications Inc. [Member]
Minimum [Member]
Sep. 30, 2014
Capital Communications Inc. [Member]
Maximum [Member]
Debt Instrument [Line Items]                
Additional capital raised through issuance of long and short-term notes to related parties     $ 2,926,391     $ 360,000    
Debt instrument, minimum interest rate     10.00%          
Debt instrument, maximum interest rate     12.00%          
Debt instrument, conversion price       $ 0.07 $ 0.25   $ 0.0025 $ 0.07
Debt instrument, maturity date range start     Mar. 31, 2008          
Debt instrument, maturity date range end     Dec. 31, 2013          
Total current notes payable outstanding   327,525 327,525          
Shares issued from conversion of convertible debt 3,750,000 13,210,663            
Conversion of convertible notes, amount $ 287,525              
Price per share $ 0.08              
Average conversion price for converted debt instruments   $ 0.17            
XML 33 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2014
SUBSEQUENT EVENTS [Abstract]  
SUBSEQUENT EVENTS

NOTE 10 - SUBSEQUENT EVENTS

In October 2014 the Company received an additional $40,000 for which a convertible note has been issued.  The note bears interest at the rate of 10% per annum and has a maturity date of July 15, 2015.

XML 34 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2014
COMMITMENTS AND CONTINGENCIES [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 8 - COMMITMENTS AND CONTINGENCIES

 

On the same date as part of the settlement agreement (see Note 7- Litigation), the Company entered into an exclusive licensing agreement that granted the Company the sole and exclusive rights to all products, devices, and commercial applications of any type or nature that relate to or are derived from the patents and application for patents controlled by Mr. deGreef and his companies. As additional compensation for the settlement the Company also received a note in the amount of $360,000 from the deGreef companies to be paid with accrued interest no later than April 8, 2015 through future royalties generated from the exclusive rights to technology specifically identified in the settlement and licensing agreements. The note has an annual interest rate of 5% and is secured by the intellectual properties of Mr. deGreef and his companies, including patents issued and those currently under application and any and all devices derived from such.

 

At the time of this filing the Company does not have orders for products or devices; contracts for, or contracts that are currently being negotiated; or any type of existing or negotiated royalty agreement that uses the patents or technology identified in the settlement and licensing agreement. And because the source of repayment of the $360,000 note receivable is from future royalty income from the sales of product, devices or uses of the technology, therefore at this time as stipulated in Accounting Standards Codification ("ACS") 450 the Company is not permit to recognize a contingent asset.  At such time as royalty income can be reasonably estimated and is "virtually certain", the Company will recognize the note receivable.  

XML 35 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
NEW ACCOUNTING PRONOUNCEMENTS
9 Months Ended
Sep. 30, 2014
NEW ACCOUNTING PRONOUNCEMENTS [Abstract]  
NEW ACCOUNTING PRONOUNCEMENTS

NOTE 9 – NEW ACCOUNTING PRONOUNCEMENTS

 

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40) whereby an entity's management, in connection with preparing financial statements for each annual and interim reporting period, should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date the financial statements are issued.  Management's evaluation is to be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued.  If conditions or events raise substantial doubt about the entity's ability to continue as a going concern the entity should disclose information that enables users of the financial statements to understand management's evaluation of the significance of the conditions or events and of management's plans to mitigate the conditions or events. 

The standard is effective for annual periods ending after December 15, 2016, and interim periods therein.  Early adoption of this amendment is allowed.  We are currently evaluating the date at which we will adopt this standard. 

In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-10, which eliminated certain financial reporting requirements of companies previously identified as “Development Stage Entities” (Topic 915).  The amendments in this ASU simplify accounting guidance by removing all incremental financial reporting requirements for development stage entities.  The amendments also reduce data maintenance and, for those entities subject to audit, audit costs by eliminating the requirement for development stage entities to present inception-to-date information in the statements of income, cash flows, and shareholder equity.  Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued (public business entities) or made available for issuance (other entities).  Upon adoption, entities will no longer present or disclose any information required by Topic 915.  The Company has adopted this standard and will not report inception to date financial information.

In May 2014, the FASB issued Accounting Standards Update No. 2014-09,
Revenue from Contracts with Customers (ASU 2014-09), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP.  The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services.  ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP.

The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods:  (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures).  We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard in 2017.

XML 36 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Condensed Consolidated Interim Financial Statements

Condensed Consolidated Interim Financial Statements – The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and  its subsidiaries (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. These statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2013 included in the Company's Form 10-K filed with the Securities and Exchange Commission on April 15, 2014. In particular, the Company's significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2014.

 

Nature of Operations

Nature of Operations – The Company is located near Salt Lake City, in Draper, Utah and is engaged principally in designing, engineering, and manufacturing sensor technology products and equipment using Bend Sensors® flexible potentiometer technology. The Company had a loss of $728,915 and used cash in operating activities of $360,225 during the nine months ended September 30, 2014. During the nine months ended September 30, 2013 the Company lost $688,183 and used cash in operating activities of $420,449. Through September 30, 2014, the Company had an accumulated deficit of $21,137,194. The Company has not earned any appreciable revenue during the period from February 24, 2004 (date of emergence from bankruptcy) through September 30, 2014. These matters raise doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

From 2008 through 2012, the Company raised $2,926,391 in additional capital, including accrued interest, through the issuance of long and short-term notes to various entities, including related parties. All of the notes had an annual interest rate of 10% to 12% and were secured by the Company's business equipment. The notes also had a conversion feature for restricted common shares ranging from $.07 to $.25 per share with maturity dates from March 31, 2008 to December 31, 2013. However, prior to December 31, 2012 all but $327,525 of  the convertible notes were converted to an aggregate of 13,210,663 shares of the Company's restricted common stock at an average share price of about $.17 per share. On December 31, 2013, the Company converted an additional 3,750,000 restricted common shares at $0.08 per share and retired $287,525 in debt plus all accrued interest

During the nine months ended September 30, 2014, the Company has raised an additional $360,000 in operating capital through the issuance of short-term notes to Capital Communication LLC.  The notes are secured by the Company's business equipment and have a conversion feature for restricted common shares ranging from $0.0025 to $0.07 per share, with various maturity dates during the year.

 

Cash and Cash Equivalents

Cash and Cash Equivalents – Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. The cash and equivalents of $25,766 at September 30, 2014 and $35,221 at December 31, 2013 represent cash on deposit in various bank accounts with a financial institution.  

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments - The carrying amounts reported in the balance sheets for accounts receivable, accounts payable and accrued liabilities approximate fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates which approximate current market rates.

 

Accounts Receivable

Accounts Receivable – Trade accounts receivable are recorded at the time product is shipped or services are provided, including any shipping and handling fees. Due to the limited amount of transactions, collectability of the trade receivables is reasonably assured.  Therefore, the Company has not created an allowance for doubtful accounts. Most contracts associated with design and development engineering require a deposit of up to 50% of the quoted price of the initial phase of such contracts prior to the commencement of work. As the Company completes each phase or milestone of such contracts, additional funding is normally required from the customer. These deposits are considered deferred income until each phase or milestone is completed and accepted by the customer, at which time the agreed upon price for that particular phase of the contract is billed to the customer and the deposit applied. As the Company's revenues and customer base increase, an allowance policy will be established.

 

Inventories

Inventories – Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method.  Inventories consist of raw materials.

 

Property and Equipment

Property and Equipment Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale, or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized.

 

Valuation of Long-lived Assets

Valuation of Long-lived Assets – The carrying values of the Company's long-lived assets are reviewed for impairment quarterly and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. The Company's analysis did not indicate any impairment of assets as of September 30, 2014.

 

Intangible Assets

Intangible Assets – Costs to obtain or develop patents are capitalized and amortized over the estimated  life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the rights to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology rights, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The Company's analysis did not indicate any impairment of intangible assets as of September 30, 2014.

 

Research and Development

Research and Development – Research and development costs are recognized as an expense during the period incurred until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.

 

Goodwill

Goodwill Goodwill represents the excess of the Company's reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in Accounting Standards Codification (“ACS”) 360, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Company's targeted market conditions, as well as relevant entity-specific events, such as a change in the market for the Company's products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 360, management has determined that the value of Company's assets is not more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods.

 

Revenue Recognition

Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer.  Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.

 

Stock-Based Compensation

Stock-Based Compensation – Under ASC Topic 718, Stock Compensation, the Company is required to recognize the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest.  Prior to 2006, no compensation was recorded in earnings for the Company's stock-based options granted under the 2005 Stock Incentive Plan (the “Plan”).  Under ASC 718, all share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period.  On January 1, 2006, the Company adopted the provisions of ASC 718, for its share-based compensations plans and began recognizing the unvested portion of employee compensation from stock options and awards equal to the unamortized grant-date fair value over the remaining vesting period.  Furthermore, compensation costs will also be recognized for any awards issued, modified, repurchased, or canceled after January 1, 2006.

             

Basic and Diluted Earnings Per Share

Basic and Diluted Earnings Per Share – Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period.  Diluted earnings per share is computed by dividing net earnings by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At September 30, 2014, there were outstanding options to purchase 2,024,000 shares of common stock and outstanding convertible notes payable with common share equivalents of 18,645,962. These options were not included in the computation of diluted earnings because the related exercise prices were greater than the average market price of the common shares and the common stock equivalents for convertible notes were excluded because their effect would have been anti-dilutive.

 

XML 37 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTION PLANS (Narrative) (Details) (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Aug. 25, 2005
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares authorized       2,500,000
Stock based compensation expense $ 0.00 $ 0.00    
Employee stock options outstanding 2,024,000   2,024,000  
XML 38 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS AND CONTINGENCIES (Details) (Settled Litigation [Member], R&D Products, LLC [Member], Notes Receivable Two [Member], USD $)
0 Months Ended
Apr. 09, 2013
Settled Litigation [Member] | R&D Products, LLC [Member] | Notes Receivable Two [Member]
 
Legal Settlement [Line Items]  
Notes receivable $ 360,000
Interest rate 5.00%
Maturity date Apr. 08, 2015
XML 39 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash Flows from Operating Activities:    
Net loss $ (728,915) $ (688,183)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 56,620 57,039
Amortization of patents and proprietary technology 78,259 80,047
Issuance of common stock and warrants for services    250,000
Amortization of discount on note payable 83,711 10,223
Gain on forgiveness of debt    (68,450)
Changes in operating assets and liabilities:    
Accounts receivable (65,564) (4,224)
Inventory (849) 273
Notes receivable    (25,000)
Deposits and prepaid expenses (43) 11,951
Accounts payable 6,037 (34,328)
Accounts payable - related parties (5,737) (5,160)
Accrued liabilities 226,256 (14,637)
Deferred revenue (10,000) 10,000
Net Cash Used in Operating Activities (360,225) (420,449)
Cash Flows from Investing Activities:    
Payments for patents (9,230)   
Net Cash Used in Investing Activities (9,230)   
Cash Flows from Financing Activities:    
Proceeds from borrowings under convertible note payable 360,000 425,000
Net Cash Provided by Financing Activities 360,000 425,000
Net Change in Cash and Cash Equivalents (9,455) 4,551
Cash and Cash Equivalents at Beginning of Period 35,221 42,024
Cash and Cash Equivalents at End of Period 25,766 46,575
Supplemental Cash Flow Information:    
Cash paid for income taxes      
Cash paid for interest      
Supplemental Disclosure on Noncash Investing and Financing Activities    
Recognition of discounts on convertible notes payable $ (138,000) $ (20,000)
XML 40 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2014
RELATED PARTY TRANSACTIONS [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 5 – RELATED PARTY TRANSACTIONS

 

The Company has a related party payable to its President, CEO and Director for reimbursement of travel and other related expenses incurred on behalf of the Company. The amount due to the President as of September 30, 2014 and December 31, 2013 is $319 and $2,055, respectively.

XML 41 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS (Details) (USD $)
9 Months Ended
Sep. 30, 2014
Subsequent Event [Line Items]  
Debt instrument, interest rate 10.00%
Subsequent Event [Member] | Convertible Notes Payable [Member]
 
Subsequent Event [Line Items]  
Debt instrument, face amount $ 40,000
Debt instrument, interest rate 10.00%
Debt Instrument, Maturity Date Jul. 15, 2015
XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 46 150 1 false 19 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.flexpoint.com/role/flxt-daei Document and Entity Information true false R2.htm 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.flexpoint.com/role/flxt-cbs1 CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.flexpoint.com/role/flxt-cbsp1 CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.flexpoint.com/role/flxt-csoo CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.flexpoint.com/role/flxt-csocf CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R6.htm 101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.flexpoint.com/role/flxt-sosap SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R7.htm 102 - Disclosure - STOCK OPTION PLANS Sheet http://www.flexpoint.com/role/flxt-sop STOCK OPTION PLANS false false R8.htm 103 - Disclosure - INVENTORIES Sheet http://www.flexpoint.com/role/flxt-i INVENTORIES false false R9.htm 104 - Disclosure - ISSUANCE OF STOCK Sheet http://www.flexpoint.com/role/flxt-ios ISSUANCE OF STOCK false false R10.htm 105 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.flexpoint.com/role/flxt-rpt RELATED PARTY TRANSACTIONS false false R11.htm 106 - Disclosure - NOTES PAYABLE Notes http://www.flexpoint.com/role/flxt-np NOTES PAYABLE false false R12.htm 107 - Disclosure - LITIGATION Sheet http://www.flexpoint.com/role/flxt-l LITIGATION false false R13.htm 108 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.flexpoint.com/role/flxt-cac COMMITMENTS AND CONTINGENCIES false false R14.htm 109 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS Sheet http://www.flexpoint.com/role/flxt-nap NEW ACCOUNTING PRONOUNCEMENTS false false R15.htm 110 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.flexpoint.com/role/flxt-se SUBSEQUENT EVENTS false false R16.htm 201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.flexpoint.com/role/flxt-sosapp SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R17.htm 303 - Disclosure - STOCK OPTION PLANS (Tables) Sheet http://www.flexpoint.com/role/flxt-sopt STOCK OPTION PLANS (Tables) false false R18.htm 40101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.flexpoint.com/role/flxt-sosapd SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) false false R19.htm 40102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Debt Instruments) (Details) Sheet http://www.flexpoint.com/role/flxt-sosapdid SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Debt Instruments) (Details) false false R20.htm 40201 - Disclosure - INVENTORIES (Details) Sheet http://www.flexpoint.com/role/flxt-id INVENTORIES (Details) false false R21.htm 40301 - Disclosure - STOCK OPTION PLANS (Narrative) (Details) Sheet http://www.flexpoint.com/role/flxt-sopnd STOCK OPTION PLANS (Narrative) (Details) false false R22.htm 40302 - Disclosure - STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) Sheet http://www.flexpoint.com/role/flxt-sopsosoad STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) false false R23.htm 40501 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.flexpoint.com/role/flxt-rptd RELATED PARTY TRANSACTIONS (Details) false false R24.htm 40601 - Disclosure - NOTES PAYABLE (Details) Notes http://www.flexpoint.com/role/flxt-npd NOTES PAYABLE (Details) false false R25.htm 40701 - Disclosure - LITIGATION (Details) Sheet http://www.flexpoint.com/role/flxt-ld LITIGATION (Details) false false R26.htm 40801 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.flexpoint.com/role/flxt-cacd COMMITMENTS AND CONTINGENCIES (Details) false false R27.htm 41001 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.flexpoint.com/role/flxt-sed SUBSEQUENT EVENTS (Details) false false All Reports Book All Reports Process Flow-Through: 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Sep. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2013' flxt-20140930.xml flxt-20140930.xsd flxt-20140930_cal.xml flxt-20140930_def.xml flxt-20140930_lab.xml flxt-20140930_pre.xml true true XML 43 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVENTORIES (Details) (USD $)
Sep. 30, 2014
Inventory Disclosure [Abstract]  
Work in progress inventory   
Finished goods inventory   

;!5!$QY!=3UO1D>M=VT1#!(6%4]*:0TTUT1JXE>4P9,#Z78UKY-H9[%^0B:3T=58+;-1 M[Z6/,NA"NJU4P+6:LN3E=!8D=PP5BOIII+DRS/LH6Z[)=4VB7D(?&I'#`(L< MP$"5?``8`/1KCP$F\TZ+BPU^9$IJ0$D<2,OZF#1I.\,Z6(`HH@50;KUX4,[8 M'(A+U0>"/?#P#94`LF]8H!?:];AS]"8XZ4JP_<@G;>P%L4AMKY4"XM9S(H&S MZIUHV`K#.8X(E9X5>CZ7U MQ10C%L!*_LC$;1LYJMN40/_J\'9HEFT0J^JS<2.="V_U.79BX?3,2\7?'1$Y M=_&T3FXNI[I#*2+6G9.1^8*>4(27="AO$QSD?I9>79WQ4RS%IN6,2[II7ZM_ MG/'!K507+`96^WS+RE3[YT%9LV#GR];!<#C#ODQJ`P M5C*-E4S?8R73N+>\2WO+`TC6^ZSK&#?9OZ=-=@<2PH$L9^SRQ%QO(7BLJQAF M7<61.WX_KON/Z_Y#7/=W5?MYI+?DY\0W![CPK.NOCERJ;1P25W M16'P>G:`%%;4XN7JPA'!2@JQ(<_IHX)ZB'>SR*-Y>MSQ"B/JS)=Q2J2D@EQX M/EI=],C!CHB<\P%BJ\M5Y`Q]H(P:IA:[0$_K1"*Y@6^N6J[)[@?Z M[NKDFY:NNX1[(UO/K`$13R MK%9L/ZUG?X:0>9-O7''>`VEB$D6(S%>KK*K0PSGGJ0ZD,(H_=N MS?#T%CJXFX322QTV=@I-3/7D=@(-3_8<+-`SL@G%AXW=;2@0-"WWH20!8VXG M2@267K:%<>HM@["_O>'J![^1?8!Y5C-7@9*L*PS4 M]XE$P6:B_C!/<#Z;;QY>OYE>84(3!V]1I\AP'G#U6:$:INQW7"Z0MM2QW917 M`ON]65W5E7H0U*GM%"IZ)E>=!)'6C[PP2?M8Z(9")%;230)9S?/8$%NG<0`? M@`*)!5CH[Q$C:#``+"B?.BV?0QZ3Q]WH=]_;O_>H`PIU!P=*C"QC+ MO;S=L#*6$9Y]U&G#JU(4SN#A%`ZOB2*+?`&.(I.F-HXU&LO'V!A6QG+R\X=R M>X01YN/4<)[1^CR4+.GCLU^]!11A(-+&A@*+U.%T54(WG7059"MI6V M`X&9G.YF(";JJP&OQO3)'7B=QX$FN,HMU:"U:CE48#'T[@A6E9X:H/K)D2T$ MB5ORV93`5H'EF_`U0"+62Q<4$.<&"/JLYJ2Z;#^QZ^\NW4O?J'<_]T@V2#?3 M$1ADU)DPXHT*$V=1U=_Y.13O2D4(M/QUDFM2`!3=Q%DP*FNH"2*H+!FCT M,,.I>A2CF/S@S>H3T8VTK'I&0RS+E8JM63J'LPXLI55=:$J$!DX_]'I_WS)/ M_#F]"'R6(+1:4ZGN'@HN]5-LW[CG3[J]]:H+FF47[_<&=I7O>/C% MVN=E//P"C.%X^&6G#K_T^I2$I7M)9;X01NXG!3IJ<4^I$_#XC),$/X?Q3`B. M)B4/&F7*'B]8@Q,8H5JZ>0O`V$T(M+G_2C9*C(^P#.81EML$^P@%Z06Q8ZGT MF8K.P89$BQH^P!:NA@QY-35#ATP'&B=)5R_MUZ,T(S0+1^,4(Q M9.B]%S&>2W7P7*HNY-J^%J&(.+VW(GJ='=1<9EUI30^GR8&,V0(.9=46PP`2 MI*:98,7L0#1=.#EX[PYX=ORI$4WD*#\TH@@"+V'JTR6QVP0MPGSQ%MT%9R]T[9CL^@ZCR# MVF?-UGA94?MDW=1=17*9>KNKBGI]<_=T-;$HXLW-E"I3FV%P4";=K@8OB7:N MXDI594U`R7?3+'PPFS*P0^G#,];*-IGM)++-6KL!9IN0YN:S379O3I]I'J_G M$.GW?5_/\1T_2:>07AMXDTXBP59_E(X#*+T4F_.M6JW$TS)A>A?IS?2.8#P) M?9*(W6?8__9;BH+3]`Q']%W6Q(MNZ+%]=#,]2U`0UM>^S3$L?]U:,G0M*3)N M))W=&#/]-],HO81<+8VZ0(])[B6OM(%R+L5O+)%0L1H/,*L2VL!\:@5T*2RX MZB`U?RL2-!CWS')NHK$]9R M>G'PA7XY"ZGX`RS7HCS>HA8N#[^2MBW0(-F/"!P?>KW$<;Q)=+Q)M.]5U?$F MT3YO$EW_3O_S2!!%?OD_4$L#!!0````(`.Z!;$7#>0&1I'D``'D7"``5`!P` M9FQX="TR,#$T,#DS,%]L86(N>&UL550)``/PS6-4\,UC5'5X"P`!!"4.```$ M.0$``.V]>W/C.)8O^/]&['?`UNW8J8IP5E5F=?=,](\)/Q^YQP\"/S'__RZ M7I%GFJ1A'/WG-^^___$;0J-YO`BCQ__\9IN^"])Y&'Y#TBR(%L$JCNA_?O-" MTV_^Y^3__#_^X_]Z]^XTH4%&%^3AA?P2+Y?D[HFN5O3EA-S$7VB2/[B\O;PC MIT'R$$?OWG&Y51C]_A?^/P]!2@ES($K%G__YS5.6;?[RPP]?OGSY_NM#LOH^ M3AY_^/#CCS_]4+;^IFC.GX::]F'$/9[OV[?T?_E)M'[_\\\__R">[IJFH:PA M4_O^A__WT]7=_(FN@W<5`VGXEU1\>!7/@TS\CL;O090M^%_ORF;O^$?OWG]X M]]/[[[^FBV_8KT=(_OLE\8K>TB7A__WU]E)I\^(L?(OK(.^HJ>*`KYK-0 MD;UL6'>FX7JSHN5G3PE=RG6MDJ2FBOOV,_?M_9^Y;_^C;N&'BJLK_M$5^U?- M+OV:T6A!%Z5EKEOSRPG3HI^$YIWN>%[3NN)]$"?2KR,4IG3^_6/\_,."ADSQ M^S_R?[SC_WCWX_OB9_X?[*._3]?,._;_V<4J>"S5B6_RG]\HGV=AQK^$Y/D/ M=:^YGIK?"4WC;3*G#4OB/W]7V@/]9K4NSQU4JUVOF&G.?1J]^_7N&Q(NU*TG MNS\)__L_?MA[WOZVTZ3>44$R+YUB_S1\D:+%#_.846Z3O:M]IV42KW5]$AM_ MQN)7$=`E?R&M=B2+B5+%#\/@\72;)-QFF,Z#U=]HD)Q'BS-&.`DT34TK*%4W M[0U8DQ?]L:NQH(>Q4G!2/"'Y(\*?$?:0\*?CX]O8L;%-!TA0KQ*I$P`,&E=< M.(OG6T[`&YJ$\4)-!&V["@L4[7I30&N_/_Y5ZO7@ETM-RH])_KE'J-?W8@S^ MP25XE[:O@QV=(/X^8UR\7X8HFI\SN8YR\2'"N:55!N;15;XQK;/='N%RY M'M\RF4G^(1&?DO+C\:&MZ[@8^"M+8"UI70;R\!M@(1; M=)^RA)$$JTLVOOWZWU0=LA7M6OANM4,"N,(^%L+;ZB$0;TJ5&"\^)^(!84]\ M0;FJ%R4PUW=X&^>-]C*@F[#A&.GQ>AU'=UD\__WN*6"PFVTS,5D81K)9$[A0 MFP-:(2Q"`#Q#8X?>%H@J.A4[WHA&1+0Z(7D[4FGH#8T@J)!Q"HXF"<$TPE*V MV:#0]?AW/P*_8)^DFA&PHJ5D#-QJB38*5OB`-PYN&X"-A)MR^[%P=1I(/!N? M*Z8>E8Z']=TO&Q$W).1C8A-6AL%_/C*',4#25LF!6EMD%DC\P.9!W80-$ZJ2 M+2X4TT->LD'6NQH^J,&@9D1%1L<)'79J=40H?I8@OW\,1K2(E/:H+0B70?H@ON0V??<8!)L4G34@6'_]].I_'6U8[18\W\2J0(9[U`_: M(#MJL`/$)W>_?OHTO?T;F5V0N\M?KB\O+D^GU_=D>GHZ^_7Z_O+Z%W(SN[H\ MO3R_(Y]+J?\]+DTL\!#;]UB#2F;!/;DZX&YPNJ6W=$[#Y^!A1:]I5JS8Z0FG M%9%33B&"23JM5Q#:931)Z164>RIS8/;)%4S*IR39/?:*7?K.5_$+`AD%PZ2B M2HZ-!;2_OW<2X=6V^N&,J=@C;=_@A+`F)Z1H=*RXV_>5<^1Q4Z-'^)O@A7MU M2U=\W]U-D&0L`\$B/414$?'UHJB$A'CI(`,8S,(9JE6TY^DF;T;>L=P@6K)/ MDFSDU8U.B%'2U0)O*M+J5*C)ZPE:7:41HTT#S;@?:;)0XP5;H5I)`Q_^&9R6XVO9=Q]-7#],!YVQV*/W!S?X*FV!2*20GA2/R&K_S!O^ M&'I;1B$00"06I?]$9#5V0&-T;7V-'ZNUZ M*PKV,[I)Z#P4[R^S?Z\H_\,FB1O-X3:_BE'U^&J1/;!#P'"[HXN/+KREE66?&A@0!WUP_G6?ALY@S M-;TXXM"4,EU@FD*.$/B_`G:20O70)APA&IY4M')2[O3R3=E+JY\>C?LM-L('.=V1GA>S-^/25VP?A4!Q'%U@NSH M.)$D'ZS68DFRBR41BR4KII5_RO\]YV%DFT<.$N\"1[#3^I>W<($-W:,+&.,6 MAI4*=;8\HP_969B*S4PW"5V'V[6JRH/*-4LVLQQ.^(3ZAU1,`3VZ#Q`FH];'Z4IS9IG),H?-BN4 MXB%.C*I90JH12IV`X)`WG>3_]81W]1^_31Q9Y[1P+QI)@(O?>989(LZ"%2!# M[%5#>Y''Z'NNG1Q>;YKCF+8_/8@DQ2LLIE5975MIG&FU142NP@_,*-0V`85S M4[*(4;MWK/Q;#-3VK0+X>BC(6="049%B0.2X*9*5ECI"B`?($CS^A_ M?"#^46GI!]/L\-)B8!>X-7D)TM'FJW=HQ2Y+ M$2'G22D\!)2-2<8EF'U,2N)&HLMHGM`@I6FD^8G1AQB(><0\EUSH0/0>Y@9I]EID"0O8?3XUV"UM4N)"EE0 M+FS).@P'"C^=#]?:=KN2OZEIG_3$JU#T,%BNP@N0WGJXP5C=T`&E\XAHM$2S#\-,9Z6&<7"\$_: M430#<=FWD#>3>$M9G>`Z@M[MOH MDD2#7GCW+#X8=UIT4M(E0J"O9G?R''-6S]8!I$A1W9:A"Q4'%!\@"]M]@-HI M0N@6NOT'//H^#GOKV'@7\X-[B7P\6I4A>R'RV;^=':,PP3QM."@7QEWC8J[& MT5W&_+@)DEERE_%;&,1HNGP569,F@9*2W&B41(L/0!_Q0H+9("P*F/1,\D9$ MM#KA]VJ3."%YRWS::7\XB#]TAT)&RG$[O,EH;=`@Y[(W8'7R%B'4+@IJRX3% M<)OFN-TPW#X+M.[.PG@=:`6E(1=X]27A:/=/*)JI4PGJ.K/"NAO66>QU:`K5 MN$3>D3_\^/V//[[?<^K?R?L??SSY,?__G%RL2-QF3W$2_I,N_IW\Z:>3G_[U M7T_>O__C[BDK(=N?AFG*K_+D#^-MEF;L'ZRF\8ZHIB4,/:HT!%0M2PR#/Q_A5@GE1A(B/3\BE0,NAH\,F0`/QX4OHS4^JRKO)'(%EK=6!N-X:FP\R M7]R$Y88E*WK49!L%3RVB>L<1:5_KJ*(!AX8O52DM;89#D\,@VS+3&4SMD)L_ M]3;F]L*3303NA"B_XO%T5YA!8W);PA27JQ)NV-3VR1&?:H8Z,*HB+^44V3?P ME%:2[C=32XD9([GVD@""#0DTU_,B4GN]$->>!VD-SHX3<_8AO2/J_`KML_V@ M&1K;)2*FX%X3<4,ZB5`2"O#@J$/$S@,%6/QSF&:#R_`!.7$'''R`38"%P[$SP3),L?%C1ZSBCZ4U^?Y3^ M%$.84#L;:(6P:`CP#(V&>EL@&NI43"K/B6A`BA:>G98(!(2,@7`@21BH$99R M<&P`.IKW,9KLB\0B)>RP&`DL;DHL\AM;:Y?1+?CAFID&R!B-61,T::S9:W])E&FMTPDC:M?%!K@\0^B5VL:%]7#:%456+" M_^3,*#[PA0ZRCI*@7]V?;:A7VLJ0[;C;'<78I@7+_L\C:(Z`Y-`1``AW<`R, M&LSX'9^749HE6SZ:O@HC>LD&UJI+I`RM&P%.V1H%\P9?<(*>VH@9_BK9B;A9 M>?^$?.;/B'CHR7#2U,\M=L"`T62)0JK-%RB2QN+-/:]-0)RIM=3RI6CI@"LU M'USPI#1@RY%<;G(W?Z*++:NR6:JXBJ/'=RQ'K4F#-2GY+)I[R9AZ+QO8(H.$ MGBE"PL02.7Z&94A>Q:?\PL0D?`RC8,4_S:]*?*_A"TA.PAZ#'!J70/[A,7Y<5PS$BY9X-O&1,U,K+>>D%,IV,#&!6$2#*1Q#5 MU<;:'`R9YQ,&^9X3L5_@^*%J'(:X`*M'PY5/0<:OZ7TY"S)ZRT\'%J="ZA(+ M6%9;FBEE'11K!C\A1&9]^1!#J0RQ;%O7J33E.2?\ ML3]DAD/(4/?!$*BO!!4Z3+6A!P#&7A.&&T5"[]_?MT;R)Z1L2WAC(EJ?D+O7 M!6!05G(%X=&STSYWGI85R=[IZIL,L/$/5(EV,&16XJ#^A'KN8I@$L&U;D!I5 MM@=0.Y%:B"A>5?#I[9^.D#,4K);0U=>N)F6F0M9+"@PP'@.Y@,T%GAIO*7L4 MSCGZRVW;2S9(J[S\[M/[E.,PP'+\YIH#:`>D6YJU.BG=:C!CZ00Z#SY\,[FK M'"F(0G1R/;L_OR,WT[]-/UZ=>W?;AZ%[I3RTOK]# M+B1GDE\%TA<^,W"EL:[A&3ENN2N4$3\M2#`>AHQ=9^[+O"O`ND::U=D/#E8-WB32^N-BB<&7]+I%,MKGI MP--WB73];%@R4@%#OS)TI7^7"((DC[8-V;PP81:WW2KD5IS1HM8D':RM;U3@BP/FVG:9Q>L[,$W];)A`AI[PJ)`R32$/ MA"1G2Y#=+V)52]<7)(X+1:!BHP^.1I]2DBXT[G/'31+.*>R=3X`\=#--6][M M;@"5OP[?_]1;[['JW]+6WA576>'?\#;^<-8.3?!%?0,@P>OX33T6B_=C8]KM MLH?),"*@I)[^X[51`1[E%N:[W/>AYI7Q$%2MJ=8Y!+#O$2 M>-7'(<\P*.SV?@=;TA)9JL'[I>UC`#GQFPG^Z.CO)R#A]C`0Q7AF!@`TY] M+-!J,@4#SQ#N-O693:,"7)K\*A)D]\;$R;U.S%MF0'>H]R@'5H>C MUK.+UI.*SJ=FAIJ/Z3D)8YIY\9&?THZWF&7I/+5B,Z/B'&!VZ0-AEKKWA)_T ME)':O/0QHJW'5)X-WCR*Y+I!UVTYV?@I^!JNM^O>$WDJA9TG]MH*!YX247VC MH2=()'Y@3I>TU-M/GHC/R[6!0HV/(:03?GM,L!@XT7VZI:FXS_2+=SP;X.P2 M:W=<$DZ1CO../>CI^"$XA3B)Z9)5!U<6A!%R65!7B%`6E`I'"U?U;S1>6;#S MPTV4*M3W+0MR-8<;PAKX10EA4DY@!+!<,4X`\X1GWI0%%7=<$DY>%A0=>R1E M@3M..2D+\%DULRD_(#O^XL M5_69A&"ZSFUSIM9:1H0!4.`H$;1M6,,A#]D%(+RZPKPK(`!AU`X2(P>\39R& M63I-4YJEU^QGVS+7-`?FZYNW0J"J.1(+]-Y@!46E%0@=%,*3\@G)'YV0_4-? M"&+H:PE30.AH$T8N)F/.*'AR%%XUQKH#BP=<8/V=@?)$*[J1@FF M=TVE.';9V:YB8-V`7:_GQ>7A]SLDF@%[?N2HEA"&=YZZ&K%P4ZZD#C4XWM@1=9N+D#(V$7S MI"+&S_9C@F0O2>JBK"S.R`O-2"'MY=DV?:`JB0S]D=\.(!UTRB+-@1')4=;J MZHDC1HG3>LY_(]/3T]FOU_>7U[^0F]O9-?OWZ?FG\^O[NS>>M`'A(5/&3=Z[ M4XQFR]-XO:%1*BJ*6[KB$_:G<9JEXJ+'CT%*%S?!B_#?>+X;CM9F0N^K%2[!ZZ'E(I\3/U(\&X'-U3> MM()9W=Q?SJ[)S=7TVI>JP5.*F2L) MST@V:G5Q'B01*W[2&YJ4+H;S:;0X"U=;]20`4*I1'1BE4((-T#?$4&*V:`X4 M)AT3\0$)(OY:I/B(7,5IRK>P\7R]9IE:R/D1&Z#X:''?#EA-9ANDV\SU`I'8 M+_5"S/4&),],91,!0M'HA+1@>MR`-"8;;$AZE2QNXE4X?S$--8%2AF31DG)" M385O#I-%VZ(]-YLZ),FBS54_B:D"AY&8>E29:-F0-M-R%#BZSA0R<[W1J,H4 M>3/RN?BO=U,(KI!IG3+Z8G/K.(72N]H\AS.Z7X85!TH31\?$W$)Z7XD ME1JN-4;3VTP[_?7B1`*L[X<4*1#<`422WE8DLR7>7=F,!]UVZ$%F12LT]=4O M"5[HA/,LN%WS4[Q25H--OP3)(KV/,WZ?_/XYGQ[*5YMNZ3Q^C/BI.^+"IIE8 MI5+=.#JH[2Y!LK_MX0(IUN\T8+!%3Q;7A//7CD_W4G5<7(8-0T(XF<.RT0H!&5,+<<1'G)KF;#/:#'D^EY1.^ M&TWDR)/\YCRR82!,/5J]0$>?.06AX0_M6FVM$:NKM,%'CAI-]L3@AV\F-Z\$ M<*9KL1$!-^;UUQ=!F/PU6&WI;'D11LRY,%CM#T))\S431:EA)=NH.8"R*$2T M\A,Q(T#MFDD)TS3AS8AHQS/$KF7ER"]/)GKLD-,B;A?@-?D+TM$FLG>XQ5[\ MAAM%@BTO;`#`]7]E?`A0&^L@E[`>=2C,W`HS>A4^T\5EE#'<\?M?Q"$(OZ9T MN5U=A4O5^5B>:D7V[_$"9$Y(W);RM M)WRV@4V;SO:@:W$9H$)"9;\@ZV2L#3:,@UTQ]MX#-BA.0-KFB%TQ65_J*N>0 M-2<@9Z#U-/VD5V%$+S.Z5FU)L!$%IY^JJ&,NM[UTG7YJ%OM0N*)(GWY2\IDW M):*M+_6D#6XLR*Q$'9S*>Q4V5-9@U@LB3^?S[7HKEB.G^45?N@.MNBN"DURI MR#7E#=_`>0!0V^\5#E1J#<'AA%0$2572^TAA@J)-W(#!VB***!1:Q13?*#)P MO:MUPP57>"U\PS[D!QSP-VENDGB3A#0+$CXE,W^*XE7\^')"@@IC@C?&*##B M%6=\+;#5-S?#A.#Y%N_V6IAGSO,H]`)F@PIC?O3F_ED@(FQ(;+Y962]L1073BHQ MF3+35Z]APA^3;WF#[PBC8:4-IV3>R@\.PM#0HJ`-B)K\T\JVZ38E` MD^SEAD$FXQNQ-FOUC2%VPLIDH!=&9B;$4^ST8+!I0U"MJF;"X(UYIBB;$]&> M[`1\(S`(11HF6Z!036B=$AVSO4&QD]&*A6DL.%<3#\LV-.50IJ\1NQ;IR`5Z M1T]0*?>1,B_/O_)3EK=A^L3]FBWY382:W`22DZ0E@QP:ET'^X24CDSD83E=O<"FP[&,V2X"3*NIA;;@ MN7@5\`0E%6R`CIM*XGC!7XV^7&^",.%.<5=5^4/;N)DT%(UQV*CU!+/&4QD" M,$XN.BD_)^'N`9D_!1=@O1&BL=`41C]7E MDQ.R?R;.+CXF%)D#1%Z#<'6$%Z1J>`&^E90WT/;+R2;L0O$JAJ=R)WI M9M:CJAS>J]60=6C]"HY"ZI[U(M),H]8R:_E(^YZNM;PB5@'D4?$/]MPQ:_.47'#(*-EGBSH5.8UZU.SU#KBN:E28843<5M."V$CWP-*?2XSIJZ/UW'CN4YGM%$(568QR1?'3``<4` M39O``D*Y17B1Z[,*,WX1QNE`RLX+!\QIO)WLU1ZZ$?'?)\$Z8X`7"3>?1*.+ MRFL@'=8/`/+:)06MO(/Y88"_J&>QV5BWG4C6:9M4WU5\;"]6^!49X%@R3#G# MX:B?@];H,4U+>X1HMXL@)L.(<)8ME?#3ZZL@/X`%%+<`MUQF<0/Q45/;WI59 M6Z&7=OGT%(C73JQA!*&'/X&..'*C8/F ML.;"[J02WN*$E&KYKAZNN'@GE9^CA`]>/_&#'7=OO8J8L:K$C#?JXR+QR,CO2UG7_!;_15>+BSCY-56= M^FDEJRZ]=++88='LIYLPI[5K%;8TFFIUS)*L]G$H\#,.`5"CBRQ@T&DBA5J' MEOM^8-8N.8/GU>"VD9`KYM??L-OLU!'0BW8U!\R:U1T=5H-2@U$LX'YH`K,S[/ECQ%Z_I719DE+MIN$[$_>MN=G5Y-KUG?]S=L_]\.K^^OR.S M"S*[.;^=\NNY_;N9VX2"-@=!L&EQ3BXE81D09T.SZC[X2M.;(%QHV=1J)651 MI14B>UJV,<<3+0M0RNQE)J=!^D18#%T0EI-(*!Z3C#_WB0KM+E100-77C"BE)?8*H@^@.LXF#SR(/B.?DV[+E=ZQ&(#O@WKXZX$)2 MB2/H>IIT;H*73AFG(0=.-SLYQT1N^(=;N!MM]N%PJ66?8#;Y)[Z3M`D)"X;* MT00G9R%OP\R!@3A<.JD:1,`A))'#X.'2/EJ@[YBJ\=)U%VF8[$KBI:%)\1E;[#SUFJPHD,,+J(09B;$,%D+3C M`720["*SB8-/?8X1P+UZ?<#MEFQ0H.M?RJDFQ%LJ]M/?!(EM]C%KL1W(-+4, M4TW*?1]RD-/R`*'4;.AL#8#(.Y+D3=@GB>>A```U^_I3BUGK6K2NK4-EZ@/X M!Q]8298[9AB8!/\_[--B$6;`R[X6T5&#,)6H%CKAL M\MAI=M$8[T)OI;K)Z1/3Q2H=QNRX;%1LU!=G2U7F#/_B*]6-V`)P'HA/,_55 MBB`QP!N,NT]<6LN8$->DLIT(*61\W$T\(-8[)#H7:/Y',K^[TAUA>`.^0L;PY[EKLN(#2:9-9N5,HF, M,4O59!RQ6.*7JWQ4-]6%I%4-JLQ3:>,K4V58`-!3#2$S(RNR$!H.C+S!DD;3 M9D\0YJ.@_,^7XT5;APS0'6^>Q?J;A/*7`KWH1N3 M@(TR8W:`*7-$7IMOXIC30%>Z4!VD>G)&Q>7S^)A9E!^49/2%>_(^DY!*U[EMKM1: MRT@P``JA#SMF2_M)HI@AWJP1]LJZMI^ M33TN`AR MG6XR40E/*JL%GC$!?OX_#!)*?IC/X1\'1,Y"9\?K+-3BU9#J_:TT:/B"1^#. M"/,C,E^$49@^T06_/"QE^6*VO*4I39XU6S;`DJIXK9/$99W91Q=17&O5@HP: M/9/RF;@WDF^@][/.!8!$S4DPPI3D5&O0\-0'>#K+#P:3*.AL9(T=5$5+49CS M$^[+UJ\#L?"$@HQ9/]+,69C.5W&Z32AX$*`14246J0@N935>N4@E__7\^GYV>WE^YQG[=)VNIIT9*DJV240U-!L'8,Z2@?$PU]'_\`(*.F*1AO2KJJ-6AHZP-8W5QP#+2+@EI>MY5@W23Q(_ME M_)U8<@13>/F&#-31B[DTXS=T78KK:LI=#YKTHFLNR2GRYFC%*1@# MI<+[C3:A>.`/T[2=+*47`!8R1LG$Y#0:`4@NAM]*.]UQ5`Z[\V%*E"D[H>K<6-RFFX#]GO.EG<9&^Q/H\5O09($499>Q,D=RQDARR&SY'05 MA&OE.*"+CF;TMM.!P\0N?F/&>4O[`-)::9R4S?DX@2%R'4J>N"'(SH8]10I1!4GRIY[2I-''1J)(,6&B2BYD)HL" M0P/2A3X&JT]!Q@<,+-V=QA$_*I)&\Y"FIATL5K)-,L%D<;AEXR<2U8`F`7_Y MR_3^D!J'-2XA.FX@YC]J>?,03'D>HI7"^;O^3^V8?:BRCM`L6;*,8KA M,!;H'5*B,5L#T-.D9%*][8XGE_QS3S@*A4.;GG9`:O'2("ZAI!\0M,P7<1:L M`/D"8K0_%GF6N.<>D28FJVW_Y94@U)P[T#'J2\8HC@(V;,8T"ZBS1$L`FYP* MCS"+.)TQ*S(VQ2?E(<[>W1H+Z'(=S_0PT?"K(:AEUM#0PEX\,5CJ@RPQ#-@_ MW5T4X-U&7UR0-X.,X'1M5[5*U-, M:/A<8\`09#V"M*]SM6KLQY,CH=C-G+F-<3PXYS/GTX^7?/K\_(Y,K\_(W?WL M]+__:W9U=GY[]R_D_'_]>GG_M]>&Z=ZS(_U1/7+Z8KXLF#?P4PD@(JTTI1-! M(K79*ZQTI+4$X:Q&P63WM/8&JZ_'3('`(&$G&$)M/JI%91P<%7B.,HC!8#\$ MBOOK@HRC+EZ6-[/&D3>##&R\`3(`%N)&CO19^"BZ\C1(J7G?FZ%Y*\*KFB.1 M3.\-5F176H%P2B$\V3\A_)%OF]],'2UA$P@:;1[)Q60<`H)I+/;HME(K&VH9 M@[F-6NF!"Y;`MU"WQ=K,\&GOM+HC#8R`[)MN"9A8,/*>Z4_!UW"]77^BZP>: M**`O;=-`?:,-"N"E=G&PWE1MAGE=8E+\23[G'WB";7E/M6"MZ]`FHFMMVV#6 M]_N`.`XC,XYE;9HXKK?!P;',+A*.&ZH!.*Y)3(H_?<.QM*?:.-9T:`O'U;82 M'&O[?3@<7]/B!>VK.%65(M(V#1PWVJ#@6&H7!\=-U68WSMF#;_1_R[K\Z[.[_@-G]'\;- M;ORZM9LD?@X7=/'QY=>4+BZCBS`*HGD8/4[G6?B[*VKG26M%6.SI M^`UPXZN]$R`.VJK-K^&[6,5?4L(90W:-R;[U7[SA<%?PR8C>#\B26&"I4!HP M#H44V+M;.WK@@A-E[2*84;609ERZ0VFD$PHRZ9*1P M-S\C#"$-`Q3!TK!6DGMI6&=XT/)@U#P`>-*W`@`Z.* M1B$XJOA(BH'2L,D#%YP`I&$920XE#0]$EZYIV#%A#B0-]TZ_O=/NX)%EK'B" M'$4ZQ8Y#"Q@8@0(M//0)"X.CW,D+29;F,>%>2Y8%QM\@WNKL44'N8\XKMJ/V M'WH"%,%RH%:1RR@!^`;NAYYZ)SI'#)W:UM!SU_A@AIX0\$'C!QS(P"BB40B. M)CZ28J"AI\D#%YP`##UE)#F4H>=`=.F:=AT3QLSL/=PJXY&KIX[U!P0=NGH4R&AE<9]R>'"4N]JH;&,>$^YE MWIMSP&^+*==X!_'@54,<<>S7!^28>ZZA)AUMR+8QCPKS#Y*5A;=(WNSL<6$^ M[M[R+]/Y/-Z*H^Z9LQ'[YYSR&R_%$?A/#(@TO8RJ;4)6FFY6@*4&-,VM8A!! M,U)@0?N.6.4CAD.0"-3?SN3Z_#?SJ_OK_S M<#H6#\^2H(5-EG8LZVU!%N3PF3A@[&.=SD+T?K$W6NQ&WI<971LCG*U\,X[! MY7&BE:V_2#')PBP@\H"U38JFE9T4_.#*_<26:.Y?G+%&53N:=`1F*V9`]4@B M@Z_8=C.0M;*."'(^C+W;;EA`Y4$W6%5/R8LC8F*`=_7_@-@W#W('0/^XT[HL M7Y?#D?Q5U_.O&QJE3::!V[?SFZH]%N?U_F".X36V0'Q62(O1^2Q[H@DI/O*& MB8:^EC$/!`\)S^1R4EZ-@RCT[3):0ST`)>8U*P]WQWL4S[\[/GA!`GEO@/D9 MJ,T#%)@<-'#C%VTP_QR3SG8`8M"B)Z"/`PX@2N"2(O.PXL02"`LGO"Z`'+D1-(1M.;X(6?ZB5ZO?AWJCWY#RC52AX&*21Z M@GQ#I:;)(H26>AT3T8`4GW*4_35(PGB;DO,H$^/T$\[7U7;!,\LM70497?`S MVO(-S%Z=1@A%CX2_-K!K10Z*1$;:[#-24F2=#1/WY+KH+O#24MX.HSKR&S3I`X%W0'>9 MIB"F47&>3Y55ZJV39D6UNTKW=<+<*LNY!/KXV6\:+:[B($IOZ9R&S]QEOK_+ MG/,@D*E*#46VN/4Q6QB[7TX^(&JDM%/)*B@W)MB<9`:ML9Y8 MVX\YJL&_,>PX7OC!XCX2`,>/]\7H!CXW!I\#U8W'[J270R-HY3NQ"\#--'F+;^<_N,T"5.OR>[_,C\^(WJ\]JQMLL MS5AMSHKRXT"1U*I773^QG&]HWXJFF/PAZC/X@UL\Z6F4-J MZK==#A->QCB-`3"_8C8T5D-CM"OZ."9--ZK(".(I*RS88,L!`/9=H<+)\5]R M*QW@L:]S#S!+6P#&/FP"(#-NF$P>@RC\9WZ_>1RE\2I*&096_W,?_ MG"V+Y8-@=<<^R5^UWK_SQUK?A8]1N`SG09157KMF^N8A3>_IU^PC^QJ_JZ+P M2&XT@_S@;N!$BY%^/:04-;SW@!`WM%.3JL434K,IHFC5*HF79&>7[`U7W\+E M,A7;9&^#73Y^FMW\CLPMR=_G+]>7%Y>GT^KYVGL_LZO+T\OSN+:*-WEMO,:W] MDXQ7Z_/M_>WWQ50EN;YULW)6M<:)X7I?,`.MTA(@&BIDB_<=0_&7)T')T+GM MV`%"0XO@`#_H$M<9,9_3LWY>5O-Q]7&`RYXN><@T6F:TDPU00V6:T1D@!P*N<#^:0'WG?I!7SC`6D2VQ6:3T$;Y-K6]@35V]H`91,"T M>'NV:,1_WZ(9V;*\#&H6Z4BO`)"7 M5`J<,5GOL?-,I33?C=X*=7N6\^3%2B*R83_64Y#26O;RE^8&7('X#L(FA/9R M13#^>X+O(5*6QC(FN#5)3`B<$"%RDB]`OV:H=\IQ^&#W*^M=1AE#(C]GP&[L MI9(SY;BVG!OJJ_QSF]$D5CMPO:6EGK\VS+G(VZ)4"0PST_X;`>B-JF[@+#%:Y`2";G]`[&3/1H6IK'0G!^$5^(YS?&\87A^ M%BAFE3A)7QN*S?G)*8X]RE3"+U!:JK74YJ"BI0.NUGQP1LO2BBT#<[DFV<@[ M\H7_RXX\_\O_/N9>28)L]Q4GX3[KX=Q+%Y:=AFFZ9'I9Y MO'L+5`<.`RME2-(3,$^X!K8YAAWZN$1AHA/JZD&^*%K$DQ-R*4!T'*BQ#-QP MW'@4DD6*2/->`T5FF8`V0-<%'!!&YI$+UC3LV%*G)M[F3_[88_Y(.]Y`(PU8 M]%RJ"IHH-2C`!BC46^;Z($U:D-<2_C%BS3)R=T6;=W%\NBOL+&)Y6P@0SZM" MSBC7]LQ=7*_9ZL:XB@IE?-^W\9=W$D"`N*<$$H1]>V$8`P<&X&!QOV&R+Q)U M\3]X%5CLE`NZH]&[G##;#^8MDH)$"I`5:E+.6"GQS5U>J!OK1L>J#F5FF/D] MZ:*&!8B/:CQ!Z%B1AO%Q<"`.EA^:-GLC4I]FBA7@])5_8UA_1:2'93A=F22RF0GW$Y2K`*HBM1CV3,[J)T[`XS6:32Q#J MU:DV-DB1L=429A*^FC1(.>L/1ATL`8!,HD"T2"H"E^45PQRK^8N#>5//SJMU M#5A(BG$"V;%331HNF!?:^S45K=HII-X*BXHRVVBD:R@'T:LF,]E]X-F=@JI> MD[%#T[T2'E1;2S&OQ<&0Z([GE"[2"_:[5*Z*.Z,/Z@+**-%"O48"B0%&GU`+ M)9TU"#W4\I/R8?Z6ZT.<)/$7_G8KV48+!J5YXSJ_\MQK7_ADQH:$6U!`M7FF ME)1Q;D04XI=">E.]0%C0T?90&G4CH\*-9-KFO$S$2K$#(N6_.W3 M>;Q>QU$Y__4E2)(@*@;8\88?L.#-N!J,(RU[01C445BN0,_DD?'K,H]H+&+` MMYU5+G?@30AOR4&@$.-U0BFGS3%D%GJLHK1SE& M8LZ.GBT%#5K6[]-Y5[LDW)L;S4"PT++2`"8=&YNB>AZ.`$&7:4)JJQ\"VZFA M>HO>BZ=##AS86:6!?L#S)O3O,M/R5-2L8H'19M0ADX,,.NIR[FHVF7\."[:& MN8[56DV+LE1;DKQ9OO?#/U;J,0*KTS3P`A5I57E@C38&,AWM^(!818!H.VFD MVX=TGH3Y6->["^-=@K3;6*(G3,=.)_)#<<3YT"^FRU%LQ=O)!2B.Q60K;W'I M##4-XC1,V:1LZ>594[;8D?&Y"_HDI`:ID7+;1_PZ&+;`[>+!M\A,U4/3ZC@^ MR:^+>2&?B_]Z=V?,7F>K"9 M*U`DH!,2T8R/@8+Y?+O>YG,4"[IAM6:XNT7J#W_ZMY]._OS3GX7H'_[TX5]/ MWO_X9\]I744.G,IMO(')RY>RX(0=!J6#I9_25C^0`M(,:W6LP.N>-ZRA-W9^ M>`Y3%EHNXN0LWCYDR^VJN`U'><0F0*2='S0B6,PS>H6;'W3F0-13*YA\#'C@ M?\C*/>O>T,S<\S*:0?$B(9E25$JR,5'F(+[K;?4#61'?\^?BO-:R17GQI#]K M<WO^-W-].K^^FI_>7LVM/[JGM M`J\[J_O?ZH*5.^C]^^N^:$1;QPH#(7Y M<8<19G2M'%T`Q6`IKB+FDOXM[YPROFJM,\GW2M2\)I]Y*R*:^J!Z5&D:%=+:>O2$%"(< M\/>O'?!=RU%TR/M8CJ8?7ZI/=-/>U@J`LS`R!4['JFJ/W0Y4I7:[CU(EZC1# MU!/R\-)X@\>K*7Q[=(&'J$:$0L>G;47PX2D`Y>,$@WQ^'$#Z>D,-NX!/UIU^.U(68@WR>;;PH.Y(+8^DG:[C2RZ@YX4"(.,GP^E#RL8'<]4>3Z@8 M,/'MQ9RFNZ9W;I-T@J$<@KA2?Z$Y(]. M2/6A+P0S]+6$6"!TM`DE%Y,1:10\.7E)5&NL.[#X3,7=]F%%@Y02<=IH*-H< M&Z8`TPQ]437R!,*FN+V:OW`*.902(-$*SQH))$89?=*"Z^><4A%]Y`D40BJ= M/0BKU/+[F]KCJ'4&9>K7(900+$BH!@50FVM*21G=1D0=_JRTWE0OR.6SSIL= M[):>'D*)C39`;,?!FS<1'G@0&$1$$^,=G<($\0F8253N&'% M^:82\0_B2#`00+14M#P23">JI^((8'09_#L>"690T0C_OAX)A@\[JQ30#W@C M)X&4LA_Z:1HMSN@S7<7BA@"_L)BG-P4AGD[#I'PL MWB:N-"CO0?&%=Q`D2(@'!U";=QI9&?%&QIVCN1N3Q9X`S$-_!8*+"@2]>MW6 M!00!P1\/A/Z&__R(EBY)H"YIDPI*2??$K/LX%#EW5GL2M-"CS!,'0,X&2.PH M*D68%4V+8Y_LR#HT//%'##"3*.AL)1%)'>/_,5RN,=POV?1`\9K)6Y&R&?FV"M.BY7>O`:>`?.(" MJ2-GDV<:;>DMG<>/4H-C<-\C)J>H)%_!0",8@`Q3R!M,!X"$,3=T`%I!%\J/J01-0O M1-4?RU,"WLM,=6OX`1[Z-E+1>'(>/;(*@"8L_9_P?2#Y7F,^K+^GJ=C85K3U MBAO:]X>D':K`N?3='R==[BB.0H]#K#0OHZ(WFPN@70H-7II.'344W3T%"7T( M4KHXC==\RD8<;#WEMXD^4CZ1\_%EWZ38%CC]$B2+67[QROE7FLS#E.\4N61$ M#:,TG/\U6&WI>T5P(\`FQ*"A=])V1)53^I&.#OS5?;%4:(L')""CLGI&+I MA.QLD;^^!1S74#_JD'.89>=%$";"_VF:;M?E=]S0>487]S19HY>=8(-892?` MX+BY`OR+0#+%,TT>8LA<@E-W':8+L_E)^2?)V-\''M'A=,&+Z+8418OG1L.( M\?SPPX(W)23,TS%C`E()R>WD=2*I6#HANX!S_Q9P'$/]J$/.89:0[4\ZI="%PER920IM?%3!TIU9!4NCV^BPYKI+F=`.H8=AQ,C4(^< MSI@>)%!>_R&'HTBNGT+]RFTBU^3BM`K'##T M(35ZTNL?8;!37@>/\%/>JPIWO@T8NGX%+Z,=]H"A%CM?W8#AT&.G\P'#H4;/ M<0<,\R>ZV*[H;"F^UL?F-[_+XOGOQ7>;SK/P.[OEPR/2&()[B9CF/H!@G M7:%]0Z3<@^$/()'T-S,I=?#9*CJY#0R)+>&X*RHY:JLK7!SQ\PW&MH`Z:"(Z$F1A<]T M<1FQ.NN1'P@]35.:I<)?8S$"5:`L.LP*D",6U&/L(@)@UR;P&-75PDO>^IUH M3O;M22Y05`#>I7TPN#1QQ1*@ZNAA4J2+$M8@'R,6P&X0A(6%#KJ4$<)*%W*P MZ/`]L..&G0LV(<1&?20X+-VH1S61'6P1];*3R"G^"0F+);AC34M"85&#/W_$74,1A^[Z26H,# M[=##@![=D*(IJA\L&#'GSTQE98XV+29I/S8G::'L1-%O.6]IH7^0.1'K[SO, M+*:-6_TG1N#60'.:U56O5+OLY6_$PN&&]@,$[PL_(4<\H7:A@0NV"J M)O6/Q<%CZR#YG8JCQ[RZDL(2/^T8T@5_K0`!4B)AOW_X1=_=`K>*!5^Q[I"W M/"%%6P'A!JJ]NMUG&!R;5Q*<(GG\? M)&&+AR-Z(-O7/)0'>!O\AOW-\`_M&,Q_X)Z^@?PIWW^D9,/_YJ.<5*P!Q[DJ M\LAUT84G$7@$=LHWV8T2(J1;ZX;Q1+&E[BU.R3UVL@%Y0->]"E+0#K6W'N[`H/'B+?N.2Z)7'O\.NR2_B9$G#;,MB])B%>4_4J"++."%TO5G%+]27B]&0,`8Z%Z8[QMKG MJXR=Y=OG(;0JFJLPHI<97:MNA<13;#OQ!E`\S/`3_`T'&DY"_$$8'IK-]#\U MAGSFVHA0Y\L>6CS`VX_%;,ED/;8R&N@P6K(GZL!QT;@,85P@0)_NLS^!Y-Y,&[F/8.,+8RQ[.V%A,3YU_W82)$!IU@;:C&]@+M-9N^+&HT?'7 M\VF!UOXK#+"J8>O41`B\GN79KJS%7WCH%S_0EQTLW7&P[/`Z(IEWR[-=_/Q-4:P9K051@9=W)7^\V'++)M M'70X\RLW.?DE?Z/HA*1Q.BAKTJ]R`G0H\DMCFOF7V/;H=995\$8?)7OAUIFJ;;]6YVE\[9MSP+ MG\,%JR=N@PR]OK:UBU59P^V.FZML?Y]ACW="\-IAB@)[,2G_(B\A71W*B4UH ME,)+%1W9C)8BH/81D\.Q!1)ORETKASV((D@E+C='A#U2,2@V`0B39!>KN-&W M4#4<'UY1L#K,&E:]*<'9K+#2$OH,L,22)[,HRM_`H\5[N9=#3(^T[>[WN1[3 M,KZ."P[F(DS$PY]U:%ET,<-P0"SWIE`TN#@*R?'G.R5;0-\"!RZ.CRQT''01 M)SGXQU$1I[&$7,1)+7D1WC6_@4=%G-Q+]_%=9K=ZFN0QE7$Z-J!'8S/UL&.Q MQ")^+#XHGOM6QJE<'(7FV&6<]*#%M\"!B^,C"QT'7<95ULROM^L'FC@JXI1V MW.W$+.UX$=B5W]_?W94[/P?=I%18U>R8Y/\L=TT>4V6GIHC+K4)2-CK<$I3; M<[KYQV_B^U;/R1T<@?-.MR#F)MX"!1YZCRA4'&8%IULK_FN\8FI68?8R])Y` MN>4A=@4V+?N[G4?^&_F_,[#E]TB[>AI^3'9;;YYW#PX\TG=@V#`[;[3T'F3G M3=V#@?;>'&IL\:;8M'39B\`RU(;!O=5CWS+H4>@:9]N@!\'K,(O=O%"?+<73 M=+K-GN(D_"=%7W,VV<$J9-5VQDTMIN\_N"Y`JD7 M$_[INR7[F(3%YR0YSK&\EEMN1_(`6CL=QFP!^'$\<0C M-TFX35(:/=9Y1\]BU;!SCIY$J\.L9J7G.LIX95>I#_@6J(W_WD0L7J)+8M9K MO&?C4**5\WK:]W@EJ9_]CE@?_)I;L'';GT#U`7Z M1FV]7F7\+<,J8=@F.U$B9$DN3#X7_[VG7S/RD0'X]__M?.4ZSV2L\O4-'$Y]!KD[+*6/:>#*;_)?P@3UH,> M8B:S"YB$?J,^-AZ/B/P^S@D7GOD[^UMQ<`S6NYS1/::C"T<-%@-.Q@X7+/R; M8.WT;2ZC+`FC-)R[?(_":,_=H*YIS[<`+_\]?![DM3P>-.XWK(,'?<'C8T(? M^9[>L-1`GH]G8Z^982[CO);4#J-]W:[3J']8<>00QHL2CT>,)+#QXUL4&0'" M1QQ'?!QR-CST=^@I<73,`.)R*+HS=4PO(WD5;08(OS+E4.=I4MFR-$R4MD>*IT@>L."@S`(E?;;F)^/!=QCXE9_0A\R4\J+M1 M0FQ3G[<)V9*046E`@#C:="*WTPDI^!V$$80N[=8ZOE1;XQ.F[8L#QM2,6%*F(MODS`GA M#\GG_+&/K)'TM)XV2FAH>;.7,A!'@Z41F3/]&H+23+.MB35Y6S>(?%';PE`(YV"R>GL^NS\^N[\C+!_W%:*^<`T"CS;EX*!J,4\C*B&@ M#11'X>%%&`71/`Q6-W$:BBDR,!^-HFI>:D2Q^6GT$IVG.HM6?%4K4O'VX_1J M>GUZ3N[^Z_S\WFNVFL&C8RT4>AKV*E5H60P'[I!LCN>_7Z;IEB[>*UG;;M)B M9[4)$@O;5K'85M,,855%('_GB^1_^L(,20=)&*#LQC;2]TUEB';:V6XF<9L& M['I]]ZX?"<4'9!DG/DW>6@/`/%T+AL"X$[1[1\ZV21@]YOM$Q.I<*E_&^R6) M4^78NJOAL6HZ+,P_DK3/C!,D)O`'H6U<'1'!S%G3',-:\Z MLLF*0[X2QX8PUC2!T,,9:BPGO^(L6'7)]IV#,0_"]]PJ.:0\;X.7#H$5@AC/ M`NEUG%'K$EDF9`RP=2%'M)%YYBKP-FQU85%-Q>3R[NY7L?`VNR!W][/3_SZ` MTD4*!0"[-!`R\ZPJ#.&<%GICL^\L3.>K.-TFE!^F*<[2M"*B1A[$2:F\0WIJ M_'4ZL%7;[LI(-C]\%EG&!'`RL$U;T_V M`N2S?T?_#@CQ#L4A/LC'+26W#RG]QY8-#L^?V?^DQN1E:M],5NKV.-0V^8.9 MC#2V`-Q52D_N?OUX=_Z_?CV_OB?G?^4;+3UAHK&OV\P#PJ/%,Y6U-E&(D$'\0HQ,XE\&+C77;KGD^,P]M2:ZIE3-'7!FIH73AA36K!F M2R[8RCHLZ?`'?K*DWJDFAL@@8&#'?;GZ`E'L"RNN3&_%&YKKV7&%_6:\P1LG M++FR>SM>)2QARY5W+\B;>MM$&Q4^#-2YTKPF#T74:!3Z1'77>.C:ZLE3MG7! MG+H?3FBS,V'-F4)20IC\B9]D:72MB2E2)!AHDLL8.:(`SGB5E_$L"5-[0PV& M?IZ$R1\WU9CEF1)*Z39Q?#Q5PMCGQA(-?+*$2LY;E7AW-UB5;^!? M1LLX60>0E]WMI%N\`DHC\08U">`C3-:DV)+PEX4U)I:V'DW5V0)(0 MMPL2VT0&:9$1VT,HNWG+V,(V&J;SU1L3JO_RNK`,6-YQB^91EW[N^7>>+2^C M1?@<+K;!2E/N:=LVDI*B+0IOM7[@)!R5"3,5Y9(3\3&_G6#_P*L23]^W+6Y! MH-#DD52FS1H8S]PF1(58A#.1?S;/JC*_;,K+<"L3$>Z+4!(H4E&P:,(4FP MH--H,:#*=S^-ME*6W=$[#9[Y$5[]0O1DY;&2;\0(FBQ,E;/Q$K*2A=@%A M`:1I4CXA^T>>\-P**6UV=P!:B],0'1(F^X93[`UY<*-(,!5OW_&&)(@61#0E M$N">D*)+/A?_]6XGWQ"@-@X!7<)ZU.'?KRE+H.=I%K(A*56-^^2-&JFFV0B% MJW++B,FC9%:KX MX7_K."K.!:Q>#.@'[7OBM!4>4'#?#"+=E+:#S0'R"#N_]?#"%8UXOBPE24F; M7);GT#9S3DB+=V]DDD'&2SIUS/'+U==,9.X??_[I1Y&W^2=_GRX6XCQTOJ*V M";-@=1N$*5U<1O/5EAMGHZQDR_]F28:FV?U3$F\?G_@AA0'KSMGR*F9MHL7N MQA+^XFQZ'XM90WY!9Y*%K7'0\(:+CAS2<*^8-_PO!(F.BWB^%:NOW"MIE!S4 M;W4\'="-R=X,F>=V2"(,D2S7*,XMYRIY,%[%_'IU%G?3_75(45Q4]DFNFFQR MW=^/&Y1'8&D\'OX;H7XX!_9IX2TZM1Q%W2HTL-L^A"=>&KH+4&_Q:4@&O*H( M)2ERO8U1'W!&F`-[[$5X^E`+3X4EDILB.UND,$9*:Z0P1TI[9+8DW")A)HFP M2;A1<8122NYC4M@E-V^1:WA>O*[(]0%S>)[/?HKSJ<2T`']38YZ$#W3Q<9O] M&N57(A4?YO%9_%J%20D6/---'SDE]9(R]#P0-F`CXLS1B]RXF9/E&QRN'`6D3!Z M9HDR3E+RY2DF3\$S95(T(L%*)+G\ZB$>-<250SY,:!T(X_7#/L\YCS-X0_/& M:GP&F4-"]6PHRG_(7XPNFQ74'G^S[4&Q4CND\9V5R`,3%OJ3E)F[24(^.,J7 MF6?+6Y80V"+O94-W]F(2#@O&W\@J:P. M/'JK[!_OD+X5XE"COT>&*-?7P.3^B9*@V$\];]8IRS@I/N3A;<%LD7"GV8N] M>UA`CET`21:U>JINA*O#)QW^"`'#(;>L$SO6NG'NC7(F&'E/.IS:OJ\3F$4] MAB^.&*Z"5&KYG1*RU[)[M:A5\S-->='_QD`3HOQG(&YY7I2"TVB1GQQD M/L/56JY6:(/D$"*,A7\8001FSA0G(%HF92NQ";PX?LO'(UKM<1)W[D(I:P'R M36IZA$XG>V'`AA&0FN]A*;`Z-6'5B_&86[`:RCPW<,5]&?5\O5G%+Y1*;V71 MM*BF@&:+_G22VT2D3[)GK"+(8H=>E=+72U*2SYW!W4BUW<`$5^B*3=`&_#\7T".@WI*OA\(^> M[L)$0'6V_"U(DB#*TLKI,XK\!A%I)#2]"`JE(5[AI"R#)3-1M0HF^P9\7].7 MH@F)?3G^S`H&+=)9@*?),9UHFU0C0\Y5VC#:[`<_<=;Q$R7/P6I+:_C+GH*, M4"Y=?RLYMO\M6N66(+-9O52ME^$Z7P5\\U`?&&/ M?[JFV5.\B%?QXXLGZ04?VL8$@@=N[!3!^W8;ID\19_B1;@,Z:*1M%+M0`E1<3W=H"C&B!"(WQ!K&P"64\8P@V%F4E?#X]%V MKTB$DOP4=I8KUX6N5NF:>C5PPP1],P+A$ZH1I1`,M&+9,9$5=[80S:,AN)J/ M*&MLG2U)1179Z>+[?DMMI**N.++EYHVM]G@[*+[B;/7!<<5JPP^X3,?R;!#F M?H#F65B:]:.&]YVYVFU!_C(7=8O0+T$87<5IRO(%5HZO-&.*!2G#"'W#V+OL-74N;%-)\CXI!!I,&1X MX#B9)-+9ZH:?5YX>#7BTR;T?>)PDX%FTWQ(\6U83_GU<.8-$EY@M5<@2-E@% M'GLLO4;D%-PRD&E0A17^S:+JAGXV7*\-P/G9J=6#_SQBIRW8Y*SM!EDIEX&J M%!SW%_CXKZ%U<0"7`;R:$?#_]A=1SL11]6TS5LC41K.\RZH'V;U6%L`*HD%X M@%M`08VZF"CJX@,R&3X49+!C@4]U_K`T`)5VP]#`42DHE/.R\_SK_(DA3;IZ M"V@N+_$DS3&YK/0&M72360'SLBV4?B'6=:M/&*;^HN5W'+ M!!(%BUIB2L8,#2NG,S]TAQFL>,\C\BNH(*(,6+3UPAEV,M`V@GV%K,M8# M9A_V4\VO((A!BX$^\$)-\E?T,5C=T8PYR\/151C1RXRNI2LNIK;5]*YNVY\: M)C\0$KO&A($+2LF)>$+VC\AG_I"(ISZ\LV7LWMBJ%V0$4,DTT`\&#Q[PU2^9 M:AMJ((_W_J'6`WRP0U\\E8M)8.[/:XGZOM3BV_Q6JE1`CVS'&'%2DJHM=<&+ MF'H[9L3H"\[.F,'=TMTP<:_:H:UKIPF%]UA;,G7V\0-AJ=X.U[F4!-3B@8>8 MKO>B%M*R#M?A^5ZRZPB$C3Y8KAPO>O\EUB1V7<,:FN4-$>"L\P`#SPK])D!+ MQ297M8-Y"7OB5:#6]F8,_]VEL)8)-'$]*$K^LK&-PKE`;7K"KX#]_KC@HYTMZ@X?W!FB,`L? MC6?TJ5O5,VF[%0;05;917]Y2_3^\O9M5^'YFDZKHE@0P\W MP-MLW4+N,%!PE"BE9JQAD:?(\E//3JCK@0Q37K3&!NYP5RR@[^]%FWX-I?/= MFF;5H"9MUA_*&NL(84VNW0!@F=`DWR%8N=;W,___YY70)L@_*$[[_/8I7BUH\AT)R((NPRADAM+MFN]=6L<1 M?2%!QAXMM]DVH6019/3;]+OOR=UV_E3>?+L.Q*%'J^V"DB"_`)[]G=\`7_&9 MGX?$'L?)@M\%3[Z$V9/P@S5WY/[HM_D6"5QD(_^V(97Q%E7^HY MY#MZTL(D/][35?L%US0=1`M3DA*Y^QKL'^P=MMH]]?. MVP<:B!,YV.,HCIH?G_!OS$_:>$G"8$%BYG!"EC3@/TTJ3ON=/P4\\M(D3+-P M[L4=%KT(K<])G2CM-"M=%CUVRW`*R$ZRYIHL56^.'IEDWN!GK885N^A4$VYG ML?(QX<_]P[ZTN[4:;&:]0R6W67--=F]WAR=%3)O\+-[PXH=&6K"[>Q>/B9G7G)#VMU: M;F@`HF-&54S/C`$A-41V;]GK#J\RNZ]+3"T.**WW0YI56N^&-2=IO6;`=5IO M&>L!-9;6/U5A=G2`LDGK'0'E,JU?!VMZ%J^#,`(D]79C34JO-D;G0]L3_'1> MLV%'@8IH.Y7SA^1S_MC#66=))VO9H`2%C@E[(3T/!@+1$`F\8:TKH,KD'7$4 M\9S-9VXW09*%_+3BY&VR^FVR>NPX8%5DV4<"IY/8LTAS?9>IK28;5MJBQ[&6 M'_BYL&K"+G+M)=N9D#WS:7N4L7NU^%>A00?^G8P>^X.`!_^<%*VECBCBZ8\_ M.WX864516R`Y&:3NM;LX:$1KK"N:/M07^]G_E;7%6PWU5D.-QWV;605K[KN< M3]"^P&)JJZF?4%]0,/F!7S]9O,RBE&S73YZ]G6#L7BWX0>^UJ&3TT!\$/,[K M)ZL77#2RK?KI.&%D53_9`LE)_=3QG9=N]9/5FR\:V;?ZZ:U^\H_[-O63-?=Q MZZUEUY]"`,H&([Q420-)WT4-V/.07/-S3):;X]<\D[4TSGS6%&0[/E6/6J6 M;#GM^)VB>]JQ9RM..R8U%YJ\2+^^\VS=,S*BZ>0:/!H37$[J/J/! M'D#C59N`UCJ'UNZJ^%KR6-,@Y5,N/&4$_&IXD@I0/@1IZ,5L"3(2]<46$A9Q M2B6M!?1*R&BM#Q0_**`HL):>['%WA(#35AE8@$.N$?@\=1HG+WQZ\#Q\?,HH MC=1+GI#V]1I!UQZ#.&9_4&H$K1DC7S32D_U3<=D7*9_[M(8%ZO8F4BR7C@;8G)%Z M@QZ/FU:L6%(7;E&D>.PO0^0=KB.(#B(:=M3$M.08$E0#Q.&VO>X`DT7A8X>8 M30CN"#*7`5C["H6AJ3KPHNZ!-WB!'G`M7I]0";98X-FN=U/'ZM`/>G5"(:+% M_!"@&2"@6KTYH19]%1"R"9Z6('(9-._H,T.%1=VJ$%`'T)8`-B,4'J$'T[8= M*T8TQ5NLV#7PEQNJSMN`G$UH[@$Z MIV$Z_&H5I&7--2&ZWAR=.S)O\,-SPXH=5VK";9[DCSUFB;3#M1S10$3'CZJ8 MGAT#@FJ(<-RRUQU@TE!\Y!"S"L+=0(8;@&_I/'Z,Q'LBL^59\>K$[H+Y+.1G M0_"=^L7]\K*@W%%%-5!;J^C/LXY>(P1T>\L&#MHJG%0$^%IX^<9,RK=BS/=" MQ8%UQ;LS'E"U*])BC)Z7$=I258/D_J/>2<;IX@,N`WAFZL0!'[8EC4("?5X; ME`;8^:^V(?8R3;?\E43M+#M4II[A3#(8Y(;YA9+#C*:,E#5HF+1>KRK;^#:S M"L9#DX)6,&HP3B_;HMCXZ'.42P!&>R(QSQ:O&XNF^(^*QD$BO/8H%:@,(,*C MGHX!]ZK@6@(Y7C\5. M$;XK&G$CO-B7_C%(Z>(T7F]HE.9W128)@X0X%.7CR[X)&T7PCZ9?@F0QVXBK MA,^_;L*$+BXCYG.4AG/E*VE.#55SB2-#_4.`TU\`(6NY\L\08-R8G>1OZ0DA M4E5,*IK)QQ=2;5=H)T(]*?23P@#96?#F?3^WG(J'0Z\L;#HQV(BUKRM6.*DQ MW'DZ1MS@U,!YS=2-:^COI[IS],'.&J ML8E?N-/#,#:C3@\K3")/$!]>[/!R_5CGZSAQ!+R&O-P%"7\'P8<>)]PN(H\: M*?Q82%8YY]U2LL[1D0(%/V"Y?'3<"\I^Q`*GB\KCQ@*O%I9W3HZYM-S9"#T-?VS)S=_;CSE_VC4*H\Y?6SB#/ M8+Z.:.CE@G.W;^%;9.RQZ'P(@^W7&._#'-JY7H7UC#0=:AM88P5Z$5AL:?&];^`AZL0*O\+N/I<&#C"M6<]IW!GD2'\19U!EAI$GC\^K%CAY8JSVM,QX@9XM?FQ"`K^ M#G\/.2ZX76<>+3+XL<8L=\V[%6:UFZ,$!C9T+!X<]]KR^-QWNJX\'O>]6E,N M7!QS1;FC"YCKR=8NC#^7V/%7\V`MV=YSQ].'M@ZAK2.7`\K7MHKU2GR8,$\1`PA0,.]PQ@V@ZR9XA]`R:0X++YL17@S4K0C^X8^!"D+ M?,1=^TX:"LSB3?IZ@TF[P0PHT0.-]@>GN("3_0)/+,B13?[TA%?^KP23AB+; M!2J1BEF`(:L"%#K(!MI%@.:'-C1)ROSC%5]*@A*E?!3+AZOK(/F=9JQE.!=C M5Y**#23!9K,*F0CK)]XJX!E<;)-F&A+ZCZTXG2L?ZG*UFR#9:4Q%W`YW<7O# MW/1B..R4$?J2S0DC!BN-6"?;ED45$6A))$3<4KSBE>-2*+?4@\Y<@;$$8HT\ M)U85!W!2M=$#IA,/2'`J#8.Y84N=TF`_\"E+'/X#L[_GE"[XG(&8`24+EE^. M%8G=BQUK++HO-LL]6VP7EQ5$#\;[7+=U!W;E>L0>UXSJ%SQ/!RI-J2WU5DK=T M0<6J#TYJD,*`-=F$G+SBX(^\)$*M0TWXE_2^`?1BIX()ZVZAXF;)5VVJ$VQX MK7#/8FO&?R_-*)"%X15-4Q*S!LF7,,TEPH@/3OV,M-8`LRT6P!!S51H(W?AK M;FH[W1#&3]I=+NE<8"D[FGADFX;A<'&0=(N[1J=?PU2=;R6-VJFVU@@+U1++ M:`FVKAL$X:I(F5;+BV\_\T]]N/)6W6'"$CFL\`$\D7&5?5G,5]L-H:P>C-E$"N;(4.X;AT[D.VTVT"W$&I!-__< M._`V^D\#7VE/J^&;-]VBAU[?,B"VY$@Q"+$03'B,,Q=Q,DMS<)$ M[,J9+:_"B,Z6IPE=A%G]/GME!`1K4`9'@`9DCH!]Q@ZI$,,V;#+K:]*,29"] M")DM"1?B_\W%R.=PG&FH:@M6-7<-6K2T=I#Q+M/&#`74-$O23-O^`?" M8&0&.,QYE]$S33/NP$K@-[VCR7,XI^E]$D1I,.>?S2(*S'^=M"ESH:4VY"C1 MZ;M@YTA;)VPBAIWN9NPHIAI%N<-6$E#[X5P<7*ZVZ0'-` MA'*?@NW=<48N26I^HQ<>@CPEV,A9_?Y+C)C56]IZ9?6*MA&"4.N[C)'5JTY@ M!YZ][JYAAVDXZ+#3AFO/L*/"?[^@L]/:-^AX0B@_LGK='6?DZI'5W^AE1I"G M!'.8U>^#AY7F=4M9*V46+EHA!X.:;>RL62JW(6PNTUI>$1][QZQZSVD8(^MB M-0]$:QV^'6+!?<#?F['&A6SA[1B081$C8=AP&=/B4Q90MZLLB+).4XY0!>I( M:%2`30R@Q^CQTVS7BD(F=4UNW<=D+W$PDQA@?.E8:8=1#5T-BK1,]@WG`^0& MB`>8F)=DE#?4F_M_5-P/G]SNF8:>Z4VBPC;!U50,0WV)UP,EN;IE!,I7%<(I M+Z0.C?0RK-G37HU8:]I75'4@_KBX'RWI-7W`Y8!5XGMC`4[Z0^/!""D0O/@$ M56"=_IS-B$,]'BKU=5Q(,JJS(+S'T]E@?'4@N_6:D$E1%YJ/AO/Q4EWG]1V` MPC?4V_?_J+AWE-SHXB).IO-YPOYU%08/X2K,0JI_S],@(TUA2AE$-AO\PDQ4 M:E-0GJHT5(A)%V)K<]&(5%KYQ$,3&A34@X%(SC6%K(I>(V+/U0E0!HL]0;C/ M#V$.0W'^7P'#U6N`(3#HXP`1\X@'C15WQS\9C/9%XX=O)K=TPWX!YD^:'TNY MCK?Y498I`*;^'#&"CU/`.1)X.$4]6^*,/F2749HE`F?76]4P6M>N6FK(V_7G ME4SK]_C)]_6-#P!YY=^3]$FGWWX_MW/[T7 MB99]]/?SB/G]B#M2;?DD88$5- M'J/P)']*BL=D]YSD#<:E![B_8]L^:5#%)+9GC&-,;=-WCT&PZ7TU[FR;I5D0 M\:-H"T+_9`/'9YH\Q+K,[]9/-:!=VIVK^(72QE&]\;[MN'1P]N7;/!H` MAPT*.K.XYZ[3+]4S6RZ#]$&`H7`R3YETE:7E)\W<67Z;4S[50!-^T\7+=;"6 M'8,(:5ITA[XI2FS3>=$O5QHLF,.*5'!2_93PC[TX%0_4J2U"`R#09*1,I$TJ M$&"&8P5+R\61Z=/'A`I6-SV4'K?76;[!'PMY%%)9^XO#-!NS9OK!M%"19ZC1,*H^)>$Z*!I[LUK##@B21PB'4SJ@:65EJM4%>CR6/ MTV`39L&*5<7K;13.\[=P+Z.Y>@\A3**Z#&*2Z#^;"?,)86G$:,@PJVF0GQ3/ M2;T!OP3C>T\X9(.!N$,GR68T]9*-N9DTBNJV0`E M[MR'4M(!Y)O4\PB>;I(`U#`"5$5">`.KK$<'A.L@^>+^2]PI7TCE`/FB(>>, MD%+_W.6+IKEN)*QKT5"0OP-Q(!24`P5$01W&(`2LR<,(.`H\\?=H@:TBX%3L MX6(/7R,H.^6%OK#$V0,&LN1B3QC8,`8V/[Q%446/#@G8]N8R5Y6W%6![1-*V M58RR^T,125]CA=T%F+TK;-07"!06+^A#L@V2%RY@76:KA0&UMDS8&0_5GKJK MNJ4VNQ%1HDJ3.KSA6FL?"\J]/? MP-NI;,>#K],"7F)NP"I>81T-P]IZ_@W8G:HH1&`/44_]/UM1POU1>Y:MK2R@ MFI+(.B.QTD]WM93,9#?:MC5I.,L;YWSU[-Q.:P2!*&L"((2O+1TPNHZ*W\&* M*+EE)"#O2JC7CMI.!106;IV63VUK`U9/T5TJ)S1$#UDW:<^( MM)6UJ)M03\RS]7.@K&-Q*"18TT1%5,\.PK.&CA5108<^0G78T704X-H53/U* M?JN#'2UT@=+-ZT1QKP*J+XX'*:#VUD8HH.K&L1`-+*!>*:+[%%"]$3U4`77_ MA6&SVU*>3AQ81K7%G=)8Y:W;C"2QVIW`+65F!I\M"9*:EQ/'0WYZ=>.90[%UEX8'9>:K4,#EQM2>TC(AI2<[UVF'>MO!!A M/EC]]10F?>HOA3BT_FJ)N^6VPEO']5?;:@\^-Y69V/S3@;%9!2@XF_60!'.Y MH<:"R^.">MCZ2V8<#]WU^NO50[E[_84&9O?U5]/@T/67S#XBHLWUUQO,.]=? M>#`?M/X*:?;4KP23:["IPIH:W)-<[O,`M5C+<$]Z-_29^+V3.3R:*V!FQW0M M5JVH7M=DR?:Q`3]\G2:QCXK\PZ_6'."[7\V&B/!A*K>&S3&*-XD+N#`_SA+. M!?9[%7*8V!]T.;-?.:?68+.H.6QV4_L\P-(F9CDGT6Z*";V^YY_4AX,?9/$(>^'A)5G'T2()H0=*G.,G>L5RTSJ\*].,\<O:3TAY7/"&_C!,DCOMU@&ATR38QK)-L=L<(9V07&%S!]I1)?A/.0G M3_,/4U;`7-`@VR;[G=(Q"[*RH3V:4O75QYV48E]RVN.;(9>"]FK(86>ZLL/7)4']28>KG4WLO;G2ZTF[:U<>]/KH?+0;JK"6-HB M.N6:DGQ*XRQ,Y_P*)K*,$_*P9^%\S\)E+GI2H:&HCT\8'-[8",360?#1Q?7? M7=QP,;&"XY5S2K(Q:]ZUP5K0D@U0`[(,GN-$3,"DFX0&"][O07XI^5.\6E#. MW.P+I9&XBGPOR5ND[!F_@#DG=,8&P7RLR]L]!ZNM&`'S/U(ZWR9A%M*4)'1. MPV?6<+MA[-\'@N_Y7HV4C9V9!L)G'A8+UJ@=*+C*>26WYY>GYS>F9T\!_S<) MHW?,ZKMU'-$7PC[B+LSC]3K,1&FP8,6M?W>I^Q18M)-/_@66,><"+IEG*=,M M78#4-VJ,^)N-4`;YX'!6 M8<%,3:E@C8'B8\8^]L`3YFD[M44P``2:/)*)M.D"`LQXK"BONP?QHM[8P(RR ML1-NU#UQPXZ=#7M^%*(RAN2//.5(HX.-+)$"PL237,C,%`6`AN-*GLX6>[^T M$SB&U@VV*%NCT,7@"PY?U$;,A%')3HH'I,(31(OMO,LO;HZ5;]982E:W60!%NV_8&3I M)<*&";A%PX(/5-'D]O\.UIM_/R/EHQ/"'GK"K4Y0B?MTH6S1`JBBL33A'TR= M7,]M8QL'LGS6[@VTYI<;\4J M,5^4_OBR__<]T$5/D35%BA*2W ME/.8?7X:1V(E;1NL[FFR_F"W-W5#DS!>G$<+\Q:,L;X+8+)P%,\F%;%RARB- M%GQS:?ZKGI`OA382Y.I(4NKC^T]+A605+CW983+"+ZF9&!V3/*IIU^%]DDSI MCO/#'&Q$_,D^(MYE09+Y&1-_\C8F_B2-B0_T,8Q$S'N+C`<<&7]ZBXS*'\:3 M4P2JIW)L>14[6Y[_8QMF+_LFJGG/[HJT9P[`%#G8D6SS#5R<4`"T;[MM&:2V M?9Y!1>R$Y((\&.>BE9:>G"C2`XR&[<\=@-V,<_8*35NE!R2)"'X?S?'QHSD^ MYJ[^_8\V+`)N]G?C);!F0K8[N\DSEN0>-_$#ZZA?V=#U>(&?+J:!-.B MHN+`_E(C)<0!WMP!N^$B,_(=`]4!2O4=8'%@`-GDYYB=B%=]XXBDO.L(98J> M@]5;@FS"Q*L4V7$K@F)/VP4CF)@95N]=4S2I[E%K->F_R4=A%6'/65NS8:-. M4V#"/R@.9/1CM4';3S'D=Y7MJ&DT;>R<<=_G+@Z$D9FPZWX>72L`\.T`SDXH MT.^LLL(!SM$E3:4N#B*1V;"$PH>CB@7ZLRSL4##F.1/\M0E1DYZN@C2=+<70 M1+,9SMB^^:N;@_G@.AH M#]RGC]K]*]JV#?(HVB*=FZSQ`X5Q0NN;CZ)UG@KA:JL"$ M6ML@]4)(&R(AGF%MC338@FR2U*J8[)^3/<6*A.05P8"(D&RDM$!2DW)Z8=GF M2BL$#OEN:A+2],*"@0")UCNJ&@FD]U2-/F&]JZHS!'E?52T_R1^2"\\)!P&` MY.U5*&I:=:!:4O86*QQJ@]:"FR!EY2]C4EI$6?$2;#$>%4+)>(^G.J M33+JA@T:R!JBL$#M`0X)I/K-')"(3?+/BO'/U+-LH>G)%@>,O=ZD0%N@S0`` M0@8\-B>(%@K(5Q\UC\01CW`.P*E803KN)M<(.-R&-YSP__4#F;4?O'U$3;L[ MFNB[$@=0MXZ?D7766/-.^BBK;:N==\*-M5H_7,P[V41J/<<7^Q3XL/V+_P]]8 M9)_\_U!+`P04````"`#N@6Q%J*A4#HPS``#,J0,`%0`<`&9L>'0M,C`Q-#`Y M,S!?<')E+GAM;%54"0`#\,UC5/#-8U1U>`L``00E#@``!#D!``#M?5MSW#B2 M[ON)V/_@];X>7^2>F6YW3.^&+%F].D=V*23US.[3!%5$2=QF$36\R%;_^@7( MNI`@$DA<6"1*]3+C5B$SD8DOD[@D$G_]C^_+]-43R8N$9K^\/GG[_O4KDLUI MG&0/O[RNBC=1,4^2UZ^*,LKB**49^>7U,RE>_\>__\O_^>N_OGESEI.H)/&K M^^=7O]+%XM7M(TE3\OQ_7UW3;R1O?KB\N;Q]=1;E]S1[\X;3I4GV^\_\?^ZC M@KQB'?U8EJN?W[W[]NW;V^_W>?J6Y@_O/KQ__\.[3>O7Z^;\U[C< M$K0;__E=\V.[::)@G61_=>7J]OY(UE&N\:)OO&;5K^+Y.>B_N,5G4=E/9):2[X"6_#_>K-I M]H;_Z)WCEU(8^L.<%)7\?-H;M^!AMC9`O8&>T,)>_X;8M0L%+:*5?2R2^+.+6#P\.6M#YPMY#&VKG3MP7)_9]J(E=NY`YN$CF MPS]8L',)E#XLX&``']ZP8I"FD8MG;CEXZ(Q+-[QTH'3I0>FE"YG38&0^O**@ MU"4Z40^?<(,XNN#2`P^.2!SIW-=P,ZXLGWDF3Q#IYWRG(_.T#?7H7D^0=5YG_H];]S?N3]?;$O[$__>.4]23F MO;E(HP=!2_#WM3:2W[N];H_^:=[5(,JW$U;VS][0=W=9UBW>K:*<\7LS?TQV M&Q.+G"YM1H3J%;QN]?_5SZ_0,EZ5])6$-\UCDO_R^L/>!O>LRKF]+I)B'J7_ M3:+\P-!T]&+)"7Y&>O!`\V?)1!0M&H!0-HJO.'7*^LZ M^%()ZZ'_N.>AOR$/">]=5GZ-EC+W5S7K#;[8+-315ZKK9_A%$>OQ_].>Q_^, M=3J/TDLV_?[^_PGL_$"['@)Z[4*%@%IA/QCHR5B#X,_[!@%=+FEV6]+Y[[>/ MS*#%K"KKL^LDDRT%\$1]>"B)@L4*WA2>@*,4N$;1R?N]SR5W\]H+]I="@AU- M2\E\LM/AQY'@T,QQ<8"0M`4AT6D;.BA@Q?W"HB-G#8R? M]@Z,.\96@87VSY+A;WX.=\0EZOD:Y(;UY@.PW8)])]V#'7Q[-HW];D8YKP\P%.K7NC,>!>D< M=0R`E2]16>7,]R6;<]CF"JQTFX>)%87*/K#29;_;H-LK5MK?VD54W-?=,PX(90TP9&YRAZ56U\/M[UZPM9WI,&H-Y(R MSJ#`!QM)Y#WU*8MX(*+ZBBO;RHX'^FT'.TJ;9?*^H]HJ#M%:;4?'N=K^P`D: MI"R`@=`O59&UEPK*2/NMK*,>WCF/9Q M3/LXIGTTJ'(" MY"TY\1!@:LAC=/S:Z6R?$64E%YX;1:>N]-HJ#@);;4?'N57J"J2LC]25%N]00NHQ=<6M7HG' MO)6]7B3:Y_R7+T^_1"4_5117M7?,\I^8[-^AR;`)K3@SQM%.^8*5BQGPEZX, MI?@[51[+:^OGK;PY;EU4[[(H*OY*G&2[7]VH[;:21OXF"!WFTA6HKAG8U='W MG34FIFC=9$[3X[O]_$OY.>TX8,;N@N8WI$SR>K-OMF!N06:+,^:%20E/^>PX M@"..X#`A,`"K<2>;:)$B+,9-A0T.H\OLB10E[TA:*U'437.+*BVCK+0*?%@&(-#T#`+#EJ%%G."DE[5-_ACN2PITXHYQ M<$21A(4ICCHL#@-)L%6&P%)'VB:1=@0TH;^#6`;&2`KV:V=HD4%0U/NF>:U" MU.T"E%D/MX*Q,(6L>D6_I>.-S#/LLY4/Z60R2\_)?>C-5\1C0\AW"AZ]S-@^^)GG]/L=%E.1?HOQW4OXM2BNI-V/:M_U: MW7[TDRC=&%)SM8$#*4#2UOG5$C9+$IY-'.#=OAKPCS1E2A2?_UDEY3,_?]/D M@.*(Q+0U#='HB$-J)9]2X),ZU6*`640GA_/#V`K8TGV<$W3 MA!]':?"J)Y!?^Y(2C'=CCG4H3M*J3)[(+9GSV\6L8Y^_S].*#>(%P_(97:ZJ M9K!GB\]1GC$%BDWD.EURE2`+^>0M&M,/[]'C`P)%=%B+JB\U2#K6N6?GIT.M M2W4!?N[.HH+G/_+_X['W*4KKY/KR+,KS9Z:N;'9E12O>>,#1!H9Q&XLX81@I M,.AJ"WPZ>IDQW>OWF)J):9GPJ_P5WS!@GEE/&G9-5`L^.T:2M:`IH\"0[&PK M)UC;2$?DP_T0I@/\2FG\+4G3R^6*+;;JT@6T@$"N;BP`&6H<&%A1.CL!$I+0 M>D@A>&"1F-FB6E9I5)+8`FL(>B7\E/1!(Q)O&8\@50K=O5-I!EL6A^_I^,#] M2MCG@2W!B0*MXUN8Z>ZV?"OT5Y/*MW%(I951;,(#$S M9;,'`:%[*#FB$_B7$YJO#&QI-Y?RWSG,PVUA;D,HHLZ5)H?'A%3P(!SI!(W" M9KN+*KU*%M`7UH04;90VZ>B1PFC8J9-E@#"`Z4$[(.`D!WU.<\-CFZ*<8^]W M<>VQ^WU<'91%+20M9'J,G@D,6YUBE(%J%6RX==8\;2ZA3A"_1-^39;54CKVT MC3#Z0IMIC'^_]`=&)14&=H4^`$ZVCT&,C@,6J+4XD+41<=!M,WD<*%0RQ$&7 MD]=X,$82I/F2'#7A`.>G4)8DNA^X:4=;OE=?#6Z,H'F)UX%H"?'B$:-FNJZ. MF:[[55N>YE5W\%E7(LB(%I6EUZ,=/0#XR-)36V2`++V>P.WER3!/J_B]/J92 M7-L(B4T$2:]4MHHD-"3B]7<#H%+.2,\@^4&=F):-`QZ22L">EBHP^)E9P0F! M6E$;$(:99<)OP=6YUO6LD#^>$*6M[-1&6VB[UH16W*_%T0:&2QN+.*$3*3#H M[=E-=B";B(BKEY>=)L:)%E,X65S1[J'>6-JKS6XG,='(; MX":]`TH2?&0028%YT?#6=O*S0;JW]L2/@>Y@\.)[&>.-]2=-<]$IP.:A(1NG MMQL\01EKC/T8),*NDG]62A=ESFS'UG3\@Z'>(G/@A+J> MHN$4&(K=K37`%1.-^"W2`YW'WN513)AVL_*1Y)NWRW=OHRG1;40KX!E)&QB" M;2SBA%FDP*`O;?]6D-GBUNX7&5-?6%2V5U>'"O(BNU]9C?;?`KY:?<85)SH:@?/X:+557 MX%1->WF.LJ8C+GI7%5O6\[>L'W)"FK)\W1Y*WTRTIN\M@M'TH[N:*F_@IY-WY<(1YZ4+16AN\KIZO@P$L&IW&<-+8]BU9)&:4W45*7 M,%J?MK(@FE?UI1+"AKJ\>\QI]?"XJ7W>G-*R6?3M(\W+.Y(OZQ>B[VC]9A@O M)Y!+REGM7W#[;84]"1[=]750HR,.A.*U!TF7MW7W]]35D9+0`0_M/H&Q+D#+ ME=S8Z93](7H@NS:=1S%DON>)9=NKG%D&XR]^C6?I"H+["&5OD]!FE#@+*+.,&&X:%[ M@=1P^_6"31?\Y86,4=BD>>)LO8^.>K040R*6-%&2A(15`^7MT:@6LEW(A;J. MJ\]FKJ-GGI!Q5N5\=`"H*5J*S]_(6H8$++VJ]GB2\K:]X:@"T>@F!LLO(G)B M4/;ME5R4,\:D-G#_#<5\N.0&.PN"O*TKBHR=J\4/HQDFEERS.R9,D:NE:BK> MMY4V#05!"$7MX"-G'&J:WV#E[:>+#,/*N!HX]$O@!A\^E"F/ZL::$#*99$9E M=%!$$9/,19D,52#9\`XUE+1G??55F/6_"V75>2258OHMI9HGS@Y/G%R?.+D^,3)\8D3>QP,^,2)2];R.D'[C"Z759;, M:VUX#3?I2!M0M'..=13CH\#X5@VU,0:$&*ST;5:Q3NK4[^+P2FT%XZT,)_)& MD@)Y[49A0@FEL@_T0((P#X5N`3/JA>?C;>?]JCW+'Z(L^:,>RLZ3$*=9W$9D MJPIZ?#$Y_I^J*&O[\]N!<\H&)25?2";^Y>L)%-GDA&"NE=>$W3-D#!IB\#B3A+C0$YL&?;A?';B5PH MW_1TENUN4LP6[9,&9@6Z7-+LMNS/G%U8R(",9O&R`&YGV3&!C^YQV&^D[&S) MO/QT2=G7I)G::R=X0'MPEM9K?_`>8&JS/<,=T;V@T[S;JLP6_$/&5Y]\FKJ7`WE#&XX%?7TW;>^]3<(%S@GK]#Q1!719D]Z=G':3%X-A MA65&@FNW1T'GRNRF6-*X]\ M;.">D0=^FVT*@"^X>H0I^/D[-T>5%(_U,W'UETA2=!/@:NA<%?A,;CN@` MFFX:USF;EA.TGD84'T3\3Y+&;/W!#`8E.IC0PJ]FJFA?C$/8V'(DIT!VU?9: M_D2NA^Z*>M:[2J=9_/LR[9%AR:QFJA-Q'=JF6KGM+HO%U6Z>00%\!8,2?^Q107)B_$%`\N- M!'UU#\-^(V]S^GM.-J?`6Z.L\UTU*1KF#'K)I'@&$S)3_U$DM(%@4JUI9*2C M1PH+"%`G^P!Q`-^/;E8N1K[Q[MC$5DJ@DO*$(6,Z-'*GDQPT%&R-$GU\8U9, MV@ES`B;5CS]><)5$]TF:2)[-L"'%@+9'>HBX5=MG>.CVY`=]3*;U3N7[+XY< M3`/QY%YF&3@LV[R\,E"0!EY6"?,US;ZVYVL=UN\ZHV$.T&F!W:,[."BK+3,P M>'O";:N?312N=4[>;LJOKJIG2JX%+T1^0B3WV9Q^^< M9DR:R3Q#0J/%;X?FX$`+6V1@I'8$&Z=/3AVT9B,3(+1@&8S]EL MSN::0-!P``GU8#,@8)CWJE,)SJ`WUNL6RJ+6V*&":3@G)"XNV)"V[FLJ,OX0 M%/V#:9CB0."+M\H@>%6*#WKSLZW9-FUPLQD$11B^6,5Q8&`%6^5 M06"J%&]\HCFM?9FV;LAY`(9$`=*#G0<8V&5PF(+S@`/;/VSJC7K8/T0PPFV( M*1D%8#YGLSF;:[H!`0,2_?ZAWF9FX4'1*\3^H;0WUHN&2>P?KJ/@'3V=LZ5Z M3IC*<<6U(\KS-C2=N&C0TQT(H$TM-`B.$9T(_%LGTW#%)IW/URDO_)K%?`=J MM813=\P9("`-,3A@;*-LMC>00[T)_-Y&3]5+9LSL@:^PS,(U1*?#=I_N4"&M ML=!^D-SO1.!)/X!]S$M!VS/"S;4-RCA/!_/6E0,'*Z=MYB;&)05]]MO_[FFP MP+"^Q#O(<)OTQK90QR2VP#L(AN->OTT_I+7;'`@H59H/@CM!8-!'V'A+.']O MG;^SAX18.YL-!6=T;X+>T_K*Y@-,T=V<.XNWIP*7)5EJIY:F]+V7>]'T'I\0 MW!T$WSXR?-]6]\4\3^[90%?E;UE2%!6)UW^LGQAK77@YKW+^-`[)$QH+-AF$ M=^=90F^\QP\:QKBAPQH8"B/8?NZ>.O36OY$R;.!'=))\79YY4[YJ5I4%6W3' MK-,R7T"2",_DJ$D"1JZ9.;P!4BMVMP[PB99NS4.S<3>&>$>LGJ-S!O`TSQY5GE[7>?D]K:.G"A*FM87Q`U4!V MT`G9+6^$<"EK(D"PVR1LM"G4]0FLKIB@MYVW3S//%GSO\2*EWW2[;QB2'L94 M)*,IS_O"!IS_'\]`>8I2?F+9[(2(9UJ`,6Q8",8Q8S&Z@Z*&GWJQ$."SJAZT MW=1,"&C5-AD$K3V1MGL)JQKV MG[/1$XP&A^H_H)G.BP9KSRI[A:MQB3F5S!W387&N[>,X0C;R_6?G MA#M0^$M4PPR44OY!Y,)Y&BCG9$?'@<(D+7I<'88P4)8)&J[C@Q=K_)KDI!;M MU6J5U@:)THU!+K,%S9<-*#3K=S-J<2F/I0X.M'9V<80L6FCHQ9OIDMQ%W_GA M4B*F,&E:]6M_=EN-#S1#X%"LRA"V3P=T0+0;)\YU/EL\VC$,XO%X'RVWZ0WGVTW"0=-"M5L0=-EN=G4 M?AOF0UW"XS>HM^A0-+U;44J:<`!EHKPMPC0R@K[EO'["0_ITAWIZ94#9JU6+ MH`P'@N:&L`4B2E+099,;75"+9-3J>`K+8E4I(&6]G\D4]0$,WEN.F,`<7H`X MW*$!5QX3-IIZL\?2ACVF0<^9S\F*%@G3M]:-G_PIOTRZYKV\?*AY`!A"ZFH, M(YAOT/M&%TF6E.0J>>)G^=UJ7O!Z#$]#SF%\IC;\E M:0H@2OQ9P,[NYP!0`NABC(<=GZ"?V@;+7<+Q!4/2?^Y#01(`:@QT-D:2FG?0 MR_76_4O<@:*>0$"6BF#TH\7U;>7N#@SNB!%#"APUJDE'=S;$$$O.'0WL`3@@ M+%=V"*F6%_2D4E#1"(]&"#P0S`V/,A%782Y[^W?NM=!2M^^C"VH?'L!0FKMB M#!(2])P"*`FBQAJ.2#P8)K0(#E5I+)Q3U6&\/RW\,$S=P*2%%"WB]$QQ6C*L`X7`B*_+C\2QFW^D4 M\I5'&A5%4\E-^9VSX"!+M`%\=0++_A.1P!\[#4CA M*FT*TM%1:J1A+[7*^AHW**N?:76XU1^,#&XYS?0T%'CI81\TQ7%M`F:,*(DO ML_6#6]!Q@+JU>!@`M9X`)$V^33BM0=QA/D6@B,"/`;;/BB@OQP'->EO]8K/` M<*31TPE`?=Y!AZ7K39>UX%&T[-\1Z;<,#$)Z;9U0)&4?])+LAI11DI'X'D5R!H/R^6NT)*??$^C,5-6T-\N3 M-1WQ^[&J\OEC5)#3AYS4"TBQA^=TR>(5^!DQI.]]3=#TH[N[) M[7Y/T.*J@HFAJV8EQJ-"0G,6*7YY_7XW#7IO&BW2T5=ATDR?+V1Y3W+081$T MN%2L#8W/IU"E@F8986U_D.IE3-=]PA1#-P'WPXP9M3<&Z'\*N:TG1C'R!G'` M8=[!`Q2Z^T:M4"BE0Z!0H#L,%*J,,00*!7D(%'Z8-@HOR'U>1?DS)S"&(DR, MP*.,^#!`J37+$,B4"47`\X=IP_/_51FY>TQX?E7Y:(51#0<$4$$.AX%6G(&& M@"PH&8';'P/`[3=F,#?'LOGNT=:%5$6G],TC6I=8*S@*#HO MTFLH`D.2D0&<@*63A,#9QWWCS-=5K?N2/R>>TJ+*B28_3=U8\CRRK/%XYS[S M1Q)7*9DM;A]I7MZ1?,G[>-=^MET\`4*0B&=!2I+1/5`SA-1*=\#WY+(ZYT)* M&;9GWV/O^=Y$V8/J0*;WNWCLL/M]7!V4N]22%C(])O/MZ5N=8I0!L+WEUCGL M:',)%;U?HN_)LEHJQU[:1AA]H@Z2Y,@;)&TG>5V@W"A-_*)5]0`X2M.>S MN3&RYC"KGDY:N3:Y"LJ<4TCJ)I?+)&#\W3P_4^KP`8P"M*)R-'V+;:BSN(Z" M5TE&ZK=TH>T.96-QHP-H'!QX4%H[(@F2L7'5L'%UQZ0I]CN4;56HVK4-&U2` MSCXQM1,QG75&O?5>,.6N\V1>J\/,7,P6-VQ.P?Y2KF^Z\(?83XLSONG.OG-1 M.N,IVJSY&>MY[X;(`)S[Q[[NG,?'JSJHT2$M">%:VB7A8-B]*YLDG'V_M@UX MP=>*3YT]@M\+PS;F'1F&`G6?=K-#N&,/-E/0B0";ZWB9,0VJNA1[!6T>J=JU M82AO%PJZ$%K:@4;.>%,ZZ>U/>Z^"AH)#Z]C]$\GJBX-\\VH3X2](5%9YG?3# M.=W1?M4#OTQAH%DQ#1.5[O;S`6&K7B"V._YDXPM,Z#T=/POC=,D,F/Q1VW6V MV)R;\XT?9O%E4BV!E16:3BP.HJ<+`.*V5C!&L8&@L6XH^,L&VGGJ95%4438G MYVP^;!P@_4V1/VVOR#KFUC,Q=!H2!P=C")D[0Q<-FYW6YT_B:Y'-NQ`?< M!`+#0+V44C((%K4&=O&UT%)*#+HH:%?1W[*HV=$@L;"1`3]N:\%!B5H-AV!A M:V(93[C5B-S@->5L/VP M_Q3HA_TZIW-"XN*"F;\UA>$Z`T!#4/0?_(8I`H(:7G-KK"E%#),'.Q$@;FWS MB>8Y_<;KL>I2[/HMH02[=LN``*?7U!IH4M9!%V#NI0@JRV5J6NLR-2=3"E.G MA_[)5Y.+%8`TQ'.O)G=W@KM&VJDS6#Z2?/UO>7$40RK%DXQ2JI`@:68">U!J MY6`N^_B!Y10&!+H9C@N*V&$0;XR#W+UD<8]5&'L>S40^Q@ M0CV9#2QX9-`I\1$;D\[XFQB/5[]_M"BE+L-S4&67NAW211)-:Z6R4XH-FC&C MIAI;EU@"V8?OOP5=%;2@T7BO<'Q>KE+Z3,@MR9^2.:DO=GR*"L+"YW)%LJ)! MW,-#3AZBDNR&H?>2I>`%WO@*_N*!K[\;`X#T/.>WKOEWZ-/SK@E;G-3Y#M^B M/)[5:Y+B\_=5DO-DB#)/LB*9RQXJ&UY0^V;!0()&#V;^X$CW."1`R'169GNO M82`EK-?6PUSLJ56XUVMYK];R[X37V"3QZ1/)HP=R0_@ZE\TP^4236[6*4KX. M%O-[QNQ"S[7WV85#=?K1AG$_X6"?ZFUF@:#B]HOB!)N8\OND:4SV\Z M*.I0'7SP89G\=QU48_-EW_?5B8&^[%L]Q_RV6W?"Y]?=HA.'ZOXC#N7DO_`6 M"FZ^\>;/I$[R&_\K:[B7+[Q2D,_O.R#H4-U[X"&9_+<=4&)B#].Y!JJUEF-^ MURV[X/.K;MR%0W7ZT89Q\E]T8_4VW_,_!9I/Z+K%0?)Y4O`THVX$A:[U#2^P ME]4XG,##"@]['Z(A@\$^E-G,$8Q=?T7RA,:?L_B`W-]R:C&!G@P7,%[J1&,Z M@QI8B#&?=OQD?A?F("8>LZHLRBB+F7&01OLP4.1QZ(GGR&/5DV/D&6900X@\ M5EIN"Y.\-2^CM))ZN(]JM`T0C=D46FOW3C@D#3><.XM&NU5Q>U3 M?"&OPUPL5B>YU42CAAK+;O@.-<;=.(::`88SB%!CK.(ZU'P,M0:TEY/ZK:UL M`XF5$-,P82CDA08!EZ&8A(L;*A!TG6U78\"[W%[F!WZE>_9WM/1C(/`W>"%$ M"+1FVV=%+3[^T]IT=;)6;\8T6+@`)7D/#1))QS!@-RAAN+Q$BZ!+$+M:1++G M,I!;*R1Y=FNII*-;VPU*"&XMU6+SY,B+=.O6W$;ZENC@`LT'VL4EH*-US2$%+/X82?X,70@A!:V9=6OQ@IBA!Q`]U M^N4Q@DP\@HR79KG'&&+\ZF1(V9-X6PVZ<0'*&2XL'#[KGA M:`Z]CR_]T:7=AB1LI[:?_+1UY=_Q,<^CL]\3/J9#T_/!6U[,UNTNWM#4M97 MID%1%CUG*+3/"OGA*CX_Y,KU,(.S7V/O(P`[]_@@'E,JCP'V!038V_DCB:N4 M(5W>[=N2(7H]L3B=E\E34C[?\-^1N&7P/^+S,*VP[`%(*Q0=]W<^#P=@I97">7 M)5D6D(]Y8^QKYZ_%>'2O\N\`/K;Z(-,#;N5-"2\[>ZW.[^8ZH_G5';?<;'&9 MQ6PV%E=1>OH]@5Q%V59`/]#VL`&-,=`^,0KTQRF<0^^2\*G]939G?4F>R'4: M94S195(MKTG._Q@]R!\#PI-UWO_`D(V/-7_QC5K;"\*;<]]V+VU@^K3!W/YK M%ED`MG_QV(0$"]1I7`7>,TC1EWKW!-#V]=P3BT+&^P(G+WB*PV2[I1J*3*.EE':_IV?NWREY7^3\H;,Z4.6 M_$'B]NZ@RR:4+]DV&U7NL@_,'<<SGD3,J*URKS?YO6CR[7W8 MTZ*HEMO".63.;#G(*T)H@;XJYB,$'FA(V-L8[24.#*G-YN*&>6GI)Y+?TXGX MO]6>!N;V_%[J2IOWP'=):9,>''+(&&44]Q=#]J6>;4VJ28<4(^\W[B&[W!Y';!IS*'>E;$MC''*`^!M-&9LT*9_W'2+DDO<1)$3)QS#A:=3" M#12B6K9%_$(/%4UU@G4R2W%:E8\TYYO:O@.#3HZO,`#+.3J]U8A,V\5A)5[F MTSVRD'>3%+]?Y(1<9DPW4I3[^NZKY`[YU9?+/;J_EQ&;=CC`*V5;&SST[_W8 M!;9\!X`)E]>:F,.[E&#>OOS,5;Z_3TUA((_%YE3.EFV.C9M(C MM^6O.2W`FS2.[$3?M69WJ"[JQ[[[\43KOFX?N`O4J7IW+OZ>E(]UM0D>81Z3 MU1W]G+&A>#ZGRRB!#BPMN>@NX>BXC.XYZALTJJLV1@8"?$`J77FA1B=UB*LV MFXS#+T0RPU*T:">#BRVF-_#(\:08E;'#K9:Y3>L694W@&A_7D)]0E%)0:%H) M4:/7*F1PX%3W!Q!0GA@)QJI.,2\H':TXQ67&.D-NF4[UE$)3+S)*U*<"\<227>3M!1C>[$NM&DMB8`G!>0U\G= MU\FQ3069Q&[O5U(V-KB"UVS2-@*TA#8A`4FEGCUL!*[6CWOR6R"C@X1F=$7X M.\2\PBA7BA]E9@71Q&8TG0@F/5U0`#,T@P/H])*"?CQZME%NK9:N'I6VO0`\ M1?N0`(=5VQYH"@E!'W[>D">2503Z$HH_"_#9_1P26@"E[,&Q8QCT'6;A9D3G MN+]U"(";L+LQ$W!FRRPD5'HQF#V&;<7;GNT.4R+BURC)^/QSUE35/"?WY>?O M\T>^6R_;$D0T;^\/*IN/CC7\K(L:JP_@2BMRNSNH%&6;.CR)J,E5N*0/LZ\M M\29_;&T'<"MT*B^T0]$D[IY M#U90\U#QA5+?#]`@44'OI8`V,-TM-MTE#A5R6`/XP)Q"ENUUI$D<5L;IY;R\9:AXFVI#J M^X`;+"KHPZ_3^'^J9IK`%N2G2YJ7R1]1NPR+`#AM>P%QBO:C0TY_HD7-%0>P M!LIJ8TPA(^A##UYD]0R! MS1'!YH:$!C*=HBZ`DO"VWG"=PC+RAIF"#<,C/]IEX3JE]2ZR>O\"1=.;Y2MI MP@*8B0%EU1D/P)G.<84$*64%&.'A8P(TQ=S`$FDX%RQ4,>K;RP M5X0;#?].\]\OL^N%_,\J:LPS18*59HW MM$YCNH*O:SCQZF4H6_$:/6SYQ!GU:UKHE-B]Q]UL:*N>AC]3RE?E>&O[NG0& MKQZ5E\]W>905;%0:[;I5KWJ[KSBRW@:LCFR\\_X&;L5U],S?[&[U-"'%697G M<**Z":F8!8`B'3TXH8>;.ED%"#0ZZ9U,`914VY7_1`J:`08Y7=:JSQ:MOYGY MKXH#SI7E'(($L+V-/.#82'C0.3"`IL6GY_8O[:)S."PK&."@+&4P"3,IZQ3" M#15J3Z;:H,5@`BYK4F40+Q7R42_5!3TEE3TF9'&19!&;;$?I;+%(YB17%J%# M4(@)9RJ*28$(KC^'UQJ!FGZY.27[8WW"24#`J@2A>MBU508G](G5;'UAR9"? MTPEL6MW.'TE<\8NKN(A_Q]<04/J'"R\Q&\2.UZ2\3(D0ZM=NAI]Q:>:(73<@ M;QZCI+F3(?4+'6@S!ZI6;M,=Q)*GU0WHJWF`QM>O7O8\#-(.3:6";KXJI[:# M^O(^KE#7\(?1%AR0YIGF4;7-Y]/>1AX^FD;"PS^9*83GX<]?4T04/%/K*RK^P/-6Y"NIYFJZY"`RP^5045NYI*)JJ%9W*CH1VN*B1 MMI`#`%(Z/B#E/J7]`Y7ZJE!AL!B5B%#&B-`6R?ZYN&@ M`J>Q+3!`[KN;7%/!AFY:H6ZM":L3FEK8`<-SP("8;^+JVS]/IAKO130G3;X& MF/:J;JZLO=MN/C5L](,!6&D7U!H'D"M9[@PL(>A$F:Y:K859\\^"&>HZ3^;D M!`4W!+T2?TKZ@`&)MXLWA"I%VMY(1GMV$-R%(LD72+: M-,P%;E0CO0%OL-YF-2QA*OD-\_MB=3+>4>3FZ:;9+I_UFA9)#1C-[KD!J>CJ M*-(Q[XM5RZH^#C\G;-19]WC/V+]34G=Q1I=+VKS:=1WEL[Q99?PM2BNR>2$:S`Y` M4_9R!!"4P<+>W"Z>$(T2'/1C;"T-:W6*RZ*HP*('FM8P*+NM#P&("OW]@Z\K M;`VXCXRU"-OFG[6Q8U,V0VA4Z*NBP$L^$RJ99?">Y(%L5! MN:VKX1`L;NWMY`G&1AW8G$2\_1!F<7U>Q+0D];,!E\QTV0,_*FP>$&BM$Q&/ MU-@S$E!NPRA8L#M;S1/F;?H1]"'<]:;+-AL`9L3]"^THXF`Q;64=3SC&R@[Z M_;"NDHC]`#V!$J,'LBN`ML(@6)3N#80Y9Y`IIMT>P!$A<'@0FP1&UA@0CY*M M@C"?6Y$II]\M0%(A4'D8>P9F]A@0E[*=`_,'J"9SVS>AQ8A'[,RJCS1E-BSX MV5WYS&];:@_7,42]8W4UT7@I0]*.X8L'&-.C##/-P@'(D:?NU@'#AZH#G>P: MO&!_:]7Q"@:,%T%>^+760AL?=.TU*D_*_^UON8)Z^[OJ6NRY",CZ%_X_]U%! MV%_^%U!+`P04````"`#N@6Q%TE.-+)P+``#8=@``$0`<`&9L>'0M,C`Q-#`Y M,S`N>'-D550)``/PS6-4\,UC5'5X"P`!!"4.```$.0$``.U<7W/B.!)_OZK[ M#CZ>9JN.$)+,S"8UF2U"(,L=`0ZM6J]66\NFW]=(Q[C$7A-'+6O/HN&9@:C&;T/EES15U)"Q":H:0 MB-K(811?UAZQJ/WV^>]_^_2/>KW-,9+8-J:/Q@V;S8S)`CL.?ORG,6(/F'L- MO7%O8K01GS):KRN^M;`OA+7`2V3`Z%1'HX?3(\;G MC>;Y^7E#M]9\4F$G$9X<'S<;?]SV)[K;+3'))ZX3JK2SL,\5$V8]Y8[/>-I0 MS5,DGLA5JRV?&(+$[QM>HT_*\2RUXP\-:/4)*:/472;3VI(WY.,*-X"H#E28 M$^N)+Y\IPH#GRGZI4ITW.'.`RR,+JDPR((HBNG8RB/_H!\P[<]8R1#MS\'K% M")5'%EL"0_/L^/STV">W,0D#+[!U-&?W#6C0Q/7C9OVTZ9.#/\\16CVQS)"8 M:D$V#2$6)"4G4U?B+N/+:SQ#K@.BN?0O%SED1A0:V,%+3&6((-`L$9]C.4!+ M+%;(PD7T@NEA&'J"($J91!*FI7[GOUVM")VQS2MXJ;SQPG?),9X9>K9<*%M? MU@19KAQE!?UNH=U/(5SWQ_MSQ?$18..3*&-GF$K[`K`(4%J+UM\.['>!N!7K M)3:;H1.VPEP2+`+SJ?%B:EG(V54M8+%QES5XND=;(1AJ62V!L5]>-3OW[/6XM\AF7(J!O7S')5 M%`G^A,76Z%!))*R>,-WY4OOEIT:TAVCGKL#VD'[6OZ/S=,.](!/A7\5P7^59X#3?0Q@O!LA#O0++`F`]$MED!2#",:" M]E"/V>8X*V:.B0E_;CL#,,6P:PQ'G7'+[`%!98A40UBSL"7@.=L4[_JLS$9;#A,NQLLO=[6UK_$TA/NG=#'K= M7KLU,(U6NSV\&YB]P8TQ`@.U>YW*#*EF"!LASP0G,1.8P_:_(?2HN&.,8'6H MH$Z!.IB*9N>A3;T)(,+PE(WQ60SCR>1.9S-U!E6"EQ$X0EDVS5QCL339T*]>R98$=G@IV)_-GQLVHJQKMK M+!%Q*J-D&X7$S4+R#1.OM.QDF*DT>E1(KK]?B5\J6Q4(6S1L*/6<;:73A.F3 M$+H&B',`XAY79BAB!I@B#$5,L7F79XX"Y4GCG3IF9+L.-MC,F$AF?3>&*]6# MT;+`2$0^5F;*+[8%[9,;S1)2KD!!LT*[0&G3#M*Y1=`@X$X>WA_C>&\+H178 M!4JB=K@FF@?XKW'`,\NBE0WR2W6A5!/G6*!YG+1ECI3K?@K4/S6B!Z`W;\(' MI?4Q:;)<,2X-FGCT.NTXOW/*F?-H_6*FUJ%!`C M^9)`00%\!C7R^^)CIEPX*#BHIE8C?J@?G]1//NXY;O+EA2(R!#D''J,2YUQ! MW_SP;''V$^6EY$BX:5%$$(?S$->+"!*\OK';E/#Y]IH2J1=#BLO@[#\7T^Z- MI`R>R*-^U+?,Q27(O(:2)4$B8P,[4OAOLN39W%[1`EW66K:MPS)RVFA%)'+& MB$!8[E'+<=5ML)9E<5<]2PRKAC07G+GS14\(5YE\..LSH*'V9`$ZFI@O!TQB M8;(Q=I1GCI`^<;]=^?[\0>-YUQ#TA:6+):.P3/+'GL1+M;``N.Y42")=)<@- M#+#R20F0U`Q*'$=]!KBL29"E9B"@YLB2H`)R]`TP33Q%CI+ILF9Q#$KYKU<0 M&YAM:@%LEVO[91B@S98@H"X031:(XPG(9G$RQ?:5*^\H`&G\@DAYH5AF`*5*]EO= MO%]2S3>_B-^"%VB.(_J/-L('$'IV3S\6F@).Y-_#@?CBW<()7,)I;48(`E"( M/#B%E.?0^0MHZ3WOI61GN7+8(\:W>#G%/*!.M&%C'GTE]<)F2T3H&TN^7F$J ML!@A8E\!V!!V(1'O^:Y'8#RU&HS0HQHZJ-F.C`<3]4`QXA$-9U_5UQ\JQ="5 M^M8V.%H8@FS*`])9@L`N$0OU0"Y#_8EOMEIFK-*.WS-:W<2,F%DG. M\2+]'0Q^-S"/^TP(%;Z[D$22>TRQ"*9HJ10'I^.0;A>?X2QH,),%DJ0$W0MS M'B`F6G)EW,[:6B`ZQXGZ)U`=3E+=AXVQ,\%2>F]52J8$#7IY.DG95NR(I+&% M.Z6]=.MW1$XS$HB3F_J3?I:Z@3R?/.!QP4(RN['J1=1&MPE2ETPG6+#;WSE$,9X'R5'Z9:V?.@REL1%:R MIT^%"9,RG[2$%D\4.2FKR21H[[%-Z/(_\B10WO$#3)OO$]\KO=U&9]A(E_1OU-'^&D\_`F! M-_#Q/<;^/_3R&_4Q\A5]/*7_G\;#-_J_@7_O/'(9O5NG4E254;55%/I\5HBZ9/79+)G#Y\IR*0_"?LK7,I7R"$JKRR:MCWSF2&@K[T>. MD+"QTGEB:_FV+D$I824?8PD)JW>&)%@[C6W3=F4LM^8]>@_;3J6%=RU$3#"_ M)Q86)@1_`4.I@D/"5OPYG1P^(DG;]^=T4FY$HE_ZDQK+^YT_+"V#K$6XCEI3 M=_'P?+Z2FS!9?G/!$TZ2[LQYF+KGS>%\OO+JC6U8F39W,?H$38E#(AE3KEMCZU[7THC!]WCS4'M"&QSYIB_<7JXN5"CCB>ZE'@7AP1DMC$OS2,L MG5NF?*2`Z'ERW#R-ZU>(_%"TA'BQBY81\D/1LHNGW(4`H2ZN%54UB>=0]/V7 MJ[WQ+"ES*,YR:-HFK9G%60Y)6_,!R';RYF2N@])Y0?@>.L>X#DYG@N5B+[6C MC`>EN?+5O31/8BR=YN&L+Z#.%:9X1BRB$BC_BD@7J_.JVYC%(+U*S2#WZNN' M)M//NGLQQ@(C;BU:U+[&]]AA*]4XXLQV+2GZ_7;2P85B'*5SDBYSN7;OF$ZQ MEM+)K@\./IH+Y@H$P*NCGUKB^,70',*WU,S[7S#>/TN`Q_\!4$L!`AX#%``` M``@`[H%L1:VA]$W.3P``8LH#`!$`&````````0```*2!`````&9L>'0M,C`Q M-#`Y,S`N>&UL550%``/PS6-4=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` M[H%L1;]%^"M.#````:@``!4`&````````0```*2!&5```&9L>'0M,C`Q-#`Y M,S!?8V%L+GAM;%54!0`#\,UC5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`.Z!;$57#AS>+18``.Q]`0`5`!@```````$```"D@;9<``!F;'AT+3(P,30P M.3,P7V1E9BYX;6Q55`4``_#-8U1U>`L``00E#@``!#D!``!02P$"'@,4```` M"`#N@6Q%PWD!D:1Y``!Y%P@`%0`8```````!````I($R&UL550%``/PS6-4=7@+``$$)0X```0Y`0``4$L!`AX#%``` M``@`[H%L1:BH5`Z,,P``S*D#`!4`&````````0```*2!)>T``&9L>'0M,C`Q M-#`Y,S!?<')E+GAM;%54!0`#\,UC5'5X"P`!!"4.```$.0$``%!+`0(>`Q0` M```(`.Z!;$724XTLG`L``-AV```1`!@```````$```"D@0`A`0!F;'AT+3(P M,30P.3,P+GAS9%54!0`#\,UC5'5X"P`!!"4.```$.0$``%!+!08`````!@`& +`!H"``#G+`$````` ` end XML 18 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
Sep. 30, 2014
Dec. 31, 2013
Current Assets    
Cash and cash equivalents $ 25,766 $ 35,221
Accounts receivable 71,989 6,425
Notes Receivable 25,000 25,000
Inventory 7,433 6,584
Deposits and prepaid expenses 11,874 11,830
Total Current Assets 142,062 85,060
Long-Term Deposits 6,550 6,550
Property and Equipment, net of accumulated depreciation of $583,636 and $527,106 2,757 59,378
Patents and Proprietary Technology, net of accumulated amortization of $665,755 and $587,496 304,459 373,489
Goodwill 4,896,917 4,896,917
Total Assets 5,352,745 5,421,394
Current Liabilities    
Accounts payable 218,180 212,142
Accounts payable - related party 319 6,056
Accrued liabilities 433,077 206,822
Deferred revenue    10,000
Convertible notes payable, net of discount of $58,942 and $4,653 826,058 520,347
Convertible notes payable to related party 40,000 40,000
Total Current Liabilities 1,517,634 995,367
Stockholders' Equity    
Preferred stock - $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding      
Common stock - $0.001 par value; 100,000,000 shares authorized; 53,377,114 shares and 53,377,114 shares issued and outstanding 53,377 53,377
Additional paid-in capital 24,918,928 24,780,929
Accumulated deficit (21,137,194) (20,408,279)
Total Stockholders' Equity 3,835,111 4,426,027
Total Liabilities and Stockholders' Equity $ 5,352,745 $ 5,421,394